TW200814928A - Fungicidal active compound combinations - Google Patents
Fungicidal active compound combinations Download PDFInfo
- Publication number
- TW200814928A TW200814928A TW96110022A TW96110022A TW200814928A TW 200814928 A TW200814928 A TW 200814928A TW 96110022 A TW96110022 A TW 96110022A TW 96110022 A TW96110022 A TW 96110022A TW 200814928 A TW200814928 A TW 200814928A
- Authority
- TW
- Taiwan
- Prior art keywords
- methyl
- group
- phenyl
- formula
- trifluoromethyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 358
- 230000000855 fungicidal effect Effects 0.000 title claims abstract description 15
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 218
- 239000000126 substance Substances 0.000 claims description 205
- -1 benzylidene, phenoxy Chemical group 0.000 claims description 180
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 132
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 121
- 241000196324 Embryophyta Species 0.000 claims description 101
- 150000003857 carboxamides Chemical class 0.000 claims description 79
- 239000001257 hydrogen Substances 0.000 claims description 72
- 229910052739 hydrogen Inorganic materials 0.000 claims description 72
- 150000001412 amines Chemical class 0.000 claims description 57
- 239000000460 chlorine Substances 0.000 claims description 55
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 55
- 239000011737 fluorine Chemical group 0.000 claims description 51
- 229910052731 fluorine Chemical group 0.000 claims description 51
- 229910052801 chlorine Inorganic materials 0.000 claims description 50
- 238000012360 testing method Methods 0.000 claims description 50
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical group [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 48
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 47
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 40
- 239000007789 gas Substances 0.000 claims description 40
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 39
- 230000000694 effects Effects 0.000 claims description 29
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 26
- 125000000217 alkyl group Chemical group 0.000 claims description 26
- 229910052736 halogen Inorganic materials 0.000 claims description 24
- 150000002367 halogens Chemical class 0.000 claims description 24
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 23
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 22
- 241000233866 Fungi Species 0.000 claims description 22
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 17
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 17
- 229910052794 bromium Inorganic materials 0.000 claims description 17
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 16
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 15
- WRPIRSINYZBGPK-UHFFFAOYSA-N quinoxyfen Chemical compound C1=CC(F)=CC=C1OC1=CC=NC2=CC(Cl)=CC(Cl)=C12 WRPIRSINYZBGPK-UHFFFAOYSA-N 0.000 claims description 15
- ZVXKYWHJBYIYNI-UHFFFAOYSA-N 1h-pyrazole-4-carboxamide Chemical compound NC(=O)C=1C=NNC=1 ZVXKYWHJBYIYNI-UHFFFAOYSA-N 0.000 claims description 14
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 14
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 claims description 13
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 13
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 claims description 13
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 13
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 claims description 13
- 239000005766 Dodine Substances 0.000 claims description 12
- 239000004202 carbamide Substances 0.000 claims description 12
- 235000013877 carbamide Nutrition 0.000 claims description 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 12
- 239000011701 zinc Substances 0.000 claims description 12
- 239000005868 Metconazole Substances 0.000 claims description 11
- 239000005831 Quinoxyfen Substances 0.000 claims description 11
- 239000005837 Spiroxamine Substances 0.000 claims description 11
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 claims description 11
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 claims description 11
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 claims description 11
- IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical compound C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 claims description 10
- 239000005747 Chlorothalonil Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- IQGKIPDJXCAMSM-UHFFFAOYSA-N triazoxide Chemical compound N=1C2=CC=C(Cl)C=C2[N+]([O-])=NC=1N1C=CN=C1 IQGKIPDJXCAMSM-UHFFFAOYSA-N 0.000 claims description 10
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 claims description 9
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 claims description 9
- 239000005752 Copper oxychloride Substances 0.000 claims description 9
- 239000005802 Mancozeb Substances 0.000 claims description 9
- 239000005810 Metrafenone Substances 0.000 claims description 9
- 239000005847 Triazoxide Substances 0.000 claims description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 125000001246 bromo group Chemical group Br* 0.000 claims description 9
- LMVPQMGRYSRMIW-KRWDZBQOSA-N fenamidone Chemical compound O=C([C@@](C)(N=C1SC)C=2C=CC=CC=2)N1NC1=CC=CC=C1 LMVPQMGRYSRMIW-KRWDZBQOSA-N 0.000 claims description 9
- 239000000417 fungicide Substances 0.000 claims description 9
- RONFGUROBZGJKP-UHFFFAOYSA-N iminoctadine Chemical compound NC(N)=NCCCCCCCCNCCCCCCCCN=C(N)N RONFGUROBZGJKP-UHFFFAOYSA-N 0.000 claims description 9
- 125000001041 indolyl group Chemical group 0.000 claims description 9
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 9
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 claims description 8
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 claims description 8
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 claims description 8
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 8
- 239000005774 Fenamidone Substances 0.000 claims description 8
- 239000005797 Iprovalicarb Substances 0.000 claims description 8
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 8
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 8
- 239000005825 Prothioconazole Substances 0.000 claims description 8
- 239000005839 Tebuconazole Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 150000001408 amides Chemical class 0.000 claims description 8
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 8
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 claims description 8
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 claims description 8
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 claims description 8
- OGYFATSSENRIKG-UHFFFAOYSA-N pencycuron Chemical compound C1=CC(Cl)=CC=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCC1 OGYFATSSENRIKG-UHFFFAOYSA-N 0.000 claims description 8
- 235000009566 rice Nutrition 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 230000009261 transgenic effect Effects 0.000 claims description 8
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 claims description 8
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 claims description 8
- XERJKGMBORTKEO-VZUCSPMQSA-N (1e)-2-(ethylcarbamoylamino)-n-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 claims description 7
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 claims description 7
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 claims description 7
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 claims description 7
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 claims description 7
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 7
- 239000005745 Captan Substances 0.000 claims description 7
- 239000005756 Cymoxanil Substances 0.000 claims description 7
- 239000005772 Famoxadone Substances 0.000 claims description 7
- 239000005776 Fenhexamid Substances 0.000 claims description 7
- 239000005778 Fenpropimorph Substances 0.000 claims description 7
- 239000005780 Fluazinam Substances 0.000 claims description 7
- 239000005781 Fludioxonil Substances 0.000 claims description 7
- 239000005784 Fluoxastrobin Substances 0.000 claims description 7
- 239000005814 Pencycuron Substances 0.000 claims description 7
- 239000005816 Penthiopyrad Substances 0.000 claims description 7
- 239000005820 Prochloraz Substances 0.000 claims description 7
- 239000005823 Propineb Substances 0.000 claims description 7
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 7
- 239000005846 Triadimenol Substances 0.000 claims description 7
- 239000005857 Trifloxystrobin Substances 0.000 claims description 7
- 239000011717 all-trans-retinol Substances 0.000 claims description 7
- 235000019169 all-trans-retinol Nutrition 0.000 claims description 7
- 229940117949 captan Drugs 0.000 claims description 7
- 239000012990 dithiocarbamate Substances 0.000 claims description 7
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 claims description 7
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 claims description 7
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 claims description 7
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 claims description 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 7
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 claims description 7
- 150000002576 ketones Chemical class 0.000 claims description 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 7
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 claims description 7
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 claims description 7
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 claims description 7
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical compound COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 claims description 7
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 claims description 7
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 claims description 7
- 150000003852 triazoles Chemical class 0.000 claims description 7
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 claims description 6
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 claims description 6
- 239000005757 Cyproconazole Substances 0.000 claims description 6
- 239000005867 Iprodione Substances 0.000 claims description 6
- 239000005818 Picoxystrobin Substances 0.000 claims description 6
- 239000005822 Propiconazole Substances 0.000 claims description 6
- 239000005828 Pyrimethanil Substances 0.000 claims description 6
- 239000005842 Thiophanate-methyl Substances 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- 125000004429 atom Chemical group 0.000 claims description 6
- RXDMAYSSBPYBFW-UHFFFAOYSA-N carpropamid Chemical compound C=1C=C(Cl)C=CC=1C(C)NC(=O)C1(CC)C(C)C1(Cl)Cl RXDMAYSSBPYBFW-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- WURGXGVFSMYFCG-UHFFFAOYSA-N dichlofluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=CC=C1 WURGXGVFSMYFCG-UHFFFAOYSA-N 0.000 claims description 6
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 claims description 6
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 claims description 6
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 claims description 6
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 claims description 6
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 claims description 6
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 claims description 6
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 claims description 6
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 claims description 6
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 claims description 6
- JRPGMCRJPQJYPE-UHFFFAOYSA-N zinc;carbanide Chemical compound [CH3-].[CH3-].[Zn+2] JRPGMCRJPQJYPE-UHFFFAOYSA-N 0.000 claims description 6
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 claims description 5
- XAYMVFWOJIOUTA-UHFFFAOYSA-N 2-[8-[8-(diaminomethylideneamino)octylamino]octyl]guanidine;2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O.NC(N)=NCCCCCCCCNCCCCCCCCN=C(N)N XAYMVFWOJIOUTA-UHFFFAOYSA-N 0.000 claims description 5
- 239000005964 Acibenzolar-S-methyl Substances 0.000 claims description 5
- 239000005734 Benalaxyl Substances 0.000 claims description 5
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 claims description 5
- 239000005750 Copper hydroxide Substances 0.000 claims description 5
- 239000005754 Cyazofamid Substances 0.000 claims description 5
- 239000005758 Cyprodinil Substances 0.000 claims description 5
- 239000005761 Dimethomorph Substances 0.000 claims description 5
- 239000005762 Dimoxystrobin Substances 0.000 claims description 5
- 239000005764 Dithianon Substances 0.000 claims description 5
- 239000005785 Fluquinconazole Substances 0.000 claims description 5
- 239000005789 Folpet Substances 0.000 claims description 5
- 239000005790 Fosetyl Substances 0.000 claims description 5
- 239000005869 Pyraclostrobin Substances 0.000 claims description 5
- 239000005843 Thiram Substances 0.000 claims description 5
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 claims description 5
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 claims description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 5
- 239000006013 carbendazim Substances 0.000 claims description 5
- 229910001956 copper hydroxide Inorganic materials 0.000 claims description 5
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 claims description 5
- 125000006317 cyclopropyl amino group Chemical group 0.000 claims description 5
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 claims description 5
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 claims description 5
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 claims description 5
- 125000001153 fluoro group Chemical group F* 0.000 claims description 5
- 244000053095 fungal pathogen Species 0.000 claims description 5
- 125000001188 haloalkyl group Chemical group 0.000 claims description 5
- 150000002460 imidazoles Chemical class 0.000 claims description 5
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 claims description 5
- 229920000940 maneb Polymers 0.000 claims description 5
- 239000011572 manganese Substances 0.000 claims description 5
- CJPQIRJHIZUAQP-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)alaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-UHFFFAOYSA-N 0.000 claims description 5
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 claims description 5
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 claims description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 5
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical class NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 5
- 229960002447 thiram Drugs 0.000 claims description 5
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 claims description 4
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 claims description 4
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 claims description 4
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 claims description 4
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 claims description 4
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 claims description 4
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 claims description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical group [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 4
- 239000005730 Azoxystrobin Substances 0.000 claims description 4
- 239000005736 Benthiavalicarb Substances 0.000 claims description 4
- URDNHJIVMYZFRT-UHFFFAOYSA-N Diclobutrazol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)CC1=CC=C(Cl)C=C1Cl URDNHJIVMYZFRT-UHFFFAOYSA-N 0.000 claims description 4
- 239000005759 Diethofencarb Substances 0.000 claims description 4
- 239000005760 Difenoconazole Substances 0.000 claims description 4
- 239000005767 Epoxiconazole Substances 0.000 claims description 4
- 239000005775 Fenbuconazole Substances 0.000 claims description 4
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 4
- 239000005805 Mepanipyrim Substances 0.000 claims description 4
- 239000005809 Metiram Substances 0.000 claims description 4
- 239000005811 Myclobutanil Substances 0.000 claims description 4
- 239000005813 Penconazole Substances 0.000 claims description 4
- 239000005821 Propamocarb Substances 0.000 claims description 4
- MKIMSXGUTQTKJU-UHFFFAOYSA-N Propamocarb hydrochloride Chemical compound [Cl-].CCCOC(=O)NCCC[NH+](C)C MKIMSXGUTQTKJU-UHFFFAOYSA-N 0.000 claims description 4
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 4
- 239000005840 Tetraconazole Substances 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- VVSLYIKSEBPRSN-PELKAZGASA-N benthiavalicarb Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@@H](NC(O)=O)C(C)C)=NC2=C1 VVSLYIKSEBPRSN-PELKAZGASA-N 0.000 claims description 4
- JHRWWRDRBPCWTF-OLQVQODUSA-N captafol Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 claims description 4
- 229960005286 carbaryl Drugs 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 4
- LNJNFVJKDJYTEU-UHFFFAOYSA-N diethofencarb Chemical compound CCOC1=CC=C(NC(=O)OC(C)C)C=C1OCC LNJNFVJKDJYTEU-UHFFFAOYSA-N 0.000 claims description 4
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 4
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 229910052748 manganese Inorganic materials 0.000 claims description 4
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 claims description 4
- CIEXPHRYOLIQQD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-2-furoylalaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)C1=CC=CO1 CIEXPHRYOLIQQD-UHFFFAOYSA-N 0.000 claims description 4
- 229920000257 metiram Polymers 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- WBTYBAGIHOISOQ-UHFFFAOYSA-N pent-4-en-1-yl 2-[(2-furylmethyl)(imidazol-1-ylcarbonyl)amino]butanoate Chemical compound C1=CN=CN1C(=O)N(C(CC)C(=O)OCCCC=C)CC1=CC=CO1 WBTYBAGIHOISOQ-UHFFFAOYSA-N 0.000 claims description 4
- 230000003032 phytopathogenic effect Effects 0.000 claims description 4
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 claims description 4
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical group COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 claims description 4
- HYVWIQDYBVKITD-UHFFFAOYSA-N tolylfluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=C(C)C=C1 HYVWIQDYBVKITD-UHFFFAOYSA-N 0.000 claims description 4
- 125000004784 trichloromethoxy group Chemical group ClC(O*)(Cl)Cl 0.000 claims description 4
- YNWVFADWVLCOPU-MAUPQMMJSA-N uniconazole P Chemical compound C1=NC=NN1/C([C@@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MAUPQMMJSA-N 0.000 claims description 4
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 claims description 3
- 125000006677 (C1-C3) haloalkoxy group Chemical group 0.000 claims description 3
- ULCWZQJLFZEXCS-UHFFFAOYSA-N 1-[[2-(2,4-dichlorophenyl)-5-(2,2,2-trifluoroethoxy)oxolan-2-yl]methyl]-1,2,4-triazole Chemical compound O1C(OCC(F)(F)F)CCC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 ULCWZQJLFZEXCS-UHFFFAOYSA-N 0.000 claims description 3
- WOHLSTOWRAOMSG-UHFFFAOYSA-N 2,3-dihydro-1,3-benzothiazole Chemical compound C1=CC=C2SCNC2=C1 WOHLSTOWRAOMSG-UHFFFAOYSA-N 0.000 claims description 3
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 claims description 3
- OILIYWFQRJOPAI-UHFFFAOYSA-N 2-(2-chlorophenyl)-1h-benzimidazole Chemical compound ClC1=CC=CC=C1C1=NC2=CC=CC=C2N1 OILIYWFQRJOPAI-UHFFFAOYSA-N 0.000 claims description 3
- YABFPHSQTSFWQB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(O)(C[Si](C)(C)C)CN1C=NC=N1 YABFPHSQTSFWQB-UHFFFAOYSA-N 0.000 claims description 3
- GTKIGDZXPDCIKR-UHFFFAOYSA-N 2-phenylbenzamide Chemical compound NC(=O)C1=CC=CC=C1C1=CC=CC=C1 GTKIGDZXPDCIKR-UHFFFAOYSA-N 0.000 claims description 3
- OVFHHJZHXHZIHT-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)quinazolin-4-one Chemical compound ClC1=CC(Cl)=CC=C1N1C(=O)C2=CC=CC=C2N=C1N1N=CN=C1 OVFHHJZHXHZIHT-UHFFFAOYSA-N 0.000 claims description 3
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 claims description 3
- 239000005765 Dodemorph Substances 0.000 claims description 3
- 239000005796 Ipconazole Substances 0.000 claims description 3
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 claims description 3
- 241001460678 Napo <wasp> Species 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 3
- 239000005859 Triticonazole Substances 0.000 claims description 3
- 239000005870 Ziram Substances 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 claims description 3
- 229950000294 azaconazole Drugs 0.000 claims description 3
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 claims description 3
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 claims description 3
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 claims description 3
- JMXKCYUTURMERF-UHFFFAOYSA-N dodemorph Chemical compound C1C(C)OC(C)CN1C1CCCCCCCCCCC1 JMXKCYUTURMERF-UHFFFAOYSA-N 0.000 claims description 3
- HASJWDPFBRPJNC-UHFFFAOYSA-N ethyl 4-[(4-ethoxycarbonylanilino)methylamino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NCNC1=CC=C(C(=O)OCC)C=C1 HASJWDPFBRPJNC-UHFFFAOYSA-N 0.000 claims description 3
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 claims description 3
- GOWLARCWZRESHU-AQTBWJFISA-N ferimzone Chemical compound C=1C=CC=C(C)C=1C(/C)=N\NC1=NC(C)=CC(C)=N1 GOWLARCWZRESHU-AQTBWJFISA-N 0.000 claims description 3
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 claims description 3
- 125000002541 furyl group Chemical group 0.000 claims description 3
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 claims description 3
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 claims description 3
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 claims description 3
- 125000004043 oxo group Chemical group O=* 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 3
- 229960002132 pyrrolnitrin Drugs 0.000 claims description 3
- 239000004308 thiabendazole Substances 0.000 claims description 3
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 claims description 3
- 235000010296 thiabendazole Nutrition 0.000 claims description 3
- 229960004546 thiabendazole Drugs 0.000 claims description 3
- WOSNCVAPUOFXEH-UHFFFAOYSA-N thifluzamide Chemical compound S1C(C)=NC(C(F)(F)F)=C1C(=O)NC1=C(Br)C=C(OC(F)(F)F)C=C1Br WOSNCVAPUOFXEH-UHFFFAOYSA-N 0.000 claims description 3
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 claims description 3
- SOIIHESTBYNJRH-PMPSAXMXSA-N (3r,6r,8as)-6-(benzylsulfonylamino)-n-[3-(diaminomethylideneamino)propyl]-5-oxo-2,3,6,7,8,8a-hexahydro-[1,3]thiazolo[3,2-a]pyridine-3-carboxamide Chemical compound N([C@@H]1CC[C@@H]2SC[C@H](N2C1=O)C(=O)NCCCN=C(N)N)S(=O)(=O)CC1=CC=CC=C1 SOIIHESTBYNJRH-PMPSAXMXSA-N 0.000 claims description 2
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 claims description 2
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 claims description 2
- GKVQZPHJTZNANS-UHFFFAOYSA-N 2-ethoxy-6-iodo-3-propylchromen-4-one Chemical compound C1=C(I)C=C2C(=O)C(CCC)=C(OCC)OC2=C1 GKVQZPHJTZNANS-UHFFFAOYSA-N 0.000 claims description 2
- JKKOLPWDKQDVJE-UHFFFAOYSA-N 3-[(3-fluoro-4-methoxyphenyl)methylamino]-6-(trifluoromethyl)quinoxaline-2-carboxylic acid Chemical compound C1=C(F)C(OC)=CC=C1CNC1=NC2=CC(C(F)(F)F)=CC=C2N=C1C(O)=O JKKOLPWDKQDVJE-UHFFFAOYSA-N 0.000 claims description 2
- NUTKUZBTFOZHPW-UHFFFAOYSA-N 6-iodo-2-propoxy-3-propylchromen-4-one Chemical compound C1=C(I)C=C2C(=O)C(CCC)=C(OCCC)OC2=C1 NUTKUZBTFOZHPW-UHFFFAOYSA-N 0.000 claims description 2
- 241000238876 Acari Species 0.000 claims description 2
- 239000005741 Bromuconazole Substances 0.000 claims description 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 2
- ZOUTYVWHWSUKPL-RNCFNFMXSA-N C[C@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O Chemical compound C[C@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O ZOUTYVWHWSUKPL-RNCFNFMXSA-N 0.000 claims description 2
- 239000005746 Carboxin Substances 0.000 claims description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000005787 Flutriafol Substances 0.000 claims description 2
- 239000005791 Fuberidazole Substances 0.000 claims description 2
- FKWDSATZSMJRLC-UHFFFAOYSA-N Iminoctadine acetate Chemical compound CC([O-])=O.CC([O-])=O.CC([O-])=O.NC([NH3+])=NCCCCCCCC[NH2+]CCCCCCCCN=C(N)[NH3+] FKWDSATZSMJRLC-UHFFFAOYSA-N 0.000 claims description 2
- 241001529936 Murinae Species 0.000 claims description 2
- IUOKJNROJISWRO-UHFFFAOYSA-N N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide Chemical compound CC(C)C(C)(C#N)NC(=O)C(C)OC1=CC=C(Cl)C=C1Cl IUOKJNROJISWRO-UHFFFAOYSA-N 0.000 claims description 2
- DSODRWWHAUGSGD-UHFFFAOYSA-N [5-(carbamimidoylsulfanylmethyl)thiophen-2-yl]methyl carbamimidothioate;dihydrochloride Chemical compound Cl.Cl.NC(=N)SCC1=CC=C(CSC(N)=N)S1 DSODRWWHAUGSGD-UHFFFAOYSA-N 0.000 claims description 2
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 claims description 2
- 125000004450 alkenylene group Chemical group 0.000 claims description 2
- 150000008059 anilinopyrimidines Chemical class 0.000 claims description 2
- 229910052786 argon Inorganic materials 0.000 claims description 2
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000000068 chlorophenyl group Chemical group 0.000 claims description 2
- 125000004802 cyanophenyl group Chemical group 0.000 claims description 2
- 125000006450 cyclopropyl cyclopropyl group Chemical group 0.000 claims description 2
- YEJGPFZQLRMXOI-PKEIRNPWSA-N diclocymet Chemical compound N#CC(C(C)(C)C)C(=O)N[C@H](C)C1=CC=C(Cl)C=C1Cl YEJGPFZQLRMXOI-PKEIRNPWSA-N 0.000 claims description 2
- 125000005805 dimethoxy phenyl group Chemical group 0.000 claims description 2
- 150000004659 dithiocarbamates Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- FKLFBQCQQYDUAM-UHFFFAOYSA-N fenpiclonil Chemical compound ClC1=CC=CC(C=2C(=CNC=2)C#N)=C1Cl FKLFBQCQQYDUAM-UHFFFAOYSA-N 0.000 claims description 2
- 150000002357 guanidines Chemical class 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 2
- 150000003233 pyrroles Chemical class 0.000 claims description 2
- 229910021653 sulphate ion Inorganic materials 0.000 claims description 2
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 claims description 2
- 238000004804 winding Methods 0.000 claims description 2
- 239000002585 base Substances 0.000 claims 8
- 241000209094 Oryza Species 0.000 claims 3
- XODZOJBRMYSETR-UHFFFAOYSA-N 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4-one Chemical compound O=C1N(CCCC)C(CCCC)=NC2=C1C=C(Cl)S2 XODZOJBRMYSETR-UHFFFAOYSA-N 0.000 claims 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims 2
- 239000012458 free base Substances 0.000 claims 2
- 239000011630 iodine Substances 0.000 claims 2
- 229910052740 iodine Inorganic materials 0.000 claims 2
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 claims 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims 1
- 125000006426 1-chlorocyclopropyl group Chemical group [H]C1([H])C([H])([H])C1(Cl)* 0.000 claims 1
- VVZRKVYGKNFTRR-UHFFFAOYSA-N 12h-benzo[a]xanthene Chemical compound C1=CC=CC2=C3CC4=CC=CC=C4OC3=CC=C21 VVZRKVYGKNFTRR-UHFFFAOYSA-N 0.000 claims 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 claims 1
- QFHVHZJGQWMBTE-UHFFFAOYSA-N 2-(trifluoromethyl)-1h-indole Chemical compound C1=CC=C2NC(C(F)(F)F)=CC2=C1 QFHVHZJGQWMBTE-UHFFFAOYSA-N 0.000 claims 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 claims 1
- BMEIGUQCIYLQRT-UHFFFAOYSA-N 2-chloro-4-[(2-fluoro-2-methylpropanoyl)amino]-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=C(NC(=O)C(C)(C)F)C=C1Cl BMEIGUQCIYLQRT-UHFFFAOYSA-N 0.000 claims 1
- FYNRTZBFTAYBQO-UHFFFAOYSA-N 3-(difluoromethyl)-1h-indole Chemical compound C1=CC=C2C(C(F)F)=CNC2=C1 FYNRTZBFTAYBQO-UHFFFAOYSA-N 0.000 claims 1
- BELDOPUBSLPBCQ-UHFFFAOYSA-N 3-bromo-5-chloropyridine Chemical compound ClC1=CN=CC(Br)=C1 BELDOPUBSLPBCQ-UHFFFAOYSA-N 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- YTOVMWYGCDIWSB-UHFFFAOYSA-N C=1(C=NN(C=1)S)C(=O)N Chemical compound C=1(C=NN(C=1)S)C(=O)N YTOVMWYGCDIWSB-UHFFFAOYSA-N 0.000 claims 1
- 229910002651 NO3 Inorganic materials 0.000 claims 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 1
- 241000237502 Ostreidae Species 0.000 claims 1
- 206010037660 Pyrexia Diseases 0.000 claims 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 claims 1
- JYZIHLWOWKMNNX-UHFFFAOYSA-N benzimidazole Chemical compound C1=C[CH]C2=NC=NC2=C1 JYZIHLWOWKMNNX-UHFFFAOYSA-N 0.000 claims 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 claims 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- ZEYJIQLVKGBLEM-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2N=C3[CH]C=CC=C3N=2)=C1 ZEYJIQLVKGBLEM-UHFFFAOYSA-N 0.000 claims 1
- 125000004438 haloalkoxy group Chemical group 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 150000002429 hydrazines Chemical class 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 235000020636 oyster Nutrition 0.000 claims 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 125000006269 biphenyl-2-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C(*)C([H])=C([H])C([H])=C1[H] 0.000 description 48
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 26
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- 244000052769 pathogen Species 0.000 description 24
- 201000010099 disease Diseases 0.000 description 23
- 238000009472 formulation Methods 0.000 description 18
- ZMYFCFLJBGAQRS-IAGOWNOFSA-N (2S,3R)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@]1(CN2N=CN=C2)[C@@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IAGOWNOFSA-N 0.000 description 14
- 239000004305 biphenyl Substances 0.000 description 14
- 235000010290 biphenyl Nutrition 0.000 description 14
- 230000012010 growth Effects 0.000 description 14
- 238000002156 mixing Methods 0.000 description 14
- 240000008042 Zea mays Species 0.000 description 12
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 230000001717 pathogenic effect Effects 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 244000068988 Glycine max Species 0.000 description 11
- 235000010469 Glycine max Nutrition 0.000 description 11
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 11
- 235000005822 corn Nutrition 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 241000894007 species Species 0.000 description 11
- 230000002195 synergetic effect Effects 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 230000001276 controlling effect Effects 0.000 description 9
- 125000001841 imino group Chemical group [H]N=* 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 229920000742 Cotton Polymers 0.000 description 8
- 244000299507 Gossypium hirsutum Species 0.000 description 8
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 8
- 241000813090 Rhizoctonia solani Species 0.000 description 8
- 239000001965 potato dextrose agar Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000002689 soil Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000005740 Boscalid Substances 0.000 description 7
- BXDZOYLPNAIDOC-UHFFFAOYSA-N N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]-1-[2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethyl]piperidine-4-carboxamide Chemical compound CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)CC3)s2)o1 BXDZOYLPNAIDOC-UHFFFAOYSA-N 0.000 description 7
- 241000209140 Triticum Species 0.000 description 7
- 235000021307 Triticum Nutrition 0.000 description 7
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 7
- 229940118790 boscalid Drugs 0.000 description 7
- 125000001309 chloro group Chemical group Cl* 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 6
- 239000005786 Flutolanil Substances 0.000 description 6
- 241000223218 Fusarium Species 0.000 description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
- 241000233614 Phytophthora Species 0.000 description 6
- 241001361634 Rhizoctonia Species 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 6
- 239000012965 benzophenone Substances 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- LDPRPCQCLNSMAO-UHFFFAOYSA-N 9h-carbazole-4-carboxamide Chemical compound N1C2=CC=CC=C2C2=C1C=CC=C2C(=O)N LDPRPCQCLNSMAO-UHFFFAOYSA-N 0.000 description 5
- 241000223600 Alternaria Species 0.000 description 5
- 239000005735 Benalaxyl-M Substances 0.000 description 5
- 241000221785 Erysiphales Species 0.000 description 5
- 239000005807 Metalaxyl Substances 0.000 description 5
- 239000005808 Metalaxyl-M Substances 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 5
- 125000005431 alkyl carboxamide group Chemical group 0.000 description 5
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 description 5
- DKVNPHBNOWQYFE-UHFFFAOYSA-N carbamodithioic acid Chemical compound NC(S)=S DKVNPHBNOWQYFE-UHFFFAOYSA-N 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 5
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 description 5
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 241000123650 Botrytis cinerea Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000233639 Pythium Species 0.000 description 4
- 244000061456 Solanum tuberosum Species 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- 229930182692 Strobilurin Natural products 0.000 description 4
- 239000003899 bactericide agent Substances 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 244000038559 crop plants Species 0.000 description 4
- 239000008121 dextrose Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- VUERQRKTYBIULR-UHFFFAOYSA-N fosetyl Chemical compound CCOP(O)=O VUERQRKTYBIULR-UHFFFAOYSA-N 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 230000002363 herbicidal effect Effects 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000002834 transmittance Methods 0.000 description 4
- VAELWSLNTRVXQS-UHFFFAOYSA-N 1,3-oxazole-4-carboxamide Chemical compound NC(=O)C1=COC=N1 VAELWSLNTRVXQS-UHFFFAOYSA-N 0.000 description 3
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 3
- BNYCHCAYYYRJSH-UHFFFAOYSA-N 1h-pyrazole-5-carboxamide Chemical compound NC(=O)C1=CC=NN1 BNYCHCAYYYRJSH-UHFFFAOYSA-N 0.000 description 3
- COOCNCOZRBMUTO-UHFFFAOYSA-N 2-(3-aminopropyl)octanoic acid Chemical compound CCCCCCC(C(O)=O)CCCN COOCNCOZRBMUTO-UHFFFAOYSA-N 0.000 description 3
- MEYCYYFOVOERCT-UHFFFAOYSA-N 2-iodochromen-4-one Chemical compound C1=CC=C2OC(I)=CC(=O)C2=C1 MEYCYYFOVOERCT-UHFFFAOYSA-N 0.000 description 3
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 description 3
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- 241000223221 Fusarium oxysporum Species 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 239000005800 Kresoxim-methyl Substances 0.000 description 3
- 241001330975 Magnaporthe oryzae Species 0.000 description 3
- 235000011430 Malus pumila Nutrition 0.000 description 3
- 235000015103 Malus silvestris Nutrition 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 241000233679 Peronosporaceae Species 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- 241000228453 Pyrenophora Species 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- 241000221662 Sclerotinia Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 239000005863 Zoxamide Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- WJZHMLNIAZSFDO-UHFFFAOYSA-N manganese zinc Chemical compound [Mn].[Zn] WJZHMLNIAZSFDO-UHFFFAOYSA-N 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000008635 plant growth Effects 0.000 description 3
- 229920000151 polyglycol Polymers 0.000 description 3
- 239000010695 polyglycol Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 3
- DIQUUDQGAZZWFJ-REOHCLBHSA-N (2s)-2-(sulfanylamino)propanoic acid Chemical compound SN[C@@H](C)C(O)=O DIQUUDQGAZZWFJ-REOHCLBHSA-N 0.000 description 2
- MPYHGNAJOKCMAQ-MRXNPFEDSA-N (R)-laudanine Chemical compound C1=C(O)C(OC)=CC=C1C[C@@H]1C2=CC(OC)=C(OC)C=C2CCN1C MPYHGNAJOKCMAQ-MRXNPFEDSA-N 0.000 description 2
- QEFVKVZVJPKJQZ-UHFFFAOYSA-N 1-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound NC(=O)C=1C=NN(C(F)(F)F)C=1 QEFVKVZVJPKJQZ-UHFFFAOYSA-N 0.000 description 2
- UEBBCHPIFFPKKL-UHFFFAOYSA-N 1h-indazole-4-carboxamide Chemical compound NC(=O)C1=CC=CC2=C1C=NN2 UEBBCHPIFFPKKL-UHFFFAOYSA-N 0.000 description 2
- RLOQBKJCOAXOLR-UHFFFAOYSA-N 1h-pyrrole-2-carboxamide Chemical compound NC(=O)C1=CC=CN1 RLOQBKJCOAXOLR-UHFFFAOYSA-N 0.000 description 2
- YRUBIFAMCRFPPC-UHFFFAOYSA-N 2-chloro-7-fluoro-1h-quinazolin-4-one Chemical compound N1C(Cl)=NC(=O)C=2C1=CC(F)=CC=2 YRUBIFAMCRFPPC-UHFFFAOYSA-N 0.000 description 2
- LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical compound NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 2
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 2
- 241000223602 Alternaria alternata Species 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241001465180 Botrytis Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241001157813 Cercospora Species 0.000 description 2
- 241000222199 Colletotrichum Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000371644 Curvularia ravenelii Species 0.000 description 2
- 241000031930 Dactuliophora Species 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000004606 Fillers/Extenders Substances 0.000 description 2
- XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 description 2
- 241000237858 Gastropoda Species 0.000 description 2
- 241000461774 Gloeosporium Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241000233654 Oomycetes Species 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000221300 Puccinia Species 0.000 description 2
- 241000918585 Pythium aphanidermatum Species 0.000 description 2
- 241000918584 Pythium ultimum Species 0.000 description 2
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 2
- 239000005835 Silthiofam Substances 0.000 description 2
- 241000865903 Thielaviopsis Species 0.000 description 2
- 241000561282 Thielaviopsis basicola Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- 125000005336 allyloxy group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001556 benzimidazoles Chemical class 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 229910052614 beryl Inorganic materials 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- SFZULDYEOVSIKM-UHFFFAOYSA-N chembl321317 Chemical compound C1=CC(C(=N)NO)=CC=C1C1=CC=C(C=2C=CC(=CC=2)C(=N)NO)O1 SFZULDYEOVSIKM-UHFFFAOYSA-N 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- 235000004879 dioscorea Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 230000003631 expected effect Effects 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 2
- 235000013882 gravy Nutrition 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 description 2
- GMTCPFCMAHMEMT-UHFFFAOYSA-N n-decyldecan-1-amine Chemical compound CCCCCCCCCCNCCCCCCCCCC GMTCPFCMAHMEMT-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 230000002940 repellent Effects 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- MXMXHPPIGKYTAR-UHFFFAOYSA-N silthiofam Chemical compound CC=1SC([Si](C)(C)C)=C(C(=O)NCC=C)C=1C MXMXHPPIGKYTAR-UHFFFAOYSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- ITOFPJRDSCGOSA-KZLRUDJFSA-N (2s)-2-[[(4r)-4-[(3r,5r,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H](CC[C@]13C)[C@@H]2[C@@H]3CC[C@@H]1[C@H](C)CCC(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 ITOFPJRDSCGOSA-KZLRUDJFSA-N 0.000 description 1
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- XDEHMKQLKPZERH-BYPYZUCNSA-N (2s)-2-amino-3-methylbutanamide Chemical compound CC(C)[C@H](N)C(N)=O XDEHMKQLKPZERH-BYPYZUCNSA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- FHCCUFZRWVYQPM-UHFFFAOYSA-N 1,1'-biphenyl;hydrofluoride Chemical group F.C1=CC=CC=C1C1=CC=CC=C1 FHCCUFZRWVYQPM-UHFFFAOYSA-N 0.000 description 1
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 1
- PLCMVACJJSYDFV-UHFFFAOYSA-N 1,3-oxazole-2-carboxamide Chemical compound NC(=O)C1=NC=CO1 PLCMVACJJSYDFV-UHFFFAOYSA-N 0.000 description 1
- ZIGVURPVSKJORL-UHFFFAOYSA-N 1-(3-methoxyphenyl)-2-(methylamino)ethanol Chemical compound CNCC(O)C1=CC=CC(OC)=C1 ZIGVURPVSKJORL-UHFFFAOYSA-N 0.000 description 1
- AMSVWDFSTNMNTP-UHFFFAOYSA-N 1-(difluoromethyl)-2-phenylbenzene Chemical group FC(F)C1=CC=CC=C1C1=CC=CC=C1 AMSVWDFSTNMNTP-UHFFFAOYSA-N 0.000 description 1
- PRJRIQDAMLNRPW-UHFFFAOYSA-N 1-(trifluoromethyl)acridine Chemical compound C1=CC=C2C=C3C(C(F)(F)F)=CC=CC3=NC2=C1 PRJRIQDAMLNRPW-UHFFFAOYSA-N 0.000 description 1
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- WTFWZOSMUGZKNZ-UHFFFAOYSA-N 1H-indol-7-amine Chemical compound NC1=CC=CC2=C1NC=C2 WTFWZOSMUGZKNZ-UHFFFAOYSA-N 0.000 description 1
- MREIFUWKYMNYTK-UHFFFAOYSA-N 1H-pyrrole Chemical compound C=1C=CNC=1.C=1C=CNC=1 MREIFUWKYMNYTK-UHFFFAOYSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- WRTHZGDBUWNFCS-UHFFFAOYSA-N 2-but-3-enoxy-6-iodochromen-4-one Chemical compound O1C(OCCC=C)=CC(=O)C2=CC(I)=CC=C21 WRTHZGDBUWNFCS-UHFFFAOYSA-N 0.000 description 1
- ZQMRDENWZKMOTM-UHFFFAOYSA-N 2-butoxy-6-iodo-3-propylchromen-4-one Chemical compound C1=C(I)C=C2C(=O)C(CCC)=C(OCCCC)OC2=C1 ZQMRDENWZKMOTM-UHFFFAOYSA-N 0.000 description 1
- YAUCKEPYKXHCFF-UHFFFAOYSA-N 2-carbamothioylsulfanylethyl carbamodithioate;manganese Chemical compound [Mn].NC(=S)SCCSC(N)=S YAUCKEPYKXHCFF-UHFFFAOYSA-N 0.000 description 1
- RHXCIWRRFMVVLI-UHFFFAOYSA-N 2-decoxybenzamide Chemical compound CCCCCCCCCCOC1=CC=CC=C1C(N)=O RHXCIWRRFMVVLI-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- ZKELPVOGKKBWIN-UHFFFAOYSA-N 2-sulfanylidene-3h-1,3-thiazole-5-carboxamide Chemical compound NC(=O)C1=CNC(=S)S1 ZKELPVOGKKBWIN-UHFFFAOYSA-N 0.000 description 1
- CLSZROKTPWVQKB-UHFFFAOYSA-N 3-(trifluoromethyl)-1h-indole Chemical compound C1=CC=C2C(C(F)(F)F)=CNC2=C1 CLSZROKTPWVQKB-UHFFFAOYSA-N 0.000 description 1
- DCOHNGVPSJBFBA-UHFFFAOYSA-N 3-butyl-6-iodo-2-propan-2-yloxychromen-4-one Chemical compound C1=C(I)C=C2C(=O)C(CCCC)=C(OC(C)C)OC2=C1 DCOHNGVPSJBFBA-UHFFFAOYSA-N 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- FYYHNGSXNUSXTE-UHFFFAOYSA-N 3H-pyrano[3,2-b]chromen-2-one Chemical compound O1C(CC=C2C1=CC1=C(O2)C=CC=C1)=O FYYHNGSXNUSXTE-UHFFFAOYSA-N 0.000 description 1
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 description 1
- IQGAEQZOWDGJQH-UHFFFAOYSA-N 4-chloropurine Chemical compound C1=NC=NC2(Cl)C1=NC=N2 IQGAEQZOWDGJQH-UHFFFAOYSA-N 0.000 description 1
- SBUKOHLFHYSZNG-UHFFFAOYSA-N 4-dodecyl-2,6-dimethylmorpholine Chemical compound CCCCCCCCCCCCN1CC(C)OC(C)C1 SBUKOHLFHYSZNG-UHFFFAOYSA-N 0.000 description 1
- UCZQXJKDCHCTAI-UHFFFAOYSA-N 4h-1,3-dioxine Chemical compound C1OCC=CO1 UCZQXJKDCHCTAI-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N Alizarin Natural products C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 241000213004 Alternaria solani Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001279740 Anopheles sinensis Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- 241001480060 Blumeria Species 0.000 description 1
- 241001480061 Blumeria graminis Species 0.000 description 1
- 241000219475 Bougainvillea Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 244000188595 Brassica sinapistrum Species 0.000 description 1
- 241000233684 Bremia Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- IUBVGWIVWFWFTA-UHFFFAOYSA-N C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(CCCCCCC)NCCCCCCCC Chemical compound C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(CCCCCCC)NCCCCCCCC IUBVGWIVWFWFTA-UHFFFAOYSA-N 0.000 description 1
- GHBYDWVSCHDKAH-UHFFFAOYSA-N CC(CC(C)(C)C)C1=C(C=CC=C1)C1=C(C=NN1)C(=O)N Chemical compound CC(CC(C)(C)C)C1=C(C=CC=C1)C1=C(C=NN1)C(=O)N GHBYDWVSCHDKAH-UHFFFAOYSA-N 0.000 description 1
- 101150010802 CVC2 gene Proteins 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- KYGYLTNBDPDWOH-UHFFFAOYSA-N Cc1ccn(n1)C(F)(F)F Chemical compound Cc1ccn(n1)C(F)(F)F KYGYLTNBDPDWOH-UHFFFAOYSA-N 0.000 description 1
- 241000530549 Cercospora beticola Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241000907567 Choanephora Species 0.000 description 1
- 241000760356 Chytridiomycetes Species 0.000 description 1
- 241000688200 Cingulata Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000221760 Claviceps Species 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- 241000228437 Cochliobolus Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 241001529387 Colletotrichum gloeosporioides Species 0.000 description 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 241001529717 Corticium <basidiomycota> Species 0.000 description 1
- 241000186031 Corynebacteriaceae Species 0.000 description 1
- 241000577200 Crocothemis erythraea Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical class CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 1
- 241001508802 Diaporthe Species 0.000 description 1
- 241001645342 Diaporthe citri Species 0.000 description 1
- 241001508801 Diaporthe phaseolorum Species 0.000 description 1
- 235000002723 Dioscorea alata Nutrition 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 1
- 241000125117 Elsinoe Species 0.000 description 1
- 241000125118 Elsinoe fawcettii Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- UUWQCRSNRXGWKL-UHFFFAOYSA-N FC(F)(F)C1=C(C=2NC3=CC=CC=C3C=2C=C1)C(=O)N Chemical compound FC(F)(F)C1=C(C=2NC3=CC=CC=C3C=2C=C1)C(=O)N UUWQCRSNRXGWKL-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 239000005782 Fluopicolide Substances 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 241000879295 Fusarium equiseti Species 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 241001208371 Fusarium incarnatum Species 0.000 description 1
- 241001149504 Gaeumannomyces Species 0.000 description 1
- 241001620302 Glomerella <beetle> Species 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 241001481828 Glyptocephalus cynoglossus Species 0.000 description 1
- 241000308375 Graminicola Species 0.000 description 1
- 241000555709 Guignardia Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000221557 Gymnosporangium Species 0.000 description 1
- 241001409809 Gymnosporangium sabinae Species 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- IVBCWQQCCNSIOS-UHFFFAOYSA-N IC1=CC=C(C(=C1)OCCC)CCC Chemical compound IC1=CC=C(C(=C1)OCCC)CCC IVBCWQQCCNSIOS-UHFFFAOYSA-N 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- 241000764238 Isis Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000228456 Leptosphaeria Species 0.000 description 1
- 241000228457 Leptosphaeria maculans Species 0.000 description 1
- 241000555723 Leptosphaerulina Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001495424 Macrophomina Species 0.000 description 1
- 241001344133 Magnaporthe Species 0.000 description 1
- 241001344131 Magnaporthe grisea Species 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 241001668538 Mollisia Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241001518729 Monilinia Species 0.000 description 1
- 241000005782 Monographella Species 0.000 description 1
- 241001459558 Monographella nivalis Species 0.000 description 1
- 101100447665 Mus musculus Gas2 gene Proteins 0.000 description 1
- 241000865901 Mycoleptodiscus Species 0.000 description 1
- 241000131448 Mycosphaerella Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 description 1
- RKMKZHRAQOVFJH-UHFFFAOYSA-N N1CCC2=CC(=CC=C12)C(C(=O)NCCC1=CC(=C(C=C1)OC)OC)=NOC Chemical compound N1CCC2=CC(=CC=C12)C(C(=O)NCCC1=CC(=C(C=C1)OC)OC)=NOC RKMKZHRAQOVFJH-UHFFFAOYSA-N 0.000 description 1
- 241000498271 Necator Species 0.000 description 1
- 241001226034 Nectria <echinoderm> Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 241000998584 Nuda Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- SKIMVEQLZDZVJR-UHFFFAOYSA-N OP(O)=O.S Chemical class OP(O)=O.S SKIMVEQLZDZVJR-UHFFFAOYSA-N 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 241000144610 Oculimacula acuformis Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736122 Parastagonospora nodorum Species 0.000 description 1
- 241001123663 Penicillium expansum Species 0.000 description 1
- 241001223281 Peronospora Species 0.000 description 1
- 241000555275 Phaeosphaeria Species 0.000 description 1
- 241000440444 Phakopsora Species 0.000 description 1
- 241000440445 Phakopsora meibomiae Species 0.000 description 1
- 241000682645 Phakopsora pachyrhizi Species 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 244000302661 Phyllostachys pubescens Species 0.000 description 1
- 235000003570 Phyllostachys pubescens Nutrition 0.000 description 1
- 241000210649 Phyllosticta ampelicida Species 0.000 description 1
- 241000233624 Phytophthora megasperma Species 0.000 description 1
- 102100026123 Pirin Human genes 0.000 description 1
- 101710176373 Pirin Proteins 0.000 description 1
- 241001503460 Plasmodiophorida Species 0.000 description 1
- 241000233626 Plasmopara Species 0.000 description 1
- 241000896242 Podosphaera Species 0.000 description 1
- 241000317981 Podosphaera fuliginea Species 0.000 description 1
- 241001337928 Podosphaera leucotricha Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000947836 Pseudomonadaceae Species 0.000 description 1
- 241000589615 Pseudomonas syringae Species 0.000 description 1
- 241001281802 Pseudoperonospora Species 0.000 description 1
- 241000520648 Pyrenophora teres Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241000599030 Pythium debaryanum Species 0.000 description 1
- 241001505297 Pythium irregulare Species 0.000 description 1
- 241001622896 Pythium myriotylum Species 0.000 description 1
- 241001552694 Rhizobacter Species 0.000 description 1
- 241001633102 Rhizobiaceae Species 0.000 description 1
- 241001515790 Rhynchosporium secalis Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 244000007853 Sarothamnus scoparius Species 0.000 description 1
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 241000341387 Scutellaria serrata Species 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 239000004113 Sepiolite Substances 0.000 description 1
- 229910007161 Si(CH3)3 Inorganic materials 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 241001250060 Sphacelotheca Species 0.000 description 1
- 241000579741 Sphaerotheca <fungi> Species 0.000 description 1
- 241000011575 Spilocaea Species 0.000 description 1
- 241001250070 Sporisorium reilianum Species 0.000 description 1
- 241000371621 Stemphylium Species 0.000 description 1
- 241000204060 Streptomycetaceae Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 241000228446 Taphrina Species 0.000 description 1
- 241001454295 Tetranychidae Species 0.000 description 1
- 241000534944 Thia Species 0.000 description 1
- 241000722133 Tilletia Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 108010021119 Trichosanthin Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000959260 Typhula Species 0.000 description 1
- 239000012963 UV stabilizer Substances 0.000 description 1
- 241000510929 Uncinula Species 0.000 description 1
- 241001154828 Urocystis <tapeworm> Species 0.000 description 1
- 241000157667 Urocystis occulta Species 0.000 description 1
- 241000221576 Uromyces Species 0.000 description 1
- 241000221577 Uromyces appendiculatus Species 0.000 description 1
- 241000221561 Ustilaginales Species 0.000 description 1
- 241000221566 Ustilago Species 0.000 description 1
- 241000317942 Venturia <ichneumonid wasp> Species 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical class ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241001272684 Xanthomonas campestris pv. oryzae Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- PMUIBVMKQVKHBE-UHFFFAOYSA-N [S].NC(N)=O Chemical class [S].NC(N)=O PMUIBVMKQVKHBE-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000005133 alkynyloxy group Chemical group 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- RQGNEYFWHWFECS-UHFFFAOYSA-N amino formate Chemical class NOC=O RQGNEYFWHWFECS-UHFFFAOYSA-N 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000005418 aryl aryl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- 150000007981 azolines Chemical class 0.000 description 1
- 125000005337 azoxy group Chemical group [N+]([O-])(=N*)* 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
- 229960004484 carbachol Drugs 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
- OWIUPIRUAQMTTK-UHFFFAOYSA-N carbazic acid Chemical compound NNC(O)=O OWIUPIRUAQMTTK-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 150000008422 chlorobenzenes Chemical class 0.000 description 1
- HRBKVYFZANMGRE-UHFFFAOYSA-N chlorpyrifos-methyl Chemical compound COP(=S)(OC)OC1=NC(Cl)=C(Cl)C=C1Cl HRBKVYFZANMGRE-UHFFFAOYSA-N 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 125000000131 cyclopropyloxy group Chemical group C1(CC1)O* 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- OAWUUPVZMNKZRY-UHFFFAOYSA-N cyprosulfamide Chemical compound COC1=CC=CC=C1C(=O)NS(=O)(=O)C1=CC=C(C(=O)NC2CC2)C=C1 OAWUUPVZMNKZRY-UHFFFAOYSA-N 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000008056 dicarboxyimides Chemical class 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- AHIHYYUBTALJCQ-UHFFFAOYSA-N difluorocarbamic acid Chemical compound OC(=O)N(F)F AHIHYYUBTALJCQ-UHFFFAOYSA-N 0.000 description 1
- USKHLWZYZGOYNL-UHFFFAOYSA-N difluoromethylhydrazine Chemical compound [H]C(F)(F)NN USKHLWZYZGOYNL-UHFFFAOYSA-N 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000006182 dimethyl benzyl group Chemical group 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000004495 emulsifiable concentrate Substances 0.000 description 1
- 229960001904 epirubicin Drugs 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 description 1
- KVDJTXBXMWJJEF-UHFFFAOYSA-N fluopyram Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CCNC(=O)C1=CC=CC=C1C(F)(F)F KVDJTXBXMWJJEF-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- UYJUZNLFJAWNEZ-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2NC3=CC=CC=C3N=2)=C1 UYJUZNLFJAWNEZ-UHFFFAOYSA-N 0.000 description 1
- 244000000004 fungal plant pathogen Species 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000003869 genetically modified organism Nutrition 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- CANPFCFJURGKAX-JTQLQIEISA-N iolopride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=C(O)C(I)=CC=C1OC CANPFCFJURGKAX-JTQLQIEISA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical class [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000005497 microtitration Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- VOTAGOIBLAQEDW-UHFFFAOYSA-N n,4-diethyl-1,3-thiazol-2-amine Chemical compound CCNC1=NC(CC)=CS1 VOTAGOIBLAQEDW-UHFFFAOYSA-N 0.000 description 1
- PBAYQDOSTYQRBU-UHFFFAOYSA-N n-[2-(3,3-dimethylbutyl)phenyl]-2-(trifluoromethyl)benzamide Chemical compound CC(C)(C)CCC1=CC=CC=C1NC(=O)C1=CC=CC=C1C(F)(F)F PBAYQDOSTYQRBU-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- GTHIVDIEQVLQIQ-UHFFFAOYSA-N n-ethyl-2-(trifluoromethyl)benzamide Chemical compound CCNC(=O)C1=CC=CC=C1C(F)(F)F GTHIVDIEQVLQIQ-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- XGXNTJHZPBRBHJ-UHFFFAOYSA-N n-phenylpyrimidin-2-amine Chemical compound N=1C=CC=NC=1NC1=CC=CC=C1 XGXNTJHZPBRBHJ-UHFFFAOYSA-N 0.000 description 1
- SNMVRZFUUCLYTO-UHFFFAOYSA-N n-propyl chloride Chemical compound CCCCl SNMVRZFUUCLYTO-UHFFFAOYSA-N 0.000 description 1
- 229940042880 natural phospholipid Drugs 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- KPRZOPQOBJRYSW-UHFFFAOYSA-N o-hydroxybenzylamine Natural products NCC1=CC=CC=C1O KPRZOPQOBJRYSW-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- AMEKQAFGQBKLKX-UHFFFAOYSA-N oxycarboxin Chemical compound O=S1(=O)CCOC(C)=C1C(=O)NC1=CC=CC=C1 AMEKQAFGQBKLKX-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- AFDMODCXODAXLC-UHFFFAOYSA-N phenylmethanimine Chemical compound N=CC1=CC=CC=C1 AFDMODCXODAXLC-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- FUWGSUOSJRCEIV-UHFFFAOYSA-N phosphonothioic O,O-acid Chemical compound OP(O)=S FUWGSUOSJRCEIV-UHFFFAOYSA-N 0.000 description 1
- 239000001007 phthalocyanine dye Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- XUWVIABDWDTJRZ-UHFFFAOYSA-N propan-2-ylazanide Chemical compound CC(C)[NH-] XUWVIABDWDTJRZ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- DVLHGMFTRAFHPR-UHFFFAOYSA-N pyrazole-1-carboxamide Chemical compound NC(=O)N1C=CC=N1 DVLHGMFTRAFHPR-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 244000195895 saibo Species 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 229910052624 sepiolite Inorganic materials 0.000 description 1
- 235000019355 sepiolite Nutrition 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- CBXWGGFGZDVPNV-UHFFFAOYSA-N so4-so4 Chemical compound OS(O)(=O)=O.OS(O)(=O)=O CBXWGGFGZDVPNV-UHFFFAOYSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- GGNIKGLUPSHSBV-UHFFFAOYSA-N thiazole-5-carboxamide Chemical compound NC(=O)C1=CN=CS1 GGNIKGLUPSHSBV-UHFFFAOYSA-N 0.000 description 1
- RSPCKAHMRANGJZ-UHFFFAOYSA-N thiohydroxylamine Chemical compound SN RSPCKAHMRANGJZ-UHFFFAOYSA-N 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- NTADARNNAPPIBY-UHFFFAOYSA-N triazolo[1,5-a]pyrimidin-7-amine Chemical compound NC1=CC=NC2=CN=NN12 NTADARNNAPPIBY-UHFFFAOYSA-N 0.000 description 1
- 125000004360 trifluorophenyl group Chemical group 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000004552 water soluble powder Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
200814928 九、發明說明: 【發明所屬之技術領域】 本發明關於新穎的活性化合物組合物,係包含 知的魏胺及第二類已知的具殺地活性化合物,這樣的 ^穎的活性化合物組合物極適於供控制不想要的植物病原 真菌。 > 【先前技術】 已知,某些的羧醯胺類具有殺真菌的性質:例如,得 10 知自W〇 2005/123689之队(3,,4,-二氟聯笨基_2_基w•甲基 -3-(三氟曱基)-1Η-吡唑羧醯胺以及得知自^ 2005/123690 之 N-(3,,4,-二氯聯苯基_2·基)_3_(二氟曱基η· 曱基-1Η-吡唑-4-羧醯胺,這些化合物之活性很好,然而在 低施用率下有時候不夠令人滿意;此外,已知有無數的嗟 15 唑衍生物、苯胺衍生物、二羧基亞醯胺(dicarboximides)及 _ 其他的雜環類’可被使用供控制真菌(參考:Ep_ a 〇 〇4〇 345,DE-A 22 01 063,DE-A 23 24 010,Pesticide Μ麵al,9th200814928 IX. OBJECTS OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to novel active compound compositions comprising a known sulphamine and a second known class of active compounds having a bactericidal activity, such active compounds. The material is extremely suitable for controlling unwanted plant pathogenic fungi. > [Prior Art] It is known that certain carboguanamines have fungicidal properties: for example, a team of 10 known from W〇2005/123689 (3,4,-difluorolinked stupid base_2_ W+methyl-3-(trifluoromethyl)-1Η-pyrazole carboxamide and N-(3,4,-dichlorobiphenyl-2·yl) from ^2005/123690 _3_(difluorodecyl η· decyl-1 Η-pyrazole-4-carboxyguanamine, these compounds have good activity, but are sometimes not satisfactory at low application rates; in addition, countless bismuths are known. 15 Azoline derivatives, aniline derivatives, dicarboxyboximides and other heterocyclics can be used to control fungi (Reference: Ep_ a 〇〇4〇345, DE-A 22 01 063, DE -A 23 24 010,Pesticide al面al,9th
Edition (1991),249 及 827 頁,EP_A〇 382 375 及 Ep_A〇 515 901),然而,這些化合物的作用在低施用率下同樣地常有不 20 足。 【發明内容】 我們目兩已發現種具有極佳的殺真菌的性質新穎的 活性化合物組合物,且其係包含第i類之具式⑴的羧醯胺 200814928Edition (1991), pages 249 and 827, EP_A 382 382 375 and Ep_A 〇 515 901), however, the effects of these compounds are often similarly low at low application rates. SUMMARY OF THE INVENTION We have found novel active compound compositions having excellent fungicidal properties, and which comprise a carboxamide of formula i (1) 200814928
其中 R 代表氫或氟, R1代表齒素,Ci-C^烷基,CVC6-鹵基烷基,氰基,硝基, CrCy烷氧基,具有1至7個氟,氯及/或溴原子之 CrC3-鹵基-燒氧基或代表_c(R4)=N-OR5, R2代表氫,鹵素,CrCV烷基,Q-CV鹵基烷基,氰基, 石肖基,燒氧基’或代表具有1至7個氟,氣及/ 或漠原子之C1-C3-鹵基烧氧基, R4代表氫或甲基’ R5代表crc5-烷基,CrC5-烯基或CrC5-炔基, 以及至少一種挑選自下述第(2)類至第(26)類的活性化合 物: ^£7}jL 具式(II)之史匕Wherein R represents hydrogen or fluorine, R1 represents dentate, Ci-C^alkyl, CVC6-haloalkyl, cyano, nitro, CrCy alkoxy, having from 1 to 7 fluorine, chlorine and/or bromine atoms CrC3-halo-alkoxy or represent _c(R4)=N-OR5, R2 represents hydrogen, halogen, CrCV alkyl, Q-CV haloalkyl, cyano, schishyl, alkoxy' or a C1-C3-halo alkoxy group having 1 to 7 fluorine, gas and/or a desert atom, R4 representing hydrogen or methyl 'R5 representing a crc5-alkyl group, a CrC5-alkenyl group or a CrC5-alkynyl group, and at least An active compound selected from categories (2) to (26) below: ^£7}jL History of formula (II)
其中 A1 代表下述基之一 200814928Where A1 represents one of the following bases: 200814928
A2 代表NH或0, A3 代表N或CH, 5 L 代表下述基之一 R12 *产*八^0丫" *八〆〆、 N^N CH3 CH3 其中以星號(*)標示的鍵係附接至苯基環上, I0 Ru代表笨基,苯亞曱基,苯氧基或吼啶基,各為選擇地 經一或二個相同或相異的,挑選自包括氣,氰基,曱 基及三氟曱基之取代基取代,或代表1-(4-氣苯基)吼唑 -3-基或代表1,2-丙二嗣-雙(0-曱基肪)-1-基’ R12代表氫或氟; 15 第(3)類 具式(III)之三唑類(Triazoles)A2 represents NH or 0, A3 represents N or CH, and 5 L represents one of the following groups: R12 *Production *8^0丫" *Bagua, N^N CH3 CH3 Among them, the bond marked with an asterisk (*) Attached to the phenyl ring, I0 Ru represents a stupid group, a benzylidene group, a phenoxy group or an acridinyl group, each of which is optionally one or two identical or different, selected from the group consisting of a gas, a cyano group, Substituted by a substituent of a fluorenyl group and a trifluoromethyl group, or represents 1-(4-phenylphenyl)oxazol-3-yl or represents 1,2-propanedi-bis(0-fluorenyl)-1- The base 'R12 stands for hydrogen or fluorine; 15 the third class (III) triazoles of formula (III)
鱼 R14 20 其中 Q 代表氫或SH, m 代表0或1, R13代表氫,氟,氣,苯基或4-氯苯氧基, R14代表氫或氣, 200814928 A代表一種直接鍵…CH2….(CH2)2·或_〇_,代 *-ch2-chr丨'或’其中以*號標示的 接至苯環, 5 其中 R15 及 R17-起代表-CH2-CH2-CH[CH(CH3)2;H ° -CH2-CH2-C(CH3)2·, ’ A5 代表C或Si(矽), A 也代表-N(R17)-及A5也一起與Rb及R!6代表 ON-R18之基,其中一起代表下面之基:Fish R14 20 wherein Q represents hydrogen or SH, m represents 0 or 1, R13 represents hydrogen, fluorine, gas, phenyl or 4-chlorophenoxy, R14 represents hydrogen or gas, and 200814928 A represents a direct bond...CH2.... (CH2)2· or _〇_, behalf of *-ch2-chr丨' or 'where the number marked with * is attached to the benzene ring, 5 where R15 and R17- represent -CH2-CH2-CH[CH(CH3) 2;H ° -CH2-CH2-C(CH3)2·, ' A5 stands for C or Si(矽), A also stands for -N(R17)- and A5 also together with Rb and R!6 stands for ON-R18 Base, which together represent the following base:
Vs 口 ,其中以*號標示的鍵係附接至rI7,Vs port, where the key chain marked with * is attached to rI7,
Rl5代表氫,羥基或氰基,Rl5 represents hydrogen, hydroxy or cyano,
Rl6代表1-環丙基乙基,κ氣環丙基,CrQ•烷基,Ci_c『 赵基烧基’ CrCr烧基幾基,CVC2·齒基烧氧基-CVCV b烷基,三甲基矽烷基_Cl_c2-烷基,單氟苯基或苯基, R 5 及 R16 尚一起代表 _〇-CH2_CH(Ri8)-〇_,_〇 Ch2_ CH(R18)-〇V,-0-CH(0CH2CF3HCH2)2-或-0-CH-(2· 氣苯基)-, A,A5及R15尚一起代表、CH=C>,其中以*號標示的鍵係 附接至笨基環, , ^18代表氫,CrC4-烷基或溴; ——具式(I V)之次續酿胺類(Sulphenamides) 20 (IV) 200814928 fci2c、Rl6 stands for 1-cyclopropylethyl, κ gas cyclopropyl, CrQ•alkyl, Ci_c 『Zhaojiaki' CrCr alkyl group, CVC2·dentate alkoxy-CVCV b alkyl, trimethyl矽alkyl_Cl_c2-alkyl, monofluorophenyl or phenyl, R 5 and R16 together represent _〇-CH2_CH(Ri8)-〇_,_〇Ch2_ CH(R18)-〇V,-0-CH( 0CH2CF3HCH2)2- or -0-CH-(2·gasphenyl)-, A, A5 and R15 are also represented together, CH=C>, wherein the bond marked with an * is attached to the stupid base ring, ^ 18 represents hydrogen, CrC4-alkyl or bromine; - Sulphenamides of formula (IV) 20 (IV) 200814928 fci2c,
ch3 其中R19代表氫或甲基; 挑潠自下诫之纈胺醯胺類(Valinamides): (5-1)異丙菌胺(iprovalicarb) (5、2) 妒-〇(4- {[3-(4-氣苯基)-2-丙炔基]氧}冬甲氧基苯 基)乙基]-7V2-(曱基磺醯基)-D-纈胺醯胺 (5'3)苯σ塞菌胺(benthiavalicarb) &-A式(V)之# 感胺類(Carboxamides) 〇 人 /丫、 (V)Ch3 wherein R19 represents hydrogen or methyl; Valinamides from the lower jaw: (5-1) Iprovalicarb (5, 2) 妒-〇 (4- {[3 -(4-Phenylphenyl)-2-propynyl]oxy}methoxyphenyl)ethyl]-7V2-(indolylsulfonyl)-D-decylamine (5'3)benzene σ 塞 val ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben
χ/^Ν 、Z 其中 15 X代表2_氯-3_响啶基,代表2,4-二氯-3-处啶基,代表在 馨 3位置經甲基,一氟甲基或三氣甲基取代且於^位置 經氫或氯取代之1_甲基吡唑_4_基,代表4_乙基_2_乙基 胺基-1,3-噻唑_5_基,代表2_甲基_4_三氟甲基_丨,3_噻^ I基’代表h甲基環己基,代表2,2_二氯小乙基冬 2〇 T基環丙基,代表2_氟_2_丙基,3,4-二氯異嗟唾·5_基, 5_,6二二氫-2-甲基+4-氧硫雜環_3_基,4,4_二氧代_5,6_ 二氫·1,4-氧硫雜環_3_基,4_甲基山2,3•噻二唑_5_基’, 4’5 一曱基_2_二甲基石浅基嘆吩各基’卜曱基吼洛·]· 基’其在4·位置經甲基或曱基取代且於5_位置經 200814928 氫或氯取代,或代表經一至三個相同或相異的挑選自 匕括氣’甲基及二氟甲基之取代基取代之苯基,或代 表甲基吱喃-3-基, Y代表一種直接鍵,選擇地經氯,氰基或氧代基之取代 基取代之CrC6_烷二基(亞烷基),代表仏<6_烯二基(亞 烯基)或硫苯二基, Z 代表鼠’ Ci-Cg-烧基或下面之基:χ/^Ν, Z wherein 15 X represents 2_chloro-3-cyanodinyl, which represents 2,4-dichloro-3-pyridinyl, which represents methyl, monofluoromethyl or tri-gas at the position of Xin 3 a 1-methylpyrazole-4-yl group substituted with a methyl group at the position of hydrogen or chlorine, representing a 4-ethyl-2-ethylamino-1,3-thiazole _5- group, representing 2_ Methyl 4-1,4-trifluoromethyl 丨, 3 thia thiol I represents 'h methylcyclohexyl, which stands for 2,2-dichloroethylidene 2〇T-cyclopropyl, representing 2_fluoro_ 2_propyl, 3,4-dichloroisoindolyl 5-yl, 5_,6 didihydro-2-methyl+4-oxathiohetero-3-yl, 4,4-dioxo 5,6_ Dihydro-1,4-oxothioheterocyclyl-3-yl, 4-methylammonium 2,3•thiadiazole_5_yl', 4'5-mercapto-2_dimethylstone shallow group叹 各 ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' a phenyl group substituted with a substituent of 'methyl and difluoromethyl, or a methyl indol-3-yl group, Y representing a direct bond, optionally substituted with a chloro, cyano or oxo group Substituted CrC6-alkyldiyl (alkylene), Represents 仏<6-enediyl(alkenylene) or thiophenyldiyl, and Z represents a murine 'Ci-Cg-alkyl group or a group below:
A6 代表 CH,CBr 或 N, 2 0 R 代表氫,氣,溴,氰基或crcv烷基,選擇地經一或 二個相同或相異的挑選自包括氯及二(crc3-燒基)胺 基羰基之取代基取代之苯基,或代表可經甲基取代之 環丙基-環丙基, r21代表氫,氯或異丙氧基, R 代表氫,氯,溴,羥基,甲基,三氟曱基,三氟甲氧 基,或二(crc3-烷基)胺基羰基, R20 及 R21 也一起代表 *-CH(CH3)-CH2-C(CH3)2-或 *_CH(CH3)_0-C(CH3)2·,其中以*號標示的鍵係附接至 R20 ; 羞IZ)類 挑選自下述之二硫胺基甲酸酯類: (7-1)鋅猛乃浦(mancozeb) (7-2) I孟乃浦(maneb) -11 - 200814928 (7-3)免得爛(metiram) (7-4) 曱基鋅乃浦(propineb) (7-5)得恩地(thiram) (7-6)鋅乃浦(zineb) (7刀)福美鋅(ziram) 第(8)類 具式(VI)之醯基丙胺酸類(Acylalanines)A6 represents CH, CBr or N, 2 0 R represents hydrogen, gas, bromine, cyano or crcv alkyl, optionally selected from one or two identical or different selected from the group consisting of chlorine and bis(rcc3-alkyl)amine a phenyl group substituted with a substituent of a carbonyl group, or a cyclopropyl-cyclopropyl group which may be substituted by a methyl group, r21 represents hydrogen, chlorine or isopropoxy group, and R represents hydrogen, chlorine, bromine, hydroxy group, methyl group, Trifluorodecyl, trifluoromethoxy, or di(crc3-alkyl)aminocarbonyl, R20 and R21 together represent *-CH(CH3)-CH2-C(CH3)2- or *_CH(CH3) _0-C(CH3)2·, where the bond indicated by the * is attached to R20; the imaginary IZ) class is selected from the following dithiocarbamates: (7-1) Zinc Meng Nai Pu (mancozeb) (7-2) I Mengnai (maneb) -11 - 200814928 (7-3) ruin (metiram) (7-4) 曱基锌奈浦 (propineb) (7-5) thiram (7) -6) Zinb (Zineb) (7 knives) ziram (Acylalanines) (8)
1010
* 代表具R-或S-組態之一種碳原子,較佳地為呈現s 組態者, 23 R 代表笨甲基,呋喃基或曱氧基曱基; 15 弟(幻遞__具式(YJI)之本胺基°密咬類(Aflilinopyrimidiiies)* represents a carbon atom with R- or S-configuration, preferably for the s configurator, 23 R for the stupid methyl, furyl or decyl fluorenyl; 15 dior (YJI) of the amine-based bite class (Aflilinopyrimidiiies)
20 其中 R 代表曱基,環丙基或1-丙炔基; ^^&丄:具式(vim的1并咪唑類 -12- 200814928 t2720 wherein R represents fluorenyl, cyclopropyl or 1-propynyl; ^^&丄: has the formula (vim of 1 imidazoles -12- 200814928 t27
其中 R及R 各代表氫或一起代表_〇_Cf2_〇_, R代表氫,烧基胺基幾基或代表3,5-二甲基異嚼唾 -4-基續g藍基, R 代表氯,甲氧基幾基胺基,氯苯基,吱喃基或嘆唾基; M11M_具式(DO之胺基甲酸酯翻Wherein R and R each represent hydrogen or together represent _〇_Cf2_〇_, R represents hydrogen, alkylamino group or represents 3,5-dimethylisox-4-yl continued g blue, R Represents chlorine, methoxylamino, chlorophenyl, fluorenyl or sinyl; M11M_ has a formula (DO urethane turns)
Η 其中 R29代表正·或異丙基, R 代表—(Ci-C〗-烧基)胺基-C2-C4-烧基或二乙氧基苯基, 15 也包括這些化合物之鹽類; , 差(12)類—挑選自下述之二幾基亞醯胺類(Dicarboximides) ·· (12-1)四氯丹(captafol) (12_2)蓋普丹(eaptan) (12·3)福爾培(f〇ipet) 20 (H4)依普同(ipr〇di〇ne) (12-5)撲滅寧(proCymid〇ne) (12-6)免克寧(vincl〇z〇lin) 蓋illl類挑選自下述之胍類(Guanidines): 多寧(dodine) -13· 200814928 (13-2)克熱淨(guazatine) (13-3)雙胍辛胺三乙酸鹽(iminoctadine triacetate) (13-4)克熱淨(烧苯石黃酸鹽)[iminoctadine tris(albesilate)] (13-5)多寧(dodine (游離驗)) 5 (13-6)克熱淨(immoctadine)(游離驗) 第(14)類 選自下述之口来口坐類(Imidazoles) · (14-1)赛座滅(cyazofamid) | (14-2) (14-3 )三嗤唤(triazoxide) ίο (14-4)稻痕 g旨(pefurazoate) 盖(15)類具式(X)之嗎啉類(或其鹽類、Η wherein R29 represents n- or isopropyl, R represents —(Ci-C)-alkyl)amino-C2-C4-alkyl or diethoxyphenyl, and 15 includes salts of these compounds; Poor (12) - selected from the following Dicarboximides · (12-1) tetramdan (captafol) (12_2) eptan (12. 3)培(f〇ipet) 20 (H4) 依普同 (ipr〇di〇ne) (12-5) 灭宁宁(proCymid〇ne) (12-6) 免克宁(vincl〇z〇lin) 盖ill class Selected from the following Guanidines: dodine -13· 200814928 (13-2) guazatine (13-3) diinoctyl triacetate (im3-4) ) 克热净 (burning benzoate) [iminoctadine tris (albesilate)] (13-5) donin (dodine) 5 (13-6) gram heat (immoctadine) (free test) (14) Classes are selected from the following mouths (Imidazoles) · (14-1) Cytofamid | (14-2) (14-3) Triazoxide ίο (14- 4) pefurazoate cover (15) morpholine (or its salt) of formula (X)
15 其中 R31及R32彼此獨立地代表氫或甲基, R33代表CrC14-烷基(較佳地為C12-C14-烷基),c5_C12-環烧 基(較佳地為ClQ-Cirb烧基)’本基-C1-C4-燒基,其可 在苯基部位經鹵素或CrCV烧基取代或代表丙烯基, 其可經氯苯基及二甲氧基苯基取代; 第(10類 具式(XI)之峨口各類(Pyrroles;、 -14- 20 200814928 -35 τWherein R31 and R32 independently of each other represent hydrogen or methyl, R33 represents CrC14-alkyl (preferably C12-C14-alkyl), c5_C12-cycloalkyl (preferably ClQ-Cirb). a radical -C1-C4-alkyl group which may be substituted at the phenyl moiety with a halogen or CrCV alkyl group or a propylene group which may be substituted with a chlorophenyl group and a dimethoxyphenyl group; XI) of all kinds of mouth (Pyrroles;, -14-20 200814928 -35 τ
其中 5 R34代表氯或氰基, R35代表氣或确基, R36代表氯, | R35及R36尚可一起代表-0-CF2-0·; 第Π7)類 挑選自下述之(硫)膦酸酯類: ίο (17-1)福賽得-鋁(fosetyl·A1) (17-2)膦酸 (17-3)曱基立枯鱗(toldophos-methyl) 第Π8)類 具式(XII)之苯基乙醯胺類Wherein 5 R34 represents chlorine or cyano, R35 represents gas or determinate, R36 represents chlorine, | R35 and R36 together represent -0-CF2-0·; and Π7) are selected from the following (thio)phosphonic acid Ester: ίο (17-1) Forsythia-aluminum (fosetyl·A1) (17-2) phosphonic acid (17-3) sulphate sulphate (toldophos-methyl) Π8) genus (XII) Phenylethylamine
(ΧΠ) 其中 R37代表無取代的或經氟-,氯·,溴-,曱基_或乙基-取代的 20 苯基,2-萘基,1,2,3,4-四氫萘基或茚滿基; 第Π9)類選自下述之殺真菌劑類 (19-1)苯并嘆二嗤酯(acibenzolar-S-methy 1) (19-2)氯塞尼(chlorothalonil) (19-3)克絕(cymoxanil) -15- 200814928 (19-4)護粒松(edifenplios) (19-5)凡殺同(famoxadone) (19-6)伏寄南(fluazinam) (19-7)氯氧化銅(copper oxychloride) 5(ΧΠ) wherein R37 represents unsubstituted or substituted by fluorine-, chloro, bromo-, decyl- or ethyl-substituted 20 phenyl, 2-naphthyl, 1,2,3,4-tetrahydronaphthyl Or 茚满基; Π9) is selected from the following fungicides (19-1) acibenzolar-S-methy 1 (19-2) chlorothalonil (19) -3) cymoxanil -15- 200814928 (19-4) granules (edifenplios) (19-5) where fascinated (famoxadone) (19-6) volts south (fluazinam) (19-7) Copper oxychloride 5
10 1510 15
(19-8) 氫氧化銅 (19-9)歐殺斯(oxadixyl) (19-10)螺環菌胺(spiroxamine) (19-11)二硫 S 昆(dkhianon) (19-12)表苯菌酮(metrafenone) (19-13) 口米哇菌酮(fenamidone) (19-14) 2,3-二丁基-6-氯噻吩并[2,3-d]嘧啶-4(3H)-酮 (19-15)撲殺熱(probenazole) (19-16)稻痕靈(isoprothiolane) (19-17)嘉賜黴素(kasugamycin) (19·18)熱必斯(phthalide) (19-19)富米熱斯(ferimzone) (19-20)三賽嗤(tricyclazole) (19-21) N-({4-[(環丙基胺基)羰基]苯基}磺醯基)-2-甲氧基 苯甲醯胺 (19-22) 2-(4-氯苯基)-N-{2-[3-f 氧基-4-(丙-2-炔-1-基氧) 苯基]乙基}丙-2-快-1 -基氧)乙酿胺 (19-23)快諾芬(quinoxyfen) 第(20)類挑選自下述之硫(脲)衍生物 (20-1)賓克隆(pencycuron) -16- 20 200814928 (20-2)曱基 _ 多保淨(thiophanate-methyl) (20-3)乙基-多保淨(thiophanate-ethyl) 第(21)類具式(XIII)之醯胺類(19-8) Copper hydroxide (19-9) oxadixyl (19-10) spiroxamine (19-11) disulfide S dkhianon (19-12) benzene Metrafenone (19-13) fenamidone (19-14) 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)- Ketone (19-15) probenazole (19-16) isofothiolane (19-17) kasugamycin (19.18) phthalide (19-19) Fermizone (19-20) tricyclazole (19-21) N-({4-[(cyclopropylamino)carbonyl)phenyl}sulfonyl)-2-methyl Oxybenzamide (19-22) 2-(4-chlorophenyl)-N-{2-[3-f-oxy-4-(prop-2-yn-1-yloxy)phenyl] Ethyl}propan-2-fast-1 -yloxy)ethinamide (19-23) quinoxyfen (20) selected from the following sulfur (urea) derivative (20-1) clone (pencycuron) -16- 20 200814928 (20-2) 曱 _ thiophanate-methyl (20-3) ethyl-polyphanate-ethyl (21) class (XIII) Amidoxime
CICI
其中among them
10 A7 代表一種直接鍵或-〇-, A8 代表-C(=0)NH·或-NHC(=0)-, R38代表氫或CrC4-烷基, R39代表CrC6-烧基; ΆίΖΖΙΜ 具式(XIV)之三唑# 嘧啶類(Triazolopvrimidines) 1510 A7 represents a direct bond or -〇-, A8 represents -C(=0)NH· or -NHC(=0)-, R38 represents hydrogen or CrC4-alkyl, R39 represents CrC6-alkyl; ΆίΖΖΙΜ XIV) Triazoles (Triazolopvrimidines) 15
其中 r4Q代表CVCV烷基或CVCV烯基, R41代表CrC6-烷基, R4G及R41也一起代表經1或2個的CrC6-烷基取代代基取 代之C4-Cr烷二基(亞烷基), •R42代表溴或氣, R及R 彼此獨立地代表氮,氣’氯或甲基’ R及R 彼此獨立地代表氮或氣, -17- 20 200814928 R 代表氫,氟或甲基, 篇(23)類 具式(XV)之破代色 j^WIodochromones) 〇Wherein r4Q represents CVCV alkyl or CVCV alkenyl, R41 represents CrC6-alkyl, and R4G and R41 together represent C4-Cr alkanediyl (alkylene) substituted with 1 or 2 CrC6-alkyl substituents. , R42 represents bromine or gas, R and R independently represent nitrogen, and gas 'chloro or methyl' R and R independently of each other represent nitrogen or gas, -17-20 200814928 R represents hydrogen, fluorine or methyl, (23) The break of the type (XV) j^WIodochromones) 〇
其中 R 代表CrC6-烧基, R49代表CrC6·烷基,C2-C6-烯基或CVC6-炔基; ΜΙΖ^ύΜ 具式 iXVI)之聯茉某藉德胺類(Biphenylcarboxamides)Wherein R represents CrC6-alkyl, R49 represents CrC6.alkyl, C2-C6-alkenyl or CVC6-alkynyl; ΜΙΖ^ύΜ has the formula iXVI) of Biphenylcarboxamides
其中 15 R 代表氫或氟, _ R51代表氟,氯,溴,甲基,三氟甲基,三氟甲氧基, -CH=N-OMe 或-C(Me)=N-OMe, 52 R 代表氫,氟,氯,溴,甲基或三I曱基,Wherein 15 R represents hydrogen or fluorine, _ R51 represents fluorine, chlorine, bromine, methyl, trifluoromethyl, trifluoromethoxy, -CH=N-OMe or -C(Me)=N-OMe, 52 R Represents hydrogen, fluorine, chlorine, bromine, methyl or tri-anthracene,
Het代表下述Hetl至Het7基之一:Het represents one of the following Hetl to Het7 bases:
53 R 代表碘,甲基,二氟曱基或三氟甲基, -18- 200814928 R54代表氫,氟,氯或曱基, R55代表甲基,二氟甲基或三氟甲基, R56代表氯,溴,碘,甲基,二氟甲基或三氟曱基, R57代表甲基或三氟曱基; 5 其中具式(XVI)的聯笨基羧醯胺與具式⑴的羧醯胺是不同 的; 第(25)類具式(XVII)之烷基羧醯胺類53 R represents iodine, methyl, difluorodecyl or trifluoromethyl, -18- 200814928 R54 represents hydrogen, fluorine, chlorine or sulfhydryl, R55 represents methyl, difluoromethyl or trifluoromethyl, R56 represents Chlorine, bromine, iodine, methyl, difluoromethyl or trifluoromethyl, R57 represents methyl or trifluoromethyl; 5 wherein the biphenyl carbamide of formula (XVI) and the carboxy hydrazine of formula (1) The amines are different; the alkyl carboxamides of formula (25) having the formula (XVII)
1010
其中among them
Het的定義如前, R58代表氫或氟, 15Het is defined as before, R58 stands for hydrogen or fluorine, 15
R59代表氫,鹵素,CrC3-烧基或具有1至7個的氟,氯及 /或溴原子之CrC3-鹵基烷基, 第(26)類具式(XVIII)之烷基羧醯胺類R59 represents hydrogen, halogen, CrC3-alkyl or CrC3-haloalkyl having 1 to 7 fluorine, chlorine and/or bromine atoms, and alkylcarboxamide having the formula (XVIII) of (26)
其中 r6()代表氫或氟, -19- 20 200814928 R代表氫,鹵素,Ci-C3-烷基或具有l至7個的氟,氯及 /或溴原子之cvc3-鹵基烷基。 A’代表下述A’l至A,8基之一Wherein r6() represents hydrogen or fluorine, and -19-20 200814928 R represents hydrogen, halogen, Ci-C3-alkyl or cvc3-haloalkyl having 1 to 7 fluorine, chlorine and/or bromine atoms. A' represents one of the following A'l to A, 8 bases
r62代表crc3-烷基, R 代表氫,鹵素,C1-C3-烷基或具有1至7個的氟,氣及 /或溴原子之crc3-鹵基烷基, r64代表氫,鹵素或CrC3-烷基, 15 R 5代表鹵素,CrCy烷基或具有1至7個的氟,氯及/或 ^ 溴原子之C1-C3-鹵基烧基, R 代表氬,鹵素或CrCy烧基,胺基,單-或二(crC3-烧 基)胺基, R 代表氫,鹵素,Ci_C3-烧基或具有1至7個的氟,氯及 20 /或溴原子之crc3-鹵基烷基, R 8代表鹵素,CrCV烧基或具有1至7個的氟,氯及/或 〉臭原子之C1-C3-鹵基烧基, r69代表鹵素,CrC3_烷基或具有1至7個的氟,氯及/或 漠原子之C1-C3- _基烧基, -20- 200814928 R7〇代表氳,鹵素,CrC3-烷基或具有1至7個的氟,氯及 /或溴原子之crc3-鹵基烷基。 5R62 represents crc3-alkyl, R represents hydrogen, halogen, C1-C3-alkyl or has 1 to 7 fluorine, gas and/or bromine atom crc3-haloalkyl, r64 represents hydrogen, halogen or CrC3- Alkyl, 15 R 5 represents halogen, CrCy alkyl or C1-C3-haloalkyl having 1 to 7 fluorine, chlorine and/or bromine atoms, R represents argon, halogen or CrCy alkyl, amine group , mono- or di(crC3-alkyl)amine, R represents hydrogen, halogen, Ci_C3-alkyl or a 1 to 7 fluoro, chloro and 20/ or bromo atomic crc3-haloalkyl, R 8 Represents halogen, CrCV alkyl or C1-C3-haloalkyl having 1 to 7 fluorine, chlorine and/or odor atoms, r69 representing halogen, CrC3_alkyl or having 1 to 7 fluorine, chlorine And/or C1-C3--based alkyl group of the atom, -20- 200814928 R7〇 represents hydrazine, halogen, CrC3-alkyl or crc3-halo having 1 to 7 fluorine, chlorine and/or bromine atoms alkyl. 5
10 1510 15
令人驚訝地,根據本發明的活性化合物組合物的殺真 菌的作用要比個別的活性化合物的活性之和大得多,於 是,有未被預期到的協乘效果存在,且非僅僅是相加的作 第(1)類的化合物以化學式(I)代表一般的定義。 較佳的式(I)之魏醯胺類為,其中 R 代表氫或氟, R1 代表氟,氯,溴,碘,曱基,乙基,正-丙基,異丙基, 三氟甲基,三氯甲基,氰基,甲氧基,乙氧基,正丙 氧基,異丙氧基,三氟曱氧基,三氯甲氧基或代表 -c(r4)=n-or5, R2 代表氫,氟,氯,溴,碘,曱基,乙基,正-丙基,異 丙基,三氟甲基,三氯曱基,氰基,甲氧基,乙氧基, 正丙氧基,異丙氧基,三氟甲氧基或代表三氯甲氧基, R4 代表氫或甲基, R5 代表CrC5_烷基。 特別佳的式⑴之羧醯胺類為,其中 R 代表氫或氟, R1代表氟,氯,曱基,三氟甲基,氰基,曱氧基,三氟 曱氧基,三氯曱氧基或代表-CH=N-OCH3, R2代表氫,氟,氯,曱基,三氟甲基,氰基,曱氧基, 三氟甲氧基或代表三氯甲氧基, -21 - 20 . 200814928 根據本發明的另一具體實施例中,較佳的具式⑴之後 酿胺類為其中R2基係位於聯苯基的遠端苯基環的2,_位置 者(鄰位於近侧的苯基環)。 式(I)包含特別是下述第(1)類之較佳的羧醯胺類(參 5 考:WO 2005/123689 及 WO 2005/123690): (1-1) N-(3,4 - 一氯聯苯基-2-基)-1-甲基-3-(三氟甲 基)-1Η』比备4-緩醯胺,(ι·2)Ν-(3、氯卓氟聯苯基基; _ 甲基-3-(三氟甲基)-1Η-吡唑羧醯胺,(1-3) N-(2,,4,-二氯聯 笨基-2-基)-1-甲基-3-(三氟甲基)·1Η_吡唑-4_羧醯胺,(1_4) Ν伐4’·二氟聯苯基-2-基)小甲基各(三說甲基)_m』比唑斗 羧醯胺,(1-5) N-(2,,5,-二氯聯苯基1基)小甲基各(三氣甲 基HH4嗤冰羧醯胺,(1_6)邮^二說聯苯基冬基)* 甲基-3-(二氟曱基)·1Η』比唾竣酿胺,(卜乃N_(4,·氯1說 聯笨基4基)-1-甲基|(三氟甲基HH•吼嗤*護醢胺,(卜0 15 队(心氣_2,-甲基聯笨基士基)小甲基冬(三敦曱基)_1H』比 • 唾+㈣胺,(1·9) 基聯苯基_2.基)]-甲基 =(三默甲基)-1Η-㈣-4遵酿胺,(1]〇) N书,备甲基聯 笨基-2-基)小曱基-3-(三氟甲私m•吼嗤*綾酿胺, 队(4’_敦_3’·甲基聯笨基1基)小甲基_3_(三敦甲基咣 唾冰賴胺,(1_12) N-(4,mr-甲基聯苯基冬基)+ 甲基-3-(二氟曱基)-ih』h4·敢酿胺,〇一⑶Νκ二氣 聯笨基-2-基)小甲基各(三氟甲基)m4-魏酿胺, (1-14) N-(2’-氣本甲氧基聯笨基·2_基)小甲基_3 _(三氟甲 基MH-口比冬4-羧醯胺,(1七)队(2,,6,_二氟聯苯基么基)小 -22 - 200814928 甲基各(三氟甲基)-lH-吡唑冬羧醯胺,(1-16)Ν-(3,,5,-二甲 基聯苯基-2-基)小曱基各(三氟甲基)_1H_吡唑-4-羧醯胺, 〇17) N-(4’-氯-3’-硝基聯苯基-2-基)-1-甲基_3-(三氟甲 基)-1Η-吼唑4-羧醯胺,(Μ8)Ν-[3\5,-雙(三氟甲基)聯苯基 5 冬基l·1,甲基各(三氟甲基)-lH-吡唑-4-羧醯胺,(1-19) Ν-(3,4 -一甲基聯苯基-2-基)-1-甲基-3-(三氟甲基坐 -4-羧醯胺,(1-20) 1-甲基硝基-3,-(三氟甲基)聯苯基 | -2-基]各(三氟甲基)-1Η^比唑-4-叛醯胺,(1-21) Ν-(4,-甲氧基 -3’-甲基聯苯基-2-基)_1-甲基-3-(三敗甲基緩醯 ίο 胺,二曱氧基聯苯基-2-基)-1-甲基-3-(三氟曱 基)-1Η-吼唑‘羧醯胺’(1·23)Ν-(3,-氟_4,-甲氧基聯苯基-2-基)小曱基-3 -(三氟甲基)-1ΙΚ唾-4-羧酿胺,.(1-24) Ν-(4,_ 氯-3’-甲氧基聯苯基冬基)小甲基_3-(三氟曱基)·1Η^比唑本 綾酿胺,(1-25) Ν·[4’_氯-3’-(三氟曱基)聯苯基·2_基]小甲基 15 -3_(三氟曱基)-1Η^比峻-4-羧醯胺,(1-26) Ν-(3,,5,-二氯聯苯 _ 基-2-基)-1-甲基-3-(三氟曱基比哇-4-叛酿胺,(1-27) >Η4,-甲氧基-2,_甲基聯苯基-2-基)_1_甲基·3_(三氟甲 基)-1Η-吡唑4-羧醯胺,(1-28)Ν-(3,,4^二氯聯笨基_2_基)小 曱基-3-(二氟曱基坐_4·魏酿胺,(1_29) N-(3,-氣-4,· 20 氟聯苯基冬基)-1•甲基-3-(二氣甲基比哇-4-緩醯胺, (1_30) N-(2f,4’-二氯聯苯基-2-基)小甲基_3_(二氟甲基)·ΐΗ_ 吡唑冰羧醯胺,(1-31) N-(3,,4,-二氟聯苯基士基)小甲基 -M二氟甲基)-1Η-°比唑-4-羧醯胺,(1·32) N-(2,,5,-二氯聯笨 基冬基)小甲基-3-(二氟甲基)-111-%唑_4-羧酿胺,(卜33) -23- 200814928 N-(2f,5’-二氟聯苯基-2-基)-1-甲基-3-(二氟甲基)_1Η-ϋ比唑 羧醯胺,(I-34) Ν·(4,-氯-2,·1聯苯基1基)+甲基各(二氟 甲基ΗΗ·-比唑-4-羧醯胺,(l-35)N-(4,-氣_2,_甲基聯苯基_2_ 基)-l-曱基-3-(二氟甲基)-lH-吡唑-4-綾醯胺,(1_36)N-(4f_ 5 氯-3 -甲基聯苯基-2-基)-1-甲基-3-(二氟甲基坐冰羧 醯胺,(1·37)队(4,-氟_2,-甲基聯苯基j基)小曱基各(二氟 甲基)-1Η^比唑冰羧醯胺,(1-38)义(4,-氟-3,_曱基聯苯基_2_ | 基)-1-甲基冬(二氟甲基)-1Η-ϋ比嗤-4-緩驗胺,(1_39) Ν-(4,_ 氯-3’-氟-2’-甲基聯苯基-2-基)-1-曱基各(二氟甲基)_道_吼唾 ίο -4-羧酿胺 ’(1-40) N-(2’,4’-二氟聯苯基-2-基)-1_ 甲基_3_(二氣^ 甲基)-1Η-吡唑冰羧醯胺,(1-41) N-(2,-氟-4’-甲氧基聯笨基 -2-基)-1-甲基 _3-(二氟甲基羧酿胺,(1-42) Ν-ΡΆ1-一氟聯苯基-2-基)-1-甲基-3-(二 I 甲基坐-4· 羧醯胺,(1-43) N-(3f,5,-二甲基聯苯基-2-基)小曱基-3-(二說 is 甲基)-1Η-吡唑-4-羧醯胺,(1·44) N-(4,-氯-3’·硝基聯苯基-2- _ 基)小甲基各(二氟甲基)-1Η-吡唑-4-羧醯胺,(1-45) N-[3,,5,- 雙(二氟甲基)聯苯基-2-基]-1-曱基-3-(二說甲基唾 -4-羧醯胺,(1-46) Ν-(3’,4’-二甲基聯苯基-2-基)-1-甲基-3-(二 氟甲基)-1Η-吡唑-4-羧醯胺,(1-47) 1-曱基-N-[4,-硝基-3H三 2〇 氟甲基)聯苯基-2-基]-3-(二氟曱基)-1Η^比唑-4-羧醯胺, (1-48) N-(4’-甲氧基-3’-甲基聯苯基-2-基)-1-甲基-3-(二氟甲 基)-1Η-吡唑-4-羧醯胺,(1·49) N-(3’,4’-二甲氧基聯苯基-2-基)-1-甲基-3-(二氟甲基)-1Η·吼唑-4-羧醯胺,(1-50) N-(3’-氟甲氧基聯苯基-2-基)小曱基-3-(二氟甲基ΜΗ-吼唑-4- -24- 200814928 羧醯胺,(1_51) N-(4,-氯-3,·甲氧基聯苯基·2-基)小甲基 各(二氟甲基)-1Η』比唑|羧醯胺,(1-52) N-[4f-氯-3,-(三氟 曱基)聯苯基冬基]小甲基各(二氟甲基)-1Η^比唑-4-羧醯 胺’(1-53) Ν-(3’,5,-二氯聯苯基_2_基)小曱基各(二氟甲 基)-1Η-吡唑-4-羧醯胺,(1-54) Ν-(4,·甲氧基-2,-甲基聯苯基 -2-基)小曱基冬(二氟曱基)_ΐΗ-π比唑_4_羧醯胺,(1-55) 3-(二 氟甲基[⑹-(甲氧基亞胺基)甲基]-u,-聯苯基 -2-基}小甲基-1仏吡唑羧醯胺,(1-56) 3兴三氟甲 基[(五)-(曱氧基亞胺基)曱基]_;[,;[,-聯苯基_2_ 基}-1-甲基-1//-吡唑-4-羧醯胺,[(五)-(甲氧基亞 胺基)甲基]-聯苯基-2-基}小曱基冬(三氟曱基)-1//-吡唑4-羧醯胺,(1_58) >(二氟甲基)善《4,_[⑹彳曱氧基亞胺基)甲 基]聯苯基_2_基}小曱基-1乐。比唑冰羧醯胺,(1-59) [(五Μ正-丁氧基亞胺基)甲基]聯苯基-2-基}-1-甲基 -3-(三氟甲基)比唑-4-羧醯胺,(1-60) Ν-{4,-[(1Ζ)-Ν-乙 氧基乙醯亞胺基]聯苯基冬基}小甲基冬(三氟曱基)-1//-吡 唾4-羧醯胺,(1-61) 1-甲基-尽{4,-[(1Ζ)-Ν-丙氧基乙醯亞胺 基]聯苯基-2-基}3·(三氟甲基比ϋ坐-4-叛酸胺,(1-62) 1{44⑹-(異丙氧基亞胺基)曱基]聯苯基冬基}-]-甲基 -3-(三氟甲基)-1/^比唑_4_羧醯胺,(1_63)#-{4,-(£>(乙氧基 亞胺基)曱基}聯本基-2-基]-1-曱基-3-(三氣曱基)-1//-u比唾 -4-羧酸胺’(1-64) 1-曱基-翠{4,-[(£>(丙氧基亞胺基)曱基] 聯苯基-2-基卜3-(三氟曱基比唑_4_羧醯胺,(1-65) A^{44(1Z)-N-異丙氧基乙醯亞胺基]聯苯基_2_基卜1-甲基 -25- 200814928 冬(三氟甲基)-1及·吡唑-4-羧醯胺,(1-66) 7V-{4,_[(1Z)-N-丁 氧基乙醯亞胺基]聯苯基-2-基卜1-曱基-3-(三氟甲基)-1丹_观 唑-4-羧醯胺,(1-67),{3,-氯-4,-[(五)-(曱氧基-亞胺基)甲基] 聯本基-2-基}-1-甲基-3-(三氣甲基)-1//-°比嗤-4-綾酸胺, 5 (1-68) 曱氧基亞胺基)甲基]聯苯基-2-基}小甲基 冬(三氟甲基)-1私吡唑-4-羧醯胺,(1-69)尽{4,-[(1Ε)-Ν-甲 氧基乙醯亞胺基]聯苯基-2-基}-1-曱基-3-(三氟甲基)-1私吡 | 唑冰羧醯胺,(1-70) 7V-{3L氟-4’-[(£>(甲氧基亞胺基)甲基] 聯苯基-2-基}-1-甲基-3-(三氟甲基)-1丑-吡唑-4-羧醯胺, ίο U-71) Μ二氟甲基氟-4’-[(五)-(甲氧基亞胺基)曱基] 聯苯基-2-基}-1-甲基-1//-吡唑冬羧醯胺,(1-72) 環丙基甲氧基)亞胺基]甲基卜聯苯基_2-基)小 甲基各(三氟曱基)-m-吡唑-4-羧醯胺,(1-73) ?H4,-[(五Η丁 氧基亞胺基)甲基]聯苯基_2-基}-3-(二氟甲基)-1-曱基-1乐 15 啦唑-本羧醯胺,(1-74) 3-(二氟曱基)U4,-[(1E)-N-甲氧基 _ 乙醯亞胺基]聯笨基-2-基}-1_甲基-1//-吡唑_4_羧醯胺,(1-75) ’{3'氟-4’-[(五)-(丙氧基亞胺基)甲基]聯苯基_2-基}小甲基 -3-(三氟甲基)-1/^吡唑冬羧醯胺,(1_76) 3-(二氟甲 基氟-44(£>(丙氧基亞胺基)甲基]聯苯基_2-基}小 20 曱基―1#•吡唑l羧醯胺,(1-77),{2,-氯-4,-[(五)-(甲氧基亞 胺基)甲基]聯苯基-2-基卜1-曱基_3·(三氟甲基)-1开-。比唑-4-羧蕴胺,(1-78) I{3’H[(1E)-N-丙氧基乙醯亞胺基]聯苯 基-2-基}小甲基-3-(三氟甲基)·ιπ。比唑-4-羧醯胺,(1-79) 3-(二氟甲基)善{3,-氟-4,-[(1Ε)-Ν-丙氧基乙醯亞胺基]聯苯 -26 - 200814928 基-2-基}小甲基-1//-吼哇-4-魏醯胺,(1-80) 3-(二氟曱 基)-尽{3’-氟·4’-[(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基-2-基}小甲基-1好-°比唑-4-羧醯胺,(1-81) Λ^{3,_1-4,-[(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基-2-基}小曱基冬(三氟曱基)-1仄 吡唑-4-羧醯胺,(1-82),{3,-氯-4,-[(^)-:^-甲氧基乙醯亞胺 基]聯苯基-2-基}-3-(二氟甲基)-1·曱基比唾-4-羧:酿胺, (1-83) 氯-44(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基-2-基}-1_甲基-3-(三I甲基)-1//-°比嗤-4-緩蕴胺,(1-84) 3-(二氟 甲基Μ -甲基-ΑΜ4’-[⑹-(丙氧基亞胺基)曱基]聯苯基-2-基}-1丑-吼唑-4-羧醯胺,(1-85) ΛΓ-{4,-[(五)-(甲氧基亞胺基) 甲基]-31-甲基聯苯基-2-基}-1-甲基冬(三氟甲基)-1好-吼唑 冰羧醯胺,(1-86) 3-(二氟甲基)小甲基U4,-[(lE)-isl·丙氧 基乙醯亞胺基]聯苯基-2-基}-1//_吡唑-4-羧醯胺,(1-87) 3-(二氟曱基)-ΛΓ-{44(1 E)-N-異丙氧基乙醯亞胺基]聯苯基 -2-基}-1-曱基·ΐπ吡唑-4-羧醯胺,(1·88) Ν-(4,-{(Ζ)-[(烯丙 氧基)亞胺基]曱基}聯本基-2-基)-3-(二氟^甲基)-1 -甲基-1 吼唑-4-羧醯胺,(1-89)Ν-(4,-{(ΖΗ(烯丙氧基)亞胺基]甲基} 聯苯基-2-基)-1·甲基-3-(三氟曱基)-1//-吼唑-4-羧醯胺, (1-90) 3-(二氟甲基[(五)-(甲氧基亞胺基)曱基]·3’-甲 基聯本基-2-基}-1-曱基-1//- ϋ比嗤-4-叛酿胺’(1-91) I{4’-{(1Z)-N-(烯丙氧基)乙醯亞胺基}聯苯基-2-基}小甲基 -3-(三氟曱基)_ι//·π比唑_4·羧醯胺,(1-92)ΛΜ4,·[(1Ε)-Ν-(烯 丙氧基)乙醯亞胺基]聯苯基-2-基}-3-(二氟曱基)-1-甲基 -1//-吡唑-4-羧醯胺,(1-93) Λ^{4,-[(1Ε)-Ν-(丁-2-炔_1_基氧) -27- 200814928 乙醯亞胺基]聯苯基-、基卜^甲基_3_(三氟甲基凡吡唑_4_ 羧醯胺,(1-94)1-曱基#(4,-{(1Ε)-Ν-[(1-甲基丙-2-烯小基) 氧]乙醯亞胺基}聯苯基-2-基)-3-(三氟甲基)-1私吡唑_4_羧 醯胺,(1-95) 1-曱基-Λ44’-{(ιε)-Ν·[(2-甲基丙-2-烯-1-基)氧] 5 乙醯亞胺基}聯苯基基)-3-(三氟甲基)-1//-啦唑_4-鲮醯 胺,(1-96) 1-曱基-iV-{4’-[(lE)-N-(丙-2-炔-1-基氧)-乙醯亞胺 基]聯苯基-2-基卜3-(三氟甲基比唾4-叛酿胺,(1-97) | Μ—氟甲基)-1-甲基專{4’-[(lE)-N-(丙H)-基氧]乙酿 亞胺基}聯苯基-2-基}-1/^比α坐_4_缓酸胺,(1-98) #-{2,-氣 10 本[⑹_(甲氧基亞胺基)甲基]聯笨基冬基卜3-(二氟甲基)小 甲基-1乐吡唑-4-羧醯胺,(1-99) 曱氧基亞胺基) 曱基]-2’-甲基聯苯基-2-基}-1-甲基}-3-(三氟甲基)-17^比唑 -4-羧醯胺,(1-100) #_{4,-[(1Ζ)-Ν-丁氧基乙醯亞胺基]聯笨 基-2-基}各(二氟甲基)小甲基比0坐_4_羧醯胺,(i-ioi) 15 3_(二氟曱基[(五Η異丙氧基亞胺基)甲基]聯苯基-2- _ 基}小甲基-1/ί- 0比嗤-4-叛醯胺,(1-102) 3-(二氟甲 基)-尽{4’-[(五)-(甲氧基亞胺基)曱基]-2,-甲基聯苯基-2-基}-1-曱基比唾-4-羧醯胺,(1_1〇3)豕{3,_氯-44(五)-(甲 氧基亞胺基)曱基]聯苯基-2-基}-3-(二氟甲基)-1-甲基-1//-2〇 吡唑-4-羧醯胺,(1-104) 3-(二氟曱基)-ΛΓ-{2,-氟-4,-[(五)-(曱氧 基亞胺基)甲基]聯苯基-2-基}_1_曱基-17/ -σ比tr坐叛酿胺, (1·105) M{2’-氟-4’-[(幻-(甲氧基亞胺基)甲基]聯苯基-2-基}-1 -甲基-3-(三敦曱基魏酿胺。 式(II)的化合物包含下述較佳的第(2)類之混合配對物: -28- 200814928 (2-1)亞托敏(azoxystrobin)(得知自:EP-A 0382 375),具化 學式為: 〇Surprisingly, the fungicidal effect of the active compound compositions according to the invention is much greater than the sum of the activities of the individual active compounds, so that unanticipated synergistic effects exist and are not merely phases The compound added as the class (1) represents the general definition by the formula (I). Preferred derivatives of the formula (I) are those wherein R represents hydrogen or fluorine, and R1 represents fluorine, chlorine, bromine, iodine, decyl, ethyl, n-propyl, isopropyl, trifluoromethyl. , trichloromethyl, cyano, methoxy, ethoxy, n-propoxy, isopropoxy, trifluoromethoxy, trichloromethoxy or -c(r4)=n-or5, R2 represents hydrogen, fluorine, chlorine, bromine, iodine, decyl, ethyl, n-propyl, isopropyl, trifluoromethyl, trichloroindolyl, cyano, methoxy, ethoxy, n-propyl Oxy, isopropoxy, trifluoromethoxy or represents trichloromethoxy, R4 represents hydrogen or methyl, and R5 represents CrC5-alkyl. Particularly preferred carboxyguanamines of the formula (1) are those wherein R represents hydrogen or fluorine, and R1 represents fluorine, chloro, decyl, trifluoromethyl, cyano, decyloxy, trifluoromethoxy, trichlorophosphonium Or represents -CH=N-OCH3, R2 represents hydrogen, fluoro, chloro, decyl, trifluoromethyl, cyano, decyloxy, trifluoromethoxy or trichloromethoxy, -21 - 20 According to another embodiment of the present invention, preferred amines of formula (1) are those in which the R 2 group is located at the 2,_ position of the distal phenyl ring of the biphenyl group (nearly adjacent) Phenyl ring). The formula (I) comprises, in particular, the preferred carboxamides of the following class (1) (Ref. 5: WO 2005/123689 and WO 2005/123690): (1-1) N-(3,4 - Monochlorobiphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1Η" than 4-sulfenylamine, (ι·2)Ν-(3, chlorobenzo fluoride biphenyl Base; _ methyl-3-(trifluoromethyl)-1Η-pyrazole carboxamide, (1-3) N-(2,4,-dichlorobiphenyl-2-yl)-1 -methyl-3-(trifluoromethyl)·1Η_pyrazole-4_carboxamide, (1_4) Ν伐 4'·difluorobiphenyl-2-yl) small methyl each (three said A Base)_m"pyrazole carboxamide, (1-5) N-(2,5,2-dichlorobiphenyl 1 yl) small methyl each (trimethylmethylHH4 嗤 ice carboxamide, ( 1_6) post ^ two said biphenyl winter base) * methyl-3-(difluoroindolyl) · 1Η" than salivary amine, (Bai N_ (4, · chlorine 1 said joint stupid base 4 base) -1-methyl|(trifluoromethyl HH•吼嗤* oxime, (Bu 0 15 team (heart 2,-methyl phenyl), small methyl winter (Santun 曱基)_1H 』••Sal+(tetra)amine, (1·9) phenylbiphenyl-2.yl)]-methyl=(trimethyl)-1Η-(tetra)-4 amide, (1)〇) N book , Methyl phenyl phenyl-2-yl) sulfhydryl-3-(trifluoromethyl)嗤* 绫 胺 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Methylbiphenylmethane)+methyl-3-(difluoroindolyl)-ih』h4·Dangan, 〇(3)Νκ二气联基基-2-yl)小methyl each (trifluoromethyl) Base) m4-Weiamine, (1-14) N-(2'-gas methoxy-linked phenyl 2) benzyl-3-yl _(trifluoromethyl MH-mouth than winter 4- Carboxylamamine, (17) team (2,6,-difluorobiphenylmethylene) small-22 - 200814928 methyl (trifluoromethyl)-lH-pyrazole winter carboxamide, (1 -16) Ν-(3,,5,-dimethylbiphenyl-2-yl) benzhydryl (trifluoromethyl)_1H-pyrazole-4-carboxamide, 〇17) N-( 4'-Chloro-3'-nitrobiphenyl-2-yl)-1-methyl-3-(3-trifluoromethyl)-1Η-indazole 4-carboxamide, (Μ8)Ν-[3 \5,-bis(trifluoromethyl)biphenyl 5 meryl l·1, methyl each (trifluoromethyl)-lH-pyrazole-4-carboxamide, (1-19) Ν-( 3,4-Methylbiphenyl-2-yl)-1-methyl-3-(trifluoromethyl-s-carboxycarboxamide, (1-20) 1-methylnitro-3, -(trifluoromethyl)biphenyl |-2-yl](trifluoromethyl)-1Η^bazole-4-treazone, (1-21) Ν-(4,-Methoxy-3'-methylbiphenyl-2-yl)_1-methyl-3-(tri-f-methyl hydrazide), dimethoxybiphenyl-2- ))-1-methyl-3-(trifluoromethyl)-1 Η-carbazole 'carboxycarboxamide' (1·23) Ν-(3,-fluoro-4,-methoxybiphenyl-2 -yl) benzhydryl-3 -(trifluoromethyl)-1 oxime-4-carboxychiral amine, (1-24) Ν-(4,_chloro-3'-methoxybiphenyl winter base ) small methyl 3-(3-trifluoromethyl)·1Η^biazole benzalamine, (1-25) Ν·[4'_chloro-3'-(trifluoromethyl)biphenyl·2 _ base] small methyl 15 -3_(trifluoromethyl)-1 Η ^ 峻 醯 carboxy carbamide, (1-26) Ν-(3,,5,-dichlorobiphenyl _ -2- -1-methyl-3-(trifluoromethyl babi-4-reamine, (1-27) > Η4,-methoxy-2, _methylbiphenyl-2-yl )_1_Methyl·3_(trifluoromethyl)-1Η-pyrazole 4-carboxamide, (1-28) Ν-(3,4^ dichlorobiphenyl-2-yl) fluorenyl -3-(difluoroindolyl sit _4·Wei-enamine, (1_29) N-(3,-gas-4,·20 fluorobiphenylmethanol)-1•methyl-3-(two gas Kibiw-4-sulfonamide, (1_30) N-(2f,4'-dichlorobiphenyl-2-yl)small methyl_3_(difluoromethyl)·ΐΗ_pyrazole ice carboamide , (1-31) N- (3,4,4-difluorobiphenylyl)methylene-M difluoromethyl)-1Η-°Bizozol-4-carboxyguanamine, (1·32) N-(2,,5 ,-dichlorobiphenyl mercapto) small methyl-3-(difluoromethyl)-111-% azole _4-carboxycarnitine, (Bu 33) -23- 200814928 N-(2f,5'- Difluorobiphenyl-2-yl)-1-methyl-3-(difluoromethyl)_1Η-indopazole carboxamide, (I-34) Ν·(4,-chloro-2,·1 Biphenyl 1 yl) + methyl each (difluoromethyl hydrazine - azole azole carboxy carbamide, (l-35) N-(4, - gas_2, _methylbiphenyl_2_ -l-mercapto-3-(difluoromethyl)-lH-pyrazole-4-decylamine, (1_36) N-(4f_ 5 chloro-3-methylbiphenyl-2-yl) -1-methyl-3-(difluoromethyl-sodium carbofuramide, (1·37) team (4,-fluoro-2,-methylbiphenylj-yl) fluorenyl (difluorocarbamate) Base)-1Η^biazole ice carbofuramide, (1-38) sense (4,-fluoro-3,-mercaptobiphenyl-2-yl)-1-methyl winter (difluoromethyl)- 1Η-ϋ比嗤-4--test amine, (1_39) Ν-(4,_chloro-3'-fluoro-2'-methylbiphenyl-2-yl)-1-indenyl (difluoro Methyl)_道_吼吼ίο -4-carboxyl-amine '(1-40) N-(2',4'-difluorobiphenyl-2-yl)-1_methyl_3_(二气^ Methyl)-1Η-pyrazole ice carboxy Amine, (1-41) N-(2,-fluoro-4'-methoxybiphenyl-2-yl)-1-methyl-3-(difluoromethylcarboxylate, (1-42) ) Ν-ΡΆ1-fluorobiphenyl-2-yl)-1-methyl-3-(di-Imethyl-s--4-carboxycarboxamide, (1-43) N-(3f,5,-two Methylbiphenyl-2-yl) benzhydrin-3-(two isis methyl)-1Η-pyrazole-4-carboxamide, (1·44) N-(4,-chloro-3' · Nitrobiphenyl-2- yl) small methyl each (difluoromethyl)-1 Η-pyrazole-4-carboxamide, (1-45) N-[3,,5,- bis ( Difluoromethyl)biphenyl-2-yl]-1-indolyl-3-(dimethylsulfate-4-carboxamide, (1-46) Ν-(3',4'-dimethyl Base phenyl-2-yl)-1-methyl-3-(difluoromethyl)-1 Η-pyrazole-4-carboxamide, (1-47) 1-mercapto-N-[4, -nitro-3H tris(2)fluoromethyl)biphenyl-2-yl]-3-(difluoroindolyl)-1Η^bazole-4-carboxamide, (1-48) N-(4 '-Methoxy-3'-methylbiphenyl-2-yl)-1-methyl-3-(difluoromethyl)-1Η-pyrazole-4-carboxyguanamine, (1·49) N-(3',4'-Dimethoxybiphenyl-2-yl)-1-methyl-3-(difluoromethyl)-1Η·carbazole-4-carboxamide, (1- 50) N-(3'-fluoromethoxybiphenyl-2-yl) benzhydrin-3-(difluoromethylhydrazine-hydrazine -4- -24- 200814928 Carboxylamidine, (1_51) N-(4,-chloro-3, methoxybiphenyl-2-yl) small methyl (difluoromethyl)-1Η Carbazole|Carboxylamidine, (1-52) N-[4f-chloro-3,-(trifluoromethyl)biphenylmungyl]methylenemethyl(difluoromethyl)-1Η^bazole-4 - Carboxylamamine '(1-53) Ν-(3',5,-Dichlorobiphenyl-2-yl)beryl (difluoromethyl)-1Η-pyrazole-4-carboxyguanamine ,(1-54) Ν-(4,·methoxy-2,-methylbiphenyl-2-yl)beryl mercapto (difluoroindolyl)_ΐΗ-π-pyrazole_4_carboxamide ,(1-55) 3-(Difluoromethyl[(6)-(methoxyimino)methyl]-u,-biphenyl-2-yl}smallmethyl-1pyrazole carboxamide ,(1-56) 3H-trifluoromethyl[(5)-(decyloxyimino)indolyl]-;[,;[,-biphenyl-2-yl}-1-methyl-1 //-pyrazole-4-carboxyguanamine, [(5)-(methoxyimino)methyl]-biphenyl-2-yl} beryllyl winter (trifluoromethyl)-1/ /-pyrazole 4-carboxyguanamine, (1_58) > (difluoromethyl) good "4, _[(6) oximeimido) methyl] biphenyl-2-yl} fluorenyl -1 music. Butyrazole carbamazepine, (1-59) [(quinone-n-butoxyimino)methyl]biphenyl-2-yl}-1-methyl-3-(trifluoromethyl) Biazole-4-carboxydecylamine, (1-60) Ν-{4,-[(1Ζ)-Ν-ethoxyethyl quinone imino]biphenyl meryl} small methyl winter (trifluoromethane -1//-pyridin 4-carboxydecylamine, (1-61) 1-methyl-exhaustion of {4,-[(1Ζ)-fluorenyl-propoxyacetamido]biphenyl- 2-yl}3·(trifluoromethyl ϋ -4--4--4-oxo-amine, (1-62) 1{44(6)-(isopropoxyimino)indolyl]biphenyl-glycolyl}-] -methyl-3-(trifluoromethyl)-1/^biazole_4_carboxamide, (1_63)#-{4,-(£>(ethoxyimino)indolyl} Benyl-2-yl]-1-mercapto-3-(trimethylsulfonyl)-1//-u than sal-4-carboxylic acid amine '(1-64) 1-mercapto-cui {4, -[(£>(propoxyimino)indolyl]biphenyl-2-ylbu-3-(trifluoromethylpyrazole-4-4carboxamide, (1-65) A^{44 (1Z)-N-isopropoxyacetammine]biphenyl-2-yl-2-methyl-25- 200814928 Winter (trifluoromethyl)-1 and pyrazole-4-carboxyindole Amine, (1-66) 7V-{4,_[(1Z)-N-butoxyacetamido]biphenyl-2-ylbu 1-indolyl-3-(trifluoromethyl) -1 Dan _ oxazol-4-carboxyguanamine, (1-67 ),{3,-chloro-4,-[(5)-(decyloxy-imino)methyl] hydrazino-2-yl}-1-methyl-3-(trimethylmethyl) -1//-° than 嗤-4-decanoate, 5 (1-68) decyloxyimido)methyl]biphenyl-2-yl}small methyl winter (trifluoromethyl)- 1 private pyrazole-4-carboxyguanamine, (1-69) to the end of {4,-[(1Ε)-Ν-methoxyethylidene imino]biphenyl-2-yl}-1-fluorenyl -3-(trifluoromethyl)-1 pirin | azole ice carboxamide, (1-70) 7V-{3L fluoro-4'-[(£>(methoxyimino)methyl] Biphenyl-2-yl}-1-methyl-3-(trifluoromethyl)-1 ugly-pyrazole-4-carboxamide, ίο U-71) Μdifluoromethylfluoro-4'- [(5)-(Methoxyimino)indenyl]biphenyl-2-yl}-1-methyl-1//-pyrazole winter carboxamide, (1-72) cyclopropyl Oxy)imido]methylidene-2-yl)methylmethyl(trifluoromethyl)-m-pyrazole-4-carboxamide, (1-73) ?H4,-[ (5Η Butoxyimino)methyl]biphenyl-2-yl}-3-(difluoromethyl)-1-indolyl-1-le-15-oxazole-carbocarboxamide, (1- 74) 3-(Difluoroindenyl) U4,-[(1E)-N-methoxy-ethylideneimido]biphenyl-2-yl}-1_methyl-1//-pyrazole _4_Carboxyamine, (1-75) '{3' Fluor-4'-[(five )-(propoxyimino)methyl]biphenyl-2-yl}small methyl-3-(trifluoromethyl)-1/^pyrazolecarboxamide, (1_76) 3-( Difluoromethylfluoro-44 (£>(propoxyimino)methyl]biphenyl-2-yl}small 20 fluorenyl-1#•pyrazole 1 carboxamide, (1-77) ,{2,-chloro-4,-[(5)-(methoxyimino)methyl]biphenyl-2-ylbu-1-indolyl_3·(trifluoromethyl)-1 -. Biazole-4-carboxycyanamine, (1-78) I{3'H[(1E)-N-propoxyethylideneimido]biphenyl-2-yl}small methyl-3-( Trifluoromethyl)·ιπ. Biazole-4-carboxyguanamine, (1-79) 3-(difluoromethyl)-good {3,-fluoro-4,-[(1Ε)-fluorenyl-propoxyacetamido]biphenyl -26 - 200814928 benzyl-2-yl}small methyl-1//-吼w-4--4-carbylamine, (1-80) 3-(difluoroindolyl)-exhaustive {3'-fluoro·4' -[(1Ε)-Ν-methoxyethinium imino]biphenyl-2-yl}small methyl-1--pyrazole-4-carboxamide, (1-81) Λ^{ 3, _1-4,-[(1Ε)-Ν-methoxyethyl quinone imino]biphenyl-2-yl} hydrazinoyl (trifluoromethyl)-1 pyrazole-4-carboxylate Indoleamine, (1-82), {3,-chloro-4,-[(^)-:^-methoxyacetamido]biphenyl-2-yl}-3-(difluoromethyl) Base)-1 - mercaptopyrene-4-carboxyl: tyrosine, (1-83) chloro-44(1Ε)-Ν-methoxyethoxylated imino]biphenyl-2-yl}-1 _Methyl-3-(tri-Imethyl)-1//-° than 嗤-4-sodium amide, (1-84) 3-(difluoromethyl hydrazine-methyl-ΑΜ4'-[(6)- (propoxyimino)indenyl]biphenyl-2-yl}-1 ugly-oxazole-4-carboxyguanamine, (1-85) ΛΓ-{4,-[(5)-(A Oxyimido)methyl]-31-methylbiphenyl-2-yl}-1-methyl winter (trifluoromethyl)-1-carbazole carbamide, (1-86) 3-(Difluoromethyl)small methyl U4,-[(lE)-isl·propoxyacetamidine Imino]biphenyl-2-yl}-1//-pyrazole-4-carboxamide, (1-87) 3-(difluoroindolyl)-indole-{44(1 E)-N -isopropoxyacetammine]biphenyl-2-yl}-1-indolyl ΐπpyrazole-4-carboxyguanamine, (1·88) Ν-(4,-{(Ζ) -[(allyloxy)imino]indenyl}bibenyl-2-yl)-3-(difluoro(methyl)-1 -methyl-1 oxazole-4-carboxamide, ( 1-89) Ν-(4,-{(ΖΗ(allyloxy)imino]methyl}biphenyl-2-yl)-1·methyl-3-(trifluoromethyl)-1 //-carbazole-4-carboxamide, (1-90) 3-(difluoromethyl[(penta)-(methoxyimino)indolyl]·3'-methylbenzidine- 2-yl}-1-indolyl-1//- ϋ比嗤-4-Rebel amine '(1-91) I{4'-{(1Z)-N-(allyloxy)ethene Amino}biphenyl-2-yl}small methyl-3-(trifluoromethyl)_ι//·π-pyrazole_4·carboxamide, (1-92)ΛΜ4,·[(1Ε)- Ν-(allyloxy)acetammine]biphenyl-2-yl}-3-(difluoroindolyl)-1-methyl-1//-pyrazole-4-carboxamide (1-93) Λ^{4,-[(1Ε)-Ν-(but-2-yne_1_yloxy) -27- 200814928 Ethylene imine]biphenyl-, phenyl-methyl _3_(trifluoromethyl-isopyrazole_4_carboxamide, (1-94)1-mercapto #(4,-{(1Ε)-Ν-[( 1-methylprop-2-enyl small group) oxy] acetamido]}biphenyl-2-yl)-3-(trifluoromethyl)-1 private pyrazole _4_carboxamide, ( 1-95) 1-decyl-Λ44'-{(ιε)-Ν·[(2-methylprop-2-en-1-yl)oxy] 5 acetamido]}biphenyl)- 3-(trifluoromethyl)-1//-lazolyl 4-mercaptoamine, (1-96) 1-indenyl-iV-{4'-[(lE)-N-(prop-2- Alkyn-1-yloxy)-acetamidomino]biphenyl-2-ylbu 3-(trifluoromethyl-pyr-4-rebel, (1-97) | fluorenyl-fluoromethyl)- 1-methyl-specific {4'-[(lE)-N-(propyl H)-yloxy]ethinyl}}biphenyl-2-yl}-1/^ ratio α sitting_4_slow acid Amine, (1-98) #-{2,-gas 10 this [(6)_(methoxyimino)methyl] phenylidene carbazyl 3-(difluoromethyl)small methyl-1 Oxazole-4-carboxyguanamine, (1-99) nonyloxyimido) fluorenyl]-2'-methylbiphenyl-2-yl}-1-methyl}-3-(trifluoromethyl) ) -17 -17 -17 -4- 醯 醯 醯 醯, (1-100) #_{4,-[(1Ζ)-Ν-butoxyacetamido]] phenyl-2-yl} (Difluoromethyl) small methyl group is 0 _4_carboxamide, (i-ioi) 15 3_(difluoroindolyl [(penta-isopropoxyimino)methyl]biphenyl- 2- _ yl} small methyl-1/ί- 0 than 嗤-4-treazone, (1-1 02) 3-(Difluoromethyl)-exhaustive {4'-[(5)-(methoxyimino)indolyl]-2,-methylbiphenyl-2-yl}-1-indole Kibi sal-4-carboxamide, (1_1〇3)豕{3,_chloro-44(penta)-(methoxyimino)indolyl]biphenyl-2-yl}-3-( Difluoromethyl)-1-methyl-1//-2-pyrazole-4-carboxamide, (1-104) 3-(difluoroindolyl)-indole-{2,-fluoro-4, -[(5)-(decyloxyimino)methyl]biphenyl-2-yl}_1_mercapto-17/-σ ratio tr aruin, (1·105) M{2' -Fluoro-4'-[(phantom-(methoxyimino)methyl]biphenyl-2-yl}-1 -methyl-3-(tripdenyl thioglycolamine). The compound of formula (II) comprises the following preferred blend of pair (2): -28- 200814928 (2-1) azoxystrobin (obtained from: EP-A 0382 375), with The chemical formula is: 〇
M CNM CN
YVYV
(2-2)氟口密菌醋(fluoxastrobin)(得知自:DE_A 196 02 095),具化學式為:(2-2) Fluoxastrobin (known from: DE_A 196 02 095), with the chemical formula:
(2-3) (2幻-2-(2- {[6-(3-氯-2-曱基苯氧基)-5-氟-4-嘧啶基] 15(2-3) (2 Magic-2-(2-{[6-(3-Chloro-2-indolylphenoxy)-5-fluoro-4-pyrimidinyl] 15
氧}苯基)-2-(甲氧基亞胺基)-Λ/"甲基乙酸胺(得知 自:DE_A 196 46 407,ΕΡ-Β 0 712 396),具化學式 為:Oxygen}phenyl)-2-(methoxyimino)-oxime/"methylacetic acid amine (obtained from: DE_A 196 46 407, ΕΡ-Β 0 712 396), with the chemical formula:
(2-4)三氟敏(trifloxystrobin)(得知自:EP-A 0 460 575),具 化學式為· 20 200814928 〇(2-4) Trifloxystrobin (available from: EP-A 0 460 575) with a chemical formula of 20 200814928 〇
(2-5) (2 五)-2-(曱氧基亞胺基甲基-2-(2-{[({(l 五)·Η3- 5 (三氟甲基)苯基]乙二基}-胺基)氧]甲基}苯基)乙醯 胺(得知自:ΕΡ-Α0 569 384),具化學式為:(2-5) (2 5)-2-(oximeoxyiminomethyl-2-(2-{[({(l 5)·Η3- 5 (trifluoromethyl)phenyl]) }}-amino)oxy]methyl}phenyl)acetamide (known from: ΕΡ-Α0 569 384), with the chemical formula:
10 〇10 〇
(2-6) (2£>2-(曱氧基亞胺基甲基-2- {2-[(五)-({1-[3-(三 氟甲基)苯基]乙氧基}亞胺基)-甲基]苯基}乙醯胺(得 知自:ΕΡ-Α0 596 254),具化學式為: 15(2-6) (2£>2-(decyloxyiminomethyl-2-{2-[(5)-({1-[3-(trifluoromethyl)phenyl]ethoxy) (imino)-methyl]phenyl}acetamide (known from: ΕΡ-Α0 596 254), with the chemical formula: 15
〇〇
(2-7)肪鱗菌胺(orysastrobinX得知自:DE-A 195 39 324), 具化學式為: 〇(2-7) Adiscalin (orsastrobin X is known from: DE-A 195 39 324), with the chemical formula: 〇
(2-8) 5-甲氧基-2·曱基-4-(2-{[({(1幻小[3_(三氟甲基)苯基] -30- 20 200814928 乙二基}胺基)氧]-甲基}苯基)_2,4-二氫-3F-1,2,4-三 唑-3-酮(得知自:WO 98/23155),具化學式為:(2-8) 5-Methoxy-2·indolyl-4-(2-{[({(1) singular [3_(trifluoromethyl)phenyl) -30- 20 200814928 ethylenediyl)amine Oxy]-methyl}phenyl)_2,4-dihydro-3F-1,2,4-triazol-3-one (obtained from: WO 98/23155), having the chemical formula:
(2-9)克收辛-甲基(kresoxim-methyl)(得知自·· EP-A 0 253 213),具化學式為:(2-9) Kresoxim-methyl (know from EP-A 0 253 213) with the chemical formula:
1515
(2-10)大滅唾丙(dimoxystrobin)(得知自:ΕΡ-Α0 398 692), 具化學式為:(2-10) dimoxystrobin (known from: ΕΡ-Α0 398 692), with the chemical formula:
(2-11)咬氧菌酯(picoxystrobin)(得知自:ΕΡ-Α0 278 595), 具化學式為: -31- .200814928 ο(2-11) picoxystrobin (known from: ΕΡ-Α0 278 595), with the chemical formula: -31- .200814928 ο
(2-12)嗤菌胺酯(pyraclostrobin)(得知自:DE_A44 23 612), 具化學式為:(2-12) Pyraclostrobin (known from: DE_A44 23 612), with the chemical formula:
10 〇10 〇
(2-13)苯氧菌胺(metominostrobin)(得知自:EP-A 0 398 692),具化學式為: 15(2-13) Metominostrobin (available from: EP-A 0 398 692) with the chemical formula: 15
(2-14)英司多丙(enestrobin)(得知自·· EP-A 0 936 213),具 化學式為:(2-14) enestrobin (known as EP-A 0 936 213) with the chemical formula:
式(III)的化合物包含下述較佳的第(3)類之混合配對 物 -32- 200814928 (3-1)氮雜康峻(azaconazole)(得知自:DE_A 25 51 560), 具化學式為:The compound of formula (III) comprises the following preferred mixture of the class (3) - 32- 200814928 (3-1) azaconazole (known from: DE_A 25 51 560), having the chemical formula for:
5 (3-2)伊他康唑(etaconazole)(得知自:DE-A25 51 560),具 化學式為:5 (3-2) Itaconazole (known from: DE-A25 51 560), with the chemical formula:
1010
(3-3)普比康嗤(propiconazole)(得知自:DE-A 25 51 560), 具化學式為:(3-3) propiconazole (known from: DE-A 25 51 560), with the chemical formula:
15 (3-4)待芬康嗤(difenoconazole)(得知自:EP-A 0 112 284),具化學式為:15 (3-4) Waiting for difanoconazole (available from: EP-A 0 112 284), with the chemical formula:
(3-5) 溴克利(bromuconazoleX得知自:EP-A 0 258 161), -33- 20 200814928(3-5) Bromoclazole (bromuconazoleX is known from: EP-A 0 258 161), -33- 20 200814928
CH—(CH2)2CH3 CH0 具化學式為:CH—(CH2)2CH3 CH0 has the chemical formula:
(3-6)西普康唾(cyproconazole)(得知自:DE-A 34 06 993), 具化學式為:(3-6) cyproconazole (known from: DE-A 34 06 993), with the chemical formula:
(3-7)菲克斯(hexaconazole)(得知自:DE-A30 42 303),具 化學式為: •(ch2)3ch3 ch2 (3-8)平康唑(penconazole)(得知自:DE-A 27 35 872),具 化學式為: C! (3-9)邁克別尼(myclobutanil)(得知自:ΕΡ-Α 0 145 294), -34- 200814928 具化學式為:(3-7) hexaconazole (known from: DE-A30 42 303), with the chemical formula: • (ch2) 3ch3 ch2 (3-8) penconazole (recognized from: DE -A 27 35 872), with the chemical formula: C! (3-9) myclobutanil (known from: ΕΡ-Α 0 145 294), -34- 200814928 with the chemical formula:
ClCl
(ch2)3ch3(ch2)3ch3
1010
1515
(3-10)四康嗤(tetraconazole)(得知自:EP-AO 234 242),具 化學式為:(3-10) tetraconazole (available from: EP-AO 234 242) with the chemical formula:
CICI
CH—CHr〇~CF2CF2H (3-11)福採扶(fhitriafblX得知自:EP-A0 015 756),具化學 式為:CH-CHr〇~CF2CF2H (3-11) Fucaifu (fhitriafblX is known from: EP-A0 015 756), with the chemical formula:
FF
(3-12)依普座(epoxiconazole)(得知自:ΕΡ-Α0 196 038),具 化學式為:(3-12) epoxiconazole (known from: ΕΡ-Α0 196 038), with the chemical formula:
(3-13)護發嗤(flusilazole)(得知自:EP-A 0 068 813),具化 -35- 20 200814928 學式為:(3-13) Flusilazole (obtained from: EP-A 0 068 813), with the formula -35- 20 200814928
(3-14)辛康唾(simeconazole)(得知自:EP-A 0 537 957),具 化學式為: ΟΗ F—y--CH—Si(CH3)3 CH2 (3-15)普硫康唾(prothioconazole)(得知自:WO 96/16048) 具化學式為: 15(3-14) simeconazole (available from: EP-A 0 537 957) with the chemical formula: ΟΗ F—y--CH—Si(CH3)3 CH2 (3-15) Prothioconazole (available from: WO 96/16048) with the chemical formula: 15
(3_16)芬布康。坐(fenbuconazole)(得知自·· DE-A37 21 786) 具化學式為: -36- 20 200814928(3_16) Fenbu Kang. Sitting (fenbuconazole) (learned from DE-A37 21 786) with the chemical formula: -36- 20 200814928
5 (3-17)得克力(tebuconazole)(得知自:EP-AO 040 345),具 化學式為:5 (3-17) tebuconazole (available from: EP-AO 040 345) with the chemical formula:
10 (3-18)10 (3-18)
艾普那唑(ipconazole)(得知自:ΕΡ-Α0 329 397),具 化學式為:Ipconazole (known from: ΕΡ-Α0 329 397) with the chemical formula:
1515
(3-19)滅康唑(metconazole)(得知自:EP-A 0 329 397),具 化學式為:(3-19) metconazole (available from: EP-A 0 329 397) having the chemical formula:
(3-20)三替康唑(triticonazole)(得知自:EP-A 0 378 953), 具化學式為: -37- 20 200814928(3-20) Triticonazole (available from: EP-A 0 378 953) with the chemical formula: -37- 20 200814928
(3-21)比多農(bitertanol)(得知自:DE-A 23 24 010),具化 學式為:(3-21) Bitertanol (known from: DE-A 23 24 010), with a chemical formula:
OH Ο - 〒H—CH—C(CH3)3 10 (3-22)三泰隆(triadimenol)(得知自:DE-A23 24 010),具化 學式為:OH Ο - 〒H-CH-C(CH3)3 10 (3-22) triadimenol (known from: DE-A23 24 010), with chemical formula:
(3-23)三泰芬(triadimefon)(得知自:DE-A22 01 063),具化 學式為.(3-23) Triadimefon (learned from: DE-A22 01 063), with a chemical formula.
(3-24)氟啥康嗤(fluquinconazoleX得知自:EP-A 0 183 458),具化學式為: -38- 20 200814928(3-24) Fluconconazole X (fluquinconazoleX is known from: EP-A 0 183 458), with the chemical formula: -38- 20 200814928
(3-25)嘻康唾(quinconazole)(得知自:EP-AO 183 458),具 化學式為:(3-25) quinconazole (known from: EP-AO 183 458), with the chemical formula:
ίο (3-26)二氯布康唾(diclobutrazole)(得知自:DE-A 27 37 489),具化學式為:Ίο (3-26) Diclobutrazole (known from: DE-A 27 37 489), having the chemical formula:
15 (3-27)得尼康唑(diniconazoleX得知自:DE-A30 10 560), 具化學式為:15 (3-27) Deconazole (diniconazoleX is known from: DE-A30 10 560), with the chemical formula:
(3-28)得尼康嗤-M(diniconazole-M),具化學式為: -39- 200814928(3-28) Nikon 嗤-M (diniconazole-M) with the chemical formula: -39- 200814928
5 (3-29)扶康嗤(furconazole)(得知自:EP-AO 230 844),具化 學式為:5 (3-29) Furconazole (available from: EP-AO 230 844), with a chemical formula:
1010
(3-30)優尼康唑(imiconazole)(得知自:0£-八 30 10 560), 具化學式為:(3-30) Uniconazole (known from: ££-eight 30 10 560), with the chemical formula:
1515
(3-31)優尼康嗤P(uniconazoleP),具化學式為:(3-31) Uniconazole P, with the chemical formula:
式(IV)的化合物包含下述較佳的第(4)類之混合配對 物: (4-1)二氯氟尼(dichlofluanidX得知自:DE-A 11 93 498), -40- 20 200814928 具化學式為:The compound of formula (IV) comprises the following preferred complex of class (4): (4-1) dichloroflunisi (dichlofluanid X is known from: DE-A 11 93 498), -40- 20 200814928 With the chemical formula:
(4-2) 曱基益發靈(tolylfhianid)(得知自 具化學式為: DE-A 11 93 498),(4-2) Tolylfhianid (known as: DE-A 11 93 498),
1010
DE_A 40 26 966), 第(5)類之較佳的混合配對物為: (5-1) 異丙菌胺(iprovalicarb)(得知自: 15 具化學式為:DE_A 40 26 966), the preferred mixed counterpart of class (5) is: (5-1) Iprovalicarb (known from: 15 chemical formula:
2〇 (5-3)苯嗟菌胺(ben1;hiavalicarb)(得知自 具化學式為: :WO 96/04252), -41 - 2008149282〇 (5-3) Benzoguanamine (ben1; hiavalicarb) (known to have the chemical formula: :WO 96/04252), -41 - 200814928
式(V)的化合物包含下述較佳的第(6)類之混合配對物: 5 (6-1) 2-氣-N-(l,1,3-二甲基印滿-4-基)於驗酸胺(得知自: ΕΡ-Α0 256 503),具化學式為:The compound of formula (V) comprises the following preferred complex of class (6): 5 (6-1) 2-Gas-N-(l,1,3-dimethylin-4-yl) In the acid test amine (known from: ΕΡ-Α0 256 503), the chemical formula is:
1010
(6-2)白克力(boscalid)(得知自:DE-A 195 31 813),具化 學式為:(6-2) Boscalid (known from: DE-A 195 31 813), with a chemical formula:
(6-3)福滅比(furametpyr)(得知自:EP-A 0315 502),具化 學式為:(6-3) Furametpyr (available from: EP-A 0315 502), with a chemical formula:
(6-4) Ν·(3-對-甲苯基噻吩-2-基)-1·曱基-3-三氟曱基-1H- 吡唑-4-羧醯胺(得知自:ΕΡ-Α0 737 682),具化學式 -42- 200814928 為(6-4) Ν·(3-p-Tolylthiophen-2-yl)-1·indolyl-3-trifluorodecyl-1H-pyrazole-4-carboxamide (available from: ΕΡ- Α0 737 682), with the chemical formula -42- 200814928
C (6-5)噻唑菌胺(ethaboxam)(得知自:EP-A 0 639 574),具 化學式為:C (6-5) ethaboxam (obtained from: EP-A 0 639 574) with the chemical formula:
〇 CN〇 CN
(6-6)環醯菌胺(fenhexamid)(得知自:EP-A0 339 418),具 化學式為:(6-6) fenhexamid (known from: EP-A0 339 418), having the chemical formula:
(6-7)卡普米(carpropamid)(得知自:ΕΡ·Α 0 341 475),具 化學式為: 20(6-7) carpropamid (from ΕΡ·Α 0 341 475), with the chemical formula: 20
(6-8) 2 -氣-4-(2-氣-2-曱基丙酿基胺基)-Ν,Ν-二曱基苯甲酿 >43- 200814928 胺(得知自:EP-A0 600 629),具化學式為: 5(6-8) 2-Gas-4-(2-Ga-2-mercaptopropylamino)-indole, fluorene-dimercaptobenzoic brewing>43- 200814928 Amine (Know from: EP- A0 600 629), with the chemical formula: 5
10 (6-9)氟啶醯菌胺(fluopicolide)(得知自:WO 99/42447), 具化學式為:10 (6-9) fluopicolide (known from: WO 99/42447), with the chemical formula:
(6-10)唾查醯胺(zoxamide)(得知自:EP-A 0 604 019),具化 學式為:(6-10) Salicin (zoxamide) (obtained from: EP-A 0 604 019), with a chemical formula:
(6-11) 3,4-二氯-N-(2-氰基苯基)異噻唑-5-羧醯胺(得知自: WO 99/24413),具化學式為:(6-11) 3,4-Dichloro-N-(2-cyanophenyl)isothiazol-5-carboxamide (available from: WO 99/24413), having the chemical formula:
(6-1¾卡保信(carb〇xin)(得知自:US 3,249,499),具化學式 -44· 200814928 為··(6-13⁄4 carb〇xin (obtained from: US 3,249,499), with the chemical formula -44· 200814928 as...
5 (6-13)噻醯菌胺(tiadinil)(得知自:US 6,616,054),具化學 式為:5 (6-13) tiadinil (obtained from: US 6,616,054) with the chemical formula:
1010
1515
(6-14 嗟菌胺(penthiopyrad)(得知自:EP-A 0 737 682),具 化學式為:(6-14 penthiopyrad (known from: EP-A 0 737 682), with the chemical formula:
(6-15)矽噻菌胺(silthiofam)(得知自:WO 96/18631),具化 學式為:(6-15) silthiofam (obtained from: WO 96/18631), with a chemical formula:
CH, (6-16) N-[2-(l,3-二甲基丁基)苯基]-1-甲基-4-(三氟曱基)- -45- 20 200814928 1H-吡咯-3-羧醯胺(得知自:WO 02/38542),具化學 式為:CH, (6-16) N-[2-(l,3-dimethylbutyl)phenyl]-1-methyl-4-(trifluoromethyl)- -45- 20 200814928 1H-pyrrole- 3-carboxyguanamine (known from: WO 02/38542) with the chemical formula:
(心1?)福多寧(flutolanilX得知自:DE-A 27 31 522),具化 學式為:(Heart 1?) Fortune (flutolanil X learned from: DE-A 27 31 522), with a chemical formula:
(6_18)芬富南(fenfuram)(得知自:0£-八20 06471),具化學 式為二(6_18) Fenfuram (known from: 0£-eight 20 06471), with a chemical formula of two
(649)嘉保信(oxycarboxin)(得知自:US 3,399,214),具化 學式為:(649) oxycarboxin (available from: US 3,399,214) with a chemical formula of:
(6-20)塞氟醯胺(thifluzamide)(得知自:EP-A 0 371 950), 具化學式為: -46- 200814928(6-20) thifluzamide (known from: EP-A 0 371 950), with the chemical formula: -46- 200814928
(6-21) N-{2-[3-氯-5-(三氟甲基)吼啶-2-基]乙基卜2-(三氟 5 甲基)苯甲醯胺,具化學式為:(6-21) N-{2-[3-Chloro-5-(trifluoromethyl)acridin-2-yl]ethyl-2-(trifluoro-5methyl)benzamide, chemical formula :
10 (6-22) N-(2-雙環丙基-2-基苯基)-1-甲基-3-三氟甲基-1H-吡唑-4-羧醯胺(得知自:WO 2006/015865),具化學 式為.10 (6-22) N-(2-Dicyclopropyl-2-ylphenyl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide (available from: WO 2006/015865), with chemical formula.
(6-23) N-(2-雙環丙基-2-基苯基)-1-甲基-3-二氟甲基-1H- 吡唑-4-羧醯胺(得知自:WO 2006/015865),具化學 式為:(6-23) N-(2-Dicyclopropyl-2-ylphenyl)-1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxamide (available from: WO 2006 /015865), with the chemical formula:
(6-24) N-[2-(l’-甲基雙環丙基-2-基)苯基]-1-甲基-3-三氟甲 基-1H-吡唑-4-羧醯胺(得知自:WO 2006/015865), -47- 200814928 具化學式為:(6-24) N-[2-(l'-Methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxyguanamine (Knowed from: WO 2006/015865), -47- 200814928 has the chemical formula:
55
10 (6-25) Ν-[2-(Γ-甲基雙環丙基-2-基)苯基]-1-甲基-3-二氟甲 基-1Η-吡唑羧醯胺(得知自:WO 2006/015865), 具化學式為:10 (6-25) Ν-[2-(Γ-Methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-difluoromethyl-1Η-pyrazole carboxamide (known From: WO 2006/015865), with the chemical formula:
1515
(6-26) Ν·[1 -(5- >臭-3-氯°比唆-2-基)乙基]-2,4-二氣終驗酿 胺,具化學式為:(6-26) Ν·[1 -(5- >odor-3-chloropyrene-pyridyl-2-yl)ethyl]-2,4-dialdehyde final amine amine, with the chemical formula:
(6-27) 比喘>2-基)甲基-2,4-二氯於驗酸胺,具 化學式為:(6-27) Bichuan>2-yl)methyl-2,4-dichloro acid in acid test, having the chemical formula:
第(7)類之較佳的混合配對物為: -48- 20 200814928 (7-1) (7-2) 5 (7-3) ίο (7-4) 15 (7-5) 鋅錳乃浦(mancozeb)(得知自:DE-A 12 34 704),具 有IUPAC名稱為:錳亞乙基雙(二硫胺基甲酸酯)(聚 合性)與鋅鹽之錯合物 錳乃浦(maneb)(得知自:US 2,504,404),具化學式為:The preferred blending partner of class (7) is: -48- 20 200814928 (7-1) (7-2) 5 (7-3) ίο (7-4) 15 (7-5) Zinc Manganese Mancozeb (known from: DE-A 12 34 704), having the IUPAC name: manganese ethylene bis(dithiocarbamate) (polymerizable) and zinc salt complex manganese (maneb) (from (US 2,504,404), with the chemical formula:
免得爛(metiram)(得知自:DE-A 1076434),具有 IUPAC名稱為:鋅氨化物亞乙基雙(二硫胺基甲酸 酯)-聚(亞乙基秋蘭姆二硫化物) 甲基鋅乃浦(propineb)(得知自:GB 935 981),具化 學式為:Free of metiram (known from: DE-A 1076434), having the IUPAC name: zinc amide ethylene bis(dithiocarbamate)-poly(ethylene thiuram disulfide) Methyl zinc is a propineb (known from: GB 935 981), with the chemical formula:
得恩地(thiram)(得知自:US 1,972,961),具化學式為:Thiram (available from: US 1,972,961) with the chemical formula:
(7-6) 鋅乃浦(zineb)(得知自·· DE-A 10 81 446),具化學式 •49- 20 .200814928(7-6) Zinna (Zineb) (known as DE-A 10 81 446), with chemical formula • 49-20.200814928
(7-7) 福美鋅(ziram)(得知自:US 2,588,428),具化學式為:(7-7) Zirma (known from: US 2,588,428) with the chemical formula:
1010
ch3 ch3 式(VI)的化合物包含下述較佳的第(8)類之混合配對 物·· (8-1)本達樂(benalaxylX得知自:DE_A 29 03 612),具化 學式為:Ch3 ch3 The compound of the formula (VI) comprises the following preferred mixed complex of the (8) class (8-1) Bendal (benalaxyl X is known from: DE_A 29 03 612), and has a chemical formula:
1515
(8-2)福達樂(furalaxyl)(得知自:DE-A 25 13 732),具化學 式為:(8-2) Furalaxyl (known from: DE-A 25 13 732), with the chemical formula:
(8-3)滅達樂(metalaxyl)(得知自:DE-A 25 15 091),具化 學式為: -50 - 20 200814928(8-3) Metalaxyl (available from: DE-A 25 15 091), with a chemical formula: -50 - 20 200814928
5 (8-4)滅達樂-Μ (得知自:WO 96/01559),具化學式為:5 (8-4) 灭达乐-Μ (known from: WO 96/01559), with the chemical formula:
ίο (8-5)本達樂-M,具化學式為:Ίο (8-5) Bunda-M, with the chemical formula:
式(VII)的化合物包含下述較佳的第(9)類之混合配對 物: (9-1)西普地尼(cyprodinil)(得知自:EP-A 0 310 550),具 化學式為.The compound of formula (VII) comprises the following preferred mixed partner of class (9): (9-1) cyprodinil (known from: EP-A 0 310 550) having the chemical formula .
ch3 (9-2)滅盤尼比(mepanipyrim)(得知自:ΕΡ·Α 0 270 111), 具化學式為: -51 - 200814928Ch3 (9-2) mepanipyrim (known from: ΕΡ·Α 0 270 111), with the chemical formula: -51 - 200814928
5 (9-3)必滅寧(pyrimethanil)(得知自:DD 151 404),具化學 式為、5 (9-3) pyrimethanil (from DD 151 404), with chemical formula,
式(VIII)的化合物包含下述較佳的第(10)類之混合配對 物:The compound of formula (VIII) comprises the following preferred blend of class (10):
(10-1) 6-氣- 5-[(3,5 -二曱基異嗯ϋ坐-4-基)石黃酸基]-2,2-二氣^ is -5H-[1,3]二噁茂并[4,5-f>苯并咪唑(得知自:WO _ 97/06171),具化學式為:(10-1) 6-Gas- 5-[(3,5-Dimercaptopurine-4-yl)-retinyl]-2,2-digas^ is -5H-[1,3 Dioxin and [4,5-f> benzimidazole (obtained from: WO _ 97/06171), with the chemical formula:
(10-2)免賴得(benomyl)(得知自:US 3,631,176),具化學式 -52 - 200814928(10-2) benomyl (available from: US 3,631, 176), with the chemical formula -52 - 200814928
(10-3)貝芬替(carbendazim)(得知自:US 3,010,968),具化 學式為:(10-3) carbendazim (available from: US 3,010,968) with a chemical formula:
(10-4)氯芬那峻(chlorfenazole),具化學式為:(10-4) Chlorfenazole, which has the chemical formula:
(10-5)麥穗寧(fuberidazoleX得知自:DE-A 12 09 799),具 化學式為:(10-5) Mai Sui Ning (fuberidazoleX is known from: DE-A 12 09 799), with the chemical formula:
(10-6)腐絕(thiabendazole)(得知自:US 3,206,468),具化學 式為:(10-6) thiabendazole (obtained from: US 3,206,468) with the chemical formula:
式(IX)的化合物包含下述較佳的第(11)類之混合配對 -53- 20 200814928 物: (1M)二硫芬克(didhofencarbX得知自:EP-A 0 078 663) 具化學式為:The compound of formula (IX) comprises the following preferred blend of pair (11) - 53-20 200814928: (1M) dithiofenac (didhofencarb X is known from: EP-A 0 078 663) :
EtO CH,EtO CH,
(11-2)普拔克(propam〇carb)(得知自:US 3,513,241),具化 學式為: .CH. 、Ν Η ! CH. (11-3)鹽酸普拔克(pr0pam〇carl>liydrochloride)(得知自:US 3,513,241),具化學式為: 15 Η CH,(11-2) propam〇carb (obtained from: US 3,513,241), with the chemical formula: .CH., Ν Η ! CH. (11-3) Propyl hydrochloride (pr0pam〇carl>liydrochloride ) (Know from: US 3,513,241), with the chemical formula: 15 Η CH,
HCI (11-4)普拔克-福賽得(fosetyi),具化學式為 20 η^Λ h^ch3 f| VN - P -〇 CH,HCI (11-4), fosetyi, with a chemical formula of 20 η^Λ h^ch3 f| VN - P -〇 CH,
H 較佳的第(12)類之混合配對物為: (12-1)四氯丹(captaf〇i)(得知自:us 3,178,447) ’ 具化學式 為: -54- 200814928H Preferred mixed partner of class (12) is: (12-1) tetramdanium (captaf〇i) (known from: us 3,178,447) ' has the chemical formula: -54- 200814928
(12-2)蓋普丹(captan)(得知自:US 2,553,770),具化學式為:(12-2) Captan (available from: US 2,553,770) with the chemical formula:
5 (12-3)福爾培(folpet)(得知自:US2,553,770),具化學式為:5 (12-3) Folpet (known from: US2, 553, 770) with the chemical formula:
10 (12-4)依普同(iprodione)(得知自:DE-A 21 49 923),具化 學式為: 1510 (12-4) Iprodione (available from: DE-A 21 49 923), with a chemical formula: 15
(12-5)撲滅寧(procymidone)(得知自:DE-A 20 12 656),具 化學式為:(12-5) Procymidone (known from: DE-A 20 12 656), with the chemical formula:
CICI
CI (12-6)免克寧(vinclozolin)(得知自:DE-A 22 07 576),具化 學式為: -55- 20 200814928CI (12-6) vinclozolin (known from: DE-A 22 07 576), with a chemical formula: -55- 20 200814928
5 較佳的第(13)類之混合配對物為: (13-1)多寧(dodine)(得知自:GB 11 03 989),具化學式為:5 The preferred mixed counterpart of class (13) is: (13-1) dodine (known from: GB 11 03 989), with the chemical formula:
(13-2)克熱淨(Suazatine)(得知自:GB 11 14 155) (13-3)雙胍辛胺二乙酸鹽 Gminoctadine triacetate)(得知 自:EP-A 0 155 509),具化學式為:(13-2) Suazatine (available from: GB 11 14 155) (13-3) Gminoctadine triacetate (known from: EP-A 0 155 509), with chemical formula for:
Hr nh2 15 )克熱淨(烧苯石黃酸鹽)[iminoctadine tris(albesilate)](得 ( 知自:ΕΡ-Α0 155 509),具化學式為:Hr nh2 15 ) gram heat (burning benzoate) [iminoctadine tris (albesilate)] (derived from: ΕΡ-Α0 155 509), with the chemical formula:
S〇3H 2〇 5)多寧(dodine (游離驗)) (1 η 〜 ml (13-6) 克熱淨(imm〇ctadine)(游離驗),具化學式為: -56- 200814928S〇3H 2〇 5) Doning (dodine) (1 η ~ ml (13-6) gram heat (imm〇ctadine) (free test), with the chemical formula: -56- 200814928
較佳的第(14)類之混合配對物為: (14-1)賽座滅(cyazofamid)(得知自:EP-A 0 298 196),具 化學式為:Preferred mixed partners of class (14) are: (14-1) cyazofamid (available from: EP-A 0 298 196) having the chemical formula:
1010
CN CI^^/N、s〇2MMe2 Φ ch3 (14-2)撲克拉(prochloraz)(得知自:DE-A 24 29 523),具化 學式為: 15CN CI^^/N, s〇2MMe2 Φ ch3 (14-2) Prochloraz (learned from: DE-A 24 29 523), with a chemical formula: 15
CICI
(14-3)三嗤嗪(triazoxide)(得知自:DE_A 28 02 488),具化 20 學式為:(14-3) Triazoxide (known from: DE_A 28 02 488), with 20 formulas:
(14-4)稻痕酯(pefurazoate)(得知自:ΕΡ·Α 0 248 086),具化 -57- 200814928 學式為:(14-4) Pefurazoate (known from: ΕΡ·Α 0 248 086), with -57- 200814928
10 1510 15
式(X)的化合物包含下述較佳的第(15)類之混合配對 物: (15-1)阿得摩福(&1出111〇卬11)(得知自:00 140 041),具化學 式為:The compound of formula (X) comprises the following preferred mixed partner of class (15): (15-1) Adelmo (&1 out 111〇卬11) (from 00 140 041) , with the chemical formula:
CH CH, (15-2)三得芬(tridemorph)(得知自:GB 988 630),具化學式 為:CH CH, (15-2) tridemorph (known from: GB 988 630), with the chemical formula:
ch3 (15-3)敵草隆(dodemorph)(得知自:DE-A 25 432 79),具化 學式為: -58 - 200814928Ch3 (15-3) dodemorph (known from: DE-A 25 432 79), with a chemical formula: -58 - 200814928
或乙酸敵草隆 5 (15-4)芬普比福(fenpropimorph)(得知自:DE-A 26 56 747),具化學式為:Or diclofenac 5 (15-4) fenpropimorph (known from: DE-A 26 56 747), with the chemical formula:
(15-5)大滅芬(dimethomorphX 得知自:EP-A 0219 756),具 化學式為:(15-5) Dafenfen (dimethomorphX is known from: EP-A 0219 756), with the chemical formula:
式(XI)的化合物包含下述較佳的第(16)類之混合配對 20 物: (16-1)芬畢克尼(fbnpiclonilK得知自:EP-A 0236 272),具 化學式為: -59- 200814928The compound of formula (XI) comprises the following preferred mixed pair 20 of class (16): (16-1) fenbikini (fbnpiclonil K is known from: EP-A 0236 272), having the chemical formula: - 59- 200814928
NCNC
NHNH
Cl Cl EP-A 0 206 999),具 :JP 65-25876),具化 (16-2)伏地噁尼(fludioxonil)(得知自 化學式為: ΗCl Cl EP-A 0 206 999), with :JP 65-25876), with (16-2) fludioxonil (known from the chemical formula: Η
(16-3) σ比略尼精(pyrrolnitrin)(得知自 學式為:(16-3) σ pyrrolnitrin (known as self-learning:
CICI
CI NO. 較佳的第(17)類之混合配對物為: 15 (17-1)福賽得-鋁(fosetyl-Al)(得知自:DE-A 24 56 627),具 化學式為: Π A1H, ΌΗ 20 (17-2)膦酸(已知的化學品),具化學式為 f?CI NO. The preferred hybrid partner of class (17) is: 15 (17-1) fosetyl-Al (known from: DE-A 24 56 627), having the chemical formula: Π A1H, ΌΗ 20 (17-2) phosphonic acid (known chemical) with chemical formula f?
HoiHoi
OH (17-3)曱基立枯磷(tolclophos-methyl)(得知自:DE-A25 01 •60- 200814928 040),具化學式為: h3cOH (17-3) tolclophos-methyl (known from: DE-A25 01 • 60- 200814928 040) with the chemical formula: h3c
ClCl
s 0令0、 Cl 〜CH, CH. 式(XII)的化合物包含下述之較佳的第(18)類之混合配 對物,其為得知自WO 96/23793且各可呈E或Z異構物存 在者,因此,式(XII)的化合物可為·由不同比例的異構物形 成之混合物,或是單種的異構物型式存在,較佳的式(XII) 的化合物為其E異構物: (18-1)化合物 2-(2,3-二氫-1H-茚-5-基)-N-[2-(3,4_二曱氧基 苯基)乙基]-2-(甲氧基亞胺基)乙醯胺,具化學式為: 15s 0 令 0, Cl 〜CH, CH. The compound of formula (XII) comprises the preferred mixed partner of class (18) below, which is known from WO 96/23793 and each may be E or Z The isomer is present, therefore, the compound of formula (XII) may be a mixture of different ratios of isomers, or a single isomer form, preferably a compound of formula (XII) E isomer: (18-1) compound 2-(2,3-dihydro-1H-indol-5-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl] -2-(methoxyimino)acetamide with the chemical formula: 15
(18-2)化合物N-[2-(3,4-二曱氧基苯基)乙基]-2-(甲氧基亞 胺基)-2-(5,6,7,8-四氮-蔡-2-基)乙酿胺’具化學式為:(18-2) Compound N-[2-(3,4-Dimethoxyphenyl)ethyl]-2-(methoxyimino)-2-(5,6,7,8-tetra Nitrogen-Cai-2-yl)Ethylamine has the chemical formula:
(18·3)化合物2-(4-氯苯基)-N-[2-(3,4-二曱氧基苯基)乙 基]甲氧基亞胺基)-乙酿胺’具化學式為·· -61 - 20 200814928(18·3) Compound 2-(4-chlorophenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]methoxyimino)-ethonamide For ·· -61 - 20 200814928
5 (18-4)化合物2-(4-溴苯基)-N-[2-(3,4-二甲氧基苯基)乙 基]-2-(甲氧基亞胺基)-乙醯胺,具化學式為:5 (18-4) Compound 2-(4-Bromophenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)-B Indoleamine, with the chemical formula:
1010
(18-5)化合物2-(4-甲基苯基)-N-[2-(3,4-二曱氧基苯基)乙 基]-2-(曱氧基亞胺基)-乙醯胺,具化學式為:(18-5) Compound 2-(4-methylphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(decyloxyimino)-B Indoleamine, with the chemical formula:
1515
(18-6)化合物2-(4-乙基苯基)-N-[2-(3,4-二甲氧基苯基)乙 基]-2-(曱氧基亞胺基)_乙醯胺,具化學式為:(18-6) Compound 2-(4-ethylphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(decyloxyimino)-B Indoleamine, with the chemical formula:
較佳的第(19)類之混合配對物為: -62- 200814928 (19-1)苯并嗟二唾S旨(acibenzolar-S_methyl)(得知自:ΕΡ-Α0 313 512),具化學式為:A preferred mixed partner of the (19) class is: -62- 200814928 (19-1) acibenzolar-S_methyl (known from: ΕΡ-Α0 313 512), having the chemical formula :
10 (19-2)氯塞尼(chlorothalonil)(得知自:US3,290,353),具化 學式為:10 (19-2) chlorothalonil (available from: US3, 290, 353) with a chemical formula:
CNCN
(19-3)克絕(cymoxanil)(得知自:DE-A 23 12 956),具化學 式為: 15(19-3) cymoxanil (available from: DE-A 23 12 956) with the chemical formula: 15
(19-4)護粒松(edifenphos)(得知自·· DE-A 14 93 736),具化 學式為:(19-4) edifenphos (known as DE-A 14 93 736), with a chemical formula:
(19_5)凡殺同(famoxadone)(得知自:EP-A 0 393 911),具 -63- 20 200814928 化學式為:(19_5) Where is the famoxadone (available from: EP-A 0 393 911), with -63- 20 200814928 The chemical formula is:
10 (19-6)伏寄南(fluazinam)(得知自:EP-A 0 031 257),具化 學式為:10 (19-6) volts to the south (fluazinam) (obtained from: EP-A 0 031 257), with a chemical formula:
1515
(19-7)氯氧化銅(copper oxychloride) (19-9)歐殺斯(oxadixyl)(得知自:0£-八30 30 026),具化學 式為:(19-7) Copper oxychloride (19-9) oxadixyl (obtained from: 0£-eight 30 30 026), with the chemical formula:
(19-10)螺環菌胺(spiroxamine)(得知自:DE-A 37 35 555), 具化學式為:(19-10) Spiroxamine (known from: DE-A 37 35 555), having the chemical formula:
h3c (19-11)二硫醌(dithianon)(得知自:JP-A 44-29464),具化學 -64- 20 200814928 式為: 〇H3c (19-11) dithianon (available from: JP-A 44-29464), with chemistry -64-20 201414928: 〇
ο (19_12)表苯菌酮(metrafenone)(得知自:ΕΡ-Α 0 897 904), 具化學式為:ο (19_12) metrafenone (known from: ΕΡ-Α 0 897 904), with the chemical formula:
(19-13)口米唾菌酮(fenamid〇ne)(得知自:ΕΡ-Α 0 629 616),具 化學式為:(19-13) fenamidone (known from: ΕΡ-Α 0 629 616), with the chemical formula:
(19-14)2,3-二丁基-6-氣噻吩并[2,3-d]嘧啶-4(3H>酮(得知 自:WO 99/14202),具化學式為:(19-14) 2,3-Dibutyl-6-oxothieno[2,3-d]pyrimidin-4 (3H> ketone (obtained from: WO 99/14202) having the chemical formula:
(19-15)撲殺熱(probenazole)(得知自:US 3,629,428),具化 學式為: -65- 200814928(19-15) Probenazole (available from: US 3,629,428) with a chemical formula: -65- 200814928
10 >〇 、 (19-16)稻瘂靈(isoprothiolane)(得知自:US 3,856,814),具化 學式為:10 > 〇 , (19-16) Isoprothiolane (obtained from: US 3,856,814), with a chemical formula:
(19-17)嘉賜黴素(1<^1^3111>^11)(得知自:〇3 1 094 567),具 化學式為:(19-17) Carbachol (1<^1^3111>^11) (from 〇3 1 094 567), with the chemical formula:
1515
(19-18)熱必斯(phthalide)(得知自:JP-A 57-55844),具化學 式為:(19-18) phthalide (known from: JP-A 57-55844), with the chemical formula:
CI (19-19)富米熱斯(ferimzone)(得知自:EP-A 0 019 450),具 化學式為: -66- 200814928CI (19-19) Ferimzone (available from: EP-A 0 019 450) with the chemical formula: -66- 200814928
(19-20)三賽唑(tricyclazole)(得知自·· DE-A 22 50 077),具 化學式為:(19-20) Tricyclazole (known as DE-A 22 50 077) with the chemical formula:
10 (19-21)N-({4-[(環丙基胺基)羰基]苯基}磺醯基)-2-甲氧基苯 甲醯胺,具化學式為··10 (19-21) N-({4-[(cyclopropylamino)carbonyl]phenyl}sulfonyl)-2-methoxybenzenecarbamamine, with the chemical formula...
1515
(19-22)2-(4-氯苯基)-N-{2-[3-甲氧基-4-(丙-2-炔-1 -基氧)苯 基]乙基丙-2-快-1-基氧)乙釀胺(得知自:WO 01/87822),具化學式為:(19-22) 2-(4-Chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethylpropan-2- Fast-1-yloxy)ethylamine (known from: WO 01/87822), with the chemical formula:
(19_23)快諾芬(quinoxyfen)(得知自:EP-A 0326 330),具化 學式為: -67- 20 200814928 C!(19_23) quinoxyfen (known from: EP-A 0326 330), with a chemical formula: -67- 20 200814928 C!
F 較佳的第(20)類之混合配對物為: (20-1)賓克隆(pencycuron)(得知自·· DE-A 27 32 257),具化 學式為:F. Preferred mixed partner of class (20) is: (20-1) pencycuron (known as DE-A 27 32 257) with a chemical formula of:
(20-2)甲基-多保淨(thiophanate-methyl)(得知自:DE-A 18 06 123),具化學式為:(20-2) thiophanate-methyl (obtained from: DE-A 18 06 123), with the chemical formula:
Η Η (20-3)乙基-多保淨(thiophanate-ethyl)(得知自:DE-A 18 06 123),具化學式為:Η Η (20-3) ethyl-polyphanate-ethyl (known from: DE-A 18 06 123), with the chemical formula:
Η Η 較佳的第(21)類之混合配對物為: -68- 200814928 (21-1) 氰菌胺(fenoxanil)(得知自:EP-A 0 262 393),具化學 式為:Η 较佳 Preferred mixed partner of class (21) is: -68- 200814928 (21-1) fenoxanil (known from: EP-A 0 262 393), having the chemical formula:
5 (21-2)雙氯氰菌胺(diclocymet)(得知自:JP-A 7-206608), 具化學式為: 較佳的第(22)類之混合配對物為: (22-1) 5-氯-N-[(lS)-2,2,2-三氟-1-甲基乙基]-6-(2,4,6·三氟 苯基)[1,2,4]三唑并[l,5-a]嘧啶-7-胺(得知自:US is 5,986,135),具化學式為:5 (21-2) Diclocymet (known from: JP-A 7-206608), with the chemical formula: The preferred blend of the (22) class is: (22-1) 5-Chloro-N-[(lS)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)[1,2,4] Zoledolo[l,5-a]pyrimidin-7-amine (obtained from: US is 5,986,135) with the chemical formula:
2〇 (22-2) 5-氣-N-[(1R)-1,2-二曱基丙基]-6-(2,4,6-三氣苯 基)[1,2,4]三唑并[l,5-a]嘧啶-7-胺(得知自:WO 02/38565),具化學式為: -69- 2008149282〇(22-2) 5-Gas-N-[(1R)-1,2-Dimercaptopropyl]-6-(2,4,6-trisylphenyl)[1,2,4] Triazolo[l,5-a]pyrimidin-7-amine (known from: WO 02/38565) with the chemical formula: -69- 200814928
(22-3) 5 -氯-6-(2-氣-6-氣苯基)-7-(4-曱基六氮ϋ比唆-1-基) 5 [1,2,4]三唑并[l,5-a]-嘧啶(得知自:US 5,593,996), 具化學式為:(22-3) 5-Chloro-6-(2-aero-6-phenylphenyl)-7-(4-mercaptohexanitropyridinium-1-yl) 5 [1,2,4]triazole And [l,5-a]-pyrimidine (known from: US 5,593,996), with the chemical formula:
1010
(22-4) 5-氯-6·(2,4,6-三氟苯基)-7-(4-曱基六氫吼啶-1-基) [1,2,4]三唑并[l,5-a]嘧啶(得知自:DE-A 101 24 208),具化學式為: 15(22-4) 5-Chloro-6·(2,4,6-trifluorophenyl)-7-(4-mercaptohexahydroacridin-1-yl)[1,2,4]triazole [l,5-a]pyrimidine (known from: DE-A 101 24 208) with the chemical formula: 15
較佳的第(23)類之混合配對物為: (23_ 1) 2- 丁氧基-6-破-3-丙基苯弁σ比喃-4-嗣(得知自· WO 03/014103),具化學式為: -70- 20 200814928 ΟA preferred mixed partner of the (23) class is: (23_ 1) 2-butoxy-6-bromo-3-propylbenzoquinone σ-pyran-4-嗣 (known from WO 03/014103 ), with the chemical formula: -70- 20 200814928 Ο
(23-2) 2-乙氧基-6-碘-3-丙基苯并吡喃-4-酮(得知自:WO 03/014103),具化學式為:(23-2) 2-Ethoxy-6-iodo-3-propylbenzopyran-4-one (obtained from: WO 03/014103), having the chemical formula:
^ ^ ch3 ch3^ ^ ch3 ch3
10 (23-3) 6-碘-2-丙氧基-3-丙基苯并吡喃-4-酮(得知自:WO 03/014103),具化學式為:10 (23-3) 6-iodo-2-propoxy-3-propylbenzopyran-4-one (obtained from: WO 03/014103), having the chemical formula:
(23-4) 2-丁-2-快基氧-6-破-3-丙基苯弁ϋ比喃-4-嗣(得知自: WO 03/014103),具化學式為: 15(23-4) 2-but-2-Quinyloxy-6-bromo-3-propylphenylpyrenepyran-4-pyrene (obtained from: WO 03/014103), with the chemical formula: 15
〇〇
(23-5) 6-蛾-2-(1-曱基丁乳基)-3-丙基苯弁1^比喃-4-嗣(得知 自:WO 03/014103),具化學式為:(23-5) 6-Moth-2-(1-decylbutyryl)-3-propylbenzoquinone 1^pyran-4-嗣 (obtained from: WO 03/014103), with the chemical formula:
(23-6) 2-丁-3-烯基氧-6-碘苯并吡喃-4-酮(得知自:WO 03/014103),具化學式為: -71 ~ 20 200814928(23-6) 2-but-3-enyloxy-6-iodobenzopyran-4-one (obtained from: WO 03/014103) with the chemical formula: -71 ~ 20 200814928
(23-7) 3-丁基-6-碘-2-異丙氧基苯并吡喃-4-酮(得知自:WO 03/014103),具化學式為:(23-7) 3-butyl-6-iodo-2-isopropoxybenzopyran-4-one (obtained from: WO 03/014103) having the chemical formula:
10 〇10 〇
較佳的第(24)類之混合配對物為: (24-1) N-(3’,4’-二氯-5-氟聯苯基-2-基)-3-(二氟甲基)-1 -甲基-1H-吡唑-4-羧醯胺(得知自:WO 03/070705), 具化學式為: 15Preferred mixed partners of class (24) are: (24-1) N-(3',4'-dichloro-5-fluorobiphenyl-2-yl)-3-(difluoromethyl) )-1 -Methyl-1H-pyrazole-4-carboxyguanamine (known from: WO 03/070705), with the chemical formula: 15
(24-2) 4-(二氟甲基)-2-甲基-N-[4f•(三氟曱基聯苯基 -2-基]-1,3-噻唑-5-羧醯胺(得知自:WO 03/066610), 具化學式為: -72- 20 200814928(24-2) 4-(Difluoromethyl)-2-methyl-N-[4f•(trifluoromethylbiphenyl-2-yl)-1,3-thiazole-5-carboxamide ( Learned from: WO 03/066610), with the chemical formula: -72- 20 200814928
5 (24-3) N-(3’-氣-4’-氯聯苯基-2-基)-4·(二氣曱基)-2-甲 基-1,3-噻唑-5-羧醯胺(得知自:WO 03/066610),具 化學式為:5 (24-3) N-(3'-Gas-4'-chlorobiphenyl-2-yl)-4·(dioxamethyl)-2-methyl-1,3-thiazole-5-carboxylate Guanamine (available from: WO 03/066610) with the chemical formula:
(24-4) N-(3’,4’-二氯-1,Γ-聯苯基-2-基 >5-氟-1,3-二甲基 -1H-吡唑-4-羧醯胺(得知自:WO 00/14701),具化學 式為.(24-4) N-(3',4'-Dichloro-1, fluorene-biphenyl-2-yl> 5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxylate Indoleamine (known from: WO 00/14701), with chemical formula.
2〇 (24-5) N-(4’-氣-3’-亂-l,r_聯苯基-2-基)-2-曱基-4-(三氣甲 基)-1,3-噻唑-5-羧醯胺(得知自:W0 03/066609),具 化學式為: -73- 2008149282〇(24-5) N-(4'-gas-3'-random-l,r_biphenyl-2-yl)-2-mercapto-4-(trimethylmethyl)-1,3 -thiazole-5-carboxamide (available from: W0 03/066609) with the chemical formula: -73- 200814928
5 (24-6) N-(4’-氯聯苯基-2-基)-4-(二氟甲基)-2-曱基-1,3- 噻唑-5-羧醯胺(得知自:WO 03/066610),具化學式5 (24-6) N-(4'-chlorobiphenyl-2-yl)-4-(difluoromethyl)-2-mercapto-1,3-thiazole-5-carboxyguanamine (known From: WO 03/066610), with chemical formula
(24-7) ΛΚ4’·溴-1,Γ-聯苯基-2-基)-4-(二氟曱基)-2-曱基 胃1,3-噻唑-5-羧醯胺(得知自:WO 03/066610),具化 15 學式為..(24-7) ΛΚ4'·bromo-1,Γ-biphenyl-2-yl)-4-(difluoroindolyl)-2-indolyl gastric 1,3-thiazole-5-carboxyguanamine Known from: WO 03/066610), with 15 learning styles:
較佳的第(25)類之混合配對物為: (25-1) Λ42-(1,3-二曱基丁基)苯基]-1,3-二甲基-lif-口 比唑-4-羧醯胺,具化學式為: -74- 20 200814928Preferred mixed partners of class (25) are: (25-1) Λ42-(1,3-dimercaptobutyl)phenyl]-1,3-dimethyl-lif-mouthbazole- 4-carboxyguanamine with the chemical formula: -74- 20 200814928
(25-2)落{2-(l,3-二甲基丁基)苯基氟-1,3-二甲基 5 吡唑-4-羧醯胺(得知自:WO 03/010149),具化學式(25-2) Falling {2-(l,3-dimethylbutyl)phenylfluoro-1,3-dimethyl-5 pyrazole-4-carboxamide (available from: WO 03/010149) With chemical formula
(25-3) Λ42-(1,3-二甲基丁基)苯基]_5-氯-1,3-二甲基-1凡吡 唑-4-羧醯胺(得知自:JP-A 10-251240),具化學式為:(25-3) Λ42-(1,3-dimethylbutyl)phenyl]_5-chloro-1,3-dimethyl-1phenazineazole-4-carboxamide (available from: JP- A 10-251240), with the chemical formula:
15 (25-4) 3-(二氟甲基)-7\^[2-(1,3-二甲基丁基)苯基]_ι·甲基 -1//-吡唑-4-羧醯胺,具化學式為:15 (25-4) 3-(Difluoromethyl)-7\^[2-(1,3-dimethylbutyl)phenyl]_ι·methyl-1//-pyrazole-4-carboxylate Indoleamine, with the chemical formula:
(25-5) 3-(三氟甲基)善[2-(1,3-二甲基丁基)苯基]冬氟小甲 基-177-吡唑-4_羧醯胺(得知自:DE-A 103 03 589), -75« 200814928 具化學式為:(25-5) 3-(Trifluoromethyl)-[2-(1,3-dimethylbutyl)phenyl]oxofluoromethyl-177-pyrazole-4-carboxamide (known From: DE-A 103 03 589), -75« 200814928 The chemical formula is:
(25-6) 3-(三氟甲基)_#_[2_(1,3_二甲基丁基)苯基]_5_氣甲 基比唾_4_叛醯胺(得知自:jp_A 仙), • 具化學式為:(25-6) 3-(Trifluoromethyl)_#_[2_(1,3-dimethylbutyl)phenyl]_5_qimethyl than salivation-4_tetamine (known from: jp_A 仙), • has the chemical formula:
(25-7) 1,3-二甲基#[2心,3,3-三甲基)苯基^比唾冰緩 酸胺(得知自·· JP-A 10-251240),具化學式為:(25-7) 1,3-Dimethyl#[2,3,3-trimethyl)phenyl^ is more than a salicylamine (known as JP-A 10-251240), with a chemical formula for:
(25-8) 5-氟-1,,3_二甲基善[2(1,3,3·三甲基丁基)笨基]•心比 n敌酿胺(得知自:WO 03/010149),具化學式為·(25-8) 5-Fluoro-1,3-dimethylso[2(1,3,3·trimethylbutyl) stupid base]• Heart ratio n entrained amine (known from: WO 03 /010149), with chemical formula
(25-9) 3-(二敗甲基)小甲基善[2_(1,3,3_三曱基丁基)笨 -76- 200814928 基]4仏吡唑-4-羧醯胺,具化學式為:(25-9) 3-(disodium methyl) small methyl good [2_(1,3,3_tridecylbutyl) stupid-76- 200814928 base]4 pyrazole-4-carboxyguanamine, With the chemical formula:
(25-10)3-(三氟曱基)-1-甲基三甲基丁基)笨 基]-1//-吡唑-4-羧醯胺,具化學式為··(25-10) 3-(Trifluoromethyl)-1-methyltrimethylbutyl)phenyl]-1//-pyrazole-4-carboxyguanamine, having the chemical formula··
(25-11)3-(二氣甲基)-5遠_1_曱基养三曱基丁基) 苯基Η凡吼唾冰羧醯胺(得知自:dE-A 103 〇3 589),具化學式為:(25-11) 3-(dimethylmethyl)-5 far-1_indolyl tridecylbutyl) phenyl hydrazine hydrazine carbaryl amide (known from: dE-A 103 〇 3 589 ), with the chemical formula:
(25_12)t(三氟甲基)·5-氯-1-甲基善[2-(1,3,3-三甲基丁基) 苯基]-1丹·^比唾-4-羧醯胺(得知自:jp A 1〇_25124〇), 具化學式為: 200814928(25_12)t(trifluoromethyl)·5-chloro-1-methyl good [2-(1,3,3-trimethylbutyl)phenyl]-1 dan·^ than sal-4-carboxyl Guanamine (known from: jp A 1〇_25124〇), with the chemical formula: 200814928
5 (25-13)#-[2-(1,3-(二甲基丁基)苯基)-2-碘苯甲醯胺(得知 自:DE-A 102 29 595),具化學式為:5(25-13)#-[2-(1,3-(dimethylbutyl)phenyl)-2-iodobenridamide (known from: DE-A 102 29 595), with chemical formula :
(25-14)2-碘,3,3-三甲基丁基)苯基]苯甲醯胺(得知 自:DE-A 102 29 595),具化學式為:(25-14) 2-iodo, 3,3-trimethylbutyl)phenyl]benzamide (found from: DE-A 102 29 595), having the chemical formula:
(25-15)豕[2-(1,3-二甲基丁基)苯基]-2-(三氟曱基)苯甲醯胺 (得知自:DE-A 102 29 595),具化學式為:(25-15) 豕[2-(1,3-Dimethylbutyl)phenyl]-2-(trifluoromethyl)benzamide (available from: DE-A 102 29 595), with The chemical formula is:
(25-16)2-(三氟甲基)-7V-[2-(l,3,3-三曱基丁基)苯基]苯甲醯 -78- 20 200814928 胺(得知自:DE-A 102 29 595),具化學式為:(25-16) 2-(Trifluoromethyl)-7V-[2-(l,3,3-tridecylbutyl)phenyl]benzamide-78- 20 200814928 Amine (Know from: DE -A 102 29 595), with the chemical formula:
5 式(XVIII)的化合物包含下述較佳的第(26)類之混合配 | 對物: (26-1) 5-氟-1,3-二曱基-N-[2-(3-曱基丁基)苯基;HH-吼唑 ίο -4-羧醯胺,具化學式為:5 The compound of the formula (XVIII) comprises the following preferred compound of the above (26) class | Pair: (26-1) 5-fluoro-1,3-didecyl-N-[2-(3-曱 butyl phenyl) phenyl; HH-carbazole ίο -4-carboxamide, with the chemical formula:
1515
(26-2) 3-(二氟曱基)-N-[2-(3,3-二曱基丁基)-4-氟苯基]-1-曱 基-1//*吡唑4-羧醯胺,具化學式為:(26-2) 3-(Difluoroindolyl)-N-[2-(3,3-dimercaptobutyl)-4-fluorophenyl]-1-indenyl-1//*pyrazole 4 - Carboxylamamine, with the chemical formula:
(26-3) 3-(二氟甲基)-Ν-[2-(3,3·二曱基丁基)苯基]-1-甲基 -1Η-吡唑-4-羧醯胺,具化學式為: -79- 200814928(26-3) 3-(Difluoromethyl)-indole-[2-(3,3·didecylbutyl)phenyl]-1-methyl-1Η-pyrazole-4-carboxamide, With the chemical formula: -79- 200814928
(26-4) N-[2-(3,3-二甲基丁基)苯基]-2-(三氟曱基)苯甲酿 胺,具化學式為:(26-4) N-[2-(3,3-dimethylbutyl)phenyl]-2-(trifluoromethyl)benzamide, having the chemical formula:
(26-5) N-[2-(3,3-二甲基丁基)-4-氟苯基]-2-甲基冰(三氟甲 ίο 基)-1,3-噻唑-5-羧醯胺,具化學式為:(26-5) N-[2-(3,3-dimethylbutyl)-4-fluorophenyl]-2-methyl ice (trifluoromethyl)-1,3-thiazole-5- Carboxyamine, with the chemical formula:
1515
(26-6) N-[2-(3,3-二甲基丁基)-3-甲基噻吩-2-羧醯胺,具化 學式為:(26-6) N-[2-(3,3-Dimethylbutyl)-3-methylthiophene-2-carboxamide, with chemical formula:
(全部均為得知自WO 2005/042494)。 化合物(6-7),加普安(caipropamid),具有三個不對稱 的經取代的碳原子,因此,化合物(6-7)可以是由不同的異 構物形成之混合物或單獨的組分之型式,特別佳的化合物 20 200814928 為··(^3i〇-2,2-二氯氣苯基)乙基]-1-乙基-3- 甲基環丙烷羧醯胺,具化學式為:(All are known from WO 2005/042494). The compound (6-7), caipropamid, has three asymmetric substituted carbon atoms, and therefore, the compound (6-7) may be a mixture formed of different isomers or a separate component. The type, particularly excellent compound 20 200814928 is (^3i〇-2,2-dichlorophenyl)ethyl]-1-ethyl-3-methylcyclopropanecarboxamide, which has the chemical formula:
以及 (/iU*S>2,2-二氣Κ(1〇小(4-氯苯基)乙基]小乙基_3_甲基 環丙烷羧醯胺,具化學式為:And (/iU*S>2,2-dioxane (1 〇 small (4-chlorophenyl)ethyl) small ethyl _3_methylcyclopropanecarboxamide, having the chemical formula:
15 特別佳的第(2)至(26)類的活性化合物為下述之活性化 ϋ 合物: (2-1)亞托敏(azoxyStr〇bin),(2-2)氟嘧菌酯(fluoxastrobin),(2_3) (2£>2-(2- {[6-(3-氯-2-甲基苯氧基)_5_氟-4-嘧啶基]氧y苯 基)-2-(甲氧基亞胺基)-ΛΓ-甲基乙醯胺,(2_4)三氟敏 2〇 (trifloxystrobin),(2-5) (2£>2-(甲氧基亞胺基)# 甲基 2-(2_{[({(1万)-1-[3_(二氟甲基)苯基]乙二基卜胺基)氧]甲基} 苯基)乙醯胺’(2·6) (2幻士(甲氧基亞胺基)·|甲^ -2-{2-[(五)-({1-[3-(三氟甲基)苯基]乙氧基丨亞胺基甲基]苯 基}乙醯胺,(2-8) 5-甲氧基_2-甲基冰(2-{[({(1幻小[3_(三氣 -81 - 200814928 甲基)苯基]乙二基}胺基)氧]-甲基}苯基)-2,4-二氫 -3F-1,2,4-三唑-3-酮 ’ (2-9) 克收辛-甲基 (kresoxim-methyl),(2-10)大滅哇丙(dimoxystrobin),(2-11) 咬氧菌酯(picoxystrobin),(2-12)唾菌胺酯(pyraclostrobin),(2 -13 ) 5 苯氧菌胺(metominostrobin),(2-14)英司多丙(enestrobin), (3-3)普比康嗤(propiconazole),(3-4)待芬康唾 (difenoconazole),(3-6)西普康唾(cyproconazole),(3-7)菲 | 克斯(hexaconazole),(3-8)平康嗤(penconazole),(3-9)邁 克別尼(myclobutanil),(3·10)四康嗤(tetraconazole),(3-12) 10 依普座(epoxiconazole),(3-13)護石夕唾(flusilazole),(3-15) 普硫康哇(prothioconazole) ,(3-16) 芬布康嗤 (fenbuconazole),(3-17)得克力(tebuconazole),(3-19)滅康 唑(metconazole),(3-21)比多農(bitertanol),(3-22)三泰隆 (triadimenol),〇23)三泰芬(triadimefon),(3-24)氟喹康 15 唑(fluquinconazole),(3-26)二氯布康唑(diclobutrazole), _ (3-27)得尼康唑(diniconazole),(4-1)二氯氟尼 (dichlofluanid) ’(4-2)曱基益發靈(tolylfhianid),(5-1)異丙 菌胺(iprovalicarb),(5-3)苯噻菌胺(benAiavalicarb),(6_2) 白克力(boscalid),(6-5)噻唑菌胺(ethaboxam),(6-6)環醯 20 菌胺(fenhexamid),(6-7)卡普米(carpropamid),(6-8) 2-氣 -4-(2-氟-2-甲基丙酿基胺基)_况#-二甲基苯甲酿胺,(6-9)殺 菌劑(picobenzamid),(6_10)唑查醯胺(zoxamide),(6-11) 3,4_二氯-N-(2-氰基苯基)異°塞唾-5-叛醢胺,(6-14) σ塞菌胺 (penthiopyrad),(6-16) Λ42-(1,3-二曱基丁基)苯基]-1-甲基 -82- 200814928 冰(三氟甲基)_1丑_吼咯-3-羧醯胺,(6-17)福多寧 (flutolanil),(6·21) N-{2-〇氯·5-(三氟甲基)π比啶冬基]乙 基}-2-(三氟甲基)苯甲醯胺,(6-22) Ν-(2-雙環丙基-2-基笨 基)_卜曱基-3-二氟甲基-lji-u比唾_4_叛酿胺,(6-23) Ν-(2-雙 5 壞丙基-2-基苯基)-1-甲基-3-二敗甲基-111-°比唾-4-叛酿胺, (6-24) Ν-[2-(Γ-甲基雙環丙基-2-基)苯基]-1-甲基-3-三氟甲 基-1Η-吡唑-4-羧醯胺,(6-25) Ν-[2-(Γ-曱基雙環丙基-2-基) , 苯基]-1-甲基-3-二氟曱基-1Η· σ比峻-4-緩酿胺,(6-26) N-[l-(5-溴-3-氣0比咬-2-基)乙基]-2,4-二氯於驗酿胺,(6,27) ίο Ν·(5-溴-3-氯吡啶-2-基)甲基-2,4-二氣菸鹼醯胺,(7-1)鋅猛 乃浦(mancozeb),(7-2)猛乃浦(maneb),(7-4)甲基鋅乃浦 (propineb),(7-5)得恩地(thiram),(7-6)鋅乃浦(zineb),(8-l) 本達樂(benalaxyl),(8-2)福達樂(furalaxyl),(8-3)滅達樂 (metalaxyl),(8,4)滅達樂-M(metalaxyl-M),(8:5)本達樂 is -M(benalaxyl-M),(9,1)西普地尼(cyprodinil),(9-2)滅盤 尼比(mepanipyrim),(9-3)必滅寧(pyrimethanil),(10-1) 6-15 Particularly preferred active compounds of the above categories (2) to (26) are the following activated compounds: (2-1) azoxy Str〇bin, (2-2) fluoxastrobin ( Fluoxastrobin),(2_3) (2£>2-(2- {[6-(3-chloro-2-methylphenoxy)_5_fluoro-4-pyrimidinyl]oxy yphenyl)-2- (methoxyanilide)-oxime-methylacetamide, (2_4) trifloxystrobin, (2-5) (2£>2-(methoxyimino)# Methyl 2-(2_{[({(1))-1-[3_(difluoromethyl)phenyl]ethanediylamino)oxy]methyl}phenyl)acetamidamine' (2· 6) (2 phantom (methoxyimino)·|^^ -2-{2-[(5)-({1-[3-(trifluoromethyl)phenyl]ethoxy oxime) Aminomethyl]phenyl}acetamidamine, (2-8) 5-methoxy-2-methyl ice (2-{[({(1) is a small [3_(three gas-81 - 200814928 methyl) Phenyl]ethylenediyl}amino)oxy]-methyl}phenyl)-2,4-dihydro-3F-1,2,4-triazol-3-one' (2-9) Kresoxim-methyl, (2-10) dimoxystrobin, (2-11) picoxystrobin, (2-12) pyracostrobin, 2 -13 ) 5 phenoxystrobin (metominostrobin), (2-14) Enestrobin, (3-3) propiconazole, (3-4) difenoconazole, (3-6) cyproconazole, (3-7) ) hexaconazole, (3-8) penconazole, (3-9) myclobutanil, (3·10) tetraconazole, (3-12) 10 epoxiconazole, (3-13) flusilazole, (3-15) prothioconazole, (3-16) fenbuconazole, (3- 17) tebuconazole, (3-19) metconazole, (3-21) than bitertanol, (3-22) triadimenol, 〇23) tritopine (triadimefon), (3-24) fluquinconazole, (3-26) diclobutrazole, _ (3-27) diniconazole, (4-1) Dichlofluanid '(4-2) 曱基益发灵 (tolylfhianid), (5-1) isopropyl carbamide (iprovalicarb), (5-3) benzothiazol (benAiavalicarb), (6_2) Boscalid, (6-5) ethaboxam, (6-6) guanidine 20 fenhexamid ), (6-7) carpropamid, (6-8) 2-gas-4-(2-fluoro-2-methylpropanylamino)_condition #-dimethylbenzamide , (6-9) bactericide (picobenzamid), (6_10) zoxamide, (6-11) 3,4-dichloro-N-(2-cyanophenyl) iso-salt- 5-treazone, (6-14) σs-subtilamine (penthiopyrad), (6-16) Λ42-(1,3-didecylbutyl)phenyl]-1-methyl-82- 200814928 ice (trifluoromethyl)_1 ugly 吼 吼 -3--3-carboxamide, (6-17) flutolanil, (6·21) N-{2-〇chloro·5-(trifluoromethyl Π-pyridinyl]ethyl}-2-(trifluoromethyl)benzamide, (6-22) Ν-(2-bicyclopropyl-2-ylphenyl)-diphenyl-3- Fluoromethyl-lji-u is more than salivary _4_ apoein, (6-23) Ν-(2-bis 5 propyl propyl-2-ylphenyl)-1-methyl-3- dioxin methyl -111-° than saliva-4-rebel, (6-24) Ν-[2-(Γ-methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-trifluoromethyl Base-1-pyrazole-4-carboxyguanamine, (6-25) Ν-[2-(indolyl-bicyclopropyl-2-yl), phenyl]-1-methyl-3-difluoro曱基-1Η· σ比峻-4- slowly brewing amine, (6-26) N-[l-(5-bromo-3-gas 0-bit-2-yl)ethyl]-2,4-di chlorine In the test of amine, (6,27) ίο Ν·(5-bromo-3-chloropyridin-2-yl)methyl-2,4-di-nicotinamide, (7-1) zinc snail (mancozeb), (7-2) Manna, (7-4) methyl zinc (propineb), (7-5) thiram, (7-6) zinc napu ( Zineb), (8-l) Benalaxyl, (8-2) furalaxyl, (8-3) metalaxyl, (8, 4) vandal-M ( metalaxyl-M), (8:5) Bendais is -M (benalaxyl-M), (9,1) cyprodinil, (9-2) mepanipyrim, (9 -3) Pyrimen (pyrimethanil), (10-1) 6-
W 氯-5-[(3,5-二甲基異噁唑-4-基)磺醯基]-2,2-二氟-5H-[1,3]二 σ惡茂并[4,5-f]-苯并味嗤,(10-3)貝芬替(carbendazim),(11-1) 二硫芬克(diethofencarb),(11-2)普拔克(propamocarb), 2〇 (11-3)鹽酸普拔克(propamocarb_hydrochloride),(11-4)普 拔克-福賽得(fosetyl),(12-2)蓋普丹(^?丨&11),(12-3)福爾 培(folpet),(12-4)依普同(iprodione),(12-5)撲滅寧 (procymidone),(13-1)多寧(dodine),(13-2)克熱淨 (guazatine),(13-3)雙胍辛胺三乙酸鹽(iminoctadine •83- 200814928 triacetate) ’(14-1)赛座滅(Cyazofainid),(14-2)撲克拉 (prochloraz),(14-3)三唑嗪(triazoxide),(15-4)芬普比福 (fenpropimorph),(15-5)大滅芬(dimethomorph),(16-2)伏 地噁尼(fludioxonil),(17-1)福赛得-鋁(fbsetyl-Al),(17-2) 5 膦酸 ’(17·3)曱基立枯磷(toldophos-methyl),(19-1)笨并 噻二唑酯(acibenzolar-S-methyl) ,(19-2)氣塞尼 (chlorothalonil),(19-3)克絕(cymoxanil),(19-5)凡殺同 瞻 (famoxadone),(19-6)伏寄南(fluazinam),(19-7)氣氧化銅 (copper oxychloride),(19_9)歐殺斯(oxadixyl),(19-10)螺 ίο 環菌胺(spiroxamine),(19-13)咪唑菌酮(fenamidone), (19-22) 2-(4-氯苯基)-N-{2-[3-曱氧基-4-(丙-2-炔小基氧)苯 基]乙基}-2-(丙-2-炔-1-基氧)乙醯胺,(19-23)快諾芬 (quinoxyfen),(20-1)賓克隆(pencycuron),(2〇-2)曱基_多 保淨(thiophanate-methyl),(22-1) 5-氯-Λ4(/5>2,2,2_三氟-l is 甲基乙基]各(2,4,6-三氟笨基)[1,2,4]三。坐并[l,5-a], 口定 胺,(22-2) 5-氯二曱基丙基]-6-(2,4,6-三氟苯 _ 基)[1,2,4]三唑并[l,5_a]嘧啶-7-胺,(22-4) 5-氯各(2,4,6-三氣 苯基)-7-(4-曱基六氫吼啶-1-基)[1,2,4]三唑并[l,5-a]嘧咬, (23-1) 2-丁氧基-6-破-3-丙基苯并吡喃-4·酮,(23-2) 2-乙氧 2〇 基-6-碘-3-丙基苯并吡喃·‘酮,(23-3) 6-碘-2-丙氧基-3·丙基 苯并啦喃-4·酮,(24-1)沁(3,,4,-二氯-5-氟·1,1’_聯苯基_2_ 基)-3·(二 It 甲基)-1-甲基比嗤-4-羧酿胺,(24-7) Λ^(4,_ 溴-1,Γ-聯苯基-2-基)-4-(二氟曱基)-2-甲基-1,3H5-竣醯 胺,(25-1) 1[2-(1,3-二曱基丁基)苯基]-ΐ,3·二甲基-1//•吡唾 -84- 200814928 领醯胺,(25_2) ^{2_(1,3_二甲基丁基)苯基卜5_氣妙二 Y 基-1心比唾-續_,(25_8) 甲基善[2(1,3,3_ 二甲基丁基)苯基Η//』比唾_4_叛_,(25·13^_[2 (ι,3 (二 甲基丁基)苯基)-2-碘苯曱醯胺,(25_15)尽{2_〇,3-二甲基丁 5 基)苯基卜三氟甲基)苯甲酸胺。 極佳的第(2)至(26)類的活性化合物為下述之活性化合 物: | (2-2)氟。治_ 酯(fluoxastrobin),(2-3)(2五)-2-(2-{[6-(3-氯-2- 甲基苯氧基)_5_氟喷啶基]氧}苯基)冬(曱氧基亞胺基)善 10 曱基乙酿胺,(2·4)、三氟敏(trifloxystrobin),(3-15)普硫康 唑(prothioconazole),(3,17)得克力(tebuconazole),(3-21) 比多農(bitertanol),(3-22)三泰隆(triadimenol),(3-24)氟 喹康唑(fluquinconazole),(4-1)二氯氟尼(dichlofluanid), (4-2)甲基益發靈(tolylfluanid),(5-1)異丙菌胺 15 (iprovalicarb),(6-6)環酸菌胺(fenhexamid),(6-7)卡普米 除 (caipropamid),(6-9)殺菌劑(picobenzamid),(6-14)嗔菌胺 (penthiopyrad),(6-17)福多寧(fhitolanil),(6-21) Ν-{2-[3-氯-5-(三氟曱基)吡啶-2-基]乙基卜2-(三氟甲基)苯甲醯胺, (6-22) N-(2-雙環丙基-2-基苯基)-1-曱基-3-三氟甲基-1H-口比 20 唑-4-羧醯胺,(6-23) Ν-(2-雙環丙基-2-基苯基)-1-曱基-3-二 氟甲基-1H-吡唑-4-羧醯胺,(6-24) Ν-[2-(Γ-甲基雙環丙基-2-基)苯基]-1-甲基-3-三氟甲基-lH-u比唑·4·羧醯胺,(6-25) Ν-〇(Γ-甲基雙環丙基-2-基)苯基]·1-曱基-3-二氟甲基-1Η-吡唑-4-羧醯胺,(6-26)Ν-[1-(5-溴-3-氣吡啶-2-基)乙基]-2,4- -85- 200814928 二氯菸鹼醯胺,(6-27) 1^-(5_溴-3_氯吡啶-2-基)曱基-2,4-二氯 於驗醯胺’(7_4)曱基鋅乃浦(pr〇pineb),(8_4)滅達樂 -M(metalaxyl-M),(8-5)本達樂_M(benalaxyl-M),(9麵3)必 滅寧(pyrimethanil),(10-3)貝芬替(carbendazim),(11-4)普 5 拔克-福賽付(f〇setyl) ’(12-4)依普同(iprocji〇ne),(14-2)撲 克拉(prochloraz),(14-3)三唾唤(triazoxide),(16-2)伏地 噁尼(fludioxonil),(17-3)甲基立枯磷(toidophos-methyl), 除 (19-10)螺環菌胺(spiroxamine),(19-22) 2-(4-氣苯 基)-N-{2-[3-甲氧基-4-(丙-2-炔-1-基氧)苯基]乙基}-2-(丙-2-ίο 炔小基氧)乙酿胺,(19-23)快諾芬(quinoxyfen),(22-4) 5- 氯-6-(2,4,6-三I苯基)-7-(4-甲基六氫吼。定-1-基)[1,2,4]三嗤 并[l,5-a]嘧啶,(24-1) A^(3f,4,-二氯-5-氟·1,Γ-聯苯基-2-基)-3-(二氟甲基)小甲基-lif-吡唑-4-羧醯胺,(25-2) Λ^2-(1,3-二曱基丁基)苯基}·5-氟-1,3-二甲基-1好-吡唑-4-15 羧醯胺,(25-13) ΛΓ-[2-(1,3-(二甲基丁基)苯基)冬碘苯甲醯 ,胺。 較佳的活性化合物組合物包含兩類的活性化合物且在 各情形為:至少一種具式(I)之羧醯胺化合物(第(1)類)’以 及至少一種如下述之第(2)類至第(26)類之化合物,這些組 2〇 合物為Α至W之活性化合物組合物。 較佳之活性化合物組合物,其中第(1)類之式(I)的綾醯 胺化合物係挑選自下面表A中所列之化合物·· -86 - 200814928 表A : 編號 羧醯胺的化學名稱 (1-1) N-(3V^二氯聯苯基-2-基)小甲基-3-(三氟甲基)-1Η ^比唑-4-羧醯胺 (1-2) N_(3’-氯-4’-氟聯苯基-2-基)小甲基-3-(三氟甲基比唑-4-羧醯 胺 (1-3) N-(2f,4L二氯聯苯基-2-基)小甲基各(三氟甲基)-1Η』比唑-4-羧醯胺 (1-4) N-(3f,4’-二氟聯苯基-2-基)小甲基各(三氟甲基)-1Η-吡唑-4-羧醯胺 (1-5) N-(2’,5f-二氯聯苯基冬基)小甲基各(三氟甲基)-1Η-吡唑斗羧醯胺 (1-6) Ν-(2*,5*-二氣聯苯基-2-基)-1-甲基-3-(二敦甲基魏驢胺 (1-7) N-(4’-氣-2’-氟聯苯基冬基)小甲基各(三氟甲基)-1ΗΜ比唑冰羧醯 胺 (1-8) N-(4T-氣-2’-甲基聯苯基-2-基)-1-甲基-3-(二氣甲基竣 醯胺 (1-9) N-(4’-氯-3’-甲基聯苯基-2-基)小甲基各(三氟甲基)-1Η-吼唑冬羧 ϋ胺 (1-10) N-(4L鼠-2’-甲基聯苯基-2-基)-1-甲基-3-(二鼠甲基)-1Η-σΛσ坐-4-竣 醯胺 (1-11) Ν-(4’-氣-3^·•甲基聯苯基-2-基)-1-甲基-3-(二氣甲基比嗤-4-竣 醯胺 (1-12) N-(4f-氣-3’-氣甲基聯苯基-2-基)-1-甲基-3-(二氣甲基)-1Η·α比嗤 -4-羧醯胺 (1-13) Ν-(2’,4’-二氟聯苯基-2-基)小甲基各(三氟甲基)-1Η』比唑斗羧醯胺 (1-14) NW-氟U氧基聯苯基-2-基)小甲基-3 -(三氟曱基)_ 1H』比唑斗 羧醯胺 (1-15) 二氣聯苯基-2-基)-1-甲基-3-(二氣甲基)-1Η-ϋΐ^坐-4-魏酿胺 -87- 200814928 編號 羧醯胺的化學名稱 (1-16) N-(3’,5f-二甲基聯苯基-2-基)小甲基-3-(三氟甲基)-1Η ^比唑冰羧醯 胺 (1-17) N-(4’-氯U肖基聯苯基-2-基)小甲基-3-(三氟甲基)-1Η ^比唑-4-羧 醯胺 (1-18) N-[3\5f-雙(二氣甲基)聯苯基-2-基]-1-甲基-3-(二氣曱基 冬羧醯胺 (1-19) N-(3’,4’-二甲基聯苯基-2-基)小甲基-3-(三氟甲基)·1Η·吼唑-4-羧醯 胺 (1-20) 1-甲基-N-[4W肖基-3’-(三氟甲基)聯苯基-2-基]各(三氟甲基)-1Η-α比 唑-4-羧醯胺 (1-21) N-(4f-甲氧基-3^甲基聯苯基-2-基)小甲基各(三氟甲基)-1Η-吼唑 -4-羧醯胺 (1-22) N-(3*,4’-二甲氧基聯苯基-2-基)-1-甲基-3-(二氣甲基)-1Η-ϋΛσ坐-4-竣 醯胺 (1-23) N-(3’-氣-4’-甲乳基聯苯基-2-基)-1-甲基-3 -(二氣甲基 羧醯胺 (1-24) N-(4’-氯-3’-甲氧基聯苯基-2-基)小甲基各(三氟甲基)-1Η-吼唑-4- 羧醯胺 (1-25) N-[4’-氯-3H三氟甲基)聯苯基-2-基]小甲基-3-(三氟甲基)-1Η^比唑 -4-羧醯胺 (1-26) N-(3\5L二氣聯苯基-2*•基)-1-甲基-3-(二氣甲基)-111-啦唾-4-竣酿胺 (1-27) N-(4’-甲氧基-2’-甲基聯苯基-2-基)-1-甲基-3-(三氟甲基)-1Η·吼唑 -4-羧醯胺 (1-28) N-(3f,4L二氯聯苯基-2-基)-1-甲基各(二氟甲基)-1Η-吼唑-4-羧醯胺 (1-29) Ν-(3、氯氟聯苯基-2-基)小甲基-3-(二氟甲基)-1Η-吼唑-4-羧醯 胺 (1-30) N-(2’,4f-二氯聯苯基-2-基)-1 -甲基各(二氟曱基)-1H-吡唑-4-羧醯胺 (1-31) N-(3’,仁二氟聯苯基-2-基)小甲基-3-(二氟甲基)-1Η-吼唑-4-羧醯胺 -88- 200814928 編號 羧醯胺的化學名稱 (1-32) ST-(2*,5*-二氣聯苯基-2-基)-1-甲基-3-(二氣甲基^^。比峻-斗-魏酿胺 (1-33) Ν-(2’,5^二氟聯苯基-2-基)小甲基-3-(二氟甲基比唑斗羧醯胺 (1-34) N-(4’-氯-2匕氟聯苯基-2-基)小甲基各(二氟甲基)-1Η-吼唑斗羧醯 胺 (1-35) N-(4*-氣-2匕甲基聯本基·2-基)-1-甲基-3-(二氣甲基)-1Η-σ比坐-4-竣 龜胺 (1-36) Ν-(4’-氯-3’画甲基聯苯基-2-基)-1鑛甲基-3-(二氟甲基)嫌111-0比口坐-4-竣 酸胺 (1-37) N-(4L氣-2f-甲基聯苯基-2-基)-1-甲基-3-(二鼠甲基敌 醯胺 (1-38) N-(4f-鼠-3’-甲基聯苯基-2-基)·1-甲基-3-(二鼠甲基)-111-°比°坐-4-竣 醯胺 (1-39) N-(4’-氯-3f-氟-2’-甲基聯苯基-2-基)小甲基各(二氟甲基)-111-¾匕唑 -4-羧醯胺 (140) N-(2’,4’-二氟聯苯基-2-基)小甲基各(二氟曱基)-1Η-咻唑-4-羧醯胺 (1-41) Ν-(2。氣-4’-甲氧基聯苯基-2-基)-1-甲基-3-(二氣甲基 羧醯胺 (1-42) N-(2f,6f-二亂聯苯基-2-基)-1-甲基-3-(二氣曱基)-1Η-ϋ比17坐-4-竣酿胺 (1-43) Ν-(3’,5’-二甲基聯苯基-2-基)-1-甲基-3-(二氣甲基)-1Η-σ比嗤-4-竣隨 胺 (1-44) N-(4f-鼠-3*-石肖基聯苯基-2-基)-1-甲基-3-(二亂曱基竣 醯胺 (1-45) N-[3’,5f-雙(三氟甲基)聯苯基-2-基]-1-甲基-3-(二氟甲基)-1Η ^比唑 斗羧醯胺 (1-46) N-(3’,4’-二甲基聯苯基-2-基)小曱基各(二氟甲基)-1Η-吼唑-4·羧醯 胺 (1-47) I-甲基"N-[4’-石肖基-3f-(二氣甲基)聯苯基-2-基]-3-(二氣甲基)-1Η-σΛ 唑-4-羧醯胺 -89- 200814928 編號 羧醯胺的化學名稱 (1-48) Ν·(4’-甲氧基-3’-曱基聯苯基-2-基)小甲基各(二氟甲基)_1H-吼唑 -4-羧醯胺 (1-49) N-(3’,4’-二甲氧基聯苯基冬基)小甲基各(二氟甲基)-1Η·吼唑斗羧 酿胺 (1-50) Ν-(3,-氣-4,-甲氧基聯苯基-2-基)-1·甲基-3-(二說甲基)-1Η-口比口坐-4- 羧醯胺 (1-51) N-(4f-氯-3f-甲氧基聯苯基-2-基)·1-甲基-3-(二氣甲基)-1Η-σ比嗤-4_ 羧醯胺 (1-52) Ν-[4’-氯-3’-(三氟甲基)聯苯基-2·基]-1-甲基各(二氟甲基)-1Η·-比唑 -4-羧醯胺 (1-53) N-dS’-二鼠聯苯基基)-1-甲基-3-(二鼠甲基)-1Η-ϋΛσ:^-4-竣酸胺 (1-54) Ν-(4’-甲氧基-2’-甲基聯苯基-2-基)-1-甲基-3-(二氣甲基)-lH-atb嗤 -4-羧醯胺 (1-55) 3-(二氟甲基)#{3’-氟-44(⑹-(甲氧基亞胺基)甲基Η,Γ-聯苯基-2-基甲基吡唑4-羧醯胺 (1-56) 3-(三氟甲基)-ΛΜ31-氟-44(£>(甲氧基亞胺基)甲基]-1,Γ-聯苯基-2-基卜1 -甲基比唑-4-魏醯胺 (1-57) Ν_{4’·[⑹-(甲氧基亞胺基)甲基]-聯苯基-2-基}小甲基各(三氟曱 基)-1//-吡唑-4-羧醯胺 (1-58) 3-(二氟甲基)[⑹-(甲氧基亞胺基)甲基]聯苯基冬基}小甲基 比峻-4-魏醯胺 (1-59) (正-丁氧基亞胺基)甲基]聯苯基-2-基}-1-甲基-3-(二氣甲 基)-1//-吡唑4-羧醯胺 (1-60) N-{44(1Z)-N-乙氧基乙醯亞胺基]聯苯基-2-基}小甲基-3-(三氟甲 基)-1//·吼唑4-羧醯胺 (1-61) 1_曱基-AL{44(1Z)-N-丙氧基乙醯亞胺基]聯苯基-2-基}3-(三氟甲 基)-1//-吼唑-4-魏醯胺 (1-62) 尽{4’-[⑹-(異丙氧基亞胺基)甲基]聯苯基-2-基卜]-曱基-3-(三氟甲 基)-1从°比嗤-4-叛ϋ胺 (1-63) ΛΜ4’-⑻·(乙氧基亞胺基)甲基}聯苯基-2-基}小甲基各(三氟甲 基)-1//-°比唑-4·羧醯胺 -90- 200814928 編號 羧醯胺的化學名稱 (1-64) 1 -甲基-^H4L[C£K丙氧基亞胺基)甲基]聯苯基-2-基} -3 -(三氤甲 基)-1//-吡唑-4-羧醯胺 (1-65) iV-{4’-[(lZ)-N-異丙氧基乙醯亞胺基]聯苯基_2-基}小甲基各(三氟 甲基比σ坐-4-幾酿胺 (1-66) ΛΓ-{44(1Ζ)-Ν-丁氧基乙醯亞胺基]聯苯基-2-基卜μ甲基_3·(三氟甲 基比唾-4-缓ϋ胺 (1-67) iV~{3L氯44(£>(曱氧基-亞胺基)甲基]聯苯基_2_基卜甲基各(三 氟甲基)-1从吡唑-4-羧醯胺 (1-68) #-{34(幻·(甲氧基亞胺基)甲基]聯苯基-2-基}-1-甲基各(三氟甲 基)-1//-吡唑-4-羧醯胺 (1-69) 7V»{44(1E)-N-甲氧基乙醯亞胺基]聯苯基冬基}小甲基各(三氟甲 基)-li/j比峻-4-叛醯胺 (1-70) 私{3’-說_44⑹·(甲氧基亞胺基)甲基]聯笨基-2-基}小甲基各(三氟 甲基)-1乐吡唑-4-羧醯胺 (1-71) 3-(二氟甲基)-尽{3’-氟44(£>(曱氧基亞胺基)甲基]聯苯基-2-基}小甲基-1乐吡唑-4-羧醯胺 (1-72) {(ZH(環丙基甲氧基)亞胺基]甲基卜聯苯基_2_基)小甲基 -3-(三氟甲基)-li^比唑冰羧醯胺 (1-73) AM44(£>( 丁氧基亞胺基)甲基]聯苯基_2·基卜3-(二氟甲基)小甲基 -1//-°比峻-4-魏Si胺 (1-74) 3-(二氟甲基)# {44( 1 E)-N-甲氧基乙醯亞胺基]聯苯基_2-基}小甲 基-1/ί-吡唑-4-羧醯胺 (1-75) iV_{3f-氟-4’-[(£)-(丙氧基亞胺基)甲基]聯苯基_2-基}-1-甲基_3-(三氟 甲基)-li/·吡唑-4-羧醯胺 (1-76) 3-(二氟甲基)善{3’H[(£>(丙氧基亞胺基)甲基]聯苯基冬 基H-甲基-1好』比唑-4-羧醯胺 (1-77) {Γ-氯卓P>(甲氧基亞胺基)甲基]聯苯基_2-基}-1 -甲基-3-(三氟 曱基咄唑-4-羧醯胺 (1-78) ΛΜ3’-氟-44(1E)-N-丙氧基乙醯亞胺基]聯苯基冬基}]-甲基;(三 1甲基)-1私°比唾-4~叛醯胺 (1-79) 3-(二氟甲基)#{,氟44(ie)-n-丙氧基乙醯亞胺基]聯苯基Z 基}小甲基-1从吡唑冰羧醯胺 -91 - 200814928 編號 羧醯胺的化學名稱 (1-80) 3-(二氟甲基氟-4’-[(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基-2- 基}小甲基比嗤-4-羧醯胺 (1-81) (1-82) M{3’-氟-^[(ΙΕ^Ν·甲氧基乙醯亞胺基]聯苯基-2-基}小甲基-3-(三 氟甲基)-1//-°比。坐-4-魏隨胺 氯-4’-[(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基丨基}各(二氟甲 基)_1_甲基-1私口比口坐-4-緩酸胺 (1-83) 氯-4’-[(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基-2-基}小甲基-3-(三 氟甲基)4杯吡唑-4-羧醯胺 (1-84) 3-(二氟甲基)小甲基#{44⑹-(丙氧基亞胺基)甲基]聯苯基-2-基}-1//^比嗤-4-魏醯胺 (1-85) iH44(£>(曱氧基亞胺基)甲基]甲基聯苯基-2-基}小甲基各(三 1甲基)-1//-°比哇-4-魏ϋ胺 (1 -86) Η二氟甲基Η-甲基#{4,-[(1Ε)-Ν-丙氧基乙醯亞胺基]聯苯基-2-基卜l/ί-吡唑-4-羧醯胺 (1-87) Η二氟甲基ΗΗ44(ιε)善異丙氧基乙醯亞胺基]聯苯基-2-基卜1· 甲基-1//^比嗤-4-羧酿胺 (1-88) N-(4I-{(ZH(烯丙氧基)亞胺基]甲基}聯苯基_2_基)冬(二氟甲基)小 甲基-1乐吡唑冰羧醯胺 (1-89) Ν·(4Η(Ζ)-[(烯丙氧基)亞胺基]甲基}聯苯基-2-基)小甲基各(三氟 甲基比哇-4-魏驢胺 (1-90) 3-(二氟甲基HV-{44(£>(甲氧基亞胺基)甲基]-3,-曱基聯苯基-2-基}-1-甲基-1//-°比嗤-4-叛醯胺 (1-91) iV-{4t-{(lZ)-N-(烯丙氧基)乙醯亞胺基}聯苯基基卜^曱基;(三 氟甲基)·17ϊ^比唑-4-羧醯胺 (1-92) Μ{44( 1 Ε)-Ν-(烯丙氧基)乙醯亞胺基;|聯苯基_2_基卜3·(二氟甲 基)小甲基-1//-°比嗤-4-籍醯胺 (1-93) 尽{4’-[(1Ε)-Ν-(丁 ·2·炔-1-基氧)乙醯亞胺基]聯苯基_2_基}小甲基 -3-(三氟甲基比哇-4-緩醯胺 (1-94) 1-甲基#(4’-{(1Ε)-Ν-[(1-甲基丙!烯小基)氧]乙醯亞胺基丨聯苯基 -2-基)_3-(三氟甲基)-1乐〇比嗤冰羧醯胺 (1-95) 1-甲基#(4f-{(lE)-N-[(2_甲基丙冬烯小基)氧]乙醯亞胺基}聯苯基 基)各(三氟甲基)-1//-咖坐-4-魏醯胺 •92- 200814928 編號 羧醯胺的化學名稱 (1-96) 1 -甲基1 EHSl·(丙-2-炔小基氧)-乙醯亞胺基]聯苯基-2-基}-3-(—'氣甲基比碎_4-幾^8^胺 (1-97) 3-f氟-甲基甲基#{44(1Ε)·Ν_(丙冬炔基氧]乙醯亞胺基} 聯苯基-2-基}-1//^比n叛醯胺 (1-98) 尽心氯卓[⑹·(甲氧基亞胺基)甲基]聯苯基冬基}各(二氟甲 基)-1 ·甲基-1丑^比唾《4_錄S蓀胺 (1-99) 曱氧基亞胺基)甲基]_2L甲基聯苯基丨基甲 基}各(三II甲基Viz/Lir比嗤_4_羧驢胺 (1-100) TV»{4L[(1Z)善丁氧基乙醯亞胺基]聯苯基·2·基卜3-(二氟甲基)小曱 基-1//-°比嗤冬繞酿胺 (1-101) 3-(二氟曱基HV^{44(£>(異丙氡基亞胺基)甲基]聯苯基基卜^甲 基-1/ί-吼嗤-4-緩醯胺 (1-102) Η二氟甲基)#{44(£>(甲氧基亞胺基)甲基]-2,-甲基聯苯基冬 基Η -甲基-1杯咣唑-4-羧醯胺 (1-103) M{3L氯4’-[(五Η甲氧基亞胺基)甲基]聯苯基-2-基卜3-(二氟甲 基)小甲基-li/』比嗤冰緩酸胺 (1-104) 3-(二氟甲基>^-{2^氟-4f-[(£)-(甲氧基亞胺基)甲基]聯苯基_2_ 基}小甲基-Li/-σ比吐-4-魏醯胺 〇105) 尽{Π44⑹-(甲氧基亞胺基)甲基]聯苯基冬基}小甲基;(三氟 曱基Hif-吡唑-4·羧醯胺。 除了具式(I)的第⑴類幾酸胺外,活性化合物組合物A 也包含第(2)類的式(II)之史托比系(strobilurin)W chloro-5-[(3,5-dimethylisoxazol-4-yl)sulfonyl]-2,2-difluoro-5H-[1,3]di-sigma oxo[4,5 -f]-benzopyrene, (10-3) carbendazim, (11-1) diefhofencarb, (11-2) propamocarb, 2〇 (11 -3) propamocarb_hydrochloride, (11-4), fosetyl, (12-2), Gapdan (^?丨 & 11), (12-3) Folpet, (12-4) iprodione, (12-5) procymidone, (13-1) dodine, (13-2) gram heat (guazatine) ), (13-3) bis-octylamine triacetate (iminoctadine • 83- 200814928 triacetate) '(14-1) Cyazofainid, (14-2) prochloraz, (14-3) Triazoxide, (15-4) fenpropimorph, (15-5) dimethomorph, (16-2) fludioxonil, (17-1)赛得-aluminium (fbsetyl-Al), (17-2) 5 phosphonic acid '(17·3) sulphate (toldophos-methyl), (19-1) benzothiazolidine (acibenzolar-S) -methyl) , (19-2) chlorothalonil, (19-3) Cymoxanil, (19-5) famoxadone, (19-6) fluazinam, (19-7) copper oxychloride, (19_9) octopus (oxadixyl), (19-10) snail ί spiroxamine, (19-13) fenamidone, (19-22) 2-(4-chlorophenyl)-N-{2- [3-methoxy-4-(prop-2-ynyloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamidamine, (19-23) Quinoxyfen, (20-1) pencycuron, (2〇-2) thiophenate- thiophenate-methyl, (22-1) 5-chloro-Λ4 (/5>2, 2,2_Trifluoro-l is methylethyl] each (2,4,6-trifluorophenyl)[1,2,4]tri. Sit and [l,5-a], dentate amine, (22-2) 5-chlorodimercaptopropyl]-6-(2,4,6-trifluorobenzene-yl)[1,2,4 Triazolo[l,5_a]pyrimidin-7-amine, (22-4) 5-chloro(2,4,6-triphenyl)-7-(4-mercaptohexahydroacridine-1 -yl)[1,2,4]triazolo[l,5-a]pyrimidine, (23-1) 2-butoxy-6-bromo-3-propylbenzopyran-4·one ,(23-2) 2-ethoxy-2-mercapto-6-iodo-3-propylbenzopyran-', (23-3) 6-iodo-2-propoxy-3-propylbenzene And ketone-4·one, (24-1) 沁(3,,4,-dichloro-5-fluoro·1,1'-biphenyl-2-yl)-3·(di-It methyl)- 1-methyl-p-indene-4-carboxylamine, (24-7) Λ^(4,_bromo-1, fluoren-biphenyl-2-yl)-4-(difluoroindolyl)-2- Methyl-1,3H5-decylamine, (25-1) 1[2-(1,3-didecylbutyl)phenyl]-indole, 3·dimethyl-1//•pyrrole- 84- 200814928 领醯amine, (25_2) ^{2_(1,3_dimethylbutyl)phenyl b-5_气妙二Y base-1 heart than saliva-continued _, (25_8) methyl good [ 2(1,3,3-dimethylbutyl)phenylhydrazine//" than saliva_4_rebellion_, (25·13^_[2 (ι,3 (dimethyl)phenyl))- 2-iodobenzoguanamine, (25_15) as far as {2_〇,3-dimethylbutanyl)phenyltrifluoro Methyl) benzoic acid amine. The excellent active compounds of the above categories (2) to (26) are the following active compounds: | (2-2) Fluorine. _ _ flu (fluoxastrobin), (2-3) (2 5)-2-(2-{[6-(3-chloro-2-methylphenoxy)_5-fluoropyridinyl]oxy}phenyl ) winter (nonoxyimino) good 10 mercaptoamine, (2.4), trifloxystrobin, (3-15) prothioconazole, (3,17) Tebuconazole, (3-21) bitertanol, (3-22) triadimenol, (3-24) fluquinconazole, (4-1) dichlorofluoride (dichlofluanid), (4-2) methyl phenylephrine (tolylfluanid), (5-1) isopropyl amide 15 (iprovalicarb), (6-6) fenhexamid, (6-7) Caipropamid, (6-9) picobenzamid, (6-14) penthiopyrad, (6-17) fhitolanil, (6-21) Ν-{ 2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl 2-(trifluoromethyl)benzamide, (6-22) N-(2-bicyclopropyl -2-ylphenyl)-1-indolyl-3-trifluoromethyl-1H-port ratio 20 azole-4-carboxyguanamine, (6-23) Ν-(2-bicyclopropyl-2-yl Phenyl)-1-mercapto-3-difluoromethyl-1H-pyrazole-4-carboxamide, (6-24) Ν-[2-(Γ-methylbicyclopropyl-2-yl) benzene 1-methyl-3-trifluoromethyl-lH-u-pyrazole·4·carboxamide, (6-25) Ν-〇(Γ-methylbicyclopropyl-2-yl)phenyl ··1-Mercapto-3-difluoromethyl-1Η-pyrazole-4-carboxamide, (6-26)Ν-[1-(5-bromo-3-pyridin-2-yl)B Base]-2,4- -85- 200814928 Dichloronicotinium amide, (6-27) 1^-(5-bromo-3-chloropyridin-2-yl)indolyl-2,4-dichloro醯 醯 ''(7_4) 曱 锌 乃 ( (pr〇pineb), (8_4) 达达乐-M (metalaxyl-M), (8-5) 达达乐_M (benalaxyl-M), (9 No. 3) Pyrimethanil, (10-3) Befendazim, (11-4) Pu 5 Buck-Fusie Fu (f〇setyl) '(12-4) Yi Putong Iprocji〇ne), (14-2) prochloraz, (14-3) triazoxide, (16-2) fludioxonil, (17-3) methyl chlorpyrifos (toidophos-methyl), except (19-10) spiroxamine, (19-22) 2-(4-phenylphenyl)-N-{2-[3-methoxy-4-( Prop-2-yne-1-yloxy)phenyl]ethyl}-2-(propyl-2-ίο alkynyloxy)ethinamide, (19-23) quinoxyfen, (22-4 ) 5-Chloro-6-(2,4,6-triIphenyl)-7-(4-methylhexahydroindole. Ding-1-yl)[1,2,4]triazino[l,5-a]pyrimidine, (24-1) A^(3f,4,-dichloro-5-fluoro·1, Γ-linked Phenyl-2-yl)-3-(difluoromethyl)succinymethyl-lif-pyrazole-4-carboxamide, (25-2) Λ^2-(1,3-dimercaptobutyl Phenyl}·5-fluoro-1,3-dimethyl-1-pyrazole-4-15 carboxamide, (25-13) ΛΓ-[2-(1,3-(dimethyl) Base) phenyl) winter iodobenzamide, amine. Preferred active compound compositions comprise two classes of active compounds and in each case: at least one carboxamide compound of formula (I) (category (1)) and at least one class (2) as described below To the compound of the class (26), these Group 2 conjugates are active compound compositions of hydrazine to W. A preferred active compound composition wherein the indoleamine compound of the formula (I) of the formula (I) is selected from the compounds listed in Table A below. - 86 - 200814928 Table A: Chemical Name of the Number Carboxamide (1-1) N-(3V^Dichlorobiphenyl-2-yl)小methyl-3-(trifluoromethyl)-1Η^Bizozol-4-carboxyguanamine (1-2) N_( 3'-Chloro-4'-fluorobiphenyl-2-yl) small methyl-3-(trifluoromethylpyrazole-4-carboxyguanamine (1-3) N-(2f, 4L dichlorinated Phenyl-2-yl)small methyl(trifluoromethyl)-1Η"pyrazole-4-carboxamide (1-4) N-(3f,4'-difluorobiphenyl-2-yl Small methyl each (trifluoromethyl)-1 Η-pyrazole-4-carboxamide (1-5) N-(2',5f-dichlorobiphenylmethylene) small methyl each (trifluoro Methyl)-1Η-pyrazol carboxamide (1-6) Ν-(2*,5*-di-biphenyl-2-yl)-1-methyl-3-(di Dunmethylmethyl) Indoleamine (1-7) N-(4'-gas-2'-fluorobiphenylmethanol) small methyl (trifluoromethyl)-1pyridazole ice carboguanamine (1-8) N- (4T-Gas-2'-Methylbiphenyl-2-yl)-1-methyl-3-(dimethylmethylguanamine (1-9) N-(4'-chloro-3'- Methyl biphenyl-2-yl) small methyl each (trifluoromethyl)-1 Η-carbazole winter carboxamide (1-10) N-(4L mouse - 2'-Methylbiphenyl-2-yl)-1-methyl-3-(dimethylmethyl)-1Η-σΛσ sit-4-decylamine (1-11) Ν-(4'-qi -3^·•Methylbiphenyl-2-yl)-1-methyl-3-(dimethyl-methyl-pyridin-4-indoleamine (1-12) N-(4f-gas-3' -gas methylbiphenyl-2-yl)-1-methyl-3-(dimethylmethyl)-1Η·α than 嗤-4-carboxyguanamine (1-13) Ν-(2',4 '-Difluorobiphenyl-2-yl) small methyl each (trifluoromethyl)-1 Η 比 azole carbamide (1-14) NW-fluoro U oxybiphenyl-2-yl) Small methyl-3-(trifluoromethyl)-1H"pyrazole carboxamide (1-15) di-biphenyl-2-yl)-1-methyl-3-(dimethyl) -1Η-ϋΐ^Sit-4-Weiamine-87- 200814928 No. Chemical name of carboxamide (1-16) N-(3',5f-dimethylbiphenyl-2-yl)methyl -3-(Trifluoromethyl)-1Η ^Bymazole Ice Carboxamide (1-17) N-(4'-Chloro U-Schothylbiphenyl-2-yl) Small Methyl-3-(Trifluoro Methyl)-1Η^Bizozol-4-carboxamide (1-18) N-[3\5f-bis(dimethylmethyl)biphenyl-2-yl]-1-methyl-3-( Dimethyl carbaryl carbamide (1-19) N-(3',4'-dimethylbiphenyl-2-yl) small methyl-3-(trifluoromethyl)·1Η·carbazole -4-carboxyguanamine (1-20) 1-methyl-N-[4W -3'-(trifluoromethyl)biphenyl-2-yl](trifluoromethyl)-1Η-α-pyrazole-4-carboxamide (1-21) N-(4f-methoxy -3^methylbiphenyl-2-yl)methylmethyl(trifluoromethyl)-1Η-indazole-4-carboxamide (1-22) N-(3*,4'-di Methoxybiphenyl-2-yl)-1-methyl-3-(dimethylmethyl)-1Η-ϋΛσ sit-4-decylamine (1-23) N-(3'-gas-4 '-Methyllacylbiphenyl-2-yl)-1-methyl-3-(dimethylcarbamoylamine (1-24) N-(4'-chloro-3'-methoxybiphenyl Benzyl-2-yl)methylmethyl(trifluoromethyl)-1Η-indazole-4-carboxamide (1-25) N-[4'-chloro-3H-trifluoromethyl)biphenyl- 2-yl]small methyl-3-(trifluoromethyl)-1Η^bazole-4-carboxamide (1-26) N-(3\5L di-biphenyl-2*•yl)- 1-methyl-3-(dimethylmethyl)-111-lasyl-4-indole amine (1-27) N-(4'-methoxy-2'-methylbiphenyl-2- 1-methyl-3-(trifluoromethyl)-1Η·carbazole-4-carboxamide (1-28) N-(3f,4L dichlorobiphenyl-2-yl)-1 -methyl each (difluoromethyl)-1 Η-carbazole-4-carboxamide (1-29) Ν-(3, chlorofluorobiphenyl-2-yl) small methyl-3-(difluoro Methyl)-1Η-indazole-4-carboxamide (1-30) N-(2',4f-dichlorobiphenyl-2-yl)-1 Di(difluorodecyl)-1H-pyrazole-4-carboxamide (1-31) N-(3', lenodifluorobiphenyl-2-yl) small methyl-3-(difluoro Methyl)-1Η-oxazole-4-carboxyguanamine-88- 200814928 No. Chemical name of carboxamide (1-32) ST-(2*,5*-di-biphenyl-2-yl)- 1-methyl-3-(dimethylmethyl^^.峻 - 斗 - weiwei amine (1-33) Ν-(2',5^difluorobiphenyl-2-yl) small methyl-3-(difluoromethylbiazole carbamoylamine (1 -34) N-(4'-Chloro-2匕fluorobiphenyl-2-yl)methylmethyl(difluoromethyl)-1Η-indazole carbamide (1-35) N-(4 *-Gas-2匕Methyl-benzino-2-yl)-1-methyl-3-(dimethylmethyl)-1Η-σ ratio -4-meramide (1-36) Ν-( 4'-Chloro-3' draw methylbiphenyl-2-yl)-1 ore methyl-3-(difluoromethyl) 111-0 than oral -4-nonanoic acid amine (1-37) N-(4L-gas-2f-methylbiphenyl-2-yl)-1-methyl-3-(di-methylmethylpropionamide (1-38) N-(4f-rat-3'-A Benzyl-2-yl)-1-methyl-3-(di-methyl)-111-° ratio 坐-4-decylamine (1-39) N-(4'-chloro-3f -Fluoro-2'-methylbiphenyl-2-yl)methanol (difluoromethyl)-111-3⁄4 oxazole-4-carboxamide (140) N-(2',4'- Difluorobiphenyl-2-yl) small methyl each (difluoroindolyl)-1Η-carbazole-4-carboxamide (1-41) Ν-(2. gas-4'-methoxy linkage Phenyl-2-yl)-1-methyl-3-(dioxamethylcarboxamide (1-42) N-(2f,6f-disorder biphenyl-2-yl)-1-methyl -3-(dimethyl fluorenyl)-1 Η-ϋ ratio 17 sitting -4- 竣 胺 (1-43) Ν-(3',5'-dimethyl Benzyl-2-yl)-1-methyl-3-(dimethylmethyl)-1Η-σ 嗤-4-竣 with amine (1-44) N-(4f-rat-3*-肖 肖 基 biphenyl-2-yl)-1-methyl-3-(disorder decyl decylamine (1-45) N-[3',5f-bis(trifluoromethyl)biphenyl-2 -yl]-1-methyl-3-(difluoromethyl)-1Η^biazole carbamide (1-46) N-(3',4'-dimethylbiphenyl-2-yl ) bismuthyl (difluoromethyl)-1 Η-carbazole-4·carboxycarboxamide (1-47) I-methyl "N-[4'-Shishouji-3f-(di-gas methyl) Phenyl-2-yl]-3-(dimethylmethyl)-1Η-σΛ azole-4-carboxyguanamine-89- 200814928 No. Chemical Name of Carboxylamamine (1-48) Ν·(4'-A Oxy-3'-mercaptobiphenyl-2-yl)methanol (difluoromethyl)_1H-indazole-4-carboxamide (1-49) N-(3',4'- Dimethoxybiphenylbiyl)small methyl(difluoromethyl)-1Η·carbazole carboxylamine (1-50) Ν-(3,-gas-4,-methoxybiphenyl Benzyl-2-yl)-1·methyl-3-(di-methyl)-1Η-oral ratio -4-carboxamide (1-51) N-(4f-chloro-3f-methoxy Biphenyl-2-yl)·1-methyl-3-(dimethylmethyl)-1Η-σ 嗤-4_ Carboxamide (1-52) Ν-[4'-chloro-3'-( Trifluoromethyl)biphenyl-2·yl]-1- Methyl (difluoromethyl)-1 Η·-Bizozol-4-carboxamide (1-53) N-dS'-di-r-phenylphenyl)-1-methyl-3-(two mouse Base)-1Η-ϋΛσ:^-4-decanoic acid amine (1-54) Ν-(4'-methoxy-2'-methylbiphenyl-2-yl)-1-methyl-3- (dimethyl)-lH-atb嗤-4-carboxamide (1-55) 3-(difluoromethyl)#{3'-fluoro-44((6)-(methoxyimino) A Base, Γ-biphenyl-2-ylmethylpyrazole 4-carboxydecylamine (1-56) 3-(trifluoromethyl)-indole 31-fluoro-44 (£>(methoxyiamine) Methyl]-1, fluorenyl-biphenyl-2-yl b-methylpyrazole-4-propanolamine (1-57) Ν_{4'·[(6)-(methoxyimino group )methyl]-biphenyl-2-yl}small methyl (trifluoromethyl)-1//-pyrazole-4-carboxamide (1-58) 3-(difluoromethyl)[ (6)-(Methoxyimino)methyl]biphenylmungyl}small methyl ratio -4--4-weisamine (1-59) (n-butoxyimino)methyl]biphenyl Benzyl-2-yl}-1-methyl-3-(dimethylmethyl)-1//-pyrazole 4-carboxamide (1-60) N-{44(1Z)-N-ethoxy Ethylene imido]biphenyl-2-yl}small methyl-3-(trifluoromethyl)-1//·carbazole 4-carboxamide (1-61) 1_mercapto-AL{ 44(1Z)-N-propoxyacetammine]biphenyl-2-yl}3-(three Methyl)-1//-carbazole-4-propanolamine (1-62) by {4'-[(6)-(isopropoxyimino)methyl]biphenyl-2-yl] - mercapto-3-(trifluoromethyl)-1 from ° 嗤-4-treazone (1-63) ΛΜ4'-(8)·(ethoxyimino)methyl}biphenyl-2 -yl}small methyl each (trifluoromethyl)-1//-°bazole-4·carboxamide-90- 200814928 No. Chemical name of carboxamide (1-64) 1 -methyl-^H4L [C£K propoxyimino)methyl]biphenyl-2-yl}-3-(3-mercaptomethyl)-1//-pyrazole-4-carboxamide (1-65) iV -{4'-[(lZ)-N-isopropoxyacetammine]biphenyl-2-yl}small methyl each (trifluoromethyl ratio σ sit-4-cartoamine (1 -66) ΛΓ-{44(1Ζ)-Ν-butoxyacetammine]biphenyl-2-ylbu-methyl-3-3(trifluoromethyl-pyria-4-hydrazide ( 1-67) iV~{3L Chlorine 44 (£>(decyloxy-imino)methyl]biphenyl-2-diylmethyl(trifluoromethyl)-1 from pyrazole-4-carboxyl Indoleamine (1-68) #-{34(幻·(methoxyimino)methyl]biphenyl-2-yl}-1-methyl each (trifluoromethyl)-1//- Pyrazole-4-carboxyguanamine (1-69) 7V»{44(1E)-N-methoxyethyl quinone imino]biphenylmethylene}methylmethyl(trifluoromethyl)-li /j ratio -4-Rebelamine (1-70) Private {3'-say _44(6)·(methoxyimino)methyl] phenylidene-2-yl}small methyl each (trifluoromethyl)- 1 Lepyrazol-4-carboxyguanamine (1-71) 3-(Difluoromethyl)-exhaustive {3'-fluoro 44 (£>(decyloxyimino)methyl]biphenyl- 2-yl}small methyl-1-leprazole-4-carboxamide (1-72) {(ZH(cyclopropylmethoxy)imido)methyl bphenyl-2-yl) small Methyl-3-(trifluoromethyl)-li^biazole carbamide (1-73) AM44 (£>(butoxyimino)methyl]biphenyl-2·kib 3 -(difluoromethyl)small methyl-1//-° ratio -4--4- Wei Si amine (1-74) 3-(difluoromethyl)# {44( 1 E)-N-methoxy Ethylene imido]biphenyl-2-yl}sodiummethyl-1/ί-pyrazole-4-carboxamide (1-75) iV_{3f-fluoro-4'-[(£)-( Propoxyimido)methyl]biphenyl-2-yl}-1-methyl-3-(3-trifluoromethyl)-li/·pyrazole-4-carboxyguanamine (1-76) 3 -(difluoromethyl)good {3'H[(£>(propoxyimino)methyl]biphenylyl-H-methyl-1-"pyrazole-4-carboxamide" 1-77) {Γ-Chloropi P>(methoxyimino)methyl]biphenyl-2-yl}-1 -methyl-3-(trifluoromethylcarbazole-4-carboxyindole Amine (1-78) ΛΜ3'-fluoro-44(1E)-N- Ethoxyacetimido]biphenylmungyl}]-methyl; (tri-1methyl)-1 private ratio salivary-4~tretachlor (1-79) 3-(difluoromethyl) #{,Fluorine 44(ie)-n-propoxyacetammine]biphenyl Z-based}small methyl-1 from pyrazole-carbocarboxamide-91 - 200814928 No. Chemical name of carboxamide 1-80) 3-(Difluoromethylfluoro-4'-[(1Ε)-fluorenyl-methoxyethylidene imino]biphenyl-2-yl}methylmethylpyrene-4-carboxyindole Amine (1-81) (1-82) M{3'-Fluoro-^[(ΙΕ^Ν·methoxyethyl quinone imino)biphenyl-2-yl}small methyl-3-(three Fluoromethyl)-1//-° ratio. -4-Si with amine chloro-4'-[(1Ε)-Ν-methoxyethyl hydrazide]biphenyl fluorenyl} each (difluoromethyl)_1_methyl-1 private ratio Oral -4-oxoamine (1-83) chloro-4'-[(1Ε)-Ν-methoxyethinylidene]biphenyl-2-yl}small methyl-3-(three Fluoromethyl) 4 cups pyrazole-4-carboxamide (1-84) 3-(difluoromethyl) small methyl #{44(6)-(propoxyimino)methyl]biphenyl-2 -yl}-1//^ is more than 嗤-4-weisamine (1-85) iH44 (£>(decyl imino)methyl]methylbiphenyl-2-yl} small methyl Each (tri-1methyl)-1//-° than wow-4-propanolamine (1 -86) Η difluoromethyl hydrazine-methyl #{4,-[(1Ε)-Ν-propoxy Ethyl imino]biphenyl-2-yl b l/ί-pyrazole-4-carboxamide (1-87) Η difluoromethyl ΗΗ 44 (ιε) good isopropoxyacetammine Biphenyl-2-yl b 1·methyl-1//^ than 嗤-4-carboxychiral amine (1-88) N-(4I-{(ZH(allyloxy)imido)] }}biphenyl-2-yl) winter (difluoromethyl) small methyl-1-leprazole carbaryl amide (1-89) Ν·(4Η(Ζ)-[(allyloxy) Amino]methyl}biphenyl-2-yl)small methyl each (trifluoromethyl-wow-4-weizamine (1-90) 3-(difluoromethyl HV-{44(£>) (methoxy imino group Methyl]-3,-fluorenylbiphenyl-2-yl}-1-methyl-1//-° than 嗤-4-treazone (1-91) iV-{4t-{(lZ) -N-(allyloxy)ethylidene imino}biphenylyl bromide; (trifluoromethyl)·17ϊ^bazole-4-carboxyguanamine (1-92) Μ{44( 1 Ε)-Ν-(allyloxy)ethylideneimine;|biphenyl-2_ylbu3·(difluoromethyl)small methyl-1//-° than 嗤-4- Indoleamine (1-93) is as far as {4'-[(1Ε)-Ν-(丁·2·alkyn-1-yloxy)ethylidene imino]biphenyl-2-yl}small methyl-3 -(Trifluoromethylbiwow-4-carboamine (1-94) 1-methyl#(4'-{(1Ε)-Ν-[(1-methylpropion!-enyl)oxy]B醯iminophosphonium biphenyl-2-yl)-3-(trifluoromethyl)-1loindole 嗤 ice carboxamide (1-95) 1-methyl#(4f-{(lE)-N -[(2_methylpropionene small)oxy]ethinylidene}biphenylyl)(trifluoromethyl)-1//-cafe-4-weizamide•92- 200814928 The chemical name of the number of carboxamide (1-96) 1 -methyl 1 EHSl · (prop-2-yne small oxygen) - acetamido] biphenyl-2-yl}-3- (-' Gas methyl ratio _4- succinimide (1-97) 3-f fluoro-methylmethyl #{44(1Ε)·Ν_(propionyloxy) etiminoimine} biphenyl Ke-2-yl}-1//^ ratio n rebel amine (1-98) Dedicated to the chlorine [[6)·(methoxyimino)methyl]biphenyl-mungyl} each (difluoromethyl)-1 ·methyl-1 ugly than the saliva "4_ recorded S-amine (1 -99) 曱oxyimino)methyl]_2L methylbiphenyl fluorenylmethyl} each (tri-II methyl Viz/Lir than 嗤_4_carboxamide (1-100) TV»{4L [(1Z) succinyloxyethylidene imino]biphenyl·2·kib 3-(difluoromethyl) fluorenyl-1//-° than 嗤 winter winding amine (1-101) 3-(Difluoroindolyl HV^{44(£>(isopropylideneimino)methyl]biphenylyl)methyl-1/ί-吼嗤-4-sulfanylamine (1 -102) ΗDifluoromethyl)#{44(£>(methoxyimino)methyl]-2,-methylbiphenyl mercaptopurine-methyl-1 carbazole-4- Carboxylamidine (1-103) M{3L chloro 4'-[(pentamethoxyanilide)methyl]biphenyl-2-ylbu 3-(difluoromethyl)smallmethyl-li /" 嗤 嗤 嗤 缓 ( 1-10 (1-104) 3-(Difluoromethyl> gt-{2^Fluoro-4f-[(£)-(methoxyimino)methyl]biphenyl _2_基}小methyl-Li/-σ ratio 吐-4-魏醯amine 〇105) Π{Π44(6)-(methoxyimino)methyl]biphenylmethylene}methyl; Fluorinyl Hif-pyrazole-4·carboxamide. In addition to the acid amine of the formula (1) of the formula (I), the active compound composition A also comprises the strobilurin of the formula (II) of the class (2).
其中A1,L及R11的定義如前。 較佳的活性化合物組合物A,其中第(2)類之式(η)之史 -93- 200814928 托比系(Strobilurin)係挑選自下列化合物: 〇1)亞托敏(azoxystrobin),(2-2)氟嘴菌酯(fluoxastrobin),(2-3) (2£>2-(2- {[6-(3-氯-2-曱基苯氧基)-5-氟-4-嘧啶基]氧}苯 基)-2-(甲氧基亞胺基曱基乙醯胺,(2-4)三氟敏 5 (trifloxystrobin),(2-5) (2五)-2-(甲氧基亞胺基甲基 -2-(2-{[({(1£>1-[3-(三氟曱基)苯基]乙二基}胺基)氧]甲基} 苯基)乙醯胺,(2-6) (2£>2-(甲氧基亞胺基甲基 , _2-{2-[(五)-({1-[3-(三氟甲基)苯基]乙氧基}亞胺基> 甲基]苯 基}乙1藍胺,(2-7)將醚菌胺(orysastrobin),(2-8) 5-甲氧基_2_ 10 甲基冰(2-{[({(1五)小[3-(三氟曱基)苯基]乙二基}胺基)氧]_ 曱基}苯基)-2,4-二氮-37^-l,2,4-三σ坐-3-嗣,(2-9)克收辛··甲 基(kresoxim-methyl),(2-10)大滅唾丙(dimoxystrobin), (2-11)咬氧菌酯(picoxystrobin),(2-12)唑菌胺酯 (pyraclostrobin) ’(2-13)苯氧菌胺(metominostrobin),(2-14) 15 英司多丙(enestrobin)。 _ 特別佳的活性化合物組合物A,其中第(2)類之式(Π) 之史托比系(Strobilurin)係挑選自下列化合物: (2-1)亞托敏(azoxystrobin),穴2-2)氟嘧菌酯饵⑽幼拊成!!),^。) (2£>2-(2-{[6_(3-氯-2-甲基苯氧基)·5-氟-4-,咬基]氧}苯 20 基)_2_(甲氧基亞胺基)-尽甲基乙醯胺,(2-4)三氟敏 (trifloxystrobin)’(2-9)克收辛-甲基(kres〇xim-methyl),(2-10) 大滅唾丙(dimoxystrobin),(2-11)啶氧菌酯(picoXyStrobin),(2-12) 嗤囷胺醋(pyraclostrobin) ’(2-13)苯氧菌胺(met〇niinostrobin)。Among them, A1, L and R11 are as defined above. Preferred active compound composition A, wherein the history of formula (2) (η)-93-200814928 Strobilurin is selected from the following compounds: 〇1) azoxystrobin, (2) -2) Fluoxastrobin, (2-3) (2£>2-(2-{[6-(3-chloro-2-indolylphenoxy)-5-fluoro-4- Pyrimidinyl]oxy}phenyl)-2-(methoxyiminomercaptoacetamide, (2-4) trifloxystrobin, (2-5) (2-5)-2-( Methoxyiminomethyl-2-(2-{[({(1£>1-[3-(trifluoromethyl)phenyl]ethanediyl}amino)oxy)methyl}benzene Ethylamine, (2-6) (2£>2-(methoxyiminomethyl, _2-{2-[(5)-({1-[3-(trifluoromethyl)) Phenyl]ethoxy}imine>methyl]phenyl}ethyl 1 leucine, (2-7) willsostazone, (2-8) 5-methoxy_2_10 Methyl ice (2-{[({(1)5)[[((((((((()))]]]]]] -37^-l,2,4-three sigma sitting -3-嗣, (2-9) 克 辛 辛 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克2-11) picoxystrobin, (2-12) pyraclostrobin (pyr Aclostrobin) '(2-13) methotrexate (metominostrobin), (2-14) 15 enestrobin. _ Particularly good active compound composition A, of which type (2) (Π) The Strobilurin line was selected from the following compounds: (2-1) Azoxystrobin, Acupoint 2-2) Fluorobacteria bait (10) Cubs!!), ^.) (2£ >2-(2-{[6_(3-Chloro-2-methylphenoxy)·5-fluoro-4-, octyl]oxy}benzene 20-yl)_2-(methoxyimino)- As far as methyl acetamide, (2-4) trifloxystrobin' (2-9) kexin-methyl (kres〇xim-methyl), (2-10) dimoxystrobin (2-11) picoXyStrobin, (2-12) pyracostrobin '(2-13) phenoxynibine (met〇niinostrobin).
特別要被強調的活性化合物組合物A,包含挑選自表A -94- 200814928 中之第⑴類的式(I)之綾醯胺,以及㈣亞托敏(az〇xys加㈣^ 特別要被強調的活性化合物組合物A,包含挑選自表A 二之第⑴類的式⑴之羧醯胺,以及(2_2)氟嘧菌萨 (fluoxastrobin)。 曰The active compound composition A to be particularly emphasized, comprising the guanamine of the formula (I) selected from the group (1) in Table A-94-200814928, and (iv) the azotoxin (az xy s plus (4) ^ The active compound composition A is emphasized, comprising a carboguanamine of the formula (1) selected from the group (1) of Table A, and (2_2) fluoxastrobin.
10 1510 15
特別要被強調的活性化合物組合物A,包含挑選自参 中之第(1)類的式(I)之羧醯胺,以及(2-3) (2£>2-(2-{[6、(3 氯甲基苯氧基)_5_氟-4-嘧啶基]氧}苯基)_2_(甲 於 基甲基乙醯胺。 "^ 特別要被強調的活性化合物組合物A,包含挑選自參A 中之第⑴類的式(I)之羧醯胺,以及(2-4)三^敏 (trifloxystrobin)。 斗寸別要被強調的活性化合物組合物A ’包含挑選自| a 中之第(1)類的式(I)之羧醯胺,以及(2-9)克收辛-甲茂 (kresoxim-methyl) 〇 特別要被強調的活性化合物組合物A,包含挑選自表a 中之第⑴類的式(I)之羧醯胺,以及(2-10)大滅嗤内 (dimoxystrobin) 〇 特別要被強調的活性化合物組合物八,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(2-11)啶氧菌龍 (picoxystrobin) 〇 特別要被強調的活性化合物組合物A,包含挑選自表A 中之第⑴類的式⑴之羧醯胺,以及(2_〗2)唑菌胺酉旨 (pyraclostrobin)。The active compound composition A to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the reference class (1), and (2-3) (2£>2-(2-{[ 6. (3 chloromethylphenoxy)_5_fluoro-4-pyrimidinyl]oxy}phenyl)_2_(methylidylmethylacetamide. "^ In particular, the active compound composition A to be emphasized, Included is a carboguanamine of the formula (I) selected from the group (1) of the reference A, and (2-4) a trifloxystrobin. The active compound composition A' to be emphasized is selected from | The carboxamide of the formula (I) of the class (1), and the active compound composition A of (2-9) kresoxim-methyl oxime, which is particularly emphasized, The carboxamide of the formula (I) of the class (1) in Table a, and the active compound composition of the (2-10) dimoxystrobin, especially emphasized, are included in Table A. Carboxylamidines of the formula (I), and (2-11) picoxystrobin 活性 The active compound composition A to be particularly emphasized, comprising the formula (1) selected from the class (1) in Table A Carboxyamine, and (2_2)azole Pyramidin (pyraclostrobin).
特別要被強調的活性化合物組合物A,包含挑選自表A -95- 20 200814928 中之第⑴類的式⑴之羧醯胺,以及(2-13)苯氧菌胺 (metominostrobin) 〇 除了具式⑴的羧醯胺(第(1)類化合物)外,活性化合物組 合物B也包含式(III)之三唑化合物(第(3)類化合物)The active compound composition A to be particularly emphasized, comprising the carboxamide of the formula (1) selected from the group (1) in Table A-95-20 200814928, and (2-13) metominostrobin in addition to In addition to the carboguanamine of the formula (1) (the compound of the formula (1)), the active compound composition B also contains the triazole compound of the formula (III) (the compound of the (3) class)
1010
⑽ 其中 Q,m,R14,R15,A4,A5,R16 及 R17 的定義如前。 較佳的活性化合物組合物B,其中第(3)類之式(III)之三 唾(triazole)係挑選自下面所列之化合物: 15 (3-1)氮雜康嗤(azaconazole),(3-2)伊他康唑(etaconazole),(3-3) 普比康嗤(propiconazole),〇4)待芬康峻(difenoconazole),(3-5) 溴克利(bromuconazole),(3-6)西普康嗤(cyproconazole), (3-7)菲克斯(hexaconazole),(3-8)平康峻(penconazole), (3-9)邁克別尼(myclobutanil) ,(3-10)四康嗤 (tetraconazole),(3-11)福採扶(flutriafol),(3-12)依普座 (epoxiconazole),(3-13)護矽嗤(fhisilazole),(3-14)辛康唑 (simeconazole),(3-15)普硫康唑(prothioconazole),(3-16) 芬布康唑(fenbuconazole),(3-17)得克力(tebuconazole), (3-18)艾普那唾(ipconazole) ,(3-19)滅康嗤 (metconazole),(3-20)三替康唾(triticonazole),(3-21)比多 農(bitertanol),(3-22)三泰隆(triadimenol),(3-23)三泰芬 -96- 20 200814928 (triadimefon),(3-24)氣喧康嗤(fluquinconazole),(3-25)哇 康峻(quinconazole),(3-26)二氯布康嗤(diclobutrazole), (3-27)得尼康嗤(diniconazole),(3-28)得尼康嗤-Μ (diniconazole-M),(3,29)扶康嗤(furconazole),(3_30)優尼 5 康唾(uniconazole),(3-31)優尼康唆 P (uniconazole P)。 特別佳的活性化合物組合物B,其中第(3)類之式(III) 之三唑係挑選自下面所列的化合物: | (3·3)普比康唾(propiconazole),(3-4)待芬康嗤 (difenoconazole),(3-6)西普康口坐(cyproconazole),(3-7)菲 ίο 克斯(hexaconazole),(3-15)普硫康嗤(prothioconazole), (3-17)得克力(tebuconazole) , (3-19)滅康唾 (metconazole),(3-21)比多農(bitertanol),(3-22)三泰隆 (triadimenol),(3-24)氣喧康嗤(fluquinconazole),(3-27)得 尼康哇(diniconazole)。(10) where Q, m, R14, R15, A4, A5, R16 and R17 are as defined above. Preferred active compound composition B, wherein the triazole of the formula (III) of the class (3) is selected from the compounds listed below: 15 (3-1) azaconazole, ( 3-2) Itaconazole, (3-3) propiconazole, 〇4) difanoconazole, (3-5) bromuconazole, (3- 6) cyproconazole, (3-7) hexaconazole, (3-8) penconazole, (3-9) myclobutanil, (3-10) ) tetraconazole, (3-11) flutriafol, (3-12) epoxiconazole, (3-13) fhisilazole, (3-14) xin Simeconazole, (3-15) prothioconazole, (3-16) fenbuconazole, (3-17) tebuconazole, (3-18) Ai Ipconazole, (3-19) metconazole, (3-20) triticonazole, (3-21) than bitertanol, (3-22) Triadimenol, (3-23) three tedin-96- 20 200814928 (triadimefon), (3-24) fluquinconazole ), (3-25) quinconazole, (3-26) diclobutrazole, (3-27) diniconazole, (3-28) Nikon 嗤-Μ (diniconazole-M), (3,29) furconazole, (3_30) uniconazole (uniconazole), (3-31) uniconazole P (uniconazole P). Particularly preferred active compound composition B, wherein the triazole of formula (III) of formula (3) is selected from the compounds listed below: | (3·3) propiconazole, (3-4) ) to dofonconazole, (3-6) cyproconazole, (3-7) hexaconazole, (3-15) prothioconazole, ( 3-17) tebuconazole, (3-19) metconazole, (3-21) than bitertanol, (3-22) triadimenol, (3-24) ) fluquinconazole, (3-27) diniconazole.
15 特別要被強調的活性化合物組合物B,包含挑選自表A • 中之第(1)類的式(I)之羧醯胺,以及(3-3)普比康唑 (propiconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(3-4)待芬康唑 2〇 (difenoconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(3-6)西普康唑 (cyproconazole)。15 The active compound composition B to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (3-3) propiconazole 〇 The active compound composition B to be emphasized, including the carboguanamine of the formula (I) selected from the class (1) in Table A, and (3-4) the difenoconazole oxime (difenoconazole) are particularly emphasized Active Compound Composition B, comprising carboxamide attached to formula (I) of Table (1), and (3-6) cyproconazole.
特別要被強調的活性化合物組合物B,包含挑選自表A -97- 200814928 中之第(1)類的式⑴之羧醯胺,以及(3-7)菲克斯 (hexaconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(3-15)普硫康唑 5 (prothioconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(3-17)得克力 , (tebuconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 10 中之第(1)類的式(I)之羧醢胺,以及(3-19)滅康唑 (metconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(3-21)比多農 (bitertanol) °The active compound composition B to be particularly emphasized, comprising the carboguanamine of the formula (1) selected from the class (1) in Table A-97-200814928, and (3-7) hexaconazole 〇 The active compound composition B, which is emphasized, comprises the carboxamide which is selected from the class (1) of the class (1) in Table A, and the activity of (3-15) prothioconazole 5 which is particularly emphasized. Compound composition B, comprising a carboguanamine of formula (I) selected from the group (1) in Table A, and (3-17) an active compound composition particularly emphasized by tebuconazole B, comprising the carboxamide of the formula (I) selected from the group (1) in Table A10, and (3-19) the active compound composition B of the conconazole, especially emphasized, comprising Carboxylidene of formula (I) of class (1) selected from Table A, and (3-21) than bitertanol °
15 特別要被強調的活性化合物組合物B,包含挑選自表A | 中之第(1)類的式(1)之羧醯胺,以及(3-22)三泰隆 (triadimenol) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第(1)類的式⑴之羧醯胺,以及(3-24)氟喹康唑 2〇 (fhiquinconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(3-27)得尼康唑 (diniconazole) 〇 除了具式⑴的羧醯胺(第(1)類化合物)外,活性化合物組 -98-15 The active compound composition B to be particularly emphasized, comprising the carboguanamine of the formula (1) selected from the group (1) in Table A |, and (3-22) triadimenol, especially to be The active compound composition B is emphasized, comprising the carboxamide which is selected from the formula (1) of the class (1) in Table A, and the activity of (3-24) fluoroquinconazole 2 (fhiquinconazole) which is particularly emphasized. Compound Composition B, comprising carboxamide attached to formula (I) of Table (1), and (3-27) diniconazole, in addition to carboxamide having formula (1) (1) Compounds), active compound group-98-
I 200814928 合物C也包含式(iv)之次磺醯胺(Sulphenamide)(第(4)類化 合物)I 200814928 Compound C also contains Sulphenamide of the formula (iv) (Group (4) compound)
其中R19的定義如前。 | 較佳的活性化合物組合物C,其中第(4)類之式(IV)之次 磺酸胺係挑選自列於下面之化合物: ίο (4-1)二氯氟尼(dichlofluanid),(4-2)甲基益發靈(tolylfluanid)。 特別要被強調的活性化合物組合物C,包含挑選自表a 中之第(1)類的式(I)之羧醯胺,以及(4-1)二氯氟尼 (dichlofluanid) 〇 特別要被強調的活性化合物組合物C,包含挑選自表a 15 中之第⑴類的式(I)之羧醯胺,以及(4-2)曱基益發靈 , (tolylfluanid)。 除了具式(I)的羧醯胺(第⑴類化合物)外,活性化合物組 合物D也包含挑選自包含下述(第(5)類)之顯胺酿胺 (valinamide): 2〇 (5-1)異丙菌胺(iprovalicarb),(5-2) 氯笨 基)-2-丙炔基]氧}-3-甲氧基苯基)乙基]-7V2-(甲基磺醯基)-;^ 纖胺酿胺,(5-3)苯嗟菌胺(benthiavalicarb)。 較佳的活性化合物組合物D,其中第(5)類之纈胺醯胺 係挑選自列於下面之化合物·· -99- 200814928 (5-1)異丙菌胺(iprovalicarb),(5-3)笨噻菌胺(benthiavw^^Wherein R19 is as defined above. A preferred active compound composition C wherein the sulfenic acid amine of the formula (IV) of the formula (4) is selected from the group consisting of: ίο (4-1) dichlofluanid, ( 4-2) Tolylfluanid. The active compound composition C to be particularly emphasized, comprising a carboguanamine of the formula (I) selected from the group (1) in Table a, and (4-1) dichlofluanid 〇 are particularly The active compound composition C is emphasized, comprising a carboxamide selected from the group (I) of the class (1) in Table a 15 and (4-2) tolylfluanid. In addition to the carboguanamine of the formula (I) (the compound of the formula (1)), the active compound composition D also comprises a valinamide selected from the following (category (5)): 2〇(5) -1) Iprovalicarb, (5-2) chlorophenyl)-2-propynyl]oxy}-3-methoxyphenyl)ethyl]-7V2-(methylsulfonyl) )-;^ Fibrin amine, (5-3) benthiavalicarb. Preferred active compound composition D, wherein the amidoxime amine of the group (5) is selected from the following compounds: -99-200814928 (5-1) iprovalicarb, (5- 3) Streptomycin (benthiavw^^
特別要被強調的活性化合物組合物D,包含挑選自表A 中之第⑴類的式⑴之缓醯胺,以及(5])異丙菌胺 (iprovalicarb) 〇 5 特別要被強調的活性化合物組合物D,包含挑選自表a 中之第(1)類的式(I)之叛驢胺,以及(5-3)苯噻菌胺 (benthiavalicarb)。 ⑩ 除了具式⑴的羧醯胺(第⑴類化合物)外,活性化合物組 合物E也包含挑選自包含下述(第(6)類)之式(v)之羧醯胺 10The active compound composition D to be particularly emphasized, comprising the slow-acting amine of the formula (1) selected from the group (1) in Table A, and (5) the active compound particularly emphasized by iprovalicarb 〇5 Composition D, comprising a rebel amine of formula (I) selected from class (1) of Table a, and (5-3) benthiavalicarb. 10 In addition to the carboxamide (formula (1) compound) of the formula (1), the active compound composition E also contains a carboxamide selected from the following formula (v) (v).
其中,X,Y及Z的定義如前面所定義者。 較佳的活性化合物組合物Ε,其中第(6)類之式之羧 15 醯胺係挑選自列於下面之化合物: _(6-1)2-氣-]^-(1,1,3-二甲基印滿-4-基)於驗_胺,(6_2)白克 力(boscalid) ’ (6-3)福滅比(furametpyr),(6-4) Ν-(3-對-甲苯 基售吩_2·基)小甲基-3·三氟甲基·ιη·吼吐—4-叛酸胺,(6-5) 噻唑菌胺(ethaboxam),(6-6)環醯菌胺(fenhexamid),(6胃7) 20 卡普米(carpropamid),(6-8) 2-氯4-(2-氟-2-曱基丙醯基胺 基、-N,N-一甲基本甲酿胺,(6-9)殺菌劑(picobenzamid), (6-10)唑查醯胺(zoxamide),(6-11) 3,4-二氣-N-(2-氰基苯基) 異α塞嗤-5-叛醯胺,(6-12)卡保信(carboxin),(6-13) σ塞醯菌 胺(tiadinil) ’(6_14)嗟菌胺(penthiopyrad),(6_15)石夕嗔菌胺 -100 - 200814928 (silthiofam),(6-16) ΛΚ2-(1,3-二曱基 丁基)苯基]小甲基 -4-(三氟甲基比咯-3-羧醯胺,(6-17)福多寧 (flutolanil),(6-18)芬富南(fenfuram),(6]9)嘉保信 (oxycarboxin),(6-20)塞氟醯胺(thifluzamide),(6-21) 5 N-{2_[3_氯,5_(三氟甲基户比咬-2_基]乙基}-2_(二氣甲基)苯甲 醯胺,(6-22) N-(2-雙環丙基-2-基苯基)小甲基各三氟甲基 -1H-吼唑-4-羧醯胺,(6-23) Ν-(2-雙環丙基-2-基苯基)-1-甲 ,基-3-二氟甲基-1H-吡唑-4-羧醯胺,(6-24) Ν-|>(Γ-曱基雙環 丙基-2-基)笨基]小甲基-3-三氟甲基-1Η-11比唾-4-叛酿胺, 10 (6-25) Ν-[2-(Γ-曱基雙環丙基-2-基)苯基]-1-甲基二氟f 基-1H-吡唑·4-羧醯胺,(6-26) N-[l-(5-溴-3-氯吡啶-2-基)乙 基]-2,4-一氯私驗酸胺’(6-27) N-(5-溴-3-氯°比咬-2-基)甲基 -2,4-二氣菸鹼醯胺。 特別佳的活性化合物組合物E,其中第(6)類之式(v)之 15 羧醯胺係挑選自列於下面之化合物: • (6-2)白克力(boscalid),(6-5) 口塞哇菌胺(ethab〇xam),(6_6) 環醯菌胺(fenhexamid),(6-7)卡普米(carpr〇pamid),(6_8) 2_ 氯-4-(2-氟-2-甲基丙醯基胺基)落二甲基苯甲醯胺,(6_9) 殺菌劑(picobenzamid),(6-10)唑查醯胺(z〇xamide),(6 u) 20 3,扣二氣^氰基苯基)異噻唑-5-羧醯胺,(6-14)噻菌胺 (penthiopyrad),(6-16)尽〇(1,3-二甲基丁基)苯基]甲基 -4-(三氟甲基)-1//-吼咯-3·羧醯胺,(心17)福多寧 (flutolanil) ’(6-21) N-{2-[3'氣士(三氟曱基)吼啶_2_基]乙 基卜2-(三氟曱基)苯曱醯胺,(6Q2) N-(2-雙環丙基-2-基笨 -101 - 200814928 基)-1-甲基-3-三氟曱基_lHl·吡唑-4-羧醯胺,(6-23) N-(2-雙 環丙基-2-基苯基)-1-甲基-3-二氟曱基-1H-吡唑-4-羧醯胺, (6-24) Ν-[2-(Γ-甲基雙環丙基-2-基)苯基]-1-甲基-3-三氟甲 基-ΙΚΜ比唑-4-羧醯胺,(6-25) Ν-[2-(Γ-甲基雙環丙基-2-基) 5 苯基]小甲基冬二氟曱基-1Η-吡唑-4-羧醯胺,(6-26) 1^-[1-(5->臭-3-氣吼唆-2-基)乙基]-2,4-二氯於驗酿胺’(6-27) Ν-(5-溴-3-氯吡啶-2-基)曱基-2,4-二氯菸鹼醯胺。 ,極佳的活性化合物組合物Ε,其中第(6)類之式(V)之羧 醯胺係挑選自列於下面之化合物: ίο (6-2)白克力(boscalid),(6-6)環醯菌胺(£€111^\311^〇1),(6-7) 卡普米(carpropamid),(6-9)殺菌劑(picobenzamid),(6-14) 嗟菌胺(pentiiiopyrad),(6-17)福多寧(flutolanil),(6-21) N-{2-[3-氯-5-(三氟曱基)吼啶-2-基]乙基}-2-(三氟甲基)苯甲 醯胺,(6-22) N-(2-雙環丙基-2-基苯基)-1-甲基-3-三氟甲基 is -1H-吡唑-4-羧醯胺,(6-23) Ν-(2-雙環丙基-2-基苯基)-1-甲 _ 基-3-二氟甲基-1H-吡唑-4-羧醯胺,(6-24) Ν-[2-(Γ-甲基雙環 丙基-2-基)苯基]-1-甲基-3-三氟甲基-1Η-吡唑-4_羧醯胺, (6-25) Ν-[2-(Γ_甲基雙環丙基-2-基)苯基]-1-曱基-3-二氟甲 基-1Η-吡唑-4-羧醯胺,(6-26) N-[l-(5-溴-3-氯吡啶-2-基)乙 2〇 基]-2,4-二氯菸鹼醯胺,(6-27) Ν-(5-溴-3-氯吼啶-2-基)甲基 -2,4-二氯菸鹼醯胺。 特別要被強調的活性化合物組合物Ε,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(6-2)白克力(boscalid)。Among them, the definitions of X, Y and Z are as defined above. A preferred active compound composition, wherein the carboxy 15 guanamine of the formula (6) is selected from the group consisting of: _(6-1) 2-gas-]^-(1,1,3 - dimethylindol-4-yl) in the test amide, (6_2) benzoic (boscalid) ' (6-3) blessing ratio (furametpyr), (6-4) Ν-(3-p-tolyl吩 · · · 小 小 小 小 · · — — — — — — — — — 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- (fenhexamid), (6 stomach 7) 20 carpropamid, (6-8) 2-chloro 4-(2-fluoro-2-mercaptopropylaminol, -N,N-methylmethyl Amine, (6-9) bactericide (picobenzamid), (6-10) zoxamide, (6-11) 3,4-digas-N-(2-cyanophenyl) α stopper-5-treazone, (6-12) carboxin, (6-13) σ xidinium '(6_14) cuminamide (penthiopyrad), (6_15) Shi Xi Triamcinol-100 - 200814928 (silthiofam), (6-16) ΛΚ2-(1,3-dimercaptobutyl)phenyl]p-methyl-4-(trifluoromethylpyrrol-3-carboxyindole Amine, (6-17) flutolanil, (6-18) fenfuram, (6] 9) jiacarin (oxycarbox) In), (6-20) thifluzamide, (6-21) 5 N-{2_[3_Chlorine, 5_(trifluoromethyl-to-bit-2-yl)ethyl}-2_ (di-gas methyl) benzepidine, (6-22) N-(2-bicyclopropyl-2-ylphenyl) small methyl each trifluoromethyl-1H-indazole-4-carboxamide ,(6-23) Ν-(2-biscyclopropyl-2-ylphenyl)-1-methyl,yl-3-difluoromethyl-1H-pyrazole-4-carboxyguanamine, (6-24 ) Ν-|>(Γ-fluorenylbicyclopropyl-2-yl) stupyl] small methyl-3-trifluoromethyl-1Η-11 is more than salivary-4, 7 (6-25) Ν-[2-(Γ-Mercaptobiscyclopropyl-2-yl)phenyl]-1-methyldifluorof-yl-1H-pyrazole·4-carboxamide, (6-26) N- [l-(5-Bromo-3-chloropyridin-2-yl)ethyl]-2,4-chloro-purine acid amine '(6-27) N-(5-bromo-3-chloro-° ratio bite -2-yl)methyl-2,4-dione nicotinamide. Particularly preferred active compound composition E, wherein the carboxamide of the formula (v) of formula (v) is selected from the following Compounds: • (6-2) boscalid, (6-5) ethab〇xam, (6_6) fenhexamid, (6-7) carp 〇pamid),(6_8) 2_ chloro-4-(2-fluoro-2-methylpropanylamino) Benzobenzamide, (6_9) fungicide (picobenzamid), (6-10) oxazolamide (z〇xamide), (6 u) 20 3, dehydrogenated 2 cyanophenyl)isothiazole-5 - Carboxylamamine, (6-14) penthiopyrad, (6-16) 〇 (1,3-dimethylbutyl)phenyl]methyl-4-(trifluoromethyl)- 1//-吼咯-3·Carboxyguanidamine, (heart 17) Futonin (flutolanil) '(6-21) N-{2-[3' gas (trifluoromethyl) acridine_2 Ethyl 2-(trifluoromethyl)benzamide, (6Q2) N-(2-bicyclopropyl-2-yl-101-200814928)-1-methyl-3-trifluoroanthracene _lHl·pyrazole-4-carboxamide, (6-23) N-(2-bicyclopropyl-2-ylphenyl)-1-methyl-3-difluoroindolyl-1H-pyrazole -4-carboxyguanamine, (6-24) Ν-[2-(Γ-methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-trifluoromethyl-indoleazole- 4-carboxyguanamine, (6-25) Ν-[2-(Γ-methylbicyclopropyl-2-yl) 5 phenyl] small methyl dimethyl difluoroindolyl-1 Η-pyrazole-4-carboxylate Indoleamine, (6-26) 1^-[1-(5->Smelly-3-athracepin-2-yl)ethyl]-2,4-dichloro in the amine ('-27 Ν-(5-Bromo-3-chloropyridin-2-yl)indolyl-2,4-dichloronicotinium amide. An excellent active compound composition, wherein the carboxamide of the formula (V) of the formula (V) is selected from the following compounds: ίο (6-2) boscalid, (6-6) Cyclosporin (£€111^\311^〇1), (6-7) carpropamid, (6-9) bactericide (picobenzamid), (6-14) guanidinamide (pentiiiopyrad), (6-17) Flutolanil, (6-21) N-{2-[3-chloro-5-(trifluoromethyl)acridin-2-yl]ethyl}-2-(three Fluoromethyl)benzamide,(6-22) N-(2-bicyclopropyl-2-ylphenyl)-1-methyl-3-trifluoromethyl is-1H-pyrazole-4- Carboxylamidine, (6-23) Ν-(2-bicyclopropyl-2-ylphenyl)-1-methyl-3-yl-3-difluoromethyl-1H-pyrazole-4-carboxamide, ( 6-24) Ν-[2-(Γ-Methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-trifluoromethyl-1Η-pyrazole-4_carboxamide, ( 6-25) Ν-[2-(Γ_Methylbicyclopropyl-2-yl)phenyl]-1-mercapto-3-difluoromethyl-1Η-pyrazole-4-carboxyguanamine, ( 6-26) N-[l-(5-Bromo-3-chloropyridin-2-yl)ethyl 2indolyl]-2,4-dichloronicotinium amide, (6-27) Ν-(5- Bromo-3-chloroacridin-2-yl)methyl-2,4-dichloronicotinium amide. The active compound composition, particularly emphasized, comprises carboxamide selected from the group (I) of Table (1), and (6-2) boscalid.
特別要被強調的活性化合物組合物E,包含挑選自表A -102 - 200814928 中之第(1)類的式⑴之羧醯胺,以及(6-6)環醯菌胺 (fenhexamid) 〇 特別要被強調的活性化合物組合物E,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(6-7)卡普米 5 (carpropamid) 〇 特別要被強調的活性化合物組合物E,包含挑選自表A 中之第(1)類的式(1)之羧醯胺,以及(6-9)殺菌劑 _ (picobenzamid) 〇 特別要被強調的活性化合物組合物E,包含挑選自表A ίο 中之第(1)類的式(I)之羧醯胺,以及(6-14)噻菌胺 (penthiopyrad) 〇 特別要被強調的活性化合物組合物E,包含挑選自表A 中之第(1)類的式(1)之羧醯胺,以及(6-17)福多寧 (flutolanil)。The active compound composition E to be particularly emphasized, comprising the carboxamide of the formula (1) selected from the group (1) in Table A-102 - 200814928, and (6-6) fenhexamid 〇 The active compound composition E to be emphasized, including the carboguanamine of the formula (I) selected from the class (1) in Table A, and (6-7) carpropamid 〇 are particularly emphasized. The active compound composition E, comprising the carboxamide which is selected from the formula (1) of the class (1) in Table A, and (6-9) the active compound composition which is particularly emphasized by the picobenzamid E, comprising a carboxamide which is selected from the group (I) of the class (1) in Table A ίο, and (6-14) penthiopyrad 活性 an active compound composition E which is particularly emphasized, including The carboxamides of the formula (1) of the class (1) in Table A, and (6-17) flutolanil were selected.
is 特別要被強調的活性化合物組合物E,包含挑選自表A _ 中之第(1)類的式(I)之羧醯胺,以及(6-21) N-{2-[3-氯-5-(三 氟甲基)吡啶-2-基]乙基}-2-(三氟甲基)苯甲醯胺。 特別要被強調的活性化合物組合物E,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(6_22)N-(2-雙環丙基-2-2〇 基本基)-1-曱基-3-^氣甲基-1Η-σ比°坐-4-竣酿胺。 特別要被強調的活性化合物組合物Ε,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(6-23)N-(2-雙環丙基-2-基苯基)-1-甲基-3-二氟曱基-1H-吡唑-4-羧醯胺。The active compound composition E to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (6-21) N-{2-[3-chloro 5-5-(Trifluoromethyl)pyridin-2-yl]ethyl}-2-(trifluoromethyl)benzamide. The active compound composition E to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (6_22) N-(2-bicyclopropyl-2-2? The basic group)-1-mercapto-3-^ gas methyl-1Η-σ ratio ° sit-4-anthracene amine. The active compound composition 特别 particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (6-23) N-(2-bicyclopropyl-2- Phenyl)-1-methyl-3-difluoroindolyl-1H-pyrazole-4-carboxamide.
特別要被強調的活性化合物組合物E,包含挑選自表A -103- 200814928 牿 氣甲基-1H-吡唑冰羧醯胺。The active compound composition E, which is particularly emphasized, comprises the selected from the group A-103-200814928, helium methyl-1H-pyrazole ice carboguanamine.
中之活性化合物組合物E,包含挑選自表A 本基]基·3·二鼠甲基·1Η“Κ4-細胺。 ^別要被強調的活性化合物組合物ε 中之第(1)類的式(I)之羧醯胺,以及 乂The active compound composition E, which is selected from the group A (group), the base, the dimethyl group, the methyl group, the quinone 4-minamine, and the class (1) of the active compound composition ε to be emphasized. Carboxamide of formula (I), and hydrazine
10 15 衫基)乙基]从二氯祕^及(6,仰备3叙 中之ΖΪΓλ觸活性化合物組合物Ε,包含挑選自表A 基)甲基-2,4-二氯菸鹼醯胺。 疋 人物=1=1)的㈣胺(第⑴類化合物)外,活性化合物級 (=1 Γ自包含下述(第(7)類)之二硫胺基甲酸酿: (-1)鋅錳乃浦(mancozeb),(7_2)錳乃浦—eb),㈤ 得爛(meti_,(7_4)甲基鋅乃浦(pr〇pineb) (75)得恩地 _ram) ’(7_6)鋅乃浦(zineb),(7 7)福美鋅⑵叫。 車父佳的活性化合物組合物F,其中第⑺類之二硫胺基 甲酸酯係挑選自列於下面之化合物: (7-1)鋅錳乃浦(mancozeb),(7-2)錳乃浦(maneb),(7_4)甲 基鋅乃浦(propineb),(7-5)得恩地(也如1!1),(7_6)鋅乃浦 (zineb) 〇 特別佳的活性化合物組合物F,其中第(7)類之二硫胺 基甲酸酯係挑選自列於下面之化合物: 〇1)鋅錳乃浦(mancozeb),(7-4)甲基鋅乃浦(pr〇pineb)。 -104· 20 200814928 特別要被強調的活性化合物組合物F,包含挑選自表a 中之第⑴類的式(I)之羧醯胺,以及(7-1)鋅錳乃浦 (mancozeb) 〇 特別要被強調的活性化合物組合物F,包含挑選自表a 中之第(1)類的式(I)之羧醯胺,以及(74)甲基鋅乃浦 (propineb) 〇 除了具式⑴的羧醯胺(第⑴類化合物)外,活性化合物組 合物G也包含挑選自包含下述(第(8)類)之式(VI)的醯基丙 胺酸10 15 基基)ethyl] from dichloromethane and (6, 备 3 3 3 3 ΖΪΓ ΖΪΓ ΖΪΓ 触 触 Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε 甲基 甲基 甲基 甲基 甲基 甲基 甲基amine. ( person=1 = 1) of the (tetra)amine (the compound of the (1) type), the active compound grade (=1 Γ from the dithiocarbamate containing the following (class (7)): (-1) zinc manganese Naipo (mancozeb), (7_2) Manganese-eb), (5) Bad (meti_, (7_4) methyl zinc napo (pr〇pineb) (75) Dean _ram) '(7_6) Zinc Napo (zineb), (7 7) Fumei Zinc (2) called. The active compound composition F of the parent company, wherein the dithiocarbamate of the (7) class is selected from the following compounds: (7-1) Manganese (mancozeb), (7-2) manganese Naipu (maneb), (7_4) methyl zinc is the propineb, (7-5) Dean (also as 1!1), (7_6) zinc napu (zineb) 〇 particularly good active compound composition F, wherein the dithiocarbamate of the (7) class is selected from the following compounds: 〇 1) Zn Mn 浦 (mancozeb), (7-4) methyl Zn pu pu (pr〇pineb ). -104· 20 200814928 The active compound composition F to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table a, and (7-1) the zinc manganese (mancozeb) 〇 The active compound composition F to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the class (1) in Table a, and (74) the propineb of the formula (1) in addition to the formula (1) In addition to the carboxamide (the compound of the formula (1)), the active compound composition G also contains the mercaptoalanine selected from the formula (VI) which is described below (category (8)).
其中,*及R23的定義如前面之定義。 15 較佳的活性化合物組合物G,其中第(8)類之式(VI)之醯 _ 基丙胺酸係挑選自列於下面之化合物: (8-1)本達樂(benalaxyl),(8-2)福達樂(fUralaxyl),(8-3)滅 達樂(metalaxyl) ’(8-4)滅達樂-M (metalaxyl-M),(8-5)本 達樂-M (benalaxyl-M) ° 20 特別佳的活性化合物組合物G,其中第(8)類之式(VI) 之醯基丙胺酸係挑選自列於下面之化合物: (8-3)滅達樂(metalaxyl),(8-4)滅達樂-M(metalaxyl-M), (8-5)本達樂-M(benalaxyl-M)。Among them, the definitions of * and R23 are as defined above. A preferred active compound composition G, wherein the hydrazine-based propylamine of the formula (8) is selected from the group consisting of: (8-1) benalaxyl, (8) -2) fUralaxyl, (8-3) metalaxyl '(8-4) tadal-M (metalaxyl-M), (8-5) borda-M (benalaxyl -M) ° 20 Particularly preferred active compound composition G, wherein the mercaptoalanine of the formula (8) is selected from the following compounds: (8-3) metalaxyl (8-4) Metalaxyl-M, (8-5) Benalaxyl-M.
特別要被強調的活性化合物組合物G,包含挑選自表A -105- 200814928 中之第⑴類的式(i)之羧醯胺,以及(8-3)滅達樂 (metalaxyl) 〇 特別要被強調的活性化合物組合物G,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(8-4)滅達樂 5 -M(metalaxyl-M)。 特別要被強調的活性化合物組合物G,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(8-5)本達樂 . -M(benalaxyl-M) 〇 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 ίο 合物Η也包含挑選自下述(第(9)類)之苯胺基嘧啶: (9-1)西普地尼(cyprodinil),(9-2)滅盤尼比(|1160&1^}^1111),(9-3) 必滅寧(pyrimethanil)。 特別要被強調的活性化合物組合物H,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(9-1)西普地尼 15 (cyprodinil)。The active compound composition G to be particularly emphasized, comprising the carboguanamine of the formula (i) selected from the group (1) in Table A-105-200814928, and (8-3) metalaxyl oxime The emphasized active compound composition G comprises carboxamide which is selected from the group (I) of the class (1) in Table A, and (8-4) metalaxyl-M. The active compound composition G to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the class (1) in Table A, and (8-5) Benalaxyl-M (benalaxyl-M) In addition to the carboguanamine of the formula (I) (the compound of the formula (1)), the active compound group Η Η Η also contains an anilinopyrimidine selected from the following (category (9)): (9-1 ) cyprodinil, (9-2) annihilation (|1160&1^}^1111), (9-3) pyrimethanil. The active compound composition H to be particularly emphasized includes carboxyguanamine of the formula (I) selected from the group (1) in Table A, and (9-1) cyprodinil.
| 特別要被強調的活性化合物組合物Η,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(9-2)滅盤尼比 (mepanipyrim) 〇 特別要被強調的活性化合物組合物H,包含挑選自表A 20 中之第⑴類的式⑴之羧醯胺,以及(9-3)必滅寧 (pyrimethanil)。 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 合物I也包含挑選自下述(第(1〇)類)之式(VIII)的苯并咪唑 -106- >27200814928 (vm) 其中,r25 ’ r26 ’ r27及R28的定義如前面之定義。 5 較佳的活性化合物組合物〗,其中第(10)類之式(Vii 之苯并咪唑係挑選自列於下面之化合物:The active compound composition 特别 particularly emphasized, comprising carboxamides of formula (I) selected from class (1) in Table A, and (9-2) mepanipyrim 〇 The emphasized active compound composition H comprises carboxamide which is selected from the formula (1) of the class (1) in Table A 20, and (9-3) pyrimethanil. In addition to the carboxamide (Formula (1) compound) of formula (I), active compound composition I also comprises benzimidazole-106 selected from formula (VIII) below (category (1)) - >27200814928 (vm) where r25 ' r26 ' r27 and R28 are as defined above. 5 Preferred active compound compositions, wherein the formula (10) (the benzimidazoles of Vii are selected from the following compounds:
10 (HM) 6-氯-5-[(3,5-二甲基異噁唑基)磺醯基]_2,厶二氟 -5H-[1,3]二噁茂并|»f]-苯并咪唑,(ι〇_2)免賴得 (benomyl) ’(10-3)貝务替(carbencJazim),(10-4)氯芬那嗅 (chlorfenazole),(10-5)麥穗寧(fuberidazole),(10-6)腐矣刀 (thiabendazole) 〇 特別佳的活性化合物組合物I,其中第(1〇)類之式(Vl 之苯并咪唑為: (10-3)貝芬替(carbendazim)。 1510 (HM) 6-Chloro-5-[(3,5-dimethylisoxazolyl)sulfonyl]_2, indole difluoro-5H-[1,3]dioxole||f]- Benzimidazole, (ι〇_2)-free (benomyl) '(10-3) baccen (carbencJazim), (10-4) chlorfenazole, (10-5) Mai Suining (fuberidazole), (10-6) thiabendazole 〇 Particularly preferred active compound composition I, wherein the formula (1〇) is (benzazole of V1 is: (10-3) befenfen (carbendazim). 15
R RR R
特別要被強調的活性化合物組合物I,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(10-3)貝芬替 (carbendazim) 〇 除了具式(I)的羧醯胺(第⑴類化合物)外,活性化合物% 合物J也包含挑選自下述(第(11)類)之式(IX)的胺基曱酸酷The active compound composition I to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the class (1) in Table A, and (10-3) the carbendazim in addition to the formula ( In addition to the carboxamide (class (1) compound) of I), the active compound % J also contains the amine bismuth acid of formula (IX) selected from the following (category (11)).
其中,R29及R30的定義如前面之定義。 較佳的活性化合物組合物J,其中第(11)類之胺基曱酸 -107- 20 200814928 酯係挑選自列於下面之化合物: (11-1)二硫芬克(diethofencarb),(11-2)普拔克(propamocarb), (11-3)鹽酸普拔克(propamocarb-hydrochloride) ’(11-4)普拔 克-福赛得(fosetyl)。Among them, the definition of R29 and R30 is as defined above. Preferred active compound composition J, wherein the amine group of the (11) class of decanoic acid-107-20 200814928 is selected from the following compounds: (11-1) diefhofencarb (11) -2) propamocarb, (11-3) propamocarb-hydrochloride '(11-4), fosetyl.
5 特別要被強調的活性化合物組合物J,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(11-1)二硫芬克 (diethofencarb) 〇5 The active compound composition J to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (11-1) diethofencarb (diethofencarb)
& 特別要被強調的活性化合物組合物J,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及普拔克 ίο (propamocarb) 〇 特別要被強調的活性化合物組合物J,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(11-3)鹽酸普拔克 (propamocarb-hydrochloride) 〇 特別要被強調的活性化合物組合物J ’包含挑選自表A 15 中之第(1)類的式(I)之羧醯胺,以及(Π-4)普拔克-福賽得 (fosetyl)。 除了具式(I)的羧酿胺(第(1)類化合物)外,活性化合物組 合物K也包含挑選自下述(第(12)類)之二羧基亞醯胺 (dicarboximide): 2〇 (12-1)四氯丹(captafol),(12-2)蓋普丹(captan),(12-3)福 爾培(folpet),(12-4)依普同(iprodione),(12-5)撲滅寧 (procymidone),(12-6)免克寧(vinclozolin)。 較佳的活性化合物組合物κ’其中第(12)類之二羧基亞 醯胺係挑選自列於下面之化合物: -108 - 200814928 (12_2)蓋普丹(captan),(12_3)福爾培(f〇ipet),(12_4)依普 同(iprodione)。& In particular, the active compound composition J, which contains the carboxamide of the formula (I) selected from the class (1) in Table A, and the activity to be particularly emphasized by Propacarb (propamocarb) Compound composition J, comprising a carboguanamine of formula (I) selected from the group (1) in Table A, and (11-3) an active compound to be particularly emphasized by propamocarb-hydrochloride Composition J' comprises carboxamide which is selected from the group (I) of the class (1) in Table A 15 and (Π-4), fosetyl. In addition to the carboxychiral amine of the formula (I) (the compound of the formula (1)), the active compound composition K also contains dicarboxyboximide selected from the following (category (12)): 2〇 (12-1) tetramdan (captafol), (12-2) captan (captan), (12-3) folfet, (12-4) iprodione, (12 -5) Procymidone, (12-6) vinclozolin. A preferred active compound composition κ' wherein the dicarboxy carbamide of the group (12) is selected from the group consisting of: -108 - 200814928 (12_2) captan, (12_3) fore (f〇ipet), (12_4) Iprodione.
特別要被強調的活性化合物組合物K,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(12-2)蓋普丹(captan)。The active compound composition K to be particularly emphasized includes carboxyguanamine of the formula (I) selected from the group (1) in Table A, and (12-2) captan.
5 特別要被強調的活性化合物組合物K,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(12-3)福爾培(folpet)。5 The active compound composition K to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (12-3) folpet.
特別要被強調的活性化合物組合物K,包含挑選自表A | 中之第⑴類的式(I)之羧醯胺,以及(12-4)依普同 (iprodi〇ne) 〇 10 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 合物L也包含挑選自下述(第(13)類)之胍(guanidine): (13-1)多寧(d〇dine),(13-2)克熱淨(guazatine),(13-3)雙 胍辛胺三乙酸鹽(iminoctadine triacetate),(13-4)克熱淨(烧 本石頁酸鹽)[iminoctadine tris(albesilate)],(13-5)多寧(dodine 15 (游離驗))’(13-6)克熱淨(immoctadine)(游離驗)。 p 較佳的活性化合物組合物L,其中第(13)類之胍係挑選 自列於下面之化合物: (13-1)多寧(dodine),(13-2)克熱淨(guazatine)。 特別要被強調的活性化合物組合物L,包含挑選自表A 20 中之第⑴類的式(I)之羧醯胺,以及(13-1)多寧(dodine)。 特別要被強調的活性化合物組合物L,包含挑選自表A 中之第⑴類的式⑴之叛醯胺,以及(13-2)克熱淨 (guazatine) 〇 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 -109- 200814928 合物Μ也包含挑選自下述(第(14)類)之咪唾(imidazole): (14-1)賽座滅(cyazofamid),(14-2)撲克拉(prochloraz),(14-3) 二口坐嘻(triazoxide) ’(14_4)稻盘醋化^\^2€^6)0 5The active compound composition K to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A | and (12-4) iprodi〇ne 〇10 In addition to the carboguanamine of the formula (I) (the compound of the formula (1)), the active compound composition L also contains guanidine selected from the following (category (13)): (13-1) tannin ( D〇dine), (13-2) guazatine, (13-3) iminoctadine triacetate, (13-4) gram heat (burning shale) [ Iminoctadine tris (albesilate)], (13-5) donin (dodine 15 (free test)) '(13-6) gram hot (immoctadine) (free test). p Preferred active compound composition L, wherein the lanthanide of class (13) is selected from the group consisting of: (13-1) dodine, (13-2) guazatine. The active compound composition L to be particularly emphasized includes carboxyguanamine of the formula (I) selected from the group (1) in Table A 20, and (13-1) dodine. The active compound composition L to be particularly emphasized, comprising the rebel amine of formula (1) selected from the class (1) in Table A, and (13-2) guazatine 〇 in addition to the carboxy group of formula (I) In addition to the indoleamine (the compound of the (1) class), the active compound group -109-200814928 compound also contains the imidazole selected from the following (category (14)): (14-1) (cyazofamid), (14-2) poker pull (prochloraz), (14-3) two sitting 嘻 (triazoxide) '(14_4) rice dish vinegar ^ \ ^ 2 € ^ 6) 0 5
10 較佳的活性化合物組合物M,其中第(14)類之咪唑係挑 選自列於下面之化合物: (14-2)撲克拉(prochloraz),(14-3)三唑嗪(triazoxide)。 特別要被強調的活性化合物組合物Μ,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(14-2)撲克拉 (prochloraz) 〇 特別要被強調的活性化合物組合物M,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(14_3)三唑嗪 (triazoxide) 〇 除了具式(I)的羧醯胺(第⑴類化合物)外,活性化合物組 合物N也包含挑選自下述(第(15)類)之式(X)之嗎啉 15A preferred active compound composition M, wherein the imidazole of the (14) class is selected from the group consisting of: (14-2) prochloraz, (14-3) triazoxide. In particular, the active compound composition Μ, including the carboxamides of formula (I) selected from class (1) in Table A, and (14-2) prochloraz 〇 are particularly emphasized The active compound composition M comprises a carboguanamine of the formula (I) selected from the group (1) in Table A, and (14_3) triazoxide, in addition to the carboguanamine having the formula (I) ( In addition to the compound of the above formula (1), the active compound composition N also contains morpholine 15 of the formula (X) selected from the following (category (15))
(morpholine)(morpholine)
(X) 其中,R31,R32及R33的定義如前。 較佳的活性化合物組合物N,其中具式(X)之第(15)類 之嗎啉係挑選自列於下面之化合物: (15-1)阿得摩福(aldimorph),(15-2)三得芬(tridemorph), (15-3)敵草隆(dodemorph),(15-4)芬普比福(fenpropimorph), (15-5)大滅芬(dimethomorph) 〇 -110- 20 200814928 特別佳的活性化合物組合物N,其中具式(X)之第(15) 類的嗎啉係挑選自列於下面之化合物: (15-4)芬普比福(fenpropimorph),(15-5)大滅芬 (dimethomorph) 〇(X) wherein R31, R32 and R33 are as defined above. Preferred active compound composition N, wherein the morpholine group of the formula (15) is selected from the following compounds: (15-1) aldimorph, (15-2) ) tridemorph, (15-3) dodemorph, (15-4) fenpropimorph, (15-5) dimethomorph 〇-110-20 2014 Particularly preferred active compound composition N, wherein the morpholine of the formula (15) of the formula (X) is selected from the following compounds: (15-4) fenpropimorph, (15-5) ) dimethomorph 〇
5 特別要被強調的活性化合物組合物N,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(15-4)芬普比福 (fenpropimorph) 〇5 The active compound composition N to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (15-4) fenpropimorph 〇
| 特別要被強調的活性化合物組合物N,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(15-5)大滅芬 ίο (dimethomorph) ° 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 合物Ο也包含挑選自下述(第(16)類)之式(XI)之吡咯 (pyrrole)The active compound composition N to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the class (1) in Table A, and (15-5) dimethomorph ° In addition to the carboguanamine of the formula (I) (the compound of the formula (1)), the active compound composition Ο also contains pyrrole of the formula (XI) selected from the following (class (16)).
其中,R34,R35及R36的定義如前。 較佳的活性化合物組合物〇’其中具式(XI)之第(16)類 之吡咯係挑選自列於下面之化合物: 2〇 (16-1)芬畢克尼(fenpiclonil),(16-2)伏地 σ惡尼 (fludioxonil),(16,3) °比洛尼精(pyrrolnitrin)。 特別佳的活性化合物組合物〇,其中具式以1)之第(16) 類之吡咯係挑選自列於下面之化合物: (16-2)伏地σ惡尼(fludioxonil)。 -111- 200814928Among them, R34, R35 and R36 are as defined above. Preferred active compound compositions 吡' wherein the pyrrole of the group (16) of the formula (XI) is selected from the following compounds: 2〇(16-1)fenpiclonil, (16- 2) Fludioxonil, (16,3) ° pyrrolnitrin. A particularly preferred active compound composition, wherein the pyrrole of the formula (16) of the formula 1) is selected from the group consisting of: (16-2) fludioxonil. -111- 200814928
特別要被強調的活性化合物組合物〇,包含挑選自表A 中之第⑴類的式⑴之羧醯胺,以及(16_2)伏地噁尼 (fludioxonil) 〇 除了具式(I)的叛醯胺(第(丨)類化合物)外,活性化合物組 $ 合物P也包含挑選自下述(第〇乃類)之膦酸酯: (Π-1)福赛得-鋁(f0Setyi_A1),(17_2)膦酸,(17·3)曱基立 枯鱗(tolclophos-methyl)。In particular, the active compound composition 〇 contains carboxyguanamines of the formula (1) selected from the group (1) in Table A, and (16_2) fludioxonil 〇 in addition to the ruthenium amine of the formula (I) In addition to the (第) compound, the active compound group P also contains a phosphonate selected from the following (diterone): (Π-1) Forsythia-aluminum (f0Setyi_A1), (17_2 Phosphonic acid, (17·3) tolclophos-methyl.
隱 特別要被強調的活性化合物組合物P,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(17_丨)福賽得_鋁 ίο (fosetyl-Al) 〇In particular, the active compound composition P to be emphasized, comprising the carboxamide of the formula (I) selected from the class (1) in Table A, and (17_丨) Forsyth_aluminum ίο (fosetyl-Al) 〇
特別要被強調的活性化合物組合物p,包含挑選自表A 中之第(1)類的式⑴之羧醯胺,以及(17-3)曱基立枯磷 (tolclophos-methyl) 〇 除了具式⑴的羧酿胺(第〇)類化合物)外,活性化合物組 15 合物Q也包含挑選自下述(第(19)類)之殺真菌劑: (19-1)本并嘆一唾醋(acibenzolar-S-methyl),(19-2)氣塞尼 (chlorothalonil),(19-3)克絕(eymoxanil),(19·4)護粒松 (edifenphos),(19-5)凡殺同(fam〇xadone),(19-6)伏寄南 (fluazinam),(19-7)氣氧化銅(copper OXyChl〇ride),(19-8) 2〇 氫氧化銅(copper hydroxide),(19-9)歐殺斯(oxadixyl), (19-10)螺環菌胺(spiroxamine),(19-11)二硫酉昆 (dithianon),(19-12)表苯菌酮(metrafenone),(19-13)咪嗤 菌酮(fenamidone),(19-14)2,3-二丁基-6-氣嗟吩并[2,3-(1]、密 ^_4(3H)_酮,(19-15)撲殺熱(probenazole),(19-16)稻瘦 112 200814928 靈(isoprothiolane) ’(19-17)嘉賜黴素(kasugamycin),(19-18) 熱必斯(phthalide),(19-19)富米熱斯(ferimzone),(19-20) 三赛唑(tricyclazole),(19-21) Ν·({4-[(環丙基胺基)幾基]苯 基}磺醯基)-2-曱氧基苯曱醯胺,(19-22) 2-(4-氯苯 5 基;曱氧基冰(丙-2-炔小基氧)苯基]乙基}-2-(丙_2_ 块-1-基氧)乙醯胺,(19-23)快諾芬(quinoxyfen)。 較佳的活性化合物組合物Q,其中第(19)類之殺真菌劑 | 係挑選自列於下面之化合物: (19-1)苯并噻二唑酯(acibenzolar-S-methyl),(19-2)氯塞尼 ίο (chlorothalonil),(19-3)克絕(cymoxanil),(19-5)凡殺同 (famoxadone),(19-6)伏寄南(fluazinam),(19-7)氯氧化銅 (copper oxychloride),(19_9)歐殺斯(oxadixyl),(19-10)螺 環菌胺(spiroxamine),(19-13)咪唾菌酮(fenamidone), (19-21) N-({4-[(環丙基胺基)羰基]苯基}磺醯基)-2-甲氧基 15 苯甲醯胺,(19-22)2-(4-氯苯基)-:^{2-[3-甲氧基-4-(丙-2-炔 p . -1·基氧)苯基]乙基丙-2-炔-1-基氧)乙隨胺,(19-23)快 諾芬(quinoxyfen) 〇 特別佳的活性化合物組合物Q,其中第(19)類之殺真菌 劑係挑選自列於下面之化合物: 2〇 (19-2)氯塞尼(chlorothalonil),(19-7)氯氧化銅(COpper oxychloride),(19-10)螺環菌胺(spiroxamine),(19_21) N-({4-[(環丙基胺基)羰基]苯基}磺醯基)-2-曱氧基苯甲醯 胺,(19-22)2-(4-氯苯基甲氧基-4-(丙-2-炔小基氧) 苯基]乙基}-2-(丙-2-炔-1-基氧)乙醯胺,(19-23)快諾芬 -113- 200814928 (quinoxyfen) 〇The active compound composition p to be particularly emphasized, comprising the carboguanamine of the formula (1) selected from the class (1) in Table A, and (17-3) tolclophos-methyl oxime In addition to the carboxychiral (terpenoid) compound of formula (1), the active compound group 15 compound Q also contains a fungicide selected from the following (category (19)): (19-1) Acibenzolar-S-methyl, (19-2) chlorothalonil, (19-3) yemoxanil, (19·4) edifenphos, (19-5)杀 同 (fam〇xadone), (19-6) volt nan (fluazinam), (19-7) copper OXyChl〇ride, (19-8) 2 〇 copper hydroxide (copper hydroxide), (19-9) oxadixyl, (19-10) spiroxamine, (19-11) dithianon, (19-12) meperfenone , (19-13) fenamidone, (19-14) 2,3-dibutyl-6-azepine [2,3-(1], 密^_4(3H)-one (19-15) probenazole, (19-16) rice thin 112 200814928 spirit (isoprothiolane) '(19-17) kasugamycin (kasugamycin), (19- 18) phthalide, (19-19) ferimzone, (19-20) tricyclazole, (19-21) Ν·({4-[(cyclopropyl) Amino)diyl]phenyl}sulfonyl)-2-decyloxybenzamine, (19-22) 2-(4-chlorophenyl-5-yl; decyloxy ice (propan-2-yne small) Phenoxy)phenyl]ethyl}-2-(propan-2-yl-1-yloxy)acetamide, (19-23) quinoxyfen. Preferred active compound composition Q, wherein 19) fungicides | are selected from the following compounds: (19-1) benzothiazolidine (acibenzolar-S-methyl), (19-2) chlorhexidine ίο (chlorothalonil), ( 19-3) cymoxanil, (19-5) famoxadone, (19-6) fluazinam, (19-7) copper oxychloride, (19_9) Oxadixyl, (19-10) spiroxamine, (19-13) fenamidone, (19-21) N-({4-[(cyclopropylamine) (carbonyl)phenyl]sulfonyl)-2-methoxyl benzoguanamine, (19-22) 2-(4-chlorophenyl)-:^{2-[3-methoxy- 4-(prop-2-yne p. -1·yloxy)phenyl]ethylprop-2-yn-1-yloxy)diethylamine (19-23) quinoxyfen 〇 a particularly preferred active compound composition Q, wherein the fungicide of class (19) is selected from the following compounds: 2〇(19-2) chlorseni (chlorothalonil), (19-7) COpper oxychloride, (19-10) spiroxamine, (19_21) N-({4-[(cyclopropylamino)carbonyl)benzene (sulfonyl)-2-decyloxybenzamide, (19-22) 2-(4-chlorophenylmethoxy-4-(prop-2-yne small oxy) phenyl] }}-2-(prop-2-yn-1-yloxy)acetamide, (19-23) vebufen-113- 200814928 (quinoxyfen) 〇
特別要被強調的活性化合物組合物Q,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(19-2)氣塞尼 (chlorothalonil)。The active compound composition Q to be particularly emphasized includes carboxamide which is selected from the group (I) of the class (1) in Table A, and (19-2) chlorothalonil.
5 特別要被強調的活性化合物組合物Q,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(19-7)氯氧化銅(copper oxychloride)- .5 The active compound composition Q to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (19-7) copper oxychloride.
• 特別要被強調的活性化合物組合物Q,包含挑選自表A 中之第(1)類的式⑴之羧醯胺,以及(19-10)螺環菌胺 10 (spiroxamine) 〇 特別要被強調的活性化合物組合物Q,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(19-21) N-({4-[(環丙基 胺基)羰基]苯基}磺醯基)_2_曱氧基苯甲醯胺。 特別要被強調的活性化合物組合物Q,包含挑選自表A 15 中之第⑴類的式(I)之羧醯胺,以及(19-22) 2-(4-氯笨 φ 基)-N-{2-[3-甲氧基斗(丙-2-炔小基氧)苯基]乙基卜2-(丙七 炔-基氧)乙醯胺。 特別要被強調的活性化合物組合物Q,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(19_23)快諾芬 2〇 (quinoxyfen) 〇 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 合物R也包含挑選自下述(第(20)類)之(硫)脲衍生物: (20-1)賓克隆(pencycuron) ,(20-2)甲基-多保淨 (thiophanate-methyl),(20-3)乙基-多保淨(thiophanate_ethyl)。 -114- 200814928 較佳的活性化合物組合物R,其中第(2〇)類之(硫)脲衍 生物係挑選自列於下面之化合物: (20-1)賓克隆(pencycur〇n),(2〇 2)曱基多保淨 (thiophanate-methyl) 〇• The active compound composition Q to be particularly emphasized, comprising the carboguanamine of the formula (1) selected from the class (1) in Table A, and (19-10) spiroxamine 10, especially The active compound composition Q is emphasized, comprising the carboxamide of formula (I) selected from the class (1) in Table A, and (19-21) N-({4-[(cyclopropylamino)) Carbonyl]phenyl}sulfonyl)_2_decyloxybenzamide. The active compound composition Q to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the class (1) in Table A 15 and (19-22) 2-(4-chlorophenyl)-N -{2-[3-Methoxy phenyl (prop-2-ynyloxy)phenyl]ethyl 2-(propyn-7-yloxy)acetamide. The active compound composition Q to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the class (1) in Table A, and (19_23) quinoxyfen in addition to the formula (I) In addition to the carboxamide (the compound of the class (1)), the active compound composition R also comprises a (thio)urea derivative selected from the following (category (20)): (20-1) penmone (pencycuron) ), (20-2) thiophanate-methyl, (20-3) ethyl-polyphanate_ethyl. -114- 200814928 A preferred active compound composition R wherein the (thio)urea derivative of the (2) class is selected from the group consisting of: (20-1) penmone (pencycur〇n), ( 2〇2) thiophanate-methyl 〇
5 特別要被強調的活性化合物紐合物R,包含挑選自表A 中之第⑴類的式⑴之羧醯胺,以及(20-1)賓克隆 (pencycuron) 〇 _ 除了具式(1)的羧醯胺(第(1)類化合物)外,活性化合物組 合物S也包含挑選自下述(第(22)類)之式(XIV)之三唑并嘧 10 口定 R415 In particular, the active compound R, which is to be emphasized, comprises carboxamide which is selected from the formula (1) of the class (1) in Table A, and (20-1) pencycuron 〇_ except for the formula (1) In addition to the carboxamide (the compound of the formula (1)), the active compound composition S also contains the triazole pyrimidine 10 of the formula (XIV) selected from the following (category (22)).
15 其中,R40,R41,R42,R43,R44,R45,R46 及 R47 的定義如 前。 較佳的活性化合物組合物S,其中第(22)類之式(XIV) 的三嗤并嘧啶係挑選自下面之化合物: (22-1) 5m仰-2,2,2-三氟小甲基乙基]-6·(2,4,6-三氟苯 2〇 基)Π,2,4]三唑并[1,5-a]嘧啶-7·胺,(22-2) 5-氯-尽[(77^1,2一 二曱基丙基]-6-(2,4,6-三氟苯基)[1,2,4]三嗤并[l,5-a>密。定-7-胺’(22-3) 5-氯-6-(2-氯氟苯基)-7-(4-曱基六氫°比唆《4_ 基)[1,2,4]三唑并[i,5-a]-嘧啶,(22-4) 5-氯各(2,4,6-三氟笨 基)-7-(4-甲基六氫π比啶基)[yj]三唑并[l,5_a]嘧啶。 -115- 200814928 特別佳的活性化合物組合物S,其中第(22)類之式(XIV) 的三哇并嘧啶係挑選自下面之化合物: (22-1) 5•氯三氟曱基乙基]_6_(2,4,6_三氟苯 基)[1,2,4]三唑并[15_a]嘧啶_7_胺,(22 2) 5 一甲基丙基P6_(2,4,6-三氟苯基)[1,2,4]三唑并[l,5-a]嘧啶-7- 胺,(22-4) 5-氯-6-(2,4,6-三氟苯基)_7_(4_甲基六氫0比啶 基)Π,2,4]三唑并p,^],啶。 響特別要被強調的活性化合物組合物s,包含挑選自表A 中之第(1)類的式(1)之綾醯胺,以及(22_1) 5-氯 1〇 Ψ &]^6»(2Λ6-^ ^ ^^)[1?2,4] 二唾并[l,5-a],唆-7-胺。 特別要被強調的活性化合物組合物s,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(22-2)5-氯_7^^/7^_1,2一 —曱基丙基]_6-(2,4,6-三氟苯基)pj,4]三唑并[L^a]嘧啶_7_ 15 胺。15 where R40, R41, R42, R43, R44, R45, R46 and R47 are as defined above. A preferred active compound composition S, wherein the triamed pyrimidine of the formula (XIV) is selected from the group consisting of: (22-1) 5m -2,2,2-trifluoropyrimidine Ethylethyl]-6·(2,4,6-trifluorobenzene-2-indenyl)indole, 2,4]triazolo[1,5-a]pyrimidin-7-amine, (22-2) 5- Chlorine-exhaustion [(77^1,2-dihydroxypropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triterpene [l,5-a> dense Ding-7-amine '(22-3) 5-chloro-6-(2-chlorofluorophenyl)-7-(4-mercaptohexahydrogen 唆 "4_ base" [1,2,4] Triazolo[i,5-a]-pyrimidine, (22-4) 5-chloro(2,4,6-trifluorophenyl)-7-(4-methylhexahydropyridinyl)[ Yj]Triazolo[l,5_a]pyrimidine. -115- 200814928 A particularly preferred active compound composition S, wherein the trihalopyrimidine of the formula (22) is selected from the following compounds: (22 -1) 5•Chlorotrifluoromethylethyl]_6_(2,4,6-trifluorophenyl)[1,2,4]triazolo[15_a]pyrimidine-7-amine, (22 2) 5 Monomethylpropyl P6_(2,4,6-trifluorophenyl)[1,2,4]triazolo[l,5-a]pyrimidin-7-amine, (22-4) 5-chloro- 6-(2,4,6-trifluorophenyl)_7_(4-methylhexahydro 0-pyridyl)indole, 2,4]triazolo p,^], pyridine. The active compound composition s, comprising the guanamine of formula (1) selected from the group (1) in Table A, and (22_1) 5-chloro 〇Ψ &]^6»(2Λ6-^ ^ ^^)[1?2,4] Disporin [l,5-a], indole-7-amine. The active compound composition s, which is particularly emphasized, contains the first (1) selected from Table A. Carboxylamidines of the formula (I), and (22-2) 5-chloro-7(^^^7^_1,2-monodecylpropyl]_6-(2,4,6-trifluorophenyl ) pj, 4] triazolo[L^a]pyrimidine_7_15 amine.
_ 将別要被強調的活性化合物組合物S,包含挑選自表A :之第⑴類的式⑴之賴胺,以及(22_4) 5'氣·6_(2,4,6、三氟 苯基>7_(4-甲基六氫錢-1·基)[U,4]三峻并[1»密啶。 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 2〇 合物T也包含挑選自下述(第(23)類)之式(XV)之碘代色酮_ The active compound composition S to be emphasized, including the lysine of the formula (1) selected from the class (1) of Table A, and (22_4) 5' gas·6_(2,4,6, trifluorophenyl) >7_(4-Methylhexahydro-l-yl)[U,4]Sanjun[1»-pyridine. In addition to the carboxamide (Formula (1)) of formula (I), The active compound group 2 chelate T also contains an iodochromone of the formula (XV) selected from the following (category (23))
其中,R48及R49的定義如前。 •116- 200814928 車父佳的活性化合物組合物T,其中第(23)類之式(χν) 的蛾代色酮係挑選自下面之化合物: (23-1) 2-丁氧基冬蛾冬丙基苯并^比喃冰酮,(23—2) 2-乙氧 基冬碘-3-丙基苯并吡喃-4-酮,(23-3) 6-碘-2-丙氧基_3-丙基 苯并吡喃+酮,(23_4)2_丁冬炔基氧冬碘冬丙基苯并吡喃 冰酮,(23-5) 6-碘-2-(1-甲基丁氧基丙基苯并吡喃冬酮, (23-6) 2-丁-3-烯基氧-6-破苯并°比喃_4-酮,(23-7) 3-丁基-6- 峨-2-異丙氧基苯并ϋ比喃·ζμ酮。 特別佳的活性化合物組合物Τ,其中第(23)類之式(XV) 的碘代色酮係挑選自下面之化合物: (23-1) 2-丁氧基-6-埃冬丙基苯并η比喃冰酮,(23-2) 2-乙氧 基-6-硬-3-丙基苯并吡喃-4-酮。 特別要被強調的活性化合物組合物Τ,包含挑選自表A 中之第⑴類的式⑴之羧醯胺,以及(23-1) 2-丁氧基-6-碘-3-丙基苯并u比喃-4-酮。 特別要被強調的活性化合物組合物τ,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(23_2)2_乙氧基_6-碘_3_ 丙基苯并吡喃-4-酮。 除了具式⑴的缓酿胺(第(1)類化合物)外,活性化合物組 合物U也包含挑選自下述(第(24)類)之式(XVI)之聯苯基羧 醢胺 、117、 200814928Among them, R48 and R49 are as defined above. • 116- 200814928 Che’s active compound composition T, wherein the moth ketone of the formula (23) (χν) was selected from the following compounds: (23-1) 2-butoxy moth winter Propyl benzopyrene, (23-2) 2-ethoxybutyrozin-3-propylbenzopyran-4-one, (23-3) 6-iodo-2-propoxy _3-propyl benzopyran + ketone, (23_4) 2 - butyrynyloxytoluene iodo-propyl benzopyrane, (23-5) 6-iodo-2-(1-methylbutyl Oxypropyl benzopyranone, (23-6) 2-but-3-enyloxy-6-branched benzopyrano-4-one, (23-7) 3-butyl-6 - Indole-2-isopropoxybenzopyrenepyrene, a particularly preferred active compound composition, wherein the iodochromone of the formula (23) is selected from the following compounds: (23-1) 2-butoxy-6-angyl benzopyrano-pyranone, (23-2) 2-ethoxy-6-bromo-3-propylbenzopyran-4 - ketone. The active compound composition 特别 particularly emphasized, comprising carboxyguanamine of formula (1) selected from the group (1) in Table A, and (23-1) 2-butoxy-6-iodo-3- Propyl benzo-pyran-4-one. Active compound composition to be particularly emphasized τ, which comprises the carboxamide of formula (I) selected from the class (1) in Table A, and (23_2)2-ethoxy-3-6-iodo-3-propylbenzopyran-4-one. In addition to the slow-acting amine of the formula (1) (the compound of the formula (1)), the active compound composition U also contains a biphenylcarbendazim of the formula (XVI) selected from the following (category (24)), 117 , 200814928
10 15 較佳的活性化合物組合物U,其中第(24)類之式(χνι) 的聯苯基羧臨胺係挑選自下面之化合物: (24-1) Λ4Ί·二氯-5备1,Γ-聯苯基一2-基)|(二氟甲基)小 甲基-1凡吡唑斗羧醯胺,(24_2) 4_(二氟甲基)·2_甲基 善[4 _(二氟甲基聯苯基·2_基]塞唾_5-羧驢胺, (24-4),(3’,4’-二氯-1,1、聯苯基 1基)士氣山3·二甲基_. 吡唑-4-羧醯胺,(24-5) ΛΚ4,-氯-3,·氟-U,-聯苯基-2-基)-2-甲基-4-(三氟曱基)-1,3-噻吐-5-叛醯胺,(24-6)1(4,-氯-1,Γ-聯苯基-2-基)-4-(二氟甲基)-2-曱基-1,3-噻唑-5-羧醯胺, (24-7) ΛΚ4’-漠-1,Γ-聯苯基-2-基)-4-(二氟甲基)-2-甲基-1,3- 噻唑-5-羧醯胺。 特別佳的活性化合物組合物U,其中第(24)類之式(XVI) 的聯苯基羧醯胺係挑選自下面之化合物: (24-1) ΛΚ3’,4’-二氯-5-氟-1,Γ-聯苯基-2-基)各(二氟甲基)小 甲基-1//-吡唑-4-羧醯胺,(24-3) 3-(三氟曱基:氟 44(五)_(甲氧基亞胺基)甲基]-U’-聯苯基_2-基}-1-甲基 • l/fj比嗤-4-叛酿胺,(24-7)豕(4’->臭-1,1/-聯苯基-2-基)-4-(二 氟曱基)-2-甲基-1,3-噻唑-5-羧醯胺。 -118- 20 200814928 t別要被強調的活性化合物組合物U,包含挑選自表A 发第(1)類的式(I)之叛酸胺,以及(24-1) AK3’,4’-二氣-5- 氟I1 ·聯笨基基)、3_(二氟甲基)-1_甲基-l/fj比唑-4-羧醯 胺。10 15 Preferred active compound composition U, wherein the biphenylcarboxylamine of the formula (24) is selected from the following compounds: (24-1) Λ4Ί·dichloro-5. Γ-biphenyl-2-yl)|(difluoromethyl)small methyl-1-propionazole carboxamide, (24_2) 4_(difluoromethyl)·2_methyl good [4 _( Difluoromethylbiphenyl·2_yl]pyrene-5-carboxyguanamine, (24-4), (3',4'-dichloro-1,1,biphenyl-1-yl) Shiqishan 3 · dimethyl _. pyrazole-4-carboxamide, (24-5) ΛΚ4,-chloro-3, fluoro-U,-biphenyl-2-yl)-2-methyl-4-( Trifluoromethyl)-1,3-thiox-5-treazone, (24-6)1(4,-chloro-1, fluorene-biphenyl-2-yl)-4-(difluoromethyl) ))-2-mercapto-1,3-thiazole-5-carboxyguanamine, (24-7) ΛΚ4'-di-1, Γ-biphenyl-2-yl)-4-(difluoromethyl )-2-methyl-1,3-thiazole-5-carboxamide. A particularly preferred active compound composition U wherein the biphenylcarbendazim of the formula (24) is selected from the group consisting of: (24-1) ΛΚ3',4'-dichloro-5- Fluorin-1, fluorene-biphenyl-2-yl) each (difluoromethyl) small methyl-1//-pyrazole-4-carboxamide, (24-3) 3-(trifluoromethyl) :Fluorum 44 (5)-(methoxyimino)methyl]-U'-biphenyl-2-yl}-1-methyl•l/fj than 嗤-4-Rebel, (24 -7) 豕(4'->Smelly-1,1/-biphenyl-2-yl)-4-(difluoroindolyl)-2-methyl-1,3-thiazole-5-carboxyindole -118- 20 200814928 t The active compound composition U to be emphasized, including the tickamines of formula (I) selected from Table A (1), and (24-1) AK3', 4 '-Digas-5-fluoro I1 · phenyl group), 3_(difluoromethyl)-1_methyl-l/fj-pyrazole-4-carboxamide.
5 特別要被強調的活性化合物組合物U,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(24-7)7\K4U,r-聯苯 基1基)冰(二氟甲基>2-曱基-1,3-噻唑-5-羧醯胺。 | 除了具式(I)的緩醯胺(第⑴類化合物)外,活性化合物組 合物V也包含挑選自下述(第(25)類)之式(XVII)之烧基叛醯 ίο 胺5 The active compound composition U to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (24-7)7\K4U,r-biphenylyl group) Ice (difluoromethyl)> 2-mercapto-1,3-thiazole-5-carboxamide. | In addition to the slow-acting amine of the formula (I) (the compound of the formula (1)), the active compound composition V is also Contains a burnt-rebel ο ο ο amine selected from the following (Class (25))
15 其中,Het,R50及R58的定義如前。 | 較佳的活性化合物組合物V,其中第(25)類之式(XVII) 的烷基羧醯胺係挑選自下面之化合物: (25-1) ,3·一 曱基 丁基)笨基]_ 1,3-二曱基-1 片 j比哇-4- 羧醯胺,(25-2) ΛΜ2-(1,3-二甲基丁基)苯基}-5-氟-1,3-二甲 2〇 基-1丑-咐唑-4-羧醯胺,(25-3) Aq2-(1,3-二甲基丁基)苯 基]-5-氯—^甲基-1//-0比17坐-4-竣酿胺,(25-4) 3-(二氣甲 基)-尽[2-(1,3-二曱基丁基)苯基H·甲基-1//^比唑-4-羧醯 胺,(25-5) 3-(三氟甲基)-Λ42-(1,3-二曱基丁基)苯基]-5_氟 -1-甲基-1//-0比°坐-4-竣酿胺 ’(25-6) 3·(三氣甲基)"Ί·[2-(1,3- -119- 200814928 二甲基丁基)苯基]·5-氯-1-曱基比嗤-4-綾酿胺,(25-7) 1,3-二甲基-’[2-(1,3,3-三甲基)苯基]-177-〇比嗤冰緩gf胺, (25-8) 5-氟-1,3-二甲基善[2(1,3,3-三曱基丁基)苯基比 唑-4-羧醯胺,(25-9) 3-(二氟甲基)-1-甲基三甲 5 基丁基)苯基]-1凡吡唑-4-羧醯胺,(25-10) 3-(三氟甲基)-1_ 曱基-7Η2-(1,3,3-三曱基丁基)苯基比唑竣醯胺, (25-11) 3-(二氟甲基)-5-氣-1-曱基-|[2-(1,3,3-三曱基 丁基) _ 苯基吡唑-4·羧醯胺,(25-12) 3-(三氟曱基)_5-氯小甲基 -ΛΓ-[2·(1,3,3-二曱基丁基)苯基]比0坐4-綾酸胺,(25-13) ίο 尽[2-(1,3-(—曱基丁基)苯基)-2-破苯曱酿胺,(25·14) 2-碘 -A^[2-(l,3,3-二甲基丁基)本基]苯甲酿胺,(25]5)jV-[2-(l,3- 二曱基丁基)苯基]-2-(三氟甲基)笨曱醯胺,(25_16) 2_(三氟 曱基)善[2-(1,3,3·三甲基丁基)苯基]苯甲醯胺。 特別佳的活性化合物組合物V,其中第(25)類之式 15 (xvii)的烧基叛酿胺係挑選自下面之化合物: • (25-1) WK1,3-二甲基丁基)笨基H,3-二甲基-1//-吡唑4一 羧醯胺,(25-2) 7V-{2-(l,3-二甲基丁基)苯基卜孓氟^^一二 基-1A吡唑-4-羧醯胺,(25-8) 5-氟],3_二甲基卩(1,3,3_ 二甲基丁基)苯基]-lii-吡唑-4-羧醯胺,(25_13) (二 20 曱基丁基)苯基)-2_碘苯曱醯胺,(25-15)Λ42-(1,3-二曱基丁 基)本基]-2-(三氟甲基)苯甲醯胺。 知別要被強調的活性化合物組合物 中之第⑴類的式(1)之細,以及㈣ 丁基)苯基]-1,3-二甲基-l/ί-吡唑_4_羧醯胺。 120- 200814928 特別要被強調的活性化合物組合物V,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(25-2)Ι{2-(1,3-二甲基 丁基)笨基氟-1,3_二甲基-l/ί-吡唑-4-羧醯胺。 特別要被強調的活性化合物組合物V,包含挑選自表A 5 中之第(1)類的式(I)之羧醯胺,以及(25-8) 5-氟-1,3-二甲基15 Among them, Het, R50 and R58 are as defined above. A preferred active compound composition V, wherein the alkylcarboxyguanamine of the formula (25) is selected from the group consisting of: (25-1), 1,3-mercaptobutyl) ] _ 1,3-dimercapto-1 tablet j-wow-4-carboxamide, (25-2) ΛΜ2-(1,3-dimethylbutyl)phenyl}-5-fluoro-1, 3-dimethyl 2-mercapto-1 ugly-oxazole-4-carboxamide, (25-3) Aq2-(1,3-dimethylbutyl)phenyl]-5-chloro-^methyl- 1//-0 to 17 -4- an amine, (25-4) 3-(dimethyl)-[2-(1,3-didecylbutyl)phenyl H.methyl -1//^Bizozol-4-carboxamide, (25-5) 3-(trifluoromethyl)-indole 42-(1,3-didecylbutyl)phenyl]-5-fluoro-1 -Methyl-1//-0 ratio ° 竣-4- 竣 胺 ' '(25-6) 3 · (three gas methyl) " Ί · [2-(1,3- -119- 200814928 dimethyl Benzyl)phenyl]·5-chloro-1-indenylpyrimidine-4-indoleamine, (25-7) 1,3-dimethyl-'[2-(1,3,3-tri Methyl)phenyl]-177-indole 嗤 嗤 缓 gf amine, (25-8) 5-fluoro-1,3-dimethyl good [2 (1,3,3-tridecylbutyl)benzene Kebizozol-4-carboxyguanamine, (25-9) 3-(difluoromethyl)-1-methyltrimethylpentyl)phenyl]-1-pyrazol-4-carboxamide 25-10) 3-(Trifluoromethyl)-1_indolyl-7Η2-(1,3,3-tridecylbutyl)phenylpyrazinium, (25-11) 3-(difluoro Methyl)-5-ani-1-indolyl-|[2-(1,3,3-tridecylbutyl) _phenylpyrazole-4.carboxamide, (25-12) 3-( Trifluoroindolyl)_5-chlorosuccinyl-indenyl-[2·(1,3,3-dimercaptobutyl)phenyl] is more than 0-position of 4-decanoic acid amine, (25-13) ίο 2-(1,3-(-decylbutyl)phenyl)-2-benzophenentamine, (25·14) 2-iodo-A^[2-(l,3,3-dimethyl Butyl)benzyl]benzamide, (25]5)jV-[2-(l,3-dimercaptobutyl)phenyl]-2-(trifluoromethyl) cumamine, 25_16) 2_(Trifluoromethyl)-[2-(1,3,3·trimethylbutyl)phenyl]benzamide. Particularly preferred active compound composition V, wherein the alkylidene amine of formula (25) of formula 15 (xvii) is selected from the following compounds: • (25-1) WK1,3-dimethylbutyl) Stupid H,3-dimethyl-1//-pyrazole 4-carboguanamine, (25-2) 7V-{2-(l,3-dimethylbutyl)phenyl bromide ^^ Di-diyl-1A pyrazole-4-carboxamide, (25-8) 5-fluoro], 3-dimethylindole (1,3,3-dimethylbenzyl)phenyl]-lii-pyrazole -4-carboxamide, (25_13) (di-20 decylbutyl) phenyl)-2_iodobenzamide, (25-15) Λ42-(1,3-didecylbutyl) group ]-2-(Trifluoromethyl)benzamide. Knowing the fineness of the formula (1) of the (1) class and the (tetra)butyl)phenyl]-1,3-dimethyl-l/ί-pyrazole_4_carboxylate in the active compound composition to be emphasized Guanamine. 120- 200814928 The active compound composition V to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the class (1) in Table A, and (25-2) Ι {2-(1,3) - dimethylbutyl) phenyl fluoride-1,3-dimethyl-l/ί-pyrazole-4-carboxamide. The active compound composition V to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A5, and (25-8) 5-fluoro-1,3-dimethyl base
善[2(1,3,3-三甲基丁基)苯基]·吡唑4羧醯胺Q 特別要被強調的活性化合物組合物V,包含挑選自表A | 中之第(1)類的式(I)之羧醯胺,以及(25-13)翠[2_(1,3_(二甲 基丁基)苯基)-2-硬笨甲醯胺。Good [2(1,3,3-trimethylbutyl)phenyl]pyrazole 4 Carboxamide Q The active compound composition V, which is particularly emphasized, contains the first (1) selected from Table A | Carboxylamidines of the formula (I), and (25-13) chloro[2-(1,3-(dimethylbenzyl)phenyl)-2-bromoformamide.
10 特別要被強調的活性化合物組合物V,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(25·15)Λ42-(1,3-二甲基 丁基)笨基]-2-(三氟甲基)笨甲酿胺。 除了具式(I)的羧醯胺(第⑴類化合物)外,活性化合物組 合物w也包含挑選自下述(第(26)類)之式(xvm)之烷基羧 15 醯胺10 The active compound composition V to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (25·15) Λ42-(1,3-dimethyl Butyl) phenyl]-2-(trifluoromethyl) benzoate. In addition to the carboguanamine of the formula (I) (the compound of the formula (1)), the active compound composition w also contains an alkylcarboxyl decylamine of the formula (xvm) selected from the following (class (26))
其中,A,,R60及R70的定義如前。 較佳的活性化合物組合物W,其中第(26)類之式(XVIII) 的烷基羧醯胺係挑選自下面之化合物: (26-1) 5-氟-1,3-二甲基-Λ42-(3·甲基丁基)苯基吼唑-4- -121- 200814928 羧醯胺,(26-2)3-(二氟甲基)-#-[2-(3,3-二曱基丁基)-4-氟苯 基]-1-甲基-1//- π比ΰ坐-4-竣酿胺’(26-3) 3-(二氣甲 基)-Ί-[2·(3,3 -二曱基丁基)苯基]-1 -甲基-1//- ^比σ坐-4-竣酿 胺,(26-4),[2-(3,3-二曱基丁基)苯基]-2-(三氟曱基)苯甲醯 5 胺,(26-5)iV-[2-(3,3-二甲基丁基)-4-氟苯基]-2-曱基-4-(三氟 曱基)-1>噻唑-5-羧醯胺,(26-6) Λ42-(3,3-二甲基丁基)-3-甲基噻吩-2-羧醯胺。 | 特別要被強調的活性化合物組合物W,包含挑選自表 A中之第(1)類的式(I)之羧醯胺,以及(26-1) 5-氟-1,3-二甲基 ίο -iV-[2-(3-甲基丁基)苯基]-177-°比0坐-4-竣酿胺。 特別要被強調的活性化合物組合物W,包含挑選自表 A中之第(1)類的式(I)之羧醯胺,以及(26-2) 3-(二氟曱 基)-ΛΓ-[2-(3,3-二甲基丁基)-4-氟苯基]-1-曱基-1//-吼唑-4-羧 醯胺。 15 特別要被強調的活性化合物組合物W,包含挑選自表 _ A中之第(1)類的式(I)之羧醯胺,以及(26-3) 3-(二氟甲 基)-7\^[2-(3,3-二甲基丁基)苯基]-1-曱基唾-4-叛酸胺。 特別要被強調的活性化合物組合物W,包含挑選自表 A中之第(1)類的式(1)之羧醯胺,以及(26-4)7\42-(3,3-二甲 20 基丁基)苯基]-2-(三氟曱基)苯甲醯胺。 特別要被強調的活性化合物組合物W,包含挑選自表 A中之第(1)類的式(I)之羧醯胺,以及(26-5) Λ42-(3,3-二甲 基丁基)-4-氣苯基]-2-曱基-4-(三氟^曱基)-1,3-嗟σ坐-5-叛酿 胺0 -122- 200814928 特別要被強調的活性化合物組合物W,包含挑選自表 之第(1)類的式(I)之羧酸胺,以及(26_6) 二甲 土丁基V3-甲基嗟吩_2_羧醯胺。 人除了式(I)的一種活性化合物外,根據本發明的活性化 &物組合物包含至少—種挑選自第(2)至(26)類的化合物, 此外,匕們可能也包含另外的殺真菌地活性添加物。Among them, A, R60 and R70 are as defined above. A preferred active compound composition W, wherein the alkylcarboxamide of the formula (26) is selected from the group consisting of: (26-1) 5-fluoro-1,3-dimethyl- Λ42-(3·methylbutyl)phenylcarbazole-4-121-200814928 Carboxylamidine, (26-2)3-(difluoromethyl)-#-[2-(3,3-di Mercaptobutyl)-4-fluorophenyl]-1-methyl-1//- π ΰ 竣-4-竣 胺 ''(26-3) 3-(dimethyl)-Ί-[ 2·(3,3-dimercaptobutyl)phenyl]-1 -methyl-1//- ^ ratio σ sit-4-anthracene, (26-4), [2-(3,3 -dimercaptobutyl)phenyl]-2-(trifluoromethyl)benzamide 5 amine, (26-5)iV-[2-(3,3-dimethylbutyl)-4-fluoro Phenyl]-2-mercapto-4-(trifluoromethyl)-1>thiazole-5-carboxamide, (26-6) Λ42-(3,3-dimethylbutyl)-3-methyl Thiophene-2-carboxamide. The active compound composition W to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (26-1) 5-fluoro-1,3-dimethyl The base ίο -iV-[2-(3-methylbutyl)phenyl]-177-° is -4-anthracene than 0. The active compound composition W to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (26-2) 3-(difluoroindolyl)-fluorene- [2-(3,3-Dimethylbutyl)-4-fluorophenyl]-1-indolyl-1//-carbazole-4-carboxamide. 15 The active compound composition W to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (26-3) 3-(difluoromethyl)- 7\^[2-(3,3-Dimethylbutyl)phenyl]-1-mercaptosin-4-tetamine. The active compound composition W to be particularly emphasized, comprising the carboguanamine of the formula (1) selected from the class (1) in Table A, and (26-4)7\42-(3,3-dimethyl 20 butyl phenyl)-2-(trifluoromethyl)benzamide. The active compound composition W to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (26-5) Λ42-(3,3-dimethylbutyl) 4-)Phenyl]-2-mercapto-4-(trifluoromethyl)-1,3-indole sitting--5-rebel amine 0-122- 200814928 Active compound to be emphasized Composition W, comprising a carboxylic acid amine of formula (I) selected from the group (1), and (26_6) dimethyl butyl V3-methyl porphin-2-carboguanamine. In addition to an active compound of formula (I), the activating & composition according to the invention comprises at least one compound selected from classes (2) to (26), and furthermore, we may also comprise additional A fungicidal active additive.
10 1510 15
以某種重I比例存在下,協乘的效果特別地明顯,然而, 在/舌性化合物組合物中之活性化合物之重量比例可在相對 地廣的範圍間變化,通常,根據本發明的活性化合物組合 物所包含之式⑴的化合物以及來自第(2)至(26)類之混合配 對物,其混合比例被例示於下面的表B中。 如果根據本發明的活性化合物組合物中之活性化合物 混合比例係以重量比為依據,即,式⑴的活性化合物: 外匕合的配對物之重量比例。 :混合的比例 混合配對物 較佳的混合比例 特別佳的混合比例 第(2)类員:史托比系(Strobilurins) 50 : 1 至 1 ·· 50 10 : 1 至 1 : 20 : (3-15)以外的三唑類 50 : 1 至 1 : 50 20 : 1 至 1 : 20 普硫康ϋ坐(prothioconazole) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(4)類:次磺醯胺類(sulphenamides) 1 : 1 至 1 : 150 1 : 1 至 1 : 100 -123- 200814928 混合配對物 較佳的混合比例 特別佳的混合比例 第(5)類:纈胺醯胺類 50 : 1 至 1 : 50 10 : 1 至 1 ·· 20 第⑹類:羧醯胺類 50 : 1 至 1 : 50 20 : 1 至 1 : 20 第(7)類:二硫胺基甲酸酯類 1 : 1 至 1 : 150 1 : 1 至 1 : 100 第⑻類:醯基丙胺酸類 10 : 1 至 1 : 150 5 : 1 至 1 : 100 第(9)類:苯胺基嘧啶類 5 : 1 至 1 : 50 1 : 1 至 1 : 20 第(10)類:苯并咪唑類 10 : 1 至 1 : 50 5 : 1 至 1 : 20 第(11)類:(1H)以外的胺基甲酸醋類 1 : 1 至 1 : 150 1 : 1 至 1 : 100 (11-1):二硫芬克(diethofencarb) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(12)類:(12-1)/(12-2)/(12-3) 1 : 1 至 1 : 150 1 : 5 至 1 : 100 第(12)類:(12-4)/(12-5)/(12-6) 5 : 1 至 1 : 50 1 : 1 至 1 : 20 第(13)類:胍 100 : 1 至 1 : 150 20 : 1 至 1 : 100 第(14)類··咪唑 50 ·· 1 至 1 ·· 50 10 : 1 至 1 : 20 第(15)類:嗎啉 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(16)類··吡咯 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(17)類:(17-3)以外的(硫)膦酸酯類 10 : 1 至 1 ·· 150 1 : 1 至 1 : 100 (17-3)甲基立枯麟(tolclophos-methyl) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(18)類:苯基乙醯胺類 50 : 1 至 1 : 50 10 : 1 至 1 : 20 -124- 200814928The effect of synergy is particularly pronounced in the presence of a certain weight I ratio, however, the weight ratio of active compound in the/tongue compound composition can vary over a relatively wide range, typically, the activity according to the invention The compound of the formula (1) and the mixed partner from the group (2) to (26) contained in the compound composition are mixed in the following Table B. If the active compound mixing ratio in the active compound composition according to the invention is based on the weight ratio, i.e. the active compound of the formula (1): the weight ratio of the externally conjugated counterpart. : Mixed proportions of mixed counterparts. Preferred mixing ratios are particularly good. Mixing ratios (2): Strobilurins 50 : 1 to 1 · · 50 10 : 1 to 1: 20 : (3- 15) Other triazoles 50 : 1 to 1: 50 20 : 1 to 1: 20 Prothioconazole 50 : 1 to 1: 50 10 : 1 to 1: 20 Category (4): Sulfenamides 1 : 1 to 1: 150 1 : 1 to 1: 100 -123- 200814928 Mixing ratios preferred mixing ratios particularly preferred mixing ratios Category (5): amidoxime 50 : 1 to 1: 50 10 : 1 to 1 ·· 20 Category (6): Carboxylamamines 50 : 1 to 1: 50 20 : 1 to 1: 20 Category (7): Dithiocarbamate 1 : 1 to 1: 150 1 : 1 to 1: 100 Class (8): Mercapto Alanine 10 : 1 to 1: 150 5 : 1 to 1: 100 Category (9): Anilinopyrimidines 5 : 1 to 1 : 50 1 : 1 to 1: 20 Category (10): Benzimidazoles 10 : 1 to 1: 50 5 : 1 to 1: 20 Category (11): Amino formates other than (1H) 1 : 1 to 1: 150 1 : 1 to 1: 100 (11-1): diethofencarb 50 : 1 to 1: 50 10 : 1 to 1: 20 Class (12): (12-1) / (12-2) / (12-3) 1 : 1 to 1: 150 1 : 5 to 1: 100 Class (12): (12 -4)/(12-5)/(12-6) 5 : 1 to 1: 50 1 : 1 to 1: 20 Class (13): 胍100 : 1 to 1: 150 20 : 1 to 1: 100 Class (14) · · Imidazole 50 ·· 1 to 1 ·· 50 10 : 1 to 1: 20 Class (15): Morpholine 50 : 1 to 1: 50 10 : 1 to 1: 20 (16) Class··pyrrole 50 : 1 to 1: 50 10 : 1 to 1: 20 Class (17): (Sulfur) phosphonates other than (17-3) 10 : 1 to 1 ·· 150 1 : 1 to 1 : 100 (17-3) tolclophos-methyl 50 : 1 to 1: 50 10 : 1 to 1: 20 Category (18): phenylacetamide 50 : 1 to 1: 50 10 : 1 to 1: 20 -124- 200814928
混合配對物 較佳的混合比例 特別佳的混合比例 (19-1):苯并噻二唑酯 (acibenzolar-S-methyl) 50 : 1 至 1 : 50 20 : 1 至 1 : 20 (19-2):氣塞尼(chlorothalonil) 1 : 1 至 1 : 150 1 : 1 至 1 : 100 (19-3) ··克絕(cymoxanil) 10 : 1 至 1 : 50 5 : 1 至 1 : 20 (19-4):護粒松(edifenphos) 10 : 1 至 1 : 50 5 : 1 至 1 : 20 (19-5):凡殺同(famoxadone) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-6):伏寄南(fluazinam) 50 ·· 1 至 1 : 50 10 : 1 至 1 : 20 (19-7):氧氯化銅(copper oxychloride) 1 : 1 至 1 : 150 1 : 5 至 1 : 100 (19-8):氫氧化銅(copper hydroxide) 1 : 1 至 1 : 150 1 : 5 至 1 : 100 (19-9) ··歐殺斯(oxadixyl) 10 : 1 至 1 ·· 150 5 ·· 1 至 1 : 100 (19-10):螺環菌胺(spiroxamine) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-11) ··二石荒酉昆(dithianon) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-12):表苯菌酮(metrafenone) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-13):味 σ坐菌酮(fenamidone) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-14) ·· 2,3-丁基-6-氯噻吩并[2,3-d]嘧 啶-4(3H)酮 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-15) ··撲殺熱(probenazole) 10 : 1 至 1 : 150 5 ·· 1 至 1 ·· 100 (19-16):稻瘦靈(isoprotiliolane) 10 : 1 至 1 : 150 5 : 1 至 1 : 100 -125- 200814928 混合配對物 較佳的混合比例 特別佳的混合比例 (19-17) ··嘉賜黴素(kasugamycin) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-18) ··熱必斯(phthalide) 10 : 1 至 1 : 150 5 ·· 1 至 1 ·· 100 (19-19):富米熱斯(ferimzone) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-20):三賽^(tricyclazole) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-21) : N-({4-[(環丙基胺基)-羰基]苯 基}磺醯基)-2-甲氧基苯甲醯 胺 10 : 1 至 1 : 150 5 : 1 至 1 : 100 (19-22) : 2-(4-氯苯基甲氧基 斗(丙-2-炔4-基氧)苯基]乙 基}-2-(丙-2-快-1-基氧)乙酿胺 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-23):快諾芬(quinoxyfen) 10 : 1 至 1 : 150 5 : 1 至 1 : 100 第(20)類:(硫)脲衍生物 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(21)類:醯胺類 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(22)類:三唑并嘧啶類 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(23)類:碘代色酮類 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(24)類:聯苯基羧醯胺 50 : 1 至 1 : 50 10 ·· 1 至 1 : 20 第(25)類:烷基羧醯胺類 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(26)類:烷基羧醯胺類 50 : 1 至 1 : 50 10 : 1 至 1 : 20A preferred mixing ratio of the mixed counterpart is particularly good (19-1): acibenzolar-S-methyl 50 : 1 to 1: 50 20 : 1 to 1: 20 (19-2 ): chlorothalonil 1 : 1 to 1: 150 1 : 1 to 1: 100 (19-3) · · cymoxanil 10 : 1 to 1: 50 5 : 1 to 1: 20 (19 -4): edifenphos 10 : 1 to 1: 50 5 : 1 to 1: 20 (19-5): famoxadone 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-6): fluazinam 50 ·· 1 to 1: 50 10 : 1 to 1: 20 (19-7): copper oxychloride 1 : 1 to 1: 150 1 : 5 to 1: 100 (19-8): Copper hydroxide 1 : 1 to 1: 150 1 : 5 to 1: 100 (19-9) · Oxdixyl 10 : 1 to 1 ·· 150 5 ·· 1 to 1: 100 (19-10): spiroxamine 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-11) ··二石荒酉昆 (dithianon 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-12): metrafenone 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-13): taste σ Fenamidone 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-14) ·· 2,3-Butyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)one 50 : 1 to 1: 50 10 : 1 to 1: 20 (19- 15) ················································ 100 -125- 200814928 Mixing ratios are preferred. Mixing ratios are particularly good (19-17) ··Kasugamycin 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-18 ························· : 20 (19-20): Tricyclazole 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-21) : N-({4-[(cyclopropylamino)-carbonyl) Phenyl}sulfonyl)-2-methoxybenzamide 10 : 1 to 1: 150 5 : 1 to 1: 100 (19-22) : 2-(4-chlorophenylmethoxy bucket (prop-2-ynyl-4-yloxy)phenyl]ethyl}-2-(propan-2-free-1-yloxy)ethinamide 50 : 1 to 1: 50 10 : 1 to 1: 20 ( 19-23): quinoxyfen 10 : 1 to 1: 150 5 : 1 to 1: 100 Category (20): (thio)urea derivative 50 : 1 to 1 : 50 10 : 1 to 1: 20 Category (21): decylamines 50 : 1 to 1: 50 10 : 1 to 1: 20 Category (22): Triazolopyrimidines 50 : 1 to 1: 50 10 : 1 to 1: 20 Class (23): Iodochromones 50 : 1 to 1: 50 10 : 1 to 1: 20 Category (24): Biphenylcarboxylamine 50 : 1 to 1 : 50 10 ·· 1 to 1: 20 Class (25): Alkylcarboxamides 50 : 1 to 1: 50 10 : 1 to 1: 20 Class (26): Alkylcarboxamides 50 : 1 to 1: 50 10 : 1 to 1: 20
各情形下,混合的比例係選用可達到協乘的混合者, -126 - 200814928 式(I)化合物與式(2)至(26)之一的化合物間之比例可視個別 的化合物而變動。 根據本發明的活性化合物組成物具有強力的殺微生物 的作用且可被使用於作物保護及材料保護方面,供控制不 5 想要的微生物,例如,真菌及細菌。 於作物保護方面,作為殺真菌劑類時,可被使用於供 控制根腫菌(Plasmodiophoromycetes)、卵菌(Oomycetes)、壺 | 菌(Chytridiomycetes)、接合菌(Zygomycetes)、子囊菌 (Ascomycetes)、擔子菌(Basidiomycetes)及不完全菌類 ίο (Deuteromycetes)之真菌。 於作物保護方面,作為殺細菌劑類時,可被使用於供 控制假單胞菌科(Pseudomonadaceae)、根瘤菌科 (Rhizobiaceae)、腸道桿菌科(Enterobacteriaceae)、棒狀桿菌 科(Corynebacteriaceae)及鏈球菌科(Streptomycetaceae)之細 15 菌0 p 列於上面的屬名下之造成真菌與細菌性疾病之一些病 原菌,可予舉例說明者如下,但不僅限於這些: 造成白粉病(powdery mildew)之病原菌,例如, 布氏白粉菌屬(Blumeria species),例如,大麥粉狀黴菌病原 2〇 後[Blumeria graminis) ·, 單囊殼屬(Podosphaera species),例如蘋果白粉病菌 {Podosphaera leucotricha) \ 單絲殼屬(Sphaerotheca species),例如,紅豆白粉病菌 (Sphaerotheca fuliginea); -127- 200814928 鉤絲殼屬(Uncinula species),例如,葡萄鉤絲殼 necator) \ 造成銹病(rust)之病原菌,例如, 鐵銹菌屬(Gymnosporangium species),例如,杜松梨鐵銹菌 5 (Gymnosporangium sabinae) ·, 咖啡銹病屬(Hemileia species),例如,駝孢銹病菌(开 vastatrix) \ , 銹菌屬(Phakopsora species),例如,大豆銹病菌(外以吵似⑺ pachyrhizi A Phakopsora meibomiae) \ i〇 銹菌屬(Puccinia secies),例如,小麥赤銹病菌 recondita) \ 單抱錄菌屬(Uromyces species),例如,疲頂單胞錄菌 {Uromyces appendiculatus); 造成疾病之卵菌綱(Oomycetes)病原菌,例如, 15 盤梗霉屬(Bremia species),例如,萵苣盤梗霉⑺ ^ lactucae) \ 霜霉屬(Peronospora species),例如,豌豆霜霉 />加)或蕓薹霜霉(戶; 疫病屬(Phytophthora species),例如,致病疫 _ (ρ知 2〇 infestans) \ 露菌屬(Plasmopara species),例如,葡萄露菌 viticola); 假霜霉菌屬(Pseudoperonospora species),例如,葎草假霜霉 (Pseudopewnospora humUliHMtMPseud〇per_sp〇ra -128- 200814928 cubensis); 腐霉菌屬(Pythium species),例如,終極腐霉菌(,如麵 ultimum); 造成葉斑點病與葉枯萎之病原菌,例如, 鏈格孢菌屬(Alternaria species),例如,早疫病鏈格抱菌 {Alternaria solani);In each case, the mixing ratio is selected from a mixture which can achieve synergy, and the ratio between the compound of the formula (I) and the compound of one of the formulas (2) to (26) may vary depending on the individual compound. The active compound compositions according to the invention have a strong microbicidal action and can be used for crop protection and material protection for controlling undesirable microorganisms such as fungi and bacteria. For crop protection, when used as a fungicide, it can be used for controlling Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and incomplete fungi ίο (Deuteromycetes) fungi. In the case of crop protection, when used as a bactericide, it can be used for controlling Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae, and Streptomycetaceae, 15 genus 0 p Listed under the generic name above, some of the pathogens causing fungal and bacterial diseases can be exemplified as follows, but not limited to these: causing powdery mildew (powdery mildew) Pathogens, for example, Blumeria species, for example, Blumeria graminis of the barley powdery fungus pathogen, Podosphaera species, such as powdery mildew (Podosphaera leucotricha) \ monofilament Sphaerotheca species, for example, Sphaerotheca fuliginea; -127- 200814928 Uncinula species, for example, necator, causing rust pathogens, for example, rust Gymnosporangium species, for example, Gymnosporangium sabinae, coffee Hemileia species, for example, Phyllostachys pubescens (Kvastatrix) \ , Phakopsora species, for example, soybean rust (external (7) pachyrhizi A Phakopsora meibomiae) \ i rust fungus ( Puccinia secies), for example, wheat rust pathreta), Uromyces species, for example, Uromyces appendiculatus; Oomycetes pathogen causing disease, for example, 15 Bremia species, for example, Phytophrenia (7) ^ lactucae), Peronospora species, for example, pea downy mildew/> plus or downy mildew (household; Phytophthora) Species), for example, Phytophthora infestation, Plasmopara species, for example, Grape bacterium viticola; Pseudoperonospora species, for example, Pseudomonas sinensis ( Pseudopewnospora humUliHMtMPseud〇per_sp〇ra -128- 200814928 cubensis); Pythium species, for example, Pythium ultimum (such as ultimum); causing leaf spot disease and leaf blight a pathogen of wilting, for example, an Alternaria species, for example, Alternaria solani;
10 1510 15
褐斑病菌屬(Cercospora species),例如,甜菜褐斑病菌 {Cercospora beticola); 星病菌屬(Cladiosporum species),例如,黃瓜黑星病菌 {Cladiosporium cucumerinum) ·, 抱腔菌屬(Cochliobolus species),例如禾旋孢腔菌 (分生孢子型:Drechslera,syn :長蠕 孢); 炭疽菌屬(Colletotrichum species),例如,炭疽菌 {Colletotrichum lindemuthaniuni) \Cercospora species, for example, Cercospora beticola; Cladiosporum species, for example, Cladiosporium cucumerinum, Cochliobolus species, for example Helminthosporium (conidial type: Drechslera, syn: Helminthosporium); Colletotrichum species, for example, Anthrax (Colletotrichum lindemuthaniuni)
Cycloconium species,例如,孔雀斑菌(Cje/oco/iiwm oleaginum) \ 蒂腐病菌屬(Diaporthe species),例如,柑桔黑點病菌 (Diaporthe citri) l 柑桔瘡痕病菌屬(Elsinoe species),例如,树桔瘡痴病菌 (Elsinoe fawcettii) \ 炭疽菌屬(Gloeosporium species),例如,桃炭疽菌 (Gloeosporium laeticolor) \ 炭疽菌屬(Glomerella species),例如,葡萄晚腐菌(G/omere//a -129- 20 200814928 cingulata); 黑腐菌屬(Guignardia sPecies),例如,葡萄專腐菌 (Guignardia bidwelli) ·, 5Cycloconium species, for example, Cje/oco/iiwm oleaginum \Diaporthe species, for example, Diaporthe citri l Elsinoe species, for example , Elsinoe fawcettii \ Gloeosporium species, for example, Gloeosporium laeticolor \ Glomerella species, for example, grape late rot fungi (G/omere//a -129- 20 200814928 cingulata); Guignardia sPecies, for example, Guignardia bidwelli ·, 5
10 1510 15
球腔菌屬(Leptosphaeriaspecies),例如,十字花科小球腔菌 {Leptosphaeria maculans) \ 稻瘟病菌屬(Magnaporthe species),例如,稻瘦黴菌 (Magnaporthe grisea) \ 蔓枯病菌屬(Mycosphaerella species),例如, graminicola ·, 葉枯病菌屬(Phaeosphaeria species),例如,小麥颖枯菌 {Phaeosphaeria nodorum) \ 核腔菌屬(Pyrenophora species),例如,圓核腔菌病菌 (Pyrenophora teres) \ 葉斑病菌屬(Ranmlaria species) ’例如,如麵仏命 collo-cygni ·, 喙孢屬(Rhyndiosporium species),例如,小麥雲紋病菌 {Rhynchosporium secalis) \ 殼針抱屬(Septoriaspecies),例如’斑栝菌叩ζ·〇 ; 淡紅核瑚菌屬(Typhula species),例如,小麥雪腐菌(办户“以 incarnata) ·, 黑星菌屬(Venturia species),例如,蘋果黑星病菌作价 inaequalis) \ 造成根與莖的疾病之病原菌,例如, 伏革菌屬(Corticium species),例如,c〇rtidum客圆纟臟围; -130- 20 200814928 鐮刀菌屬(Fusarium species),例如,蘿S黃葉病菌(FMsar/wm oxysporum) \ 禾頂囊殼菌屬(Gaeumannomyces species),例如,小麥全钱 病菌; 5Leptosphaeria species, for example, Leptosphaeria maculans \ Magnaporthe species, for example, Magnaporthe grisea \ Mycosphaerella species, For example, graminicola ·, Phaeosphaeria species, for example, Phaeosphaeria nodorum, Pyrenophora species, for example, Pyrenophora teres \ Leaf spot genus (Ranmlaria species) 'For example, collo-cygni, Rhyndosporium species, for example, Rhynchosporium secalis, Septoriaspecies, such as 'Saccharomyces cerevisiae · 〇; Typhula species, for example, wheat rot fungus (housekeeper "in incarnata"), genus Ventura species (for example, apple black spot disease as inaequalis) \ causing roots a pathogen of a disease of the stem, for example, a Corticium species, for example, c〇rtidum, a round body; -130- 20 200814928 Fusarium species, for example, FMsar/wm oxysporum \ Gaeumannomyces species, for example, wheat whole pathogen; 5
10 1510 15
根腐病菌屬(Rhizoctonia species),例如,立枯絲核菌 (Rhizoctonia solani) ·,Rhizoctonia species, for example, Rhizoctonia solani,
Tapesia species,例如,Tapesia acuformis ; 黑腐菌屬(Thielaviopsis species),例如,煙草根黑腐菌 {Thielaviopsis basicola); 造成穗與花序(包括玉米穗軸)的疾病(ear and panicle diseases)之病原菌,例如, 鏈格抱菌屬(Alternaria species),例如,鏈格抱菌(Alternaria spp.); 麴黴屬(Aspergillus species),例如,黃麴菌 flavus); 星病菌屬(Cladiosporium species),例如,星病菌屬 (Cladiosporium spp·) ·, 麥角菌屬(Claviceps species),例如,麥角病菌 purpurea); 錄孢菌屬(Fusarium species),例如大刀鐮抱 culmorum); 赤徽菌屬(Gibberella species),例如,玉蜀黍赤黴 zeae) \ 雪黴菌屬(Monographella species),例如,小麥雪腐病菌 -131 - 20 200814928 (Monographella nivalis) \ 造成黑穗病(smuts)之真菌,例如, 軸黑粉菌屬(Sphacelotheca species),例如,絲轴專粉菌 (Sphacelotheca reiliana) \ 腥黑粉菌屬(Tilletia species),例如小麥網腥黑粉菌(乃心如 caries) \ 黑麥桿黑穗病菌 條黑粉菌屬(Urocystis species),例如Tapesia species, for example, Tapesia acuformis; Thielaviopsis species, for example, Thielaviopsis basicola; pathogens causing ear and panicle diseases, including corn and cob, For example, Alternaria species, for example, Alternaria spp.; Aspergillus species, for example, Flavobacterium flavus; Cladiosporium species, for example, Cladicporium spp. ·, Claviceps species, for example, ergot fungus purpurea; Fusarium species, such as culmorum; Gibberella species ), for example, Zeaeus zeae) \Monographella species, for example, wheat snow rot - 131 - 20 200814928 (Monographella nivalis) \ A fungus that causes smuts, for example, A. sphaeroides Sphacelotheca species, for example, Sphacelotheca reiliana \ Tilletia species, such as wheat net Black powder fungus (heart is like caries) \ rye stem smut (Urocystis species), for example
10 1510 15
{Urocystis occulta); 黑穗菌屬(Ustilago species) ’例如’散黑穗病菌(仍价叹〇 nuda) \ 造成水果腐壞(fruit rot)之病原菌,例如, 麴徽屬(Aspergillus species) ’例如,黃麴 flavus); 灰黴菌屬(Botiytis species),例如,灰葡萄孢⑺输少怡 cinerea); ’擴展青黴菌 油采囷核病菌 ’黃萎輪枝徽 青黴菌屬(Penicillium species),例如 {Penicillium expansum) \ 菌核菌屬(Sclerotinia species),例如, (Sclerotinia sclerotiorum); 黃萎菌屬(Verticilium species),例如 {Verticilium alboatrum) \ 種子-與土壤-攜帶的造成腐爛與枯萎病,以及造成幼苗 疾病之病原菌,例如, 鐮孢菌屬(Fusarium species),例如,大刀鐮孢 20 200814928 culmorum) \ 疫病屬(Phytophthora species),例如,疫黴菌(Ρ/叫叩; cactorum); 腐霉菌屬(Pythium species),例如,終極腐霉菌(巧如画 ultimum); 根腐病菌屬(Rhizoctonia species),例如,立枯絲核菌 (Rhizoctonia solani);{Urocystis occulta); Ustilago species 'eg 'S. serrata nuda' \ A pathogen causing fruit rot, for example, Aspergillus species 'eg , Astragalus flavous; Botititis species, for example, Botrytis cinerea (7) to lose cinerea); 'Expanding Penicillium oil 囷 病 ' 'Penicilium species, for example, Penicillium species, for example {Penicillium expansum) \Sclerotinia species, for example, (Sclerotinia sclerotiorum); Verticilium species, such as {Verticilium alboatrum) \ Seed-and soil-borne causing decay and blight, and Pathogens causing seedling diseases, for example, Fusarium species, for example, Fusarium oxysporum 20 200814928 culmorum) Phytophthora species, for example, Phytophthora (Ρ/Ρ 叩; cactorum); Pythium (Pythium species), for example, Pythium ultimum (ultimate); Rhizoctonia species, for example, Rhizoctonia solani (Rhi) Zoctonia solani);
10 15 白絹病菌屬(Sclerotium species),例如,白絹病菌(&/"〇(〜所 rolfsii); 造成癌種,蟲癌(galls)及簇葉(witches’broom)的疾病之 病原囷,例如, 腐爛菌屬(Nectria species),例如,梨樹潰瘍菌(TVecir/a galligena); 造成枯萎病之病原菌,例如, 褐腐菌屬(Monilinia species),例如,鏈核盤菌 laxa) \ 造成葉、花與果實的變形之病原菌,例如, 外囊囷屬(Taphrina species),例如,崎形外囊菌(rop/zWwfl deformans); 造成木質植物的退化性疾病之病原菌,例如,10 15 Sclerotium species, for example, chalk pathogens (&/"〇(~所rolfsii); pathogens causing cancer, galls and witches'broom For example, Nectria species, for example, TVecir/a galligena; a pathogen causing blight, for example, Monilinia species, for example, Trichophyton laxa) Pathogenic bacteria causing deformation of leaves, flowers and fruits, for example, Taphrina species, for example, rop/zWwfl deformans; pathogens causing degenerative diseases of woody plants, for example,
Esca species,例如,Phaemoniella ; 造成花及種子的疾病之病原菌,例如, 灰黴菌屬(Botrytis species),例如,灰葡萄孢(万沿 cinerea); >133- 20 200814928 造成植物球莖的疾病之病原菌,例如, 根腐病菌屬(Rhizoctonia species),例如,&上 ^ 立枯絲核菌 (Rhizoctonia solani); 造成疾病之細菌病原菌,例如, 野菜黃單胞桿 黃單胞桿菌屬(Xanthomonas species),例如, ϋ (Xanthomonas campestris pv. oryzae); 瓜類細菌性褐斑 假單胞菌屬(Pseudomonas species),例如,Esca species, for example, Phaemoniella; pathogens causing diseases of flowers and seeds, for example, Botrytis species, for example, Botrytis cinerea; >133-20 200814928 Pathogen causing disease of plant bulbs For example, Rhizoctonia species, for example, & Rhizoctonia solani; bacterial pathogen causing disease, for example, Xanthomonas species For example, Xanthomonas campestris pv. oryzae; Pseudomonas species, for example,
10 1510 15
8 {Pseudomonas syringae pv. Lachrymans); 軟腐病菌屬(Erwinia species),例如,蘋果熱萎调菌(^^仏 amylovora) \ 較佳者係用於供控制下述的大豆疾病類: 造成葉子、莖、豆莢及種子的真菌疾病之病原菌,例如, 鏈格菌葉斑病(alternaria leaf spot) 印此· temiissima),炭疽病(anthracnose) {Colletotrichum gloeosporoides dematium var. truncatum)^ M (brown spot) (大丑殼針抱,*’葉斑與枯萎病(cercospora leaf spot and blight)(大丑紫斑病菌,灸汝wcAzz), 濕、腐(ehomephora)葉始萎病(Choanephora infundibuiifera trispora (syn·)) ,dactuliophora 葉 iii 病(Dactuliophora gfyches) ’ 霜黴病(downy mildew)(毛豆露病菌,尸 mfl似/iwrfcfl),drechslera 枯萎病,灰斑病 (frogeye leaf spot)(大豆灰斑病菌,so力·ηα),小 光殼屬(leptosphaerulina)葉班病(胡麻斑病菌, 的/〇///),phyllostica 葉斑病(大豆葉斑病 -134- 20 200814928 58 {Pseudomonas syringae pv. Lachrymans); Erwinia species, for example, apple heat-treating bacteria (^^仏amylovora) \ Preferred for use in controlling the following soybean diseases: causing leaves, stems Pathogens of fungal diseases such as pods and seeds, for example, alternaria leaf spot, temiissima, anthracnose {Colletotrichum gloeosporoides dematium var. truncatum)^ M (brown spot) Ugly shell needle, *' cercospora leaf spot and blight (large ugly pathogen, moxibustion wcAzz), wet and rot (ehomephora) leaf wilting (Choanephora infundibuiifera trispora (syn)), Dactuliophora leaf iii disease (Dactuliophora gfyches) 'downy mildew (d. edema, corpse mfl / iwrfcfl), drechslera blight, frogeye leaf spot (soybean gray spot, soli · ηα ), Leptosphaerulina (Isolation), phyllostica leaf spot (Soybean leaf spot) -134-20 200814928 5
10 15 菌,白粉病(powdery mildew)(厚朴 白粉病菌,¢/¾^^),剛毛殼孢(pyrenochaeta) 葉斑病CPy⑼oc/m以fl g/jc/«es),絲核菌屬的結球,鎮葉, 與網狀枯萎(rhizoctonia aerial,foliage,and web blight)(立 枯絲核菌,Rhizoctonia solani),錢病{Phakopsora pachyrhizi),結蘇病(scab,Sphaceloma glycines),黑、腐病 (stemphylium leaf blight) ,高粱葉 斑病(target spot)(黃瓜斑病菌,; 造成根及莖基部的真菌疾病之病原菌,例如,黑根腐 病(black root rot)(麗赤殼菌,,炭 腐病(charcoal rot)(菜豆殼球抱,Macrophomina /?/ζαχβ〇/ζ>2β),萎〉周病或疫病(fusarium blight or wilt),根腐 病,以及豆莢與根頸腐病[大豆根腐病菌謂 oxyworwm),直琢鐮刀菌(F⑽ar/wm oribcer似),半裸鐮刀 菌(Fusarium semitectum),表賊钃:刀菌(Fusarium equiseti)], mycoleptodiscus 根腐病(鳳眼蓮孢黴, terrestris),新赤殼菌(neocosmospora) (Neocosmopspora voszTz/ecifl),豆莢與莖萎凋病(p〇d and stem blight)(大豆黑點 病菌,Diaporthe phaseolorum),i 腐病(stem canker)(大 l 良、廣瘍病嵐 ’ Diaporthe phaseolorum var· caulivora),疫霉r 瘸病立疫霉菌,Phytophthora megasperma),褐 1 腐病 (brown stem rot)(大豆莖褐腐病菌,gregfl/iz), 藤% 截屬病(Pythium aphanidermatum,Pythium irregulare, Pythium debaryanum ,Pythium myriotylum ,Pythium -135- 20 200814928 w/Umi/m),rhizoctonia根腐病,莖腐朽病,以及猝倒病 (damping-off)(立枯絲核菌,穴Zn’zoc⑹z/fl仰/⑽/),莖菌核病 (sclerotinia stem decay)(油菜菌核病菌,Sc/eroOWa sc/eroi/orwm),白絹病(sclerotinia southern blight)(白絹病 菌,Sc/er加/ma ro//hz·),thielaviopsis 根腐病(根串珠黴, Thielaviopsis basicola)。 根據本發明的活性化合物組合物在需用於供控制植物 疾病的濃度下,可被植物忍受得很好的事實下,允許以其 處理整株的植物(植物在地表上部分及根系),繁殖用的材料 以及種子,及用於處理土壤,根據本發明的活性化合物組 合物可被使用於葉面之施用或是作為種子敷料。 ★根據本發明的活性化合物在需用於供控制植物疾病的 /辰度下,可被植物忍受得很好的事實下,允許以其處理種 =因此,根據本發明的活性化合物可被使用作為種子敫 棣旦十病原A真菌造成對作物植物之大部分的傷害,可能 3 =子儲存期間及種子被引人土壤中、植物萌發時及 20 内即受到攻擊,此期間特別地為關鍵點, ==的植物的根及幼苗為特職敏感,且甚至是 成物以_^= Λ 亡,藉由㈣適當的組 趣。υ子及明發中的植物因此特別地令人感到興 處理土壤及地表上的植物部位,由於考慮到作 ~ 136 - 200814928 劑對環境以及對人類及動物健康之 有待,力叫少活性化合物被施用的量。的鱗’仍 藉由處理植物的種子以防治病原直 好長-段時間4不斷的被改進之目標_ 已被知道 理常遭遇到一遠志|、、木址人 …、而’種子的處 有必要發展供保護種子及萌發中的植於疋 在播,植物萌發後立即再施用作物保護以= ^外的此外也有必要最適化所應用二二2 =’ Μ提供對種子及萌芽中的植物之最適#的保== ^到病原真ϋ之攻擊,但又不會讓所 ==;特別的,供處理種子的方法也應= 才物的内殺真菌的性質列人考慮,使種子與萌芽中 植物可以使用最低量的作物保護劑以達到最適當的保護作 用。 又 15 20 本發明因此特別也關於一種用於保護種子與萌芽中的 植物’使其免於受到病原錢攻擊的方法,係藉由以根據 本發明的組合物處理種子。. 本^明同樣也關於使用根據本發明的組合物用於處理 種子以保護種子及萌芽中的植物,使其免於受到病原真菌 侵害的用途。 ’ 此外,本發明也關於已經過根據本發明的組合物處 理,受到保護可提供免於病原真菌傷害之種子。 本發明的優點之一為,根據本發明的組成物之特別的 全身性性質,以這些組成物處理種子,不僅能保護種子本 -137- 200814928 身,也使得萌芽後的植物得 以此種方式,y 即進行的處理。 〜伹初得到保護,免於病原真菌之攻擊, 可省去在作物播種時以及之後短時間内需立 此外要被視為優點者係根據本發明的混合物也可被 應用於,特別是轉殖基因植物的種子。 室林業或園藝中之任何所述的植物 使用在祓物的種子(例如,小麥、大麥 根據本發明的組合物適於供保護被應用在農業、溫10 15 bacteria, powdery mildew (powdery mildew) (Anopheles sinensis, ¢/3⁄4^^), Pyrreochaeta leaf spot disease CPy (9) oc / m to fl g / jc / « es), Rhizoctonia Ball, leaf, and rhizoctonia aerial (foliage, and web blight) (Rhizoctonia solani), money disease {Phakopsora pachyrhizi), saab (Sabceloma glycines), black, rot Disease (stemphylium leaf blight), sorghum leaf spot (P. oleracea); a pathogen causing fungal diseases at the base of roots and stems, for example, black root rot (L. erythraea, Charcoal rot (Macrophomina /?/ζαχβ〇/ζ> 2β), Fusarium blight or wilt, root rot, and pod and root rot [ Soybean root rot is called oxyworwm), Fusarium oxysporum (F(10)ar/wm oribcer-like), Fusarium semitectum, Fusarium equiseti, mycoleptodiscus root rot , terrestris), Neocapmospora (Neocosmopspora) voszTz/ecifl), pod and stem blight (Diaporthe phaseolorum), i stem disease (stem canker) (Dalporthe phaseolorum var· caulivora) ), Phytophthora megasperma, brown stem rot (gum stem rot, gregfl/iz), Pythium aphanidermatum, Pythium irregulare, Pythium debaryanum , Pythium myriotylum, Pythium -135- 20 200814928 w/Umi/m), rhizoctonia root rot, stem rot, and damping-off (Rhizobacter serrata, Zn'zoc(6)z/fl/ (10)/), sclerotinia stem decay (Sclerotium sclerotiorum, Sc/eroOWa sc/eroi/orwm), sclerotinia southern blight (Cretaceous, Sc/er plus /ma ro/ /hz·), thielaviopsis root rot (Telecaopsis, Thielaviopsis basicola). The active compound composition according to the present invention allows plants which are treated with the whole plant (plants on the surface part and roots) to be propagated under the fact that they can be tolerated by plants at a concentration required for controlling plant diseases. The active compound compositions according to the invention can be used for foliar application or as seed dressings for the materials and seeds used, as well as for the treatment of soil. The active compound according to the invention is allowed to be treated by the plant under the fact that it can be used to control the disease of the plant, and the active compound according to the invention can be used as Seeds of the pathogenic A fungi cause most of the damage to crop plants, possibly 3 during sub-storage and when the seeds are introduced into the soil, when the plants are germinated and within 20, which is particularly critical. The roots and seedlings of plants with == are sensitive to special duties, and even the objects are _^= ,, with (4) appropriate group interest. The plants in the scorpion and the hair are therefore particularly pleasing to the soil and on the surface of the plant. Due to the consideration of the environment and the health of humans and animals, the active compounds are called The amount administered. The scales are still treated by treating the seeds of the plants to prevent the pathogens from being long-lasting. The goal of continuous improvement is _ _ has been known to encounter a distant ambition |,, wooden site people ... and 'the seed's Necessary development for the protection of seeds and germination of plants in the planting, plant protection immediately after plant germination to = = outside the external is also necessary to optimize the application of 2 2 = ' Μ provide seed and germinated plants The best #的保== ^ to the pathogen Zhenzhen attack, but will not let the ==; special, the method for processing the seed should also = the nature of the fungus inside the funeral, consider the seed and the sprout Medium plants can use the lowest amount of crop protection agent to achieve the most appropriate protection. Still 15 20 The invention thus relates in particular to a method for protecting seed and germinated plants from attack by pathogens by treating the seed with the composition according to the invention. The invention also relates to the use of a composition according to the invention for treating seeds to protect plants from germinating plants from pathogenic fungi. Furthermore, the invention also relates to seeds which have been treated according to the invention and which are protected from pathogenic fungi. One of the advantages of the present invention is that, according to the particular systemic nature of the compositions of the present invention, the treatment of seeds with these compositions not only protects the seed body, but also allows the post-emergence plant to behave this way. y is the processing performed. ~ The initial protection is protected from the attack of pathogenic fungi, and it is possible to dispense with the need to be considered as an advantage when crops are planted and shortly thereafter. The mixture according to the invention can also be applied, in particular, the transgenic gene. Plant seeds. Any of the plants described in the field of forestry or horticulture (see, wheat, barley) The composition according to the invention is suitable for protection in agriculture, warm
:從用匕分離自植物並已除去穗軸、殼、莖椁、外套(莢)、 j毛或果肉者,於是,例如,有可能處理已被收穫、清理 過及水分已被乾燥至15%重量以下的種子,或者,有可能 處理乾燥後,經水處理並再乾燥之種子。 μ 當處理種子時,需非常地小心地選用施加至種子的根 據本發明之組成物的量及/或其他添加物的量以避免種子的 萌發受到傷害,例如,特別要牢記在心的是,在某種施用 200814928 率下可能造成植物毒害效果之活性化合物。 根據本發明的組成物可被直接地施用,即是說,不需 要包含另外的組分或無需稀釋下被使用;習慣上,宜以適 當的配製劑型式施用組成物至種子;用於處理種子之適當 的配製劑及方法,為行家所知,且被彼露於,例如,下述: from the use of cockroaches to separate plants from the cob, shell, stem, coat (pod), j hair or pulp, so, for example, it is possible that the treatment has been harvested, cleaned and the moisture has been dried to 15% Seeds below the weight, or, possibly, treated with water, dried and then dried. μ When handling seeds, the amount of the composition according to the invention applied to the seed and/or the amount of other additives must be chosen with great care to avoid damage to the germination of the seed, for example, in particular, An active compound that may cause a plant toxic effect at a rate of 200814928. The composition according to the invention can be applied directly, that is to say without the need to contain additional components or used without dilution; it is customary to apply the composition to the seed in a suitable formulation form; for treating the seed Suitable formulations and methods are known to the expert and are disclosed by, for example, the following
10 15 20 文件中·· US 4,272,417 A,US 4,245,432 A,us 4,8〇M30 A, US 5,876,739 A,US 2003/0176428 A卜 WO 2002/080675 A1,WO 2002/028186 A2 〇 根據本發明的活性化合物組成物也適於供增加作物的 產量’此外’它們顯現對植物為減少的毒性及更好的耐受 性。 在某種濃度及施用率下,根據本發明的活性化合物組 成物也具有在植物内強化植物之潛力,它們因此適於供固 定化植物的防禦力,用於對抗不想要的微生物之攻擊。 植物-強化的(抗性_誘發的)物質,可理解的,在本文中 係才曰一種具有能力激發植物的防禦系統的物質,當植物接 著在受到不想要的微生物接種後,經處理 银 實質的對抗這錄生物之能力。 了,、、、員現 本發明的情況下,可理解的,不想要的微生物係指上 述提及的病原真8、細«及病毒,於是,以根據本發明9 化合物處理植物後’可被顧供賴植物以對抗上述的 原菌之攻擊達-段時間,此有效的保護期間通常在以活= 化合物處理植物後可延續1至10天,宜為自丨至7天。 在用於控制植物疾病所需的濃度下,活性化合物可被 -139- 200814928 植物耐受得很好的事實下,允許以其處理空氣中的植物部 分、用於繁殖的樹桿及種子、以及土壤。 在此’根據本發明的活性化合物被使用於供控制下述 的疾病方面有特別好的結果··穀類方面之疾病,例如,用 於對抗銹菌屬(pucciniaspecips)引起之疾病,以及葡萄中的 疾病與果樹及蔬菜的栽培中之疾病,例如,用於對抗灰黴 il 屬(Botrytis species)、黑星菌屬(Venturia species)或鏈格抱 菌屬(Alternaria species)之菌。 根據本發明的活性化合物也適於供增加收穫量,此 外’它們對植物顯現較低程度的毒性且能被植物耐受得很 好。 適當地’根據本發明的活性化合物也可在某種濃度及 施用率下被作為殺草劑使用、用於調節植物生長及用於供 控制動物有害生物,適當地,它們也可作為中間物及前驅 物’用於合成其他的活性化合物。 根據本發明,有可能處理全株的植物及植物的各部 .位,在此可理解的,所稱之植物係指全部的植物與植物族 群,例如,想要的與不想要的野生植物或作物植物(包括天 然出現的作物植物);作物植物為可被種植、得自藉由傳統 的育種及最適化方法或藉由生物科技的與基因工程法,或 併用這些方法取得者,包括轉殖基因的植物愈包括可受植 物育種者的認證保護的與不被保護的植物品種;植物部分 可了解的係指植物在地表上的與在地下部分的全部植物斑 器官’例如’幼芽,葉’花與根’可提及的實例為葉子? -140- 200814928 針葉、莖桿、樹桿、花、果實體、果子以及種子,及根, 球莖與匍匐莖;植物的部分也包括被收穫的材料及生長中 部分及繁殖用材料,例如,種苗、球莖、匍匐莖、插及 種子。 5 根據本發明以活性化合物處理植物與植物部分,係以 傳統的方式直接地處理植物本身或作用其周圍、環境^生 活空間或儲存處,例如藉由滴浸、喷灌、蒸散、霧=、撒 • 佈、刷上、以及,對於繁殖材料,特別是種子,尚可藉由 施用-或多詹塗覆物之方式;在此,活性化合物組合^可 ι〇 在處理前將個別的活性化合物藉由混合被製備,或^處理 方式係以相繼地先施用(1)類之羧醯胺,接著再施用至 類之活性化合物之方式處5里’然而,也有可能以⑺至⑽ 類之活性化合物處理植物或植物的部位,接著以G)類之羧 酿胺處理。 、 15 如前面已提過的,根據本發明,可處理全部植物及 • 各部位,於一較佳的具體實施例中,用於處理野生植物2 種及植物栽培品種,或那些藉由傳統生物育種方法取得^ 植物,例如那些經雜交或原生質融合而得者,以及其各部 位;在另一較佳的具體實施例中,用於處理藉由基因二程 20 &,且適當的併用傳統方法取得之轉殖基因植物與植物栽 培品種(基因改造的有機體),以及其各部位;所謂的“部位”、 ‘‘植物的部位”或“植物部分,,,其含義如前面的解釋。 特別適宜地,根據本發明用於處理之植物為那些可講 得或被使用中之植物栽培品種。 -141 - 200814928 視植物的品種或植物栽培品種,其分佈與生長條件(土 壤,氣候,生長期間,營養狀態),根據本發明的處理也可 導致超加成的(“協乘的,,)效果,於是,例如,減少的施用率 及/或增廣的活性譜及/或增加可根據本發明被使用的物質 5 及組成物的活性,較佳的植物生長,更财高溫或财低溫, 更耐乾旱或耐水或耐土壤鹽分含量,增加的開花期,更容 易的收割,加速的成熟,更高的收穫量,更佳的品質及/或 • 具較咼的營養價值之收穫物,收穫產品的更佳儲存安定性 及/或加工性,均可能超出實際被預期的效果。 10 根據本發明被處理之較佳的轉殖基因的植物或植物栽 培如種(即那些藉由基因工程的方法取得者)包括所有那 些,由基因改造,獲得有利的有用性質(“特色”)之基因材料 之植物,這類特色的實例為:較佳的植物生長、更耐高溫 或耐低溫,更耐乾旱或水或土壤中鹽含量、增加的開花期、 15 ^容易的收割、加速的成熟、更高收量、收穫品之較佳品 • 貝及/或較高的營養價值、收穫品之較佳的儲存安定性及/ 或加工性’值得特別被強調之這類特色的實例為,植物對 抗動物及微生物等有害生物(例如,昆蟲,蟎類,植物病原 真菌、細菌及/或病毒類)之具更佳的防禦性,也增加植物對 2〇 某些具除草活性化合物之耐性,可提及的轉殖基因的植物 為重要的作物植物,例如穀物(小麥、稻米),玉米,大豆, 馬,薯,棉花,油菜以及果樹(蘋果樹,梨樹,柑橘樹與葡 ,藤)’且特別要強調的為玉米,大豆,馬鈐薯,棉花與油 菜’尤其被強調的特色為藉由形成於植物中的毒素使增加 -142- 200814928 植物抵抗力以對抗昆蟲之能力,特別是那些藉由來自於蘇 力菌桿菌(万的基因材料者(例如,藉由 基因 CrylA(a),CrylA(b),CrylA(c),CryllA,CrylllA,10 15 20 In the document ... US 4,272,417 A, US 4,245,432 A,us 4,8〇M30 A, US 5,876,739 A, US 2003/0176428 A, WO 2002/080675 A1, WO 2002/028186 A2 活性Activity according to the invention Compound compositions are also suitable for increasing crop yields 'in addition' they exhibit reduced toxicity and better tolerance to plants. At certain concentrations and application rates, the active compound compositions according to the invention also have the potential to reinforce plants within plants, which are therefore suitable for the defense of fixed plants for attack against unwanted microorganisms. Plant-enhanced (resistance-induced) substance, understandably, in this context, a substance that has the ability to provoke a plant's defense system, when the plant is subsequently inoculated with unwanted microorganisms, the treated silver substance The ability to fight this creature. In the case of the present invention, it is understood that the undesired microorganism refers to the pathogens mentioned above, the fine «and the virus, and thus, after treating the plant with the compound according to the present invention 9 can be The plants are protected against the above-mentioned original bacteria for a period of time, and the effective protection period is usually 1 to 10 days after the treatment of the plants with the live = compound, preferably from 7 to 10 days. The fact that the active compound can be well tolerated by the plant at -139-200814928 at the concentration required to control plant diseases allows for the treatment of plant parts in the air, tree stems and seeds for propagation, and soil. Herein, the active compound according to the present invention is used for controlling diseases which are particularly good. · Diseases in cereals, for example, for diseases caused by the genus Puccinia specips, and in grapes. Diseases and diseases in the cultivation of fruit trees and vegetables, for example, bacteria against Botrytis species, Venturia species, or Alternaria species. The active compounds according to the invention are also suitable for increasing the yield, in addition they exhibit a lower degree of toxicity to plants and are well tolerated by plants. Appropriately, the active compounds according to the invention can also be used as herbicides at certain concentrations and application rates, for regulating plant growth and for controlling animal pests, suitably they can also serve as intermediates and Precursor' is used to synthesize other active compounds. According to the present invention, it is possible to treat plants and plants of the whole plant, and it is understood herein that the term "plant" refers to all plants and plant communities, for example, desired and unwanted wild plants or crops. Plants (including naturally occurring crop plants); crop plants can be grown, obtained by traditional breeding and optimization methods or by biotechnology and genetic engineering, or by using these methods, including transgenic genes The more plants include the unprotected plant species that are certified by the plant breeder; the plant parts are understood to refer to all plant plaques on the surface and in the underground part of the plant, such as 'sprouts, leaves' An example of a flower and root can be mentioned as a leaf? -140- 200814928 Needles, stems, tree stems, flowers, fruit bodies, fruits and seeds, and roots, bulbs and stolons; parts of plants also include harvested materials and growing parts and propagation materials, for example, seedlings , bulbs, stolons, seeds and seeds. 5 According to the invention, the plant and plant parts are treated with the active compound, in a conventional manner, directly treating the plant itself or acting on its surroundings, in the living space or in the storage, for example by dripping, sprinkling, evapotranspiration, fog =, sprinkling • cloth, brush, and, for propagation material, especially seeds, by means of application- or multi-Jan coating; here, the active compound combination can be used to treat individual active compounds before treatment. Prepared by mixing, or treated in such a manner that the carboxamide in the class (1) is applied successively, followed by the application to the active compound of the class 5, however, it is also possible to use the active compound of the class (7) to (10) The site of the plant or plant is treated, followed by treatment with a carboxamide of the G) class. 15, as already mentioned, according to the invention, all plants and parts can be treated, in a preferred embodiment, for the treatment of two species of wild plants and plant cultivars, or those by conventional organisms Breeding methods for obtaining plants, such as those obtained by hybridization or protoplast fusion, and their various parts; in another preferred embodiment, for processing by gene two-way 20 & and appropriate combination of traditions Methods The transgenic plants and plant cultivars (genetically modified organisms) obtained by the method, and various parts thereof; so-called "sites", "plant parts" or "plant parts", whose meanings are as explained above. Particularly suitably, the plants for treatment according to the invention are those which can be mentioned or used in plant cultivars. -141 - 200814928 Depending on the plant variety or plant cultivar, its distribution and growth conditions (soil, climate, growth period, nutritional status), the treatment according to the invention may also lead to super-addition ("co-multiplied,") The effect, therefore, for example, a reduced application rate and/or an augmented activity profile and/or an increase in the activity of the substance 5 and the composition which can be used according to the invention, preferably plant growth, more economical or low temperature, More resistant to drought or water or soil salt, increased flowering, easier harvesting, accelerated ripening, higher yield, better quality and / or • Harvest with more nutritious value, harvest Better storage stability and/or processability of the product may exceed the actual expected effect. 10 Plants or plant cultivation of preferred transgenic genes to be treated according to the invention (ie those by genetic engineering) Method acquirer) includes all those plants genetically engineered to obtain beneficial useful properties ("features") of genetic material, examples of which are: better plant growth, more High temperature or low temperature resistance, more resistant to drought or salt content in water or soil, increased flowering period, 15^ easy harvesting, accelerated ripening, higher yield, better harvested products • shellfish and/or higher nutrition Value, better storage stability and/or processability of harvested products. An example of such a characteristic that deserves special emphasis is that plants are resistant to pests such as animals and microorganisms (eg, insects, mites, phytopathogenic fungi, bacteria). And/or virus) has better defensiveness and also increases plant tolerance to certain herbicidal compounds. Plants that can be mentioned as transgenic genes are important crop plants, such as grains (wheat, rice). ), corn, soybeans, horses, potatoes, cotton, canola and fruit trees (apple, pear, citrus and Portuguese, vine) and especially emphasize corn, soybean, horse yam, cotton and rapeseed The emphasis is on the ability to increase the resistance of plants to - insects by the toxins formed in plants, especially those from the genetic material from S. faecalis (10,000) For example, by gene CrylA (a), CrylA (b), CrylA (c), CryllA, CrylllA,
CryIIIB2,Cry9c,Cry2Ab,Cry3Bb 及 CrylF 以及也包括其 5CryIIIB2, Cry9c, Cry2Ab, Cry3Bb and CrylF and also include 5
10 15 組合物)(後面歸之為“Bt植物”);其他也特別要強調的特色 為,植物對某些具除草地活性化合物(例如,味嗤琳酮類, 石黃酿基脲類,嘉構塞(glyphosate)或膦基三辛 (phosphinotricin)(例如“PAT”基因))之增加的而f性;參與至所 要的特色的基因毫無疑問的也可與他種基因成混合型式出 現於轉殖基因的植物中,可被提及的“Bt植物”之實例為以 下述的貿易名稱(trade name)被販售之玉米品種、棉花品 種、大豆品種及馬鈴薯品種:YIELD GARD⑧(例如玉米, 棉花’大豆),KnockOut⑧(例如玉米),StarLink® (例如玉 米),Bollgard㊣(棉花),Nucotn® (棉花)與 NewLeaf® (馬鈴 薯);可提及的耐-殺草劑的植物類為玉米品種、棉花品種及 大豆品種,其以下列貿易名稱被販售:Roundup Ready⑧(耐 最石粦基’例如玉米,棉花,大豆),Liberty Link⑧(财膦基三 辛’例如油菜),IMI⑧(耐咪唑啉酮)及STS⑧(耐磺醯基脲, 例如玉米),可提及的财-除草劑之植物(以傳統方式育成的 耐除草劑之植物)包括以Clearfielf⑧之名稱販賣者(例如玉 米),當然,這些聲明也適用於具這些基因特色或其在將來 會被發展及/或販售而具有將被發展的基因特色之植物栽培 品種。 視其個別的物理及/或化學性質,此活性化合組合物可 -143- 20 200814928 被轉變成習用的配製劑,例如,溶液、乳液、懸浮液、粉 劑、塵劑、泡沫物、糊劑、可溶性粉末、粒劑,氣溶液、 懸浮-乳液濃縮物、浸潤了活性化合物之天然及合成的材 料、以及包覆於聚合性材料内之微膠囊及供種子使用之塗 覆用組成物,以及ULV冷及溫熱的霧狀配製劑。 這些配製物係以已知的方式產生,例如,將活性化合 物與展延劑混合,展延劑係指液體溶劑類、加壓下的液化 氣體、及/或固體載劑類,選擇地使用界面活性劑類,即, 乳化劑類及/或分散劑類,及/或泡沫形成劑。 如果使用的展延劑為水時,也有可能使用,例如,有 機/谷劑作為輔助溶劑類,主要地,適當的液態溶劑類為: 芳族類,例如二甲苯、甲苯或烷基萘類;氯化的芳族類或 氯化的脂肪族烴類,例如,氯苯類、氯乙烯類或二氯甲烷; 脂肪族烴類,例如環己烷或石蠟類,例如石油分劃物;礦 物及植物油類;醇類,例如,丁醇或甘醇及彼等之醚類與 酯類,酮類,例如丙酮、甲基乙基_、甲基異丁基酮或環 己酮,強極性溶劑類,例如,二甲基甲醯胺及二甲亞碉; 或是水。 液化的氣體展延劑或載劑,可理解的,係指在標準的 溫度及壓力下為氣體之液體,例如,氣溶液喷射劑類,例 如,丁烷,丙烷,氮氣及二氧化碳。 適當的固體載劑類為,例如,錢鹽類與研磨過的天然 礦物類,例如,高嶺土、粘土、滑石、白堊土、石英、美 國活性白土、蒙脫土或矽藻土以及研細的合成材料類,^ -144 - 200814928 510 15 Composition) (hereinafter referred to as "Bt plant"); other features that are particularly emphasized are that plants have certain herbicidal compounds (eg, misoprostone, scutellaria, An increase in glyphosate or phosphinotricin (such as the "PAT" gene); the genes involved in the desired characteristics can be undoubtedly mixed with other genes. Among the plants of the transgenic gene, an example of a "Bt plant" that can be mentioned is a corn variety, a cotton variety, a soybean variety, and a potato variety sold under the trade name: YIELD GARD8 (for example, corn). , cotton 'soybean', KnockOut8 (eg corn), StarLink® (eg corn), Bollgard (cotton), Nucotn® (cotton) and NewLeaf® (potato); the herbicide-tolerant plant species Corn varieties, cotton varieties and soybean varieties are sold under the following trade names: Roundup Ready8 (resistant to the most stone bases such as corn, cotton, soybeans), Liberty Link 8 (Finyl Phosphate Trisin' such as oil Dish), IMI8 (imidazole-resistant ketone) and STS8 (sulfonyl-resistant urea, such as corn), which can be mentioned as a herbicide-weaking plant (a herbicide-tolerant plant bred in a conventional manner) including the name of Clearfielf8 Vendors (such as corn), of course, these statements also apply to plant cultivars that have these genetic characteristics or that will be developed and/or sold in the future with the genetic characteristics to be developed. Depending on its individual physical and/or chemical nature, the active compound composition can be converted into conventional formulations, for example, solutions, emulsions, suspensions, powders, dusts, foams, pastes, Soluble powders, granules, gas solutions, suspension-emulsion concentrates, natural and synthetic materials infiltrated with active compounds, microcapsules coated in polymeric materials, and coating compositions for seed use, and ULV Cold and warm misty formulation. These formulations are produced in a known manner, for example, by mixing the active compound with a spreading agent, which is a liquid solvent, a liquefied gas under pressure, and/or a solid carrier, optionally using an interface. Active agents, ie, emulsifiers and/or dispersants, and/or foam formers. If the extender used is water, it is also possible to use, for example, an organic/treat agent as an auxiliary solvent. Primarily, suitable liquid solvents are: aromatics such as xylene, toluene or alkylnaphthalenes; Chlorinated aromatic or chlorinated aliphatic hydrocarbons, for example, chlorobenzenes, vinyl chlorides or methylene chloride; aliphatic hydrocarbons such as cyclohexane or paraffin, such as petroleum repellents; minerals and Vegetable oils; alcohols, for example, butanol or glycol and their ethers and esters, ketones, such as acetone, methyl ethyl, methyl isobutyl ketone or cyclohexanone, strong polar solvents For example, dimethylformamide and dimethylhydrazine; or water. By liquefied gas extender or carrier, it is understood to mean a liquid which is a gas at standard temperature and pressure, for example, a gaseous solution propellant such as butane, propane, nitrogen and carbon dioxide. Suitable solid carriers are, for example, money salts and ground natural minerals such as kaolin, clay, talc, chalk, quartz, American activated clay, montmorillonite or diatomaceous earth, and fine synthetic Materials, ^ -144 - 200814928 5
10 15 如南度分散的二氧切,氧化缺械細;肖於顆 粒體之適當的固態_為:例如,碾碎並分_的天然岩 石,例如,方解石、大理石、輕石、海泡石與白雲石”戈 是無機與有機碎料之合成的顆粒,及有機材料的顆粒,例 如、,鑛屑、、椰子殼、玉耗軸與料莖;適當的乳化劑及/ 或泡沫形成劑為:例如,非離子與陰離子乳化劑類,例如 聚氧乙烯脂肪酸i旨類,聚氧乙稀脂肪族醇醚類,例如,烧 基芳基聚甘醇醚類、烷基磺酸鹽類、烷基硫酸鹽類、芳基 磺酸鹽類,或是蛋自質水解產物;適當的分散劑為 例如, 木質素亞硫酸廢液及甲基纖維素。 枯著劑類’例如,竣甲基纖維素及呈粉狀、粒狀或乳 膠態之天然與合成的聚合物類,例如,阿拉伯膠、聚乙烯 醇與聚乙烯醋酸酯,以及天然磷脂質類,例如,腦磷脂與 卵麟脂,以及合成的磷脂質類,均可被加於調配物中,其 他可能的添加物為礦物油類及植物油類。 也有可能用及著色劑,例如,無機色素類,例如,氧 化鐵,一氧化欽及晋魯士藍,以及有機染料類,例如,茜 素染料,偶氮類染料與金屬酞花青染料,以及微量營養成 分,例如鐵、锰、蝴、銅、鈷、钥與鋅等的鹽類。 由市售的配製劑調配得的使用型式中之活性化合物含 量可在廣範圍間變化,供控制動物有害生物(例如昆蟲及蜘 蛛蟎類)的使用型式之活性化合物的濃度,可為包含自 〇.〇〇〇〇〇〇1與95%重量計間的活性化合物且較佳地為包含自 0.0001至1%重量計間者,以習用的適用於使用变式的方式 -145- 20 200814928 施用。 用於供控制不想要的病原真菌的調配劑中通常包含介 於0·1與95%重量計的活性化合物,宜為介於0.5與90%間 者。 5 根據本發明的活性化合物組合物可呈現為其市售可得 的配製劑以及由這些配製劑製備得的使用型式被使用,例 如,即用溶液、可乳化的濃縮物、乳液、懸浮液、可濕性 | 粉末、可溶性粉末、塵染劑及粒劑,它們係以習用的方式 被使用,例如,藉由洗水(浸水)、灌派、喷瀵、霧化、撒佈、 10 塵染、泡沫、鋪上、以及以乾粉處理種子、以溶液處理種 子、以可溶於水的粉劑處理種子、以可溶於水的粉漿處理 種子、或藉由形成於外殼的方式等等。 根據本發明的活性化合物組合物可呈現為其市售可得 的配製劑以及由這些配製劑製備得的使用型式,與其他已 15 知的活性化合物類(例如,殺昆蟲劑,引誘劑,不孕劑,殺 I 菌劑,殺蟎劑,殺線蟲劑,殺真菌劑,生長調節劑或殺草 劑)作成混合物被使用。 當使用根據本發明的活性化合物組合物時,施用率可 視施用的種類在實際上相對地廣大的範圍内變化,當用於 20 處理植物部位時,活性化合物組合物之施用率通常為介於 0.1與10 000克/公頃間,宜為介於10與1000克/公頃間, 當用於處理種子時,活性化合物組合物之施用率通常為介 於0·001與50克/公斤種子間,宜為介於0·01與10克/公斤 種子間,當用於處理土壤時,活性化合物之施用率通常為 -146 - 200814928 介於0·1與10 〇〇〇克/公頃間,宜為介於i與5〇〇〇 間〇 活性化合物組合物可呈濃縮物或,通常為被配製成配 製劑使用,例如被配製成粉劑’粒劑,溶液劑,懸浮气_ 乳劑或糊劑。10 15 If the south is dispersed, the oxidizing is not fine; the appropriate solid state of the granule is: for example, natural rock crushed and divided, for example, calcite, marble, pumice, sepiolite And dolomite "go is a synthetic particle of inorganic and organic scrap, and particles of organic material, for example, mineral chips, coconut shell, jade shaft and stem; suitable emulsifier and / or foam forming agent is : for example, nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid i, polyoxyethylene aliphatic alcohol ethers, for example, alkyl aryl polyglycol ethers, alkyl sulfonates, alkanes a base sulfate, an aryl sulfonate, or an egg-derived hydrolysate; suitable dispersants are, for example, lignin sulfurous acid waste liquid and methyl cellulose. Drying agents 'for example, 竣 methyl fiber And natural and synthetic polymers in powder, granule or latex form, for example, gum arabic, polyvinyl alcohol and polyvinyl acetate, and natural phospholipids, for example, cephalin and egg ly, Synthetic phospholipids can be added to the formulation Other possible additives are mineral oils and vegetable oils. It is also possible to use coloring agents, for example, inorganic pigments such as iron oxide, monomethicone and Jinluslan, and organic dyes such as alizarin. Dyes, azo dyes and metal phthalocyanine dyes, and trace nutrients such as salts of iron, manganese, butterfly, copper, cobalt, molybdenum and zinc, etc. used in the formulation of commercially available formulations. The active compound content can vary over a wide range, and the concentration of active compound used to control the use of animal pests (eg, insects and spider mites) can be comprised from 〇.1 and 95% by weight. The active compound in between and preferably comprises from 0.0001 to 1% by weight, administered in a conventional manner suitable for the use of the variant -145-20 200814928. Used in a formulation for controlling unwanted pathogenic fungi The active compound is usually comprised between 0.1 and 95% by weight, preferably between 0.5 and 90%. 5 The active compound composition according to the invention can be present as a commercially available formulation and Formulations prepared using the formulations are used, for example, ready-to-use solutions, emulsifiable concentrates, emulsions, suspensions, wettables|powders, soluble powders, dusting agents, and granules, which are conventionally used. Use, for example, by washing (soaking), irrigating, sneezing, atomizing, spreading, dusting, foaming, laying, and treating the seeds with dry powder, treating the seeds with solution, and being water soluble Powder treatment of seeds, treatment of seeds with water-soluble slips, or by formation in the outer shell, etc. The active compound compositions according to the invention may be presented as commercially available formulations and from these formulations The prepared form and other active compounds (eg, insecticides, attractants, infertile agents, fungicides, acaricides, nematicides, fungicides, growth regulators or The herbicide) is used as a mixture. When the active compound composition according to the invention is used, the application rate can vary within a substantially relatively broad range depending on the type of application, and when used for 20 treatment of plant parts, the application rate of the active compound composition is usually between 0.1. Between 10 000 g / ha, preferably between 10 and 1000 g / ha, when used to treat seeds, the application rate of the active compound composition is usually between 0. 001 and 50 g / kg of seed, preferably Between 0. 01 and 10 g / kg of seed, when used to treat soil, the application rate of active compound is usually -146 - 200814928 between 0 · 1 and 10 gram / hectare, should be The active compound composition may be in the form of a concentrate or, usually, formulated as a formulation, for example, as a powder, a granule, a solution, a suspension gas, an emulsion or a paste.
10 20 上述的調配劑可採用已知的方式配製,例如,將活性 化合物混合與至少一種的溶劑或稀釋劑、乳化劑、分散, 及/或枯結劑或固定劑、潑水劑混合,有需要的話,加入f 燥劑及UV安定劑,且,有需要的話,加入著色劑及色素^ 及其他的加工辅助劑。 根據本發明的活性化合物組合物之良好的殺真菌的作 用,可由下述實例獲得應證,雖然個別的活性化;^物顯現 弱的殺真菌的作用,組合物所呈現的作用遠超過其個別成 分的作用之總和。 當活性化合物組合物在殺真菌的作用上常超過其個別 的活性化合物的作用之總和時,其為具有協乘效果。 對於一種包含所給兩種活性化合物的級合物之被預期 的氣真繭的作用,可根據S.R· Colby的算式,^1(ϊιιΜη§ Synergistic and Antagonistic Responses Herbicide10 20 The above formulation may be formulated in a known manner, for example, by mixing the active compound with at least one solvent or diluent, emulsifier, dispersion, and/or dry or fixative, water repellent, If necessary, add a desiccant and a UV stabilizer, and if necessary, add a coloring agent and a pigment and other processing aids. The good fungicidal action of the active compound compositions according to the invention can be exemplified by the following examples, although the individual activations exhibit a weak fungicidal effect, and the compositions exhibit far more effects than their individual The sum of the effects of the ingredients. When the active compound composition often exceeds the sum of the effects of its individual active compounds in the fungicidal action, it has a synergistic effect. For a desired gas enthalpy effect of a fraction comprising the two active compounds given, according to the formula of S.R. Colby, ^1(ϊιιΜη§ Synergistic and Antagonistic Responses Herbicide
Combinations”,Weeds 1967. U,20-22),被計算如下: 如果 X 代表以迟克/么^#的施用率施用活性化合物A時之致 力、 -147- 200814928 γ 代表以沒;/么1境的施用率施用活性化合物Β時之咬 力、 Ε 代表以m及η克/么ν礞的施用率施用活性化合物人與^ 時之政力, 5 • τ X X γ 貝1J Ε-Χ +Υ--- 100 祕在此,效力以%表示,〇%代表相當於未經處理之對照 組之效力,而100%的效力代表無感染被發現。 如果真正的殺農菌一赴作用超過計算得的數值時,則組 合物的活性係超加成的,即,出現一種協乘效果,此情況 中,真正被觀祭到的效力需超過使用上述公式計算得之被 15 預期的效力(Ε)。 ^ 本發明以下述實例予以說明,但本發明不限於這些實 【實施方式】 5途實例 直例Α ·_Α枯絲核菌(及/^z〇c如試驗(被營中)/名 定板 此微型試驗係於微滴定板上,使用馬鈐薯右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 活性化合物係使用溶解於丙酮内之工業級(technical_grade) 活性成分’接種入立枯絲核菌(麗⑺⑽〇之菌絲懸 -148 - 200814928 浮液,在暗室及振搖(10 Hz)下接種5天後,以光電比色計 測定微滴定板的各充填的孔腔之透光性。 0%代表相當於對照組中生長的效力,100%效力代表沒 見到真菌的生長。 下面的表A1及A2清楚地顯示,根據本發明的活性化 合物組合物之活性要大於計算得的活性,即,其中呈現有 協乘性效果。 表A1 :立枯絲核菌試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-1) 0.01 83 (1-28) 0.1 28 (1-31) 0.1 53 (1-31) 0.03 36 (1-31) 0.003 63 (1-39) 1 46 (1-39) 03 37 (GBO 827) 0.3 46 表苯菌酮(metrafenone) 1 46 表苯菌酮(metrafenone) 0.1 1 滅康峻(metconazole) 0.003 12 環氧康峻(epoxyconazole) 0.1 25 環氧康 ^(epoxyconazole) 0.03 14 .-149 - 200814928 環氧康嗤(epoxyconazole) 0.01 73 根據本發明: (1-1)+環氧康嗤(1 : 1) 0.01+0.01 實測得 97 計算得 95 (1-28)+環氧康唑(1 : 1) 0.1+0.1 52 46 (1-31)+滅康唑(1 : 1) 0.1+0.1 63 53 (1-31)+表苯菌酮(1 : 1) 0.003 + 0.003 82 67 (1-31)+環氡康唑(1 : 1) 0.03 + 0.03 62 45 (1-39)+表苯菌酮(1 : 1) 1 + 1 92 71 (1-39)+ GBO 827(1 : 1) 03 + 03 98 66 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 表A2:立枯絲核菌試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-39) 0·1 43 環氧康 ^(epoxyconazole) 0.1 42 根據本發明: (1-39)+環氧康唑(1 : 1) 0.1+0.1 實測得 計算得 91 67 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 -150- 200814928 實例衫一:—Φ f摄撒繭(Pg/|/ei7/|·!!所知gy/m⑽/g)試驗(試管 ίι/微滴定板 此微型試驗係於微滴定板上,使用馬鈴薯右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 5 活性化合物係使用溶解於丙酮内之工業級(technical-grade) 活性成为’接種入小帚樣徽菌Z>reWcanw/e)之抱 子懸浮液,在暗室及振搖(1〇 Hz)下接種4天後,以光電比 _ 色計測定微滴定板的各充填的孔腔之透光性。 〇%代表相當於對照組中生長之效力,而1〇〇。/0效力代表 ίο 沒見到真菌的生長。 下面的表B清楚地顯示,根據本發明的活性化合物組 合物之活性要大於計算得的活性,即,其中呈現有協乘性 效果。 表B:小帚樣黴菌試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%)— (1-39) 03 65 滅康嗤(metconazole) 0.3 3 根據本發明: (1-39)+滅康唑(1 : 1) 0.3+ 0.3 實測得 計算得 73 66 L·'--L- ——— 15 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 -151 - 200814928 宜例C :灰葡葙孢(如的沿試驗(試管中)/微滴定_ 此微型試驗係於微滴定板上,使用馬鈴薯右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 活性化合物係使用溶解於丙酮内之工業級(technical-grade) 活性成分’接種入灰葡萄抱(万0^;沿之抱子懸浮 液,在暗室及振搖(10 Hz)下接種4天後,以光電比色計測 定微滴定板的各充填的孔腔之透光性。 〇%代表相當於對照組中生長之效力,而1〇〇%效力代表 沒見到真菌的生長。 下面的表C1及C2清楚地顯示,根據本發明的活性化 合物組合物之活性要大於計算得的活性,即,其中呈現有 協乘性效果。 表C1:灰葡萄孢(試管中)/微滴定板 活性化合物 活性化合物施用率 (Ppm) 效力(%) (1-1) 〇·01 18 (1-29) 1 54 (1-39) 〇J 51 百克敏(pyrachlostrobin) 0.1 42 百克敏(pyrachlostrofoin) 1 27 滅康嗤(metconazole) 0.01 5 根據本發明: (1-1)+ 滅康口圭(1 : 1) —---- 0.01+0.01 實測得 31 計算得 22 -152- 200814928 (1-29)+ 百克敏(1 : 1) 1 + 1 93 66 (1-39)+百克敏(1 : 1) 0.1+0.1 94 72 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 表C2:灰葡萄孢(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-1) 03 31 (1-4) 1 29 (1-31) 0·1 39 百克敏(pyrachlostiObm) 0.3 20 百克敏(pyrachlostrobin) 1 16 百克敏(pyradilostrobin) 0.1 42 根據本發明: (1-4)+ 百克敏(1 : 1) 1 + 1 實測得 78 計算得 40 (1_1)+ 百克敏(1 : 1) 0.3 + 0.3 90 45 (1-31)+百克敏(1 : 1) 0.1 +0.1 86 65 實測得=實際發現的效力;計算得二使用Colby公式計算得的效力 •153- 200814928 實例D :稻疲繭(PyriVrt</ar/a orvza)試驗(試營中)/微滴定板 此微型試驗係於微滴定板上,使用馬鈴薯右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 活性化合物係使用溶解於丙酮内之工業級(technical-grade) 5 活性成分’接種入稻盘菌(jPyr/cw/flr/fl orj;za)之孢子懸浮液, 在暗室及振搖(10 Hz)下接種4天後,以光電比色計測定微 滴定板的各充填的孔腔之透光性。 〇%效力代表相當於對照組的生長情形,100%效力代表 > 沒見到真菌的生長。 ίο 下面的表Dl,D2及D3清楚地顯示,根據本發明的活 性化合物組合物之活性要大於計算得的活性,即,其中呈 現有協乘性效果。 表D1 :稻痙菌試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-29) 3 55 (1-29) 0.03 18 (1-4) 1 9 (1-31) 0.1 16 (M) 0.03 6 GBO 827 0.03 76 GBO 827 0.1 87 GBO 827 3 80 表苯菌酮(metrafenone) 3 60 -154- 200814928 滅康口坐(metconazole) 1 74 滅康 ^(metconazole) 0.03 66 環氧康嗤(epoxyconazole) 3 81 根據本發明: (1-29)+環氧康唑(1 : 1) (1-29)+ 滅康唑(1 : 1) 3 + 3 0.03 + 0.03 實測得 98 85 計算得 91 72 (1-29)+表苯菌酮(1 : 1) 3 + 3 90 82 (1-4)+ 滅康唑(1 : 1) 1 + 1 97 76 (1-31)+ GBO 827(1 : 1) 0.1 +0.1 99 89 (1-1)+ GBO 827(1 : 1) 0.03 + 0.03 87 77 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 表D2 #·稻瘂菌(Pjr/cw^r/fl )試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-4) 3 33 (1-28) 0.03 19 滅康 ^(metconazole) 0.03 10 表苯菌 _(metrafeiKme) 3 80 表苯菌酮(metrafenone) 0.03 45 根據本發明: (1-4)+ GBO 827(1 : 1) 3 + 3 實測得 99 計算得 87 (1-28)+表苯菌酮(1 : 1) 0.03 + 0.03 95 55 -155 - 200814928 (1-28)+ 滅康唑(1 : 1) 0.03 + 〇.〇3 58 27 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 表D3 :稻瘟菌(Pjr/c«/ariVi 試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-4) 3 33 表苯菌酮(metrafenone) 3 55 根據本發明: (1·4)+表苯菌酮(1 : 1) 3 + 3 實測得 計算得 75 70 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 _實_例E :玉蜀黍赤徽⑽g)試驗(試管中v檄滴定柄 此被型试驗係於微滴定板上,使用馬铃箸右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 活性化合物係使用溶解於丙酮内之工業級(technical_grade) 活性成分,接種入玉蜀黍赤黴之孢子懸浮 液,在暗室及振搖(10 Hz)下接種3天後,以光電比色計測 定微滴定板的各充填的孔腔之透光性。 0%效力代表相當於對照組的生長情形,1〇〇0/。效力代表 沒見到真菌的生長。 下面的表E清楚地顯示,根據本發明的活性化合物組 合物之活性要大於計算得的活性,即,其中呈現有協乘性 效果。 -156- 200814928 表E:玉蜀黍赤黴試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-4) 1 —---—___ — (1-28) 0·1 (1-29) 0.3 —_ -_ 59 環氧康嗤(epoxyconazole) 1 65 GBO 827 0.1 ] GBO 827 03 --- 24 根據本發明: 0.1+0.1 實測得 計算得, (1-29)+ GBO 827(1 : 1) 78 69 (1-28)+ GBO 827(1 : 1) 0.3 + 0.3 43 37 (1-4)+環氧康唑(1 : 1) 1 + 1 ---- 84 73 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 實例F :蘋果键格孢菌試驗(試管中)/衍;济 5 此微型試驗係於微滴定板上,使用馬鈐薯右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 活性化合物係使用溶解於丙酮内之工業級(technical_grade) 活性成分’接種入蘋果鏈格孢菌(乂/化⑺狀以W(3//)之抱子懸 10 浮液,在暗室及振搖(10 Hz)下接種3天後,以光電比色計 測疋微滴定板的各充填的孔腔之透光性。 -157- 200814928 〇%效力代表相當於對照組的生長情形,100%效力代表 沒見到真菌的生長。 下面的表F清楚地顯示,根據本發明的活性化合物組 合物之活性要大於計算得的活性,即,其中呈現有協乘性 效果 表F ·蘋果鏈格孢菌(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(°/〇) (1_1) 0.03 66 表苯菌酮(metrafenone) 0.03 14 根據本發明: (1-1)+表苯菌酮(1 : 1) 03 + 03 實測得 計算得*) 72 71 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 复例G :_I核腔菌(Pyrg/i即/Wg化rgs)試驗(大來V徭謹性 讓溶劑: 50份重的ΛΓ,τν-二f差乙鏞屉 乳化劑·· 1份重的烷基芳基聚甘醇醚 為產生適當的活性化合物配製劑,將1份重的活性化 合物或活性化合物組合物,混合所述量的溶劑及乳化劑, 15 再以水將此濃縮物稀釋至所要的濃度。 為測5式保遵的活性,以所述的施用率將活性化合物製 劑喷灑幼年植物,待喷灑層乾燥後,對植物喷灑上圓核腔 菌ieres)之分生抱子的懸浮液,植物被留置在 •158· 200814928 20°C及100%相對濕度之培養箱内經48小時。 再將植物移至約2(TC及約80%相對濕度之溫室中。 接種後10天進行評估,0%代表相當於對照組之效力, 而100%之效力代表沒見到感染。 表G ··圓核腔菌試驗(大麥)/保護性 活性化合物 活性化合物施用率(克/ 公頃) 效力(%) (1-2) 3L25 22 (1-12) 31.25 ---—----- 56 百克司多賓 (pyraclostobin) 31.25 78 表苯菌 _(metrafenone) 31.25 0 環氧康哇(epoxyconazole) 31.25 0 滅康哇(metconazole) 31.25 0 得克力(tebuconazole) 31.25 0 GBO 827 31.25 0 白克力(boscalid) 31.25 22 根據本發明: (1_2)+百克司多賓 31.25 + 31.25 實測得 —94 78 計算得 83 22 (1-2) +表苯菌酮 31.25 + 31.25 (1-2)+環氧康α坐 31.25 + 31.25 89 22 (1-2)+滅康0坐 31.25 + 31.25 89 22 (1-2) + HWG1608 3L25 + 3L25 100 22 -159- 200814928 (1-2) + GB0827 31,25+ 31.25 78 22 (l-2) + RK02273 31.25 + 31.25 100 39 (1-12)+百克司多賓 31.25 + 31.25 100 92 (1-12)+表苯菌_ 31.25 + 31.25 89 56 (1_12) +環氧康唑 31.25+ 31.25 89 56 (1-12) +滅康嗤 31.25 + 31.25 94 56 (1-2) +得克力 31.25 + 31.25 89 56 (1-2) + GB0827 3L25 + 3L25 94 56 (1-2)+白克力 31.25+ 3L25 89 66 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 實例H: 疫菌(P/IV加/?/|认仍71)試驗(蕃茄V保護性 溶劑:24.5份重的丙酮 5 24.5份重的二甲基乙醯胺 I 乳化劑:1份重的烧基芳基聚甘醇醚 為產生適當的活性化合物配製劑,將1份重的活性化 合物或活性化合物組合物,混合所述量的溶劑及乳化劑, ίο 再以水將此濃縮物稀釋至所要的濃度。 為測試保護的活性,以所述的施用率將活性化合物製 劑喷灑幼年植物,待喷灑層乾燥後,對植物喷灑上致病疫 菌/«/⑵加則)之抱子的水性懸浮液,將植物留 置在2(TC及100%相對濕度之培養箱内。 -160- 200814928 而::二進二:代表相當於對照組之效力Combinations", Weeds 1967. U, 20-22), calculated as follows: If X represents the exertion of active compound A at the application rate of gram/m^^, -147-200814928 γ represents no; The rate of application of the active compound Β, Ε represents the application rate of the active compound at the application rate of m and ηg / νν礞, 5 • τ XX γ 1 1J Ε-Χ +Υ --- 100 Secrets here, the efficacy is expressed in %, 〇% represents the equivalent of the untreated control, and 100% of the efficacy represents no infection was found. If the real bactericidal effect is more than calculated The value of the composition is superadditive, that is, a synergistic effect occurs. In this case, the effectiveness of the actual sacrifice is greater than the expected effect of 15 using the above formula (Ε). The present invention is illustrated by the following examples, but the present invention is not limited to these embodiments. [Examples] 5 examples of straight cases Α · Α 丝 核 ( ( and / ^ z 〇 c such as test (in the camp) / name This micro-test is attached to a microtiter plate using a horse yam dextrose gravy (Potat) o-Dextrose Broth, PDB) was carried out as a liquid test medium, and the active compound was inoculated into Rhizoctonia solani using a technical grade (active material) dissolved in acetone (Li (7) (10) 菌 菌 悬 -148 - 200814928 After floating for 5 days in a dark room and shaking (10 Hz), the light transmittance of each filled cavity of the microtiter plate was measured by a photoelectric colorimeter. 0% represents the efficacy of growth in the control group. The 100% potency represents no growth of the fungus. Tables A1 and A2 below clearly show that the active compound composition according to the invention is more active than the calculated activity, i.e., exhibits a synergistic effect. Table A1 : Rhizoctonia solani test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) (1-1) 0.01 83 (1-28) 0.1 28 (1-31) 0.1 53 ( 1-31) 0.03 36 (1-31) 0.003 63 (1-39) 1 46 (1-39) 03 37 (GBO 827) 0.3 46 meperfenone 1 46 meperfenone 0.1 1 metconazole 0.003 12 epoxyconazole 0.1 25 epoxyconazole 0.03 14 .-149 - 200814928 Epoxyconazole 0.01 73 According to the invention: (1-1) + epoxy conjugate (1: 1) 0.01+0.01 Calculated 97 Calculated 95 (1-28)+ Epoxyconazole (1 : 1) 0.1+0.1 52 46 (1-31) + thiconazole (1 : 1) 0.1+0.1 63 53 (1-31) + benzophenone (1 : 1) 0.003 + 0.003 82 67 (1-31) + Cycloconazole (1 : 1) 0.03 + 0.03 62 45 (1-39) + benzophenone (1 : 1) 1 + 1 92 71 (1-39) + GBO 827(1 : 1) 03 + 03 98 66 measured = actual found efficacy; calculated = effectiveness calculated using the Colby formula Table A2: Rhizoctonia solani test (in vitro) / microtiter active compound active compound Application rate (ppm) Efficacy (%) (1-39) 0·1 43 Epoxyconazole 0.1 42 According to the invention: (1-39) + epoxyconazole (1 : 1) 0.1+0.1 Calculated 91 67 measured = the actual found effectiveness; calculated = the effectiveness calculated using the Colby formula -150- 200814928 Example one: - Φ f photo 茧 (Pg / | / ei7 / | ·!! Gy/m(10)/g) test (test tube ίι/microtiter plate) This micro-test is applied to microtiter plates using potato dextrose gravy (Potato-Dextrose Broth, PDB) was carried out as a liquid test medium, and 5 active compounds were used as the 'technical-grade' dissolved in acetone to become 'inoculated into the sputum-like bacteria Z> reWcanw/e) The sub-suspension was inoculated for 4 days in a dark room and shaking (1 Hz), and the light transmittance of each filled cavity of the microtiter plate was measured by a photoelectric ratio meter. 〇% represents the equivalent of the growth in the control group, while 1〇〇. /0 effectiveness representative ίο did not see the growth of fungi. Table B below clearly shows that the active compound composition according to the present invention is more active than the calculated activity, i.e., exhibits a synergistic effect. Table B: Ophiopogon fungus test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) - (1-39) 03 65 metconazole 0.3 3 according to the invention: 1-39) + diconazole (1: 1) 0.3 + 0.3 The calculated 73 66 L·'--L-———— 15 measured = the actual found effect; calculated = calculated using the Colby formula Efficacy - 151 - 200814928 Example C: Fusarium oxysporum (eg, along the test (in vitro) / microtiter _ This micro-test is on a microtiter plate using Potato-Dextrose Broth (PDB) The reaction is carried out as a liquid test medium, and the active compound is inoculated into a gray grape hug using a technical-grade active ingredient dissolved in acetone (approximately 0 ^; along the stalk suspension, in a dark room and shaken (10) After 4 days of inoculation at Hz), the light transmittance of each filled cavity of the microtiter plate was measured by a photoelectric colorimeter. 〇% represents the efficacy equivalent to growth in the control group, and 1% of the efficacy represents no Growth of fungi. Tables C1 and C2 below clearly show the active compound group according to the invention The activity of the substance is greater than the calculated activity, that is, it exhibits a synergistic effect. Table C1: Botrytis cinerea (in vitro) / microtiter plate Active compound active compound application rate (Ppm) Efficacy (%) (1- 1) 〇·01 18 (1-29) 1 54 (1-39) 〇J 51 pyrachlostrobin 0.1 42 pyrachlostrofoin 1 27 metconazole 0.01 5 According to the invention: (1 1)+ 灭康口圭 (1 : 1) —---- 0.01+0.01 Measured 31 Calculated 22 -152- 200814928 (1-29)+ Bai Kemin (1 : 1) 1 + 1 93 66 (1 -39)+100gmin (1:1) 0.1+0.1 94 72 measured = actual found efficacy; calculated = potency calculated using the Colby formula C2: Botrytis cinerea (in vitro) / microtiter active compound Active compound application rate (ppm) Efficacy (%) (1-1) 03 31 (1-4) 1 29 (1-31) 0·1 39 100 gram (pyrachlostiObm) 0.3 20 pyrachlostrobin 1 16 克克敏(pyradilostrobin) 0.1 42 According to the invention: (1-4) + baikemin (1 : 1) 1 + 1 measured 78 calculated 40 (1_1) + 100 gram (1 : 1) 0.3 + 0.3 90 45 (1- 31) + Bai Kemin (1 : 1) 0.1 +0.1 86 65 measured = actual found efficacy; calculated using the Colby formula calculated 153-200814928 Example D: rice fatigue (PyriVrt </ar/a orvza) test (in trial camp) / micro Titration plate This microtest was performed on a microtiter plate using Potato-Dextrose Broth (PDB) as a liquid test medium, and the active compound was used in a technical-grade 5 dissolved in acetone. The active ingredient was inoculated into a spore suspension of rice blast fungus (jPyr/cw/flr/fl orj; za), and after inoculation for 4 days in a dark room and shaking (10 Hz), the microtiter plate was determined by photoelectric colorimeter. Transparency of each filled cavity. The 〇% potency represents the growth of the control group, and the 100% potency represents > no fungal growth was observed. Ίο The following Tables D1, D2 and D3 clearly show that the activity of the active compound composition according to the present invention is greater than the calculated activity, i.e., it exhibits an existing synergistic effect. Table D1: Rice blast test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) (1-29) 3 55 (1-29) 0.03 18 (1-4) 1 9 ( 1-31) 0.1 16 (M) 0.03 6 GBO 827 0.03 76 GBO 827 0.1 87 GBO 827 3 80 Metrafenone 3 60 -154- 200814928 Metaconazole 1 74 Meconazole ^ (metconazole) 0.03 66 epoxyconazole 3 81 According to the invention: (1-29) + epoxyconazole (1 : 1) (1-29) + diconazole (1 : 1) 3 + 3 0.03 + 0.03 Measured 98 85 Calculated 91 72 (1-29) + benzophenone (1 : 1) 3 + 3 90 82 (1-4) + thiconazole (1 : 1) 1 + 1 97 76 (1 -31)+ GBO 827(1 : 1) 0.1 +0.1 99 89 (1-1)+ GBO 827(1 : 1) 0.03 + 0.03 87 77 Measured = actual found effect; calculated = calculated using Colby formula Table of potency D2 #· rice blast fungus (Pjr/cw^r/fl) test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) (1-4) 3 33 (1- 28) 0.03 19 灭康^(metconazole) 0.03 10 苯苯菌_(metrafeiKme) 3 80 phenoxylinone (metrafenone) 0.03 45 according to this hair : (1-4)+ GBO 827(1 : 1) 3 + 3 Measured 99 Calculated 87 (1-28) + benzophenone (1 : 1) 0.03 + 0.03 95 55 -155 - 200814928 (1- 28) + Deconazole (1 : 1) 0.03 + 〇.〇3 58 27 Measured = actual found efficacy; calculated = potency table D3 calculated using Colby formula: rice blast fungus (Pjr/c«/ariVi Test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) (1-4) 3 33 mettrafenone 3 55 according to the invention: (1·4) + benzene The ketone (1: 1) 3 + 3 was calculated to be 75 70 measured = the actual found efficacy; calculated = the effect calculated using the Colby formula _ real _ case E: maize red emblem (10) g) test (in test tube v檄Trip handle This type test was applied to a microtiter plate using Pot-Dextrose Broth (PDB) as a liquid test medium, and the active compound was used in an industrial grade dissolved in acetone ( Technical_grade) Active ingredient, inoculated into a spore suspension of Gibberella zeae, inoculated in a dark room and shaken (10 Hz) for 3 days, the microtiter plate was determined by photoelectric colorimeter Transparency of each filled cavity. The 0% potency represents the growth of the control group, 1〇〇0/. The efficacy representative did not see the growth of fungi. Table E below clearly shows that the active compound composition according to the present invention is more active than the calculated activity, i.e., exhibits a synergistic effect. -156- 200814928 Table E: Gibberella rubrum test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) (1-4) 1 —---—___ — (1-28) 0·1 (1-29) 0.3 —_ —_ 59 Epoxyconazole 1 65 GBO 827 0.1 ] GBO 827 03 --- 24 According to the invention: 0.1+0.1 Calculated, (1-29 ) + GBO 827 (1 : 1) 78 69 (1-28) + GBO 827 (1 : 1) 0.3 + 0.3 43 37 (1-4) + Epoxyconazole (1 : 1) 1 + 1 --- - 84 73 Measured = actual found efficacy; calculated = effectiveness calculated using the Colby formula Example F: Pseudomonas pallidum test (in test tube) / derivative; ji 5 This micro-test is applied to a microtiter plate Potato-Dextrose Broth (PDB) was carried out as a liquid test medium, and the active compound was inoculated into Alternaria alternata using a technical grade (active) formulated in acetone. (7) The suspension was suspended with W(3//), and after inoculation for 3 days in the dark room and shaking (10 Hz), the light transmittance of each filled cavity of the microtiter plate was measured by photoelectric colorimeter. Sex. -157- 2008 14928 〇% potency represents the growth of the control group, 100% efficacy means no growth of the fungus. Table F below clearly shows that the activity of the active compound composition according to the invention is greater than the calculated activity, ie , which exhibits a synergistic effect table F · Alternaria alternata (in vitro) / microtiter plate active compound active compound application rate (ppm) potency (° / 〇) (1_1) 0.03 66 phenacridone (metrafenone 0.03 14 According to the invention: (1-1) + benzophenone (1 : 1) 03 + 03 Calculated by calculation *) 72 71 Measured = actual found efficacy; calculated = calculated using the Colby formula Efficacy of the case G: _I nuclear cavity (Pyrg / i or / Wgized rgs) test (Daily V 徭 让 让 让 让 溶剂 溶剂 溶剂 : : : : : : : : : : : : τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ The heavy alkylaryl polyglycol ether is a suitable active compound formulation, 1 part by weight of the active compound or active compound composition, mixed with the amount of solvent and emulsifier, 15 and this concentrate in water Dilute to the desired concentration. To measure the activity of the formula 5, at the stated application rate. The active compound preparation is sprayed on the young plant, and after the spray layer is dried, the plant is sprayed with a suspension of the genus of the genus of the genus, and the plant is left at 158·200814928 20° C. and 100% relative The humidity in the incubator was carried out for 48 hours. The plants were then transferred to a greenhouse of about 2 (TC and about 80% relative humidity. Evaluation was performed 10 days after inoculation, 0% represents the efficacy equivalent to the control group, and 100% of the efficacy represents no infection. Table G · · Bougainvillea test (barley) / protective active compound active compound application rate (g / ha) potency (%) (1-2) 3L25 22 (1-12) 31.25 --------- 56 Pycrostobin 31.25 78 Epirubicone _ (metrafenone) 31.25 0 Epoxyconazole 31.25 0 metconazole 31.25 0 tebuconazole 31.25 0 GBO 827 31.25 0 white (boscalid) 31.25 22 According to the invention: (1_2) + 100 gram dorbin 31.25 + 31.25 Measured - 94 78 Calculated 83 22 (1-2) + benzophenone 31.25 + 31.25 (1-2) + epoxy Kang α Sit 31.25 + 31.25 89 22 (1-2) + 灭康0 sit 31.25 + 31.25 89 22 (1-2) + HWG1608 3L25 + 3L25 100 22 -159- 200814928 (1-2) + GB0827 31,25+ 31.25 78 22 (l-2) + RK02273 31.25 + 31.25 100 39 (1-12) + 克克司多宾31.25 + 31.25 100 92 (1-12) + Epirubicin _ 31.25 + 31.25 89 56 (1_12) + Epoxy Oxazole 31.25+ 31 .25 89 56 (1-12) + 消康嗤31.25 + 31.25 94 56 (1-2) + 克力力31.25 + 31.25 89 56 (1-2) + GB0827 3L25 + 3L25 94 56 (1-2)+白克力31.25+ 3L25 89 66 Measured = actual found efficacy; calculated = effectiveness calculated using the Colby formula Example H: Phytophthora (P/IV plus /? / | recognized still 71) test (tomato V protective solvent: 24.5 parts by weight of acetone 5 24.5 parts by weight of dimethylacetamide I emulsifier: 1 part by weight of aryl aryl polyglycol ether to give a suitable active compound formulation, 1 part by weight of active compound or active The compound composition is mixed with the amount of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration. In order to test the protective activity, the active compound preparation is sprayed onto the juvenile plant at the stated application rate, and after the spray layer is dried, the plant is sprayed with the aqueous suspension of the disease-causing bacteria/«/(2) plus) Liquid, the plants are placed in 2 (TC and 100% relative humidity incubator. -160- 200814928 and:: two into two: represents the equivalent of the control group
表H·疫菌(P办師/|从_)試驗(蕃霖)/保 活性化合物 活性化合物施用率 (克/公頃) —-—---- 效力(%) (1-2) 20 —-~—---- 8 賽座滅(Cyazofamid), 實例14-1 2 ——-- 24 根據本發明: (1-2)+ 賽座滅(lO^JL 20 + 2 46 計算得^ Λα 實測得==實際發現的效力,δ十异得=使用Colby公式計算得的饮力 -161-Table H· Phytophthora (P-engineer/|from_) test (fanlin)/protective compound active compound application rate (g/ha) —----- effectiveness (%) (1-2) 20 — -~—---- 8 Cyazofamid, Example 14-1 2 ——-- 24 According to the invention: (1-2)+ Saibo (lO^JL 20 + 2 46 calculated ^ Λα Measured == the actual found effectiveness, δ ten different = the use of Colby formula calculated drinking power -161-
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE200610013784 DE102006013784A1 (en) | 2006-03-24 | 2006-03-24 | Fungicidal active combination used to combat phytopathogenic fungus, comprises carboxamide compound and e.g. strobilurin- or triazole- compound |
| DE200610014723 DE102006014723A1 (en) | 2006-03-30 | 2006-03-30 | Fungicide combinations useful for plant and material protection comprise a pyrazole carboxamide and at least one fungicide selected from 24 groups of compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200814928A true TW200814928A (en) | 2008-04-01 |
Family
ID=38442052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW96110022A TW200814928A (en) | 2006-03-24 | 2007-03-23 | Fungicidal active compound combinations |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2001299A2 (en) |
| AR (1) | AR060066A1 (en) |
| CL (1) | CL2007000765A1 (en) |
| TW (1) | TW200814928A (en) |
| WO (1) | WO2007110173A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4410099A3 (en) * | 2008-02-05 | 2024-10-09 | Basf Se | Plant health composition |
| EP2512244B1 (en) | 2009-12-16 | 2014-06-25 | Bayer CropScience AG | Active compound combinations comprising proquinazid, bixafen and optionally prothioconazole |
| EP2443928A1 (en) | 2010-10-25 | 2012-04-25 | LANXESS Deutschland GmbH | Fungicide penflufen mixtures |
| WO2012055674A1 (en) | 2010-10-25 | 2012-05-03 | Lanxess Deutschland Gmbh | Fungicidal penflufen mixtures |
| EP2443927A1 (en) | 2010-10-25 | 2012-04-25 | LANXESS Deutschland GmbH | Penflufen as agent for protecting woods against wood-destroying basidiomycetes |
| PL2632266T3 (en) | 2010-10-25 | 2017-07-31 | Lanxess Deutschland Gmbh | Penflufen as a wood preservative against xylophagous basidiomycetes |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10347090A1 (en) * | 2003-10-10 | 2005-05-04 | Bayer Cropscience Ag | Synergistic fungicidal drug combinations |
| US20080108686A1 (en) * | 2004-06-18 | 2008-05-08 | Basf Aktiengesellschaft | N-(Ortho-Phenyl)-1-Methyl-3-Difluoromethylpyrazole-4-Carboxanilides And Their Use As Fungicides |
| ATE458722T1 (en) * | 2004-06-18 | 2010-03-15 | Basf Se | 1-METHYL-3-TRIFLUORMETHYL-PYRAZOLE-4-CARBONIC ACID (ORTHO-PHENYL) ANILIDES AND THEIR USE AS A FUNGICIDE |
| PE20070409A1 (en) * | 2005-06-29 | 2007-05-07 | Basf Ag | FUNGICIDE MIXTURES BASED ON PYRAZOLCARBOXYL ACID BIPHENYLAMIDES DISUSTITUTED IN 2.4 |
| WO2007003540A1 (en) * | 2005-06-30 | 2007-01-11 | Basf Aktiengesellschaft | Fungicidal mixtures based on 2,5-disubstituted pyrazol carboxylic acid biphenylamides |
| WO2007003564A1 (en) * | 2005-07-01 | 2007-01-11 | Basf Aktiengesellschaft | Fungicide mixtures based on 3,5-disubstituted pyrazol-carboxylic acid biphenylamides |
| WO2007003603A2 (en) * | 2005-07-05 | 2007-01-11 | Basf Aktiengesellschaft | Fungicide mixtures based on 3-monosubstituted pyrazole carboxylic acid biphenyl amides |
| WO2007003643A1 (en) * | 2005-07-06 | 2007-01-11 | Basf Aktiengesellschaft | Fungicidal mixtures based on 3,4-disubstituted pyrazolecarboxylic acid biphenylamides |
| JP2009500375A (en) * | 2005-07-06 | 2009-01-08 | ビーエーエスエフ ソシエタス・ヨーロピア | Disinfectant mixture prepared from 1-methylpyrazol-4-ylcarboxyanilides |
| BRPI0613007A2 (en) * | 2005-07-14 | 2016-11-29 | Basf Ag | fungicidal mixtures to combat phytopathogenic harmful fungi, agent, process to combat phytopathogenic harmful fungi, seed, and, use of compounds |
| AU2007224576A1 (en) * | 2006-03-14 | 2007-09-20 | Basf Se | Method of inducing tolerance of plants against bacterioses |
-
2007
- 2007-03-20 WO PCT/EP2007/002449 patent/WO2007110173A2/en not_active Ceased
- 2007-03-20 EP EP07723413A patent/EP2001299A2/en not_active Withdrawn
- 2007-03-22 AR ARP070101184 patent/AR060066A1/en not_active Application Discontinuation
- 2007-03-23 TW TW96110022A patent/TW200814928A/en unknown
- 2007-03-23 CL CL2007000765A patent/CL2007000765A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR060066A1 (en) | 2008-05-21 |
| EP2001299A2 (en) | 2008-12-17 |
| WO2007110173A2 (en) | 2007-10-04 |
| WO2007110173A3 (en) | 2009-03-19 |
| CL2007000765A1 (en) | 2008-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102037333B1 (en) | Fungicidal pyrazoles and their mixtures | |
| JP5101491B2 (en) | Bactericidal active substance combination showing synergistic action | |
| CN105492432B (en) | Tetrazolinone compounds and their uses | |
| JP5816871B2 (en) | Plant disease control agent and control method containing D-tagatose as active ingredient | |
| JP5101496B2 (en) | Active substance combinations | |
| KR102185569B1 (en) | Binary fungicidal and bactericidal combinations | |
| US9888688B2 (en) | Tetrazolinone compounds and applications thereof | |
| CN105408322B (en) | Tetrazolinone compounds and their uses | |
| JP2018070635A (en) | Fungicidal composition | |
| TW200810691A (en) | Synergistic active compound combinations | |
| KR101302266B1 (en) | Fungicidal mixtures of thiophene derivative | |
| TW200528023A (en) | Synergistic fungicidal active compound combinations | |
| BR122020019349B1 (en) | composition, its preparation process, method for controlling one or more harmful microorganisms, seed resistant to harmful microorganisms and its method of treatment | |
| BR112016002063B1 (en) | tetrazolinone compound, its use, agent and method of pest control | |
| CN107108661A (en) | Kill the benzoxaborole heterocyclic pentene of microorganism | |
| KR20200041892A (en) | How to control rice pests from rice | |
| TW200814928A (en) | Fungicidal active compound combinations | |
| MX2008014416A (en) | Synergistic active ingredient combinations. | |
| BR112016008406B1 (en) | tetrazolinone compound and its application | |
| JP5000636B2 (en) | Synergistic fungicidal active substance combinations | |
| TW200812484A (en) | Fungicidal active compound combinations | |
| KR20090096430A (en) | Fungicidal mixtures | |
| CN106132952B (en) | Tetrazolinone compounds and their applications | |
| CN109843065A (en) | Active agent combinations comprising the 5- imdazole derivatives replaced | |
| CN105557702B (en) | A kind of active ingredient compositions |